0001750106 2022-01-01 2022-09-30 0001750106 2022-11-14 0001750106 2022-09-30 0001750106 2021-12-31 0001750106 2022-07-01 2022-09-30 0001750106 2021-07-01 2021-09-30 0001750106 2021-01-01 2021-09-30 0001750106 AEI:RentalMember 2022-07-01 2022-09-30 0001750106 AEI:RentalMember 2021-07-01 2021-09-30 0001750106 AEI:RentalMember 2022-01-01 2022-09-30 0001750106 AEI:RentalMember 2021-01-01 2021-09-30 0001750106 AEI:PropertyMember 2022-07-01 2022-09-30 0001750106 AEI:PropertyMember 2021-07-01 2021-09-30 0001750106 AEI:PropertyMember 2022-01-01 2022-09-30 0001750106 AEI:PropertyMember 2021-01-01 2021-09-30 0001750106 AEI:BiohealthMember 2022-07-01 2022-09-30 0001750106 AEI:BiohealthMember 2021-07-01 2021-09-30 0001750106 AEI:BiohealthMember 2022-01-01 2022-09-30 0001750106 AEI:BiohealthMember 2021-01-01 2021-09-30 0001750106 AEI:DigitalTransformationTechnologyMember 2022-07-01 2022-09-30 0001750106 AEI:DigitalTransformationTechnologyMember 2021-07-01 2021-09-30 0001750106 AEI:DigitalTransformationTechnologyMember 2022-01-01 2022-09-30 0001750106 AEI:DigitalTransformationTechnologyMember 2021-01-01 2021-09-30 0001750106 AEI:OtherMember 2022-07-01 2022-09-30 0001750106 AEI:OtherMember 2021-07-01 2021-09-30 0001750106 AEI:OtherMember 2022-01-01 2022-09-30 0001750106 AEI:OtherMember 2021-01-01 2021-09-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001750106 us-gaap:CommonStockMember 2021-12-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001750106 us-gaap:RetainedEarningsMember 2021-12-31 0001750106 us-gaap:ParentMember 2021-12-31 0001750106 us-gaap:NoncontrollingInterestMember 2021-12-31 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001750106 us-gaap:CommonStockMember 2022-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001750106 us-gaap:RetainedEarningsMember 2022-03-31 0001750106 us-gaap:ParentMember 2022-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2022-03-31 0001750106 2022-03-31 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001750106 us-gaap:CommonStockMember 2022-06-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001750106 us-gaap:RetainedEarningsMember 2022-06-30 0001750106 us-gaap:ParentMember 2022-06-30 0001750106 us-gaap:NoncontrollingInterestMember 2022-06-30 0001750106 2022-06-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001750106 us-gaap:CommonStockMember 2020-12-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001750106 us-gaap:RetainedEarningsMember 2020-12-31 0001750106 us-gaap:ParentMember 2020-12-31 0001750106 us-gaap:NoncontrollingInterestMember 2020-12-31 0001750106 2020-12-31 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0001750106 us-gaap:CommonStockMember 2021-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001750106 us-gaap:RetainedEarningsMember 2021-03-31 0001750106 us-gaap:ParentMember 2021-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2021-03-31 0001750106 2021-03-31 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-06-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-06-30 0001750106 us-gaap:CommonStockMember 2021-06-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001750106 us-gaap:RetainedEarningsMember 2021-06-30 0001750106 us-gaap:ParentMember 2021-06-30 0001750106 us-gaap:NoncontrollingInterestMember 2021-06-30 0001750106 2021-06-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001750106 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001750106 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001750106 us-gaap:ParentMember 2022-01-01 2022-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001750106 2022-01-01 2022-03-31 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001750106 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001750106 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001750106 us-gaap:ParentMember 2022-04-01 2022-06-30 0001750106 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001750106 2022-04-01 2022-06-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001750106 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001750106 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001750106 us-gaap:ParentMember 2022-07-01 2022-09-30 0001750106 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001750106 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001750106 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001750106 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001750106 us-gaap:ParentMember 2021-01-01 2021-03-31 0001750106 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001750106 2021-01-01 2021-03-31 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001750106 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001750106 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001750106 us-gaap:ParentMember 2021-04-01 2021-06-30 0001750106 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001750106 2021-04-01 2021-06-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001750106 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001750106 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001750106 us-gaap:ParentMember 2021-07-01 2021-09-30 0001750106 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001750106 us-gaap:CommonStockMember 2022-09-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001750106 us-gaap:RetainedEarningsMember 2022-09-30 0001750106 us-gaap:ParentMember 2022-09-30 0001750106 us-gaap:NoncontrollingInterestMember 2022-09-30 0001750106 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0001750106 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0001750106 us-gaap:CommonStockMember 2021-09-30 0001750106 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001750106 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001750106 us-gaap:RetainedEarningsMember 2021-09-30 0001750106 us-gaap:ParentMember 2021-09-30 0001750106 us-gaap:NoncontrollingInterestMember 2021-09-30 0001750106 2021-09-30 0001750106 AEI:ChanHengFaiMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetGlobalPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetGlobalPteLtdMember 2022-09-30 0001750106 AEI:AlsetGlobalPteLtdMember 2021-12-31 0001750106 AEI:AlsetBusinessDevelopmentPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetBusinessDevelopmentPteLtdMember 2022-09-30 0001750106 AEI:AlsetBusinessDevelopmentPteLtdMember 2021-12-31 0001750106 AEI:GlobaleHealthLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:GlobaleHealthLimitedMember 2022-09-30 0001750106 AEI:GlobaleHealthLimitedMember 2021-12-31 0001750106 AEI:AlsetInternationalIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetInternationalIncMember 2022-09-30 0001750106 AEI:AlsetInternationalIncMember 2021-12-31 0001750106 AEI:SingaporeConstructionDevelopmentPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:SingaporeConstructionDevelopmentPteLtdMember 2022-09-30 0001750106 AEI:SingaporeConstructionDevelopmentPteLtdMember 2021-12-31 0001750106 AEI:ArtEStudioPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:ArtEStudioPteLtdMember 2022-09-30 0001750106 AEI:ArtEStudioPteLtdMember 2021-12-31 0001750106 AEI:SingaporeConstructionPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:SingaporeConstructionPteLtdMember 2022-09-30 0001750106 AEI:SingaporeConstructionPteLtdMember 2021-12-31 0001750106 AEI:GlobalBioMedicalPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:GlobalBioMedicalPteLtdMember 2022-09-30 0001750106 AEI:GlobalBioMedicalPteLtdMember 2021-12-31 0001750106 AEI:AlsetInnovationPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetInnovationPteLtdMember 2022-09-30 0001750106 AEI:AlsetInnovationPteLtdMember 2021-12-31 0001750106 AEI:HealthWealthHappinessPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:HealthWealthHappinessPteLtdMember 2022-09-30 0001750106 AEI:HealthWealthHappinessPteLtdMember 2021-12-31 0001750106 AEI:SeDCapitalPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:SeDCapitalPteLtdMember 2022-09-30 0001750106 AEI:SeDCapitalPteLtdMember 2021-12-31 0001750106 AEI:LiquidValueAssetManagementPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:LiquidValueAssetManagementPteLtdMember 2022-09-30 0001750106 AEI:LiquidValueAssetManagementPteLtdMember 2021-12-31 0001750106 AEI:AlsetSolarLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetSolarLimitedMember 2022-09-30 0001750106 AEI:AlsetSolarLimitedMember 2021-12-31 0001750106 AEI:AlsetFBOnePteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetFBOnePteLtdMember 2022-09-30 0001750106 AEI:AlsetFBOnePteLtdMember 2021-12-31 0001750106 AEI:GlobalTechFundOfFundPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:GlobalTechFundOfFundPteLtdMember 2022-09-30 0001750106 AEI:GlobalTechFundOfFundPteLtdMember 2021-12-31 0001750106 AEI:SingaporeEChainLogisticPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:SingaporeEChainLogisticPteLtdMember 2022-09-30 0001750106 AEI:SingaporeEChainLogisticPteLtdMember 2021-12-31 0001750106 AEI:BMICapitalPartnersInternationalLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:BMICapitalPartnersInternationalLimitedMember 2022-09-30 0001750106 AEI:BMICapitalPartnersInternationalLimitedMember 2021-12-31 0001750106 AEI:SeDPerthPtyLtdMember 2022-01-01 2022-09-30 0001750106 AEI:SeDPerthPtyLtdMember 2022-09-30 0001750106 AEI:SeDPerthPtyLtdMember 2021-12-31 0001750106 AEI:SeDIntelligentHomeIncMember 2022-01-01 2022-09-30 0001750106 AEI:SeDIntelligentHomeIncMember 2022-09-30 0001750106 AEI:SeDIntelligentHomeIncMember 2021-12-31 0001750106 AEI:LiquidValueDevelopmentIncMember 2022-01-01 2022-09-30 0001750106 AEI:LiquidValueDevelopmentIncMember 2022-09-30 0001750106 AEI:LiquidValueDevelopmentIncMember 2021-12-31 0001750106 AEI:AlsetEHomeIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetEHomeIncMember 2022-09-30 0001750106 AEI:AlsetEHomeIncMember 2021-12-31 0001750106 AEI:SeDUSALLCMember 2022-01-01 2022-09-30 0001750106 AEI:SeDUSALLCMember 2022-09-30 0001750106 AEI:SeDUSALLCMember 2021-12-31 0001750106 AEI:OneHundredFiftyBlackOakGPIncMember 2022-01-01 2022-09-30 0001750106 AEI:OneHundredFiftyBlackOakGPIncMember 2022-09-30 0001750106 AEI:OneHundredFiftyBlackOakGPIncMember 2021-12-31 0001750106 AEI:SeDDevelopmentUSAIncMember 2022-01-01 2022-09-30 0001750106 AEI:SeDDevelopmentUSAIncMember 2022-09-30 0001750106 AEI:SeDDevelopmentUSAIncMember 2021-12-31 0001750106 AEI:OneHundredFiftyCCMBlackOakLtdMember 2022-01-01 2022-09-30 0001750106 AEI:OneHundredFiftyCCMBlackOakLtdMember 2022-09-30 0001750106 AEI:OneHundredFiftyCCMBlackOakLtdMember 2021-12-31 0001750106 AEI:SeDTexasHomeLLCMember 2022-01-01 2022-09-30 0001750106 AEI:SeDTexasHomeLLCMember 2022-09-30 0001750106 AEI:SeDTexasHomeLLCMember 2021-12-31 0001750106 AEI:SeDBallengerLLCMember 2022-01-01 2022-09-30 0001750106 AEI:SeDBallengerLLCMember 2022-09-30 0001750106 AEI:SeDBallengerLLCMember 2021-12-31 0001750106 AEI:SeDMarylandDevelopmentLLCMember 2022-01-01 2022-09-30 0001750106 AEI:SeDMarylandDevelopmentLLCMember 2022-09-30 0001750106 AEI:SeDMarylandDevelopmentLLCMember 2021-12-31 0001750106 AEI:SeDDevelopmentManagementLLCMember 2022-01-01 2022-09-30 0001750106 AEI:SeDDevelopmentManagementLLCMember 2022-09-30 0001750106 AEI:SeDDevelopmentManagementLLCMember 2021-12-31 0001750106 AEI:SeDBuilderLLCMember 2022-01-01 2022-09-30 0001750106 AEI:SeDBuilderLLCMember 2022-09-30 0001750106 AEI:SeDBuilderLLCMember 2021-12-31 0001750106 AEI:GigWorldIncMember 2022-01-01 2022-09-30 0001750106 AEI:GigWorldIncMember 2022-09-30 0001750106 AEI:GigWorldIncMember 2021-12-31 0001750106 AEI:HotAppBlockChainPte.LtdMember 2022-01-01 2022-09-30 0001750106 AEI:HotAppBlockChainPte.LtdMember 2022-09-30 0001750106 AEI:HotAppBlockChainPte.LtdMember 2021-12-31 0001750106 AEI:HotAppInternationalLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:HotAppInternationalLimitedMember 2022-09-30 0001750106 AEI:HotAppInternationalLimitedMember 2021-12-31 0001750106 AEI:HWHInternationalIncMember 2022-01-01 2022-09-30 0001750106 AEI:HWHInternationalIncMember 2022-09-30 0001750106 AEI:HWHInternationalIncMember 2021-12-31 0001750106 AEI:HealthWealthHappinessIncMember 2022-01-01 2022-09-30 0001750106 AEI:HealthWealthHappinessIncMember 2022-09-30 0001750106 AEI:HealthWealthHappinessIncMember 2021-12-31 0001750106 AEI:HWHMultiStrategyInvestmentIncMember 2022-01-01 2022-09-30 0001750106 AEI:HWHMultiStrategyInvestmentIncMember 2022-09-30 0001750106 AEI:HWHMultiStrategyInvestmentIncMember 2021-12-31 0001750106 AEI:SeDREITIncMember 2022-01-01 2022-09-30 0001750106 AEI:SeDREITIncMember 2022-09-30 0001750106 AEI:SeDREITIncMember 2021-12-31 0001750106 AEI:GigStablecoinIncMember 2022-01-01 2022-09-30 0001750106 AEI:GigStablecoinIncMember 2022-09-30 0001750106 AEI:GigStablecoinIncMember 2021-12-31 0001750106 AEI:HWHWorldIncMember 2022-01-01 2022-09-30 0001750106 AEI:HWHWorldIncMember 2022-09-30 0001750106 AEI:HWHWorldIncMember 2021-12-31 0001750106 AEI:HWHWorldPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:HWHWorldPteLtdMember 2022-09-30 0001750106 AEI:HWHWorldPteLtdMember 2021-12-31 0001750106 AEI:UBeautyLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:UBeautyLimitedMember 2022-09-30 0001750106 AEI:UBeautyLimitedMember 2021-12-31 0001750106 AEI:WeBeautyKoreaIncMember 2022-01-01 2022-09-30 0001750106 AEI:WeBeautyKoreaIncMember 2022-09-30 0001750106 AEI:WeBeautyKoreaIncMember 2021-12-31 0001750106 AEI:HWHWorldLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:HWHWorldLimitedMember 2022-09-30 0001750106 AEI:HWHWorldLimitedMember 2021-12-31 0001750106 AEI:HWHWorldIncOneMember 2022-01-01 2022-09-30 0001750106 AEI:HWHWorldIncOneMember 2022-09-30 0001750106 AEI:HWHWorldIncOneMember 2021-12-31 0001750106 AEI:AlsetBioHealthPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetBioHealthPteLtdMember 2022-09-30 0001750106 AEI:AlsetBioHealthPteLtdMember 2021-12-31 0001750106 AEI:AlsetEnergyPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetEnergyPteLtdMember 2022-09-30 0001750106 AEI:AlsetEnergyPteLtdMember 2021-12-31 0001750106 AEI:GDCREITIncMember 2022-01-01 2022-09-30 0001750106 AEI:GDCREITIncMember 2022-09-30 0001750106 AEI:GDCREITIncMember 2021-12-31 0001750106 AEI:AlsetWorldPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetWorldPteLtdMember 2022-09-30 0001750106 AEI:AlsetWorldPteLtdMember 2021-12-31 0001750106 AEI:BioHealthWaterIncMember 2022-01-01 2022-09-30 0001750106 AEI:BioHealthWaterIncMember 2022-09-30 0001750106 AEI:BioHealthWaterIncMember 2021-12-31 0001750106 AEI:ImpactBioHealthPte.LtdMember 2022-01-01 2022-09-30 0001750106 AEI:ImpactBioHealthPte.LtdMember 2022-09-30 0001750106 AEI:ImpactBioHealthPte.LtdMember 2021-12-31 0001750106 AEI:AmericanHomeREITIncMember 2022-01-01 2022-09-30 0001750106 AEI:AmericanHomeREITIncMember 2022-09-30 0001750106 AEI:AmericanHomeREITIncMember 2021-12-31 0001750106 AEI:AlsetSolarIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetSolarIncMember 2022-09-30 0001750106 AEI:AlsetSolarIncMember 2021-12-31 0001750106 AEI:HWHKORIncMember 2022-01-01 2022-09-30 0001750106 AEI:HWHKORIncMember 2022-09-30 0001750106 AEI:HWHKORIncMember 2021-12-31 0001750106 AEI:OpenHouseIncMember 2022-01-01 2022-09-30 0001750106 AEI:OpenHouseIncMember 2022-09-30 0001750106 AEI:OpenHouseIncMember 2021-12-31 0001750106 AEI:OpenRentalIncMember 2022-01-01 2022-09-30 0001750106 AEI:OpenRentalIncMember 2022-09-30 0001750106 AEI:OpenRentalIncMember 2021-12-31 0001750106 AEI:HapiCafeIncNevadaMember 2022-01-01 2022-09-30 0001750106 AEI:HapiCafeIncNevadaMember 2022-09-30 0001750106 AEI:HapiCafeIncNevadaMember 2021-12-31 0001750106 AEI:GlobalSolarREITIncMember 2022-01-01 2022-09-30 0001750106 AEI:GlobalSolarREITIncMember 2022-09-30 0001750106 AEI:GlobalSolarREITIncMember 2021-12-31 0001750106 AEI:OpenBizIncMember 2022-01-01 2022-09-30 0001750106 AEI:OpenBizIncMember 2022-09-30 0001750106 AEI:OpenBizIncMember 2021-12-31 0001750106 AEI:HapiCafeIncTexasMember 2022-01-01 2022-09-30 0001750106 AEI:HapiCafeIncTexasMember 2022-09-30 0001750106 AEI:HapiCafeIncTexasMember 2021-12-31 0001750106 AEI:HWHSPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:HWHSPteLtdMember 2022-09-30 0001750106 AEI:HWHSPteLtdMember 2021-12-31 0001750106 AEI:TruePartnerInternationalLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:TruePartnerInternationalLimitedMember 2022-09-30 0001750106 AEI:TruePartnerInternationalLimitedMember 2021-12-31 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2022-09-30 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2021-12-31 0001750106 AEI:LiquidValueDevelopmentLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:LiquidValueDevelopmentLimitedMember 2022-09-30 0001750106 AEI:LiquidValueDevelopmentLimitedMember 2021-12-31 0001750106 AEI:EPowerIncMember 2022-01-01 2022-09-30 0001750106 AEI:EPowerIncMember 2022-09-30 0001750106 AEI:EPowerIncMember 2021-12-31 0001750106 AEI:AlsetEPowerIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetEPowerIncMember 2022-09-30 0001750106 AEI:AlsetEPowerIncMember 2021-12-31 0001750106 AEI:AHRAssetManagementIncMember 2022-01-01 2022-09-30 0001750106 AEI:AHRAssetManagementIncMember 2022-09-30 0001750106 AEI:AHRAssetManagementIncMember 2021-12-31 0001750106 AEI:HWHWorldIncNevadaMember 2022-01-01 2022-09-30 0001750106 AEI:HWHWorldIncNevadaMember 2022-09-30 0001750106 AEI:HWHWorldIncNevadaMember 2021-12-31 0001750106 AEI:AlsetFBHoldingsPteIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetFBHoldingsPteIncMember 2022-09-30 0001750106 AEI:AlsetFBHoldingsPteIncMember 2021-12-31 0001750106 AEI:CredasCapitalPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:CredasCapitalPteLtdMember 2022-09-30 0001750106 AEI:CredasCapitalPteLtdMember 2021-12-31 0001750106 AEI:CredasCapitalGmbhMember 2022-01-01 2022-09-30 0001750106 AEI:CredasCapitalGmbhMember 2022-09-30 0001750106 AEI:CredasCapitalGmbhMember 2021-12-31 0001750106 AEI:SmartRewardExpressLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:SmartRewardExpressLimitedMember 2022-09-30 0001750106 AEI:SmartRewardExpressLimitedMember 2021-12-31 0001750106 AEI:AHRTexasTwoLLCMember 2022-01-01 2022-09-30 0001750106 AEI:AHRTexasTwoLLCMember 2022-09-30 0001750106 AEI:AHRTexasTwoLLCMember 2021-12-31 0001750106 AEI:AHRBlackOakOneLLCMember 2022-01-01 2022-09-30 0001750106 AEI:AHRBlackOakOneLLCMember 2022-09-30 0001750106 AEI:AHRBlackOakOneLLCMember 2021-12-31 0001750106 AEI:HapiAirIncMember 2022-01-01 2022-09-30 0001750106 AEI:HapiAirIncMember 2022-09-30 0001750106 AEI:HapiAirIncMember 2021-12-31 0001750106 AEI:AHRTexasThreeLLCMember 2022-01-01 2022-09-30 0001750106 AEI:AHRTexasThreeLLCMember 2022-09-30 0001750106 AEI:AHRTexasThreeLLCMember 2021-12-31 0001750106 AEI:AlsetCapitalPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetCapitalPteLtdMember 2022-09-30 0001750106 AEI:AlsetCapitalPteLtdMember 2021-12-31 0001750106 AEI:HapiCafeKoreaIncMember 2022-01-01 2022-09-30 0001750106 AEI:HapiCafeKoreaIncMember 2022-09-30 0001750106 AEI:HapiCafeKoreaIncMember 2021-12-31 0001750106 AEI:GreenEnergyIncMember 2022-01-01 2022-09-30 0001750106 AEI:GreenEnergyIncMember 2022-09-30 0001750106 AEI:GreenEnergyIncMember 2021-12-31 0001750106 AEI:GreenEnergyManagementIncMember 2022-01-01 2022-09-30 0001750106 AEI:GreenEnergyManagementIncMember 2022-09-30 0001750106 AEI:GreenEnergyManagementIncMember 2021-12-31 0001750106 AEI:AlsetMetaverseIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetMetaverseIncMember 2022-09-30 0001750106 AEI:AlsetMetaverseIncMember 2021-12-31 0001750106 AEI:AlsetManagementGroupIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetManagementGroupIncMember 2022-09-30 0001750106 AEI:AlsetManagementGroupIncMember 2021-12-31 0001750106 AEI:AlsetAcquisitionSponsorLLCMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetAcquisitionSponsorLLCMember 2022-09-30 0001750106 AEI:AlsetAcquisitionSponsorLLCMember 2021-12-31 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-09-30 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2021-12-31 0001750106 AEI:AlsetSpacGroupIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetSpacGroupIncMember 2022-09-30 0001750106 AEI:AlsetSpacGroupIncMember 2021-12-31 0001750106 AEI:AlsetMiningPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetMiningPteLtdMember 2022-09-30 0001750106 AEI:AlsetMiningPteLtdMember 2021-12-31 0001750106 AEI:AlsetIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetIncMember 2022-09-30 0001750106 AEI:AlsetIncMember 2021-12-31 0001750106 AEI:HapiTravelPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:HapiTravelPteLtdMember 2022-09-30 0001750106 AEI:HapiTravelPteLtdMember 2021-12-31 0001750106 AEI:HapiWealthBuilderPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:HapiWealthBuilderPteLtdMember 2022-09-30 0001750106 AEI:HapiWealthBuilderPteLtdMember 2021-12-31 0001750106 AEI:HWHMarketingPlacePteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:HWHMarketingPlacePteLtdMember 2022-09-30 0001750106 AEI:HWHMarketingPlacePteLtdMember 2021-12-31 0001750106 AEI:HWHInternationalIncNevadaMember 2022-01-01 2022-09-30 0001750106 AEI:HWHInternationalIncNevadaMember 2022-09-30 0001750106 AEI:HWHInternationalIncNevadaMember 2021-12-31 0001750106 AEI:HapiCafeSGPteMember 2022-01-01 2022-09-30 0001750106 AEI:HapiCafeSGPteMember 2022-09-30 0001750106 AEI:HapiCafeSGPteMember 2021-12-31 0001750106 AEI:AlsetReitsIncMember 2022-01-01 2022-12-31 0001750106 AEI:AlsetReitsIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetReitsIncMember 2022-09-30 0001750106 AEI:AlsetReitsIncMember 2021-12-31 0001750106 AEI:RoboticgHomeIncMember 2022-01-01 2022-09-30 0001750106 AEI:RoboticgHomeIncMember 2022-09-30 0001750106 AEI:RoboticgHomeIncMember 2021-12-31 0001750106 AEI:HWHMergerSubIncMember 2022-01-01 2022-09-30 0001750106 AEI:HWHMergerSubIncMember 2022-09-30 0001750106 AEI:HWHMergerSubIncMember 2021-12-31 0001750106 AEI:AlsetHomeREITIncMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetHomeREITIncMember 2022-09-30 0001750106 AEI:AlsetHomeREITIncMember 2021-12-31 0001750106 AEI:AlsetInternationalLimitedMember AEI:SecuritiesPurchaseAgreementMember 2021-03-12 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2021-03-09 2021-03-12 0001750106 AEI:TruePartnerCapitalHoldingLimitedMember AEI:SecuritiesPurchaseAgreementMember 2021-03-09 2021-03-12 0001750106 AEI:AmericanPacificBancorpIncMember AEI:SecuritiesPurchaseAgreementMember 2021-03-09 2021-03-12 0001750106 AEI:SecuritiesPurchaseAgreementMember 2021-03-12 0001750106 AEI:AmericanPacificBancorpMember AEI:HengfengFinanceLimitedMember 2020-10-14 2020-10-15 0001750106 AEI:AmericanPacificBancorpMember AEI:HengfengFinanceLimitedMember 2020-10-15 0001750106 AEI:AmericanPacificBancorpMember 2020-10-14 2020-10-15 0001750106 2021-03-12 0001750106 2021-03-09 2021-03-12 0001750106 AEI:AlsetCPNMember 2021-05-11 2021-05-13 0001750106 AEI:AlsetCPNMember 2021-06-14 0001750106 us-gaap:SeriesBPreferredStockMember AEI:AlsetCPNMember 2021-05-09 2021-06-14 0001750106 us-gaap:CommonStockMember AEI:AlsetCPNMember 2021-05-09 2021-06-14 0001750106 srt:MinimumMember AEI:ManufacturersAndTradersTrustCompanyMember 2022-09-30 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember 2022-03-14 2022-03-15 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember 2022-09-30 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember 2021-12-31 0001750106 country:AU 2022-09-30 0001750106 AEI:NationalAustralianBankLimitedMember AEI:LoanAgreementMember 2021-12-31 0001750106 AEI:BrokerageMember 2022-09-30 0001750106 AEI:BrokerageMember 2021-12-31 0001750106 AEI:AmarantusBioScienceHoldingsMember 2022-09-30 0001750106 AEI:TrustPartnerMember 2021-12-31 0001750106 AEI:ValueExchangeInternationalMember 2021-04-10 2021-04-12 0001750106 AEI:ValueExchangeInternationalMember 2021-04-12 0001750106 AEI:ValueExchangeInternationalMember 2022-09-30 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2022-09-30 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2021-12-31 0001750106 AEI:HolistaCollTechLimitedMember 2022-09-30 0001750106 AEI:AmericanPremiumWaterCorpMember 2022-09-30 0001750106 AEI:AmericanMedicalREITIncMember 2020-03-02 0001750106 AEI:AmericanMedicalREITIncMember 2021-10-29 0001750106 AEI:AmericanMedicalREITIncMember 2021-01-01 2021-12-31 0001750106 AEI:AmericanMedicalREITIncMember 2022-09-30 0001750106 AEI:VivacitasMember 2022-01-01 2022-09-30 0001750106 AEI:VivacitasMember 2022-09-30 0001750106 AEI:VivacitasMember 2020-12-31 0001750106 AEI:NovumAlphaFundMember 2022-06-30 0001750106 2022-07-01 2022-07-31 0001750106 AEI:LiquidValueAssetManagementLimitedMember 2022-09-30 0001750106 AEI:LiquidValueAssetManagementLimitedMember 2021-12-31 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2021-03-16 2021-03-18 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2021-03-18 0001750106 AEI:NervotecPteLtdMember 2020-09-06 2020-09-08 0001750106 AEI:NervotecPteLtdMember 2020-09-08 0001750106 AEI:HytenGlobalThailandCoLtdMember 2020-09-28 2020-09-30 0001750106 AEI:HytenGlobalThailandCoLtdMember 2020-09-30 0001750106 AEI:HytenGlobalThailandCoLtdMember 2022-01-01 2022-09-30 0001750106 AEI:KBeautyResearchLabCoLtdMember 2021-12-31 0001750106 AEI:NovumAlphaPteLtdMember AEI:SeDCapitalPteLtdMember 2021-04-20 0001750106 AEI:CredasCapitalPteLtdMember AEI:SeDCapitalPteLtdMember 2021-04-20 0001750106 us-gaap:CommonStockMember 2021-03-09 2021-03-12 0001750106 AEI:SeriesACommonStockMember 2021-09-07 2021-09-08 0001750106 AEI:AmericanPacificBancorpIncMember 2021-09-07 2021-09-08 0001750106 AEI:AmericanPacificBancorpIncMember 2021-09-08 0001750106 AEI:AmericanPacificBancorpIncMember 2021-09-07 2021-12-31 0001750106 AEI:AmericanPacificBancorpIncMember 2022-07-01 2022-09-30 0001750106 AEI:AmericanPacificBancorpIncMember 2022-01-01 2022-09-30 0001750106 AEI:AmericanPacificBancorpIncMember 2022-09-30 0001750106 AEI:AmericanPacificBancorpIncMember 2021-12-31 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-02-02 2022-02-03 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-02-03 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-02-02 2022-02-03 0001750106 AEI:SponsorMember us-gaap:PrivatePlacementMember 2022-02-02 2022-02-03 0001750106 AEI:SponsorMember us-gaap:CommonClassBMember us-gaap:PrivatePlacementMember 2022-02-02 2022-02-03 0001750106 AEI:AlsetCapitalAcquisitionCropMember srt:ChiefExecutiveOfficerMember 2022-02-03 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-06-30 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-06-01 2022-06-30 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-03-01 2022-03-31 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-01-01 2022-09-30 0001750106 AEI:SponsorMember 2022-09-30 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-09-01 2022-09-30 0001750106 AEI:AlsetCapitalAcquisitionCorpMember 2022-09-30 0001750106 AEI:KetomeiPteLtdMember 2021-06-10 0001750106 AEI:KetomeiPteLtdMember 2022-06-01 2022-06-10 0001750106 AEI:KetomeiPteLtdMember 2022-06-10 0001750106 AEI:KetomeiPteLtdMember 2022-07-01 2022-09-30 0001750106 AEI:KetomeiPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:KetomeiPteLtdMember 2022-09-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-09-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-07-14 0001750106 AEI:VectorComcoLtdMember 2021-02-26 0001750106 AEI:VectorComcoLtdMember 2021-02-24 2021-02-26 0001750106 AEI:VectorComcoLtdMember 2022-09-30 0001750106 AEI:HWHWorldMember 2022-09-30 0001750106 AEI:HWHWorldMember 2022-01-01 2022-09-30 0001750106 AEI:HWHWorldCoMember 2022-09-30 0001750106 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-09-30 0001750106 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2021-12-31 0001750106 AEI:AmericanMedicalReitIcbMember AEI:LoanOneMember 2021-12-31 0001750106 AEI:AmericanMedicalReitIcbMember 2021-12-31 0001750106 AEI:AmericanMedicalReitIcbMember 2022-09-30 0001750106 AEI:AmericanMedicalReitIcbMember us-gaap:SubsequentEventMember 2023-11-29 0001750106 AEI:AMREAndAMREManagementMember 2022-09-30 0001750106 AEI:AmericanMedicalReitIcbMember AEI:LoanOneMember 2022-03-31 0001750106 AEI:AMREAndAMREManagementMember 2022-03-31 0001750106 AEI:AmericanMedicalReitIcbMember AEI:LoanOneMember 2022-07-12 0001750106 us-gaap:ConvertibleDebtMember AEI:DocumentSecuritiesSystemsIncMember 2022-07-11 2022-07-12 0001750106 AEI:AmericanMedicalReitIcbMember 2022-07-11 2022-07-12 0001750106 AEI:AmericanMedicalReitIcbMember 2022-07-13 2022-09-30 0001750106 AEI:AmericanMedicalReitIcbMember 2022-09-30 0001750106 AEI:AmericanMedicalReitIcbMember 2021-12-31 0001750106 srt:MinimumMember 2022-01-01 2022-09-30 0001750106 srt:MaximumMember 2022-01-01 2022-09-30 0001750106 AEI:BallengerProjectsMember 2022-01-01 2022-09-30 0001750106 AEI:BallengerProjectsMember 2021-01-01 2021-09-30 0001750106 srt:MinimumMember AEI:FrontFootBenefitAssessmentsMember 2022-01-01 2022-09-30 0001750106 srt:MaximumMember AEI:FrontFootBenefitAssessmentsMember 2022-01-01 2022-09-30 0001750106 AEI:FrontFootBenefitAssessmentsMember 2022-07-01 2022-09-30 0001750106 AEI:FrontFootBenefitAssessmentsMember 2021-07-01 2021-09-30 0001750106 AEI:FrontFootBenefitAssessmentsMember 2022-01-01 2022-09-30 0001750106 AEI:FrontFootBenefitAssessmentsMember 2021-01-01 2021-09-30 0001750106 AEI:DeferredRevenueMember 2022-01-01 2022-09-30 0001750106 AEI:DeferredRevenueMember 2021-01-01 2021-12-31 0001750106 AEI:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001750106 AEI:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001750106 AEI:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001750106 AEI:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001750106 AEI:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001750106 AEI:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001750106 AEI:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001750106 AEI:RealEstateSegmentMember 2022-01-01 2022-09-30 0001750106 AEI:DigitalTransformationTechnologyMember 2022-01-01 2022-09-30 0001750106 AEI:BiohealthBusinessMember 2022-01-01 2022-09-30 0001750106 AEI:OtherMember 2022-01-01 2022-09-30 0001750106 AEI:RealEstateSegmentMember 2021-01-01 2021-09-30 0001750106 AEI:DigitalTransformationTechnologyMember 2021-01-01 2021-09-30 0001750106 AEI:BiohealthBusinessMember 2021-01-01 2021-09-30 0001750106 AEI:OtherMember 2021-01-01 2021-09-30 0001750106 AEI:RealEstateSegmentMember 2022-09-30 0001750106 AEI:DigitalTransformationTechnologyMember 2022-09-30 0001750106 AEI:BiohealthBusinessMember 2022-09-30 0001750106 AEI:OtherMember 2022-09-30 0001750106 AEI:RealEstateSegmentMember 2021-12-31 0001750106 AEI:DigitalTransformationTechnologyMember 2021-12-31 0001750106 AEI:BiohealthBusinessMember 2021-12-31 0001750106 AEI:OtherMember 2021-12-31 0001750106 srt:SingleFamilyMember 2022-09-30 0001750106 srt:SingleFamilyMember 2021-12-31 0001750106 srt:SingleFamilyMember 2022-01-01 2022-09-30 0001750106 AEI:LotPurchaseAgreementMember AEI:SeDMarylandDevelopmentLLCMember 2015-11-30 0001750106 AEI:LotPurchaseAgreementMember AEI:SeDMarylandDevelopmentLLCMember 2015-11-29 2015-11-30 0001750106 AEI:LotPurchaseAgreementMember AEI:SeDMarylandDevelopmentLLCMember 2019-01-03 0001750106 AEI:LotPurchaseAgreementMember AEI:SeDMarylandDevelopmentLLCMember 2020-04-28 0001750106 AEI:LotPurchaseAgreementMember 2022-09-30 0001750106 AEI:LotPurchaseAgreementMember 2021-12-31 0001750106 AEI:PPPLoanMember 2022-09-30 0001750106 AEI:PPPLoanMember 2021-12-31 0001750106 AEI:AustraliaLoanMember 2022-09-30 0001750106 AEI:AustraliaLoanMember 2021-12-31 0001750106 AEI:HirePurchaseOneMember 2022-09-30 0001750106 AEI:HirePurchaseOneMember 2021-12-31 0001750106 AEI:HirePurchaseTwoMember 2022-09-30 0001750106 AEI:HirePurchaseTwoMember 2021-12-31 0001750106 AEI:LoanAgreementMember AEI:SeDMarylandDevelopmentLLCMember 2019-04-17 0001750106 AEI:LoanAgreementMember AEI:SeDMarylandDevelopmentLLCMember 2019-04-15 2019-04-17 0001750106 AEI:LoanAgreementMember AEI:SeDMarylandDevelopmentLLCMember 2022-01-01 2022-09-30 0001750106 2022-03-09 2022-03-15 0001750106 2022-03-15 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember AEI:LoanAgreementMember AEI:AlsetEHomeIncMember 2020-06-18 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember AEI:LoanAgreementMember AEI:AlsetEHomeIncMember 2020-06-15 2020-06-18 0001750106 srt:MinimumMember AEI:ManufacturersAndTradersTrustCompanyMember AEI:LoanAgreementMember AEI:AlsetEHomeIncMember 2020-06-18 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember AEI:LoanAgreementMember AEI:AlsetEHomeIncMember 2020-01-01 2020-12-31 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember AEI:LoanAgreementMember AEI:AlsetEHomeIncMember 2020-12-31 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember AEI:LoanAgreementMember AEI:AlsetEHomeIncMember 2021-05-27 2021-05-28 0001750106 AEI:ManufacturersAndTradersTrustCompanyMember AEI:LoanAgreementMember AEI:AlsetEHomeIncMember 2021-01-01 2021-12-31 0001750106 AEI:PaycheckProtectionProgramLoanMember 2021-02-11 0001750106 AEI:AustraliaLoanMember AEI:SeDPerthPtyLtdMember 2017-01-07 0001750106 AEI:AustraliaLoanMember AEI:SeDPerthPtyLtdMember 2017-01-05 2017-01-07 0001750106 srt:MinimumMember AEI:AustraliaLoanMember AEI:SeDPerthPtyLtdMember 2021-09-30 0001750106 srt:MaximumMember AEI:AustraliaLoanMember AEI:SeDPerthPtyLtdMember 2021-09-30 0001750106 AEI:AustraliaLoanMember AEI:SeDPerthPtyLtdMember 2017-09-07 0001750106 AEI:AustraliaLoanMember AEI:SeDPerthPtyLtdMember 2020-01-01 2020-12-31 0001750106 AEI:HongLeongFinanceLimitedMember 2021-05-17 0001750106 AEI:HongLeongFinanceLimitedMember 2021-05-16 2021-05-17 0001750106 AEI:UnitedOverseasBankLimitedMember 2022-09-22 0001750106 AEI:UnitedOverseasBankLimitedMember 2022-09-20 2022-09-22 0001750106 AEI:HirePurchaseAgreementMember 2022-09-20 2022-09-22 0001750106 AEI:DirectorsMember 2022-01-01 2022-09-30 0001750106 AEI:DirectorsMember 2021-01-01 2021-12-31 0001750106 AEI:AmericanMedicalREITIncMember 2020-07-16 2020-07-17 0001750106 AEI:AmericanMedicalREITIncMember 2020-07-17 0001750106 AEI:AmericanPremiumWaterCorpMember 2022-09-30 0001750106 AEI:AmericanPremiumWaterCorpMember 2021-12-31 0001750106 AEI:AmericanPremiumWaterCorpMember 2022-01-01 2022-09-30 0001750106 AEI:StockAndWarrantMember AEI:AmericanPremiumWaterCorpMember 2022-01-01 2022-09-30 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2021-03-16 2021-03-18 0001750106 AEI:VivacitasMember 2021-03-16 2021-03-18 0001750106 AEI:VivacitasMember 2021-03-18 0001750106 AEI:DocumentSecuritiesSystemsIncMember 2021-03-18 0001750106 AEI:TruePartnersCapitalHoldingLimitedMember 2021-03-09 2021-03-12 0001750106 AEI:TruePartnersCapitalHoldingLimitedMember 2021-03-12 0001750106 AEI:TruePartnersCapitalHoldingLimitedMember 2022-05-16 2022-05-17 0001750106 AEI:TruePartnersCapitalHoldingLimitedMember us-gaap:CommonStockMember 2022-05-16 2022-05-17 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2022-09-30 0001750106 AEI:LiquidValueDevelopmentPteLtdMember 2021-12-31 0001750106 AEI:SeDPerthPtyLtdMember 2022-09-30 0001750106 AEI:SeDPerthPtyLtdMember 2021-12-31 0001750106 AEI:ChanHengFaiMember 2020-08-19 2020-08-20 0001750106 AEI:ChanHengFaiMember 2020-08-20 0001750106 AEI:ChanHengFaiMember 2021-12-31 0001750106 AEI:ChanHengFaiMember 2022-09-30 0001750106 AEI:LiquidValueDevelopmentPteLtdMember AEI:SecuritiesPurchaseAgreementMember 2021-03-09 2021-03-12 0001750106 AEI:AlsetCPNMember 2021-06-11 2021-06-14 0001750106 AEI:AlsetCPNMember 2021-05-13 0001750106 us-gaap:SeriesBPreferredStockMember AEI:AlsetCPNMember 2021-05-11 2021-05-13 0001750106 us-gaap:SeriesBPreferredStockMember AEI:AlsetCPNMember 2021-06-11 2021-06-14 0001750106 AEI:ChanHengFaiMember 2021-05-14 0001750106 AEI:ChanHengFaiMember 2022-09-30 0001750106 AEI:ChanHengFaiMember 2021-12-31 0001750106 AEI:MacKenzieEquityPartnersMember 2017-12-30 2018-01-01 0001750106 AEI:MacKenzieEquityPartnersMember 2022-06-01 2022-06-30 0001750106 AEI:MacKenzieEquityPartnersMember 2022-01-01 2022-09-30 0001750106 AEI:MacKenzieEquityPartnersMember 2021-07-01 2021-09-30 0001750106 AEI:MacKenzieEquityPartnersMember 2021-01-01 2021-09-30 0001750106 AEI:MacKenzieEquityPartnersMember 2022-07-01 2022-09-30 0001750106 AEI:MacKenzieEquityPartnersMember 2021-12-31 0001750106 AEI:MacKenzieEquityPartnersMember 2022-09-30 0001750106 AEI:MacKenzieEquityPartnersMember 2022-09-30 0001750106 AEI:MacKenzieEquityPartnersMember 2021-12-31 0001750106 srt:MaximumMember AEI:LiquidValueDevelopmentPteLtdMember 2022-09-30 0001750106 AEI:AmericanMedicalREITIncMember 2020-02-29 2020-03-02 0001750106 AEI:AmericanMedicalREITIncMember 2022-03-31 0001750106 us-gaap:CommonStockMember AEI:AmericanMedicalREITIncMember 2022-03-01 2022-03-31 0001750106 srt:MinimumMember AEI:LiquidValueDevelopmentPteLtdMember 2022-03-31 0001750106 srt:MaximumMember AEI:LiquidValueDevelopmentPteLtdMember 2022-03-31 0001750106 AEI:AmericanMedicalREITIncMember 2022-07-11 2022-07-12 0001750106 AEI:AmericanMedicalREITIncMember 2022-07-13 2022-09-30 0001750106 AEI:AmericanMedicalREITIncMember 2021-12-31 0001750106 AEI:AmericanMedicalREITIncMember 2022-09-30 0001750106 AEI:SeDPerthPtyLtdMember 2021-01-24 0001750106 AEI:SeDCapitalPteLtdMember AEI:IGalenInternationalMember 2017-01-24 0001750106 AEI:SeDCapitalPteLtdMember AEI:IGalenInternationalMember 2017-01-23 2017-01-24 0001750106 AEI:SeDCapitalPteLtdMember AEI:IGalenInternationalMember 2020-12-31 0001750106 AEI:SeDCapitalPteLtdMember AEI:IGalenInternationalMember 2021-12-01 2021-12-31 0001750106 AEI:HWHWorldCoMember 2022-01-01 2022-09-30 0001750106 AEI:HWHWorldCoMember 2022-09-30 0001750106 AEI:AlsetInvestmentPteLTDMember AEI:OneOfOurDirectorMember 2022-03-31 0001750106 AEI:AlsetInvestmentPteLTDMember AEI:OneOfOurDirectorMember 2022-09-30 0001750106 AEI:OneOfOurDirectorMember 2022-01-01 2022-06-30 0001750106 srt:DirectorMember 2022-06-30 0001750106 us-gaap:SubsequentEventMember 2022-12-31 0001750106 AEI:AlsetCapitalAcquisitionCropMember 2022-09-30 0001750106 AEI:AlsetInvestmentPteLTDMember 2021-12-31 0001750106 AEI:HapiCafeIncMember 2022-07-27 2022-07-28 0001750106 AEI:HapiCafeIncMember 2022-06-28 0001750106 AEI:HapiCafeIncMember 2022-08-03 2022-08-04 0001750106 AEI:HapiCafeIncMember 2022-07-28 0001750106 AEI:KetomeiDrewMember 2022-08-31 0001750106 AEI:HapiCafeIncMember 2022-09-30 0001750106 AEI:ChanTungMoeMember AEI:AmericanPacificBancorpIncMember 2020-11-24 0001750106 AEI:ChanTungMoeMember AEI:AmericanPacificBancorpIncMember 2020-11-22 2020-11-24 0001750106 AEI:LimShengHonDannyMember AEI:AmericanPacificBancorpIncMember 2020-11-24 0001750106 AEI:LimShengHonDannyMember AEI:AmericanPacificBancorpIncMember 2020-11-22 2020-11-24 0001750106 AEI:ChanTungMoeMember AEI:AmericanPacificBancorpIncMember 2021-01-01 2021-12-31 0001750106 AEI:LimShengHongMember AEI:AmericanPacificBancorpIncMember 2021-01-01 2021-12-31 0001750106 2021-06-14 0001750106 us-gaap:SeriesAPreferredStockMember 2022-09-30 0001750106 us-gaap:SeriesBPreferredStockMember 2022-09-30 0001750106 us-gaap:SeriesAPreferredStockMember 2021-06-14 0001750106 us-gaap:SeriesBPreferredStockMember 2021-06-14 0001750106 2021-01-18 2021-01-19 0001750106 AEI:SeriesAConvertiblePreferredStockMember 2021-04-27 2021-05-03 0001750106 AEI:ChanHengFaiMember AEI:SeriesAConvertiblePreferredStockMember 2021-06-01 2021-06-30 0001750106 AEI:ChanHengFaiMember us-gaap:SeriesBPreferredStockMember 2021-05-11 2021-05-12 0001750106 AEI:ChanHengFaiMember us-gaap:SeriesBPreferredStockMember 2021-06-01 2021-06-30 0001750106 us-gaap:CommonStockMember AEI:UnderwrittenPublicOfferingMember 2021-05-09 2021-05-10 0001750106 us-gaap:CommonStockMember AEI:UnderwrittenPublicOfferingMember 2021-05-10 0001750106 AEI:SeriesAWarrantMember AEI:UnderwrittenPublicOfferingMember 2021-05-10 0001750106 AEI:SeriesBWarrantMember AEI:UnderwrittenPublicOfferingMember 2021-05-10 0001750106 AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-05-09 2021-05-10 0001750106 AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-05-10 0001750106 AEI:InvestorsMember AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-05-09 2021-05-10 0001750106 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-05-09 2021-05-10 0001750106 AEI:SeriesAWarrantMember us-gaap:OverAllotmentOptionMember 2021-05-10 0001750106 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-05-10 0001750106 AEI:SeriesBWarrantMember us-gaap:OverAllotmentOptionMember 2021-05-09 2021-05-10 0001750106 AEI:SeriesBWarrantMember us-gaap:OverAllotmentOptionMember 2021-05-10 0001750106 AEI:SeriesAWarrantMember us-gaap:OverAllotmentOptionMember 2021-05-09 2021-05-10 0001750106 AEI:SeriesAWarrantMember us-gaap:OverAllotmentOptionMember 2021-06-01 2021-06-30 0001750106 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember AEI:AegisCapitalCorpMember 2022-09-30 0001750106 AEI:SeriesBWarrantMember us-gaap:OverAllotmentOptionMember AEI:AegisCapitalCorpMember 2022-09-30 0001750106 AEI:InvestorsMember AEI:SeriesAWarrantMember 2022-09-30 0001750106 AEI:InvestorsMember AEI:SeriesBWarrantMember 2022-09-30 0001750106 2021-05-31 0001750106 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetInternationalLimitedMember 2022-01-01 2022-09-30 0001750106 us-gaap:CommonStockMember AEI:UnderwrittenPublicOfferingMember 2021-07-26 2021-07-27 0001750106 us-gaap:CommonStockMember AEI:UnderwrittenPublicOfferingMember 2021-07-27 0001750106 AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-07-26 2021-07-27 0001750106 AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-07-27 0001750106 AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-07-28 2021-07-30 0001750106 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-07-27 0001750106 AEI:PrefundedWarrantsMember us-gaap:OverAllotmentOptionMember 2021-07-27 0001750106 AEI:PrefundedWarrantsMember AEI:UnderwrittenPublicOfferingMember 2021-07-26 2021-07-27 0001750106 AEI:PrefundedWarrantsMember AEI:UnderwrittenPublicOfferingMember 2021-07-27 0001750106 2021-07-26 2021-07-27 0001750106 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-09-01 2021-09-09 0001750106 AEI:JulyOfferingMember 2021-12-31 0001750106 us-gaap:CommonStockMember AEI:UnderwrittenPublicOfferingMember 2021-12-01 2021-12-05 0001750106 us-gaap:CommonStockMember AEI:UnderwrittenPublicOfferingMember 2021-12-05 0001750106 AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-12-05 0001750106 AEI:PreFundedUnitsMember AEI:UnderwrittenPublicOfferingMember 2021-12-01 2021-12-05 0001750106 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-12-05 0001750106 AEI:PrefundedWarrantsMember us-gaap:OverAllotmentOptionMember 2021-12-14 0001750106 AEI:PrefundedWarrantsMember AEI:UnderwrittenOverAllotmentMember 2021-12-14 0001750106 AEI:PrefundedWarrantsMember us-gaap:OverAllotmentOptionMember 2021-12-12 2021-12-14 0001750106 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-12-01 2021-12-05 0001750106 AEI:DecembersOfferingMember 2022-09-30 0001750106 AEI:GigWorldMember 2021-01-01 2021-06-30 0001750106 AEI:GigWorldMember 2021-01-01 2021-09-30 0001750106 AEI:GigWorldMember 2022-09-30 0001750106 AEI:GigWorldMember 2022-01-01 2022-09-30 0001750106 AEI:AlsetInternationalLimitedMember 2021-12-31 0001750106 AEI:AlsetInternationalLimitedMember 2021-01-01 2021-12-31 0001750106 srt:OfficerMember AEI:AlsetInternationalLimitedMember 2021-01-01 2021-12-31 0001750106 srt:OfficerMember AEI:AlsetInternationalLimitedMember 2022-01-01 2022-09-30 0001750106 AEI:ChanHengFaiMember AEI:SecuritiesPurchaseAgreementMember 2022-01-16 2022-01-17 0001750106 AEI:ChanHengFaiMember AEI:SecuritiesPurchaseAgreementMember 2022-02-27 2022-02-28 0001750106 2022-01-17 0001750106 AEI:AlsetInternationalLimitedMember 2021-12-31 0001750106 AEI:AlsetInternationalLimitedMember 2022-09-30 0001750106 AEI:ChanHengFaiMember AEI:SecuritiesPurchaseAgreementMember 2021-12-13 0001750106 2022-01-26 2022-01-27 0001750106 us-gaap:WarrantMember 2022-04-10 2022-04-11 0001750106 AEI:MaysOfferingMember AEI:OfferingMember 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:OfferingMember 2022-01-01 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:ExerciseOfPreFundedWarrantsMember 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:ExerciseOfPreFundedWarrantsMember 2022-01-01 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:ExerciseOfUnderwritersSeriesAWarrantsMember 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:ExerciseOfUnderwritersSeriesAWarrantsMember 2022-01-01 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:ExerciseOfSeriesAAndSeriesBWarrantsMember 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:ExerciseOfSeriesAAndSeriesBWarrantsMember 2022-01-01 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:OfferingExpensesMember 2022-09-30 0001750106 AEI:MaysOfferingMember AEI:OfferingExpensesMember 2022-01-01 2022-09-30 0001750106 AEI:MaysOfferingMember 2022-09-30 0001750106 AEI:MaysOfferingMember 2022-01-01 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:OfferingMember 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:OfferingMember 2022-01-01 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:ExerciseOfPreFundedWarrantsMember 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:ExerciseOfPreFundedWarrantsMember 2022-01-01 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:ExerciseOfUnderwritersOverAllotmentOptionMember 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:ExerciseOfUnderwritersOverAllotmentOptionMember 2022-01-01 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:OfferingExpensesMember 2022-09-30 0001750106 AEI:JulyOfferingMember AEI:OfferingExpensesMember 2022-01-01 2022-09-30 0001750106 AEI:JulyOfferingMember 2022-09-30 0001750106 AEI:JulyOfferingMember 2022-01-01 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:OfferingMember 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:OfferingMember 2022-01-01 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:ExerciseOfPreFundedWarrantsMember 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:ExerciseOfPreFundedWarrantsMember 2022-01-01 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:ExerciseOfUnderwritersOverAllotmentOptionMember 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:ExerciseOfUnderwritersOverAllotmentOptionMember 2022-01-01 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:OfferingExpensesMember 2022-09-30 0001750106 AEI:DecembersOfferingMember AEI:OfferingExpensesMember 2022-01-01 2022-09-30 0001750106 AEI:DecembersOfferingMember 2022-01-01 2022-09-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-12-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-12-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-01-01 2022-03-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-03-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-04-01 2022-06-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2022-04-01 2022-06-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-04-01 2022-06-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-06-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-06-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-07-01 2022-09-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-07-01 2022-09-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-09-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2022-09-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2020-12-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-01-01 2021-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-01-01 2021-03-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-03-31 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-03-31 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-04-01 2021-06-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2021-04-01 2021-06-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-04-01 2021-06-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-06-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-06-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-07-01 2021-09-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-07-01 2021-09-30 0001750106 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-09-30 0001750106 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0001750106 us-gaap:AociAttributableToNoncontrollingInterestMember 2021-09-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-01-01 2022-09-30 0001750106 AEI:APWWarrantsMember 2022-01-01 2022-09-30 0001750106 AEI:InvestmentSecuritiesFairValueMember 2022-09-30 0001750106 AEI:InvestmentSecuritiesFairValueMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001750106 AEI:InvestmentSecuritiesFairValueMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001750106 AEI:InvestmentSecuritiesFairValueMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001750106 AEI:InvestmentsSecuritiesTradingMember 2022-09-30 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001750106 us-gaap:NotesReceivableMember 2022-09-30 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel1Member 2022-09-30 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001750106 us-gaap:WarrantMember AEI:AmericanPremiumMiningMember 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member AEI:AmericanPremiumMiningMember 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member AEI:AmericanPremiumMiningMember 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member AEI:AmericanPremiumMiningMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member 2022-09-30 0001750106 us-gaap:FairValueInputsLevel2Member 2022-09-30 0001750106 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001750106 AEI:InvestmentSecuritiesFairValueMember 2021-12-31 0001750106 AEI:InvestmentSecuritiesFairValueMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001750106 AEI:InvestmentSecuritiesFairValueMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001750106 AEI:InvestmentSecuritiesFairValueMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember 2021-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001750106 AEI:InvestmentsSecuritiesTradingMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001750106 us-gaap:NotesReceivableMember 2021-12-31 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001750106 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001750106 us-gaap:WarrantMember AEI:AmericanPremiumMiningMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member AEI:AmericanPremiumMiningMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member AEI:AmericanPremiumMiningMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member AEI:AmericanPremiumMiningMember 2021-12-31 0001750106 us-gaap:WarrantMember AEI:AmericanMedicalREITIncMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member AEI:AmericanMedicalREITIncMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member AEI:AmericanMedicalREITIncMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member AEI:AmericanMedicalREITIncMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001750106 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001750106 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001750106 AEI:DSSConvertiblePreferredStockMember 2021-09-30 0001750106 AEI:DSSConvertiblePreferredStockMember 2021-01-01 2021-09-30 0001750106 us-gaap:MeasurementInputExpectedDividendRateMember AEI:SharingServicesIncMember 2022-09-30 0001750106 AEI:AmericanMedicalREITIncMember 2022-01-01 2022-09-30 0001750106 AEI:AmericanPremiumMiningCorporationMember 2020-07-17 0001750106 AEI:AmericanPremiumMiningCorporationMember 2020-07-16 2020-07-17 0001750106 AEI:AmericanPremiumMiningCorporationMember 2021-01-01 2021-12-31 0001750106 AEI:AmericanPremiumMiningCorporationMember 2021-12-31 0001750106 AEI:AmericanPremiumMiningCorporationMember us-gaap:WarrantMember 2022-01-01 2022-09-30 0001750106 AEI:AmericanPremiumMiningCorporationMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:DocumentSecuritiesSystemsIncMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:DocumentSecuritiesSystemsIncMember 2022-01-01 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmarantusBioScienceHoldingsMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmarantusBioScienceHoldingsMember 2022-01-01 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:HolistaCollTechLimitedMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:HolistaCollTechLimitedMember 2022-01-01 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmericanPremiumMiningMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmericanPremiumMiningMember 2022-01-01 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:ValueExchangeInternationalIncMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:ValueExchangeInternationalIncMember 2022-01-01 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:TradingStocksMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:TradingStocksMember 2022-01-01 2022-09-30 0001750106 AEI:NervotecPteLtdMember 2022-09-30 0001750106 AEI:NervotecPteLtdMember 2022-01-01 2022-09-30 0001750106 AEI:HytenGlobalMember 2022-09-30 0001750106 AEI:HytenGlobalMember 2022-01-01 2022-09-30 0001750106 AEI:UBeautyLimitedMember 2022-09-30 0001750106 AEI:UBeautyLimitedMember 2022-01-01 2022-09-30 0001750106 us-gaap:FairValueInputsLevel1Member AEI:DocumentSecuritiesSystemsIncMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:DocumentSecuritiesSystemsIncMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmarantusBioScienceHoldingsMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmarantusBioScienceHoldingsMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:HolistaCollTechLimitedMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:HolistaCollTechLimitedMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmericanPremiumMiningMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:AmericanPremiumMiningMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:TruePartnerCapitalHoldingLimitedMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:TruePartnerCapitalHoldingLimitedMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:ValueExchangeInternationalIncMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:ValueExchangeInternationalIncMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:TradingStocksMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel1Member AEI:TradingStocksMember 2021-01-01 2021-12-31 0001750106 AEI:NervotecPteLtdMember 2021-12-31 0001750106 AEI:NervotecPteLtdMember 2021-01-01 2021-12-31 0001750106 AEI:HytenGlobalMember 2021-12-31 0001750106 AEI:HytenGlobalMember 2021-01-01 2021-12-31 0001750106 AEI:UBeautyLimitedMember 2021-12-31 0001750106 AEI:UBeautyLimitedMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember AEI:SharingServicesIncMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember AEI:SharingServicesIncMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember AEI:SharingServicesIncMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember AEI:SharingServicesIncMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember AEI:SharingServicesIncMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember AEI:SharingServicesIncMember 2021-12-31 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember AEI:SharingServicesIncMember 2022-01-01 2022-09-30 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember AEI:SharingServicesIncMember 2021-01-01 2021-12-31 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember AEI:SharingServicesIncMember 2022-09-30 0001750106 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember AEI:SharingServicesIncMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001750106 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2021-12-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-01-01 2022-03-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-03-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-04-01 2022-06-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-06-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-07-01 2022-09-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2022-09-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2020-12-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2021-01-01 2021-03-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2021-03-31 0001750106 AEI:SharingServicesConvertibleNoteMember 2021-04-01 2021-06-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2021-06-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2021-07-01 2021-09-30 0001750106 AEI:SharingServicesConvertibleNoteMember 2021-09-30 0001750106 AEI:SeDMarylandDevelopmentLLCMember AEI:BallengerRunMember AEI:LotsSalesAgreementMember 2015-11-22 2015-11-23 0001750106 AEI:SeDMarylandDevelopmentLLCMember AEI:BallengerRunMember AEI:LotsSalesAgreementMember 2015-11-23 0001750106 AEI:RBGFamilyLLCMember AEI:BallengerRunMember AEI:LotsSalesAgreementMember 2014-05-27 2014-05-28 0001750106 AEI:RBGFamilyLLCMember AEI:BallengerRunMember AEI:LotsSalesAgreementMember 2014-05-28 0001750106 AEI:LotPurchaseAgreementMember 2018-12-30 2018-12-31 0001750106 AEI:LotPurchaseAgreementMember 2022-07-01 2022-09-30 0001750106 AEI:LotPurchaseAgreementMember 2021-07-01 2021-09-30 0001750106 AEI:LotPurchaseAgreementMember 2022-01-01 2022-09-30 0001750106 AEI:LotPurchaseAgreementMember 2021-01-01 2021-09-30 0001750106 AEI:LotPurchaseAgreementOneMember 2022-07-01 2022-09-30 0001750106 AEI:LotPurchaseAgreementOneMember 2021-01-01 2021-12-31 0001750106 country:SG 2021-01-01 2021-12-31 0001750106 AEI:SGFandBMember 2021-01-01 2021-12-31 0001750106 AEI:SingaporeFourSeasonsParkMember 2021-01-01 2021-12-31 0001750106 country:HK 2021-01-01 2021-12-31 0001750106 AEI:KRWMember 2021-01-01 2021-12-31 0001750106 AEI:TXMember 2021-01-01 2021-12-31 0001750106 stpr:MD 2021-01-01 2021-12-31 0001750106 AEI:IncentiveCompensationPlanMember 2022-09-30 0001750106 2021-01-01 2021-12-31 0001750106 us-gaap:SubsequentEventMember 2022-10-27 2022-10-28 0001750106 us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-17 0001750106 AEI:SubsidiaryOneMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-16 2022-10-17 0001750106 AEI:SubsidiaryOneMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-17 0001750106 AEI:SubsidiaryTwoMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-16 2022-10-17 0001750106 AEI:SubsidiaryTwoMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-17 0001750106 AEI:SubsidiaryThreeMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-16 2022-10-17 0001750106 AEI:SubsidiaryThreeMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-17 0001750106 AEI:SubsidiaryFourMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-16 2022-10-17 0001750106 AEI:SubsidiaryFourMember us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-17 0001750106 us-gaap:SubsequentEventMember AEI:StockPurchaseAgreementMember 2022-10-16 2022-10-17 0001750106 us-gaap:SubsequentEventMember 2022-10-16 2022-10-17 0001750106 us-gaap:SubsequentEventMember 2022-10-17 iso4217:USD shares iso4217:USD shares pure iso4217:SGD utr:acre AEI:Integer utr:sqft iso4217:AUD 0001750106 false Q3 --12-31 10-Q true 2022-09-30 2022 false 001-39732 Alset Inc. TX 83-1079861 4800 Montgomery Lane Suite 210 Bethesda MD 20814 301 971-3940 Common Stock, $0.001 par value AEI NASDAQ Yes Yes Non-accelerated Filer true true false false 148507188 22605541 56061309 630285 4740870 171380 39622 401405 334788 2674074 12792671 206344 1202451 36410 47290 30684973 36337023 98129 99216 52830182 30801129 275204 110338723 142731573 31485036 24820253 20098778 15695127 1265171 659620 387118 39653 1089680 263917 164664506 184210143 3555619 11341789 65091 728343 31553 619355 283989 193645 317671 12088 833658 4445798 13537003 658802 383354 5104600 13920357 0.001 0.001 25000000 25000000 0 0 0 0 0.001 0.001 250000000 250000000 148507188 148507188 87368446 87368446 148507 87368 322318500 296181977 -175407945 -148233473 485331 341646 147544393 148377518 12015513 21912268 159559906 170289786 164664506 184210143 569791 133302 1206273 155249 3414094 1288434 11870820 22154 1248171 771847 4919844 6365 14066 123595 319862 721905 4795567 3600482 16945913 813369 2204401 2478596 8510205 1979548 2539584 6500701 13466414 2792917 4743985 8979297 21976619 -2071012 51582 -5378815 -5030706 -319768 22614 49271 78902 330 316615 132092 -578903 2617896 1842128 -11006833 -5268531 -21773223 -35972445 -145122 -2515949 -6500573 -2218988 -171385 189696 -387435 87390 887 -27798 -450000 -50871869 346591 53135 897129 77591 -11163538 -8126066 -25546935 -87293906 -13234550 -8074484 -30925750 -92324612 -153159 68955 446757 -13081391 -8074484 -30994705 -92771369 -1369265 -964347 -3827934 -12771919 -11712126 -7110137 -27166771 -79999450 49915 -19060 40201 -56969 434011 -1238356 -3729724 -4077987 -12597465 -9331900 -34684228 -96906325 -1183223 -1350889 -4554792 -14264651 -11414242 -7981011 -30129436 -82641674 -0.08 -0.19 -0.22 -4.14 148507188 38030098 124122891 19785922 87368446 87368 296181977 341646 -148233473 148377518 21912268 170289786 15819452 15820 -11925 3895 3895 10000000 10000 6203000 6213000 6213000 17160800 17160800 2227744 19388544 737572 737572 737572 450000 450000 450000 -316459 459069 142610 -142610 -7027 -7027 -2096 -9123 -499967 -499967 -149173 -649140 -6467286 -6467286 -1463167 -7930453 113187898 113188 320404965 293721 -154700759 166111115 22382966 188494081 35319290 35319 -35319 -2624585 -2624585 -206377 -2830962 4557454 3266996 7824450 -7824450 -505 -505 -86 -591 -3002167 -3002167 -512428 -3514595 -8987359 -8987359 -995502 -9982861 148507188 148507 322302515 558045 -163688118 159320949 12844123 172165072 15985 -486134 -470149 470149 42642 42642 7273 49915 370778 370778 63233 434011 -11719827 -11719827 -1369265 -13089092 148507188 148507 322318500 485331 -175407945 147544393 12015513 159559906 8570000 8570 102729944 2143338 -44910297 59971555 38023260 97994815 10000 10 60890 60900 60900 -57190499 -57190499 -57190499 2279872 2279872 2279872 3274060 3274060 3274060 50770192 50770192 50770192 46099 46099 34677 80776 142675.00 142675 107325 250000 76412 -39067 37345 -37345 -1135 -1135 -852 -1987 -1010527 -1010527 -758913 -1769440 82250 82250 -6238449 -6238449 -3569112 -9807561 8580000 8580 102189645 1092609 -51148746 52142088 33716790 85858878 8389324 8389 39260191 39268580 39268580 6380 6 -6380000 -6380 6374 2132 2 12999998 13000000 13000000 -6380 -6 -2132 -2 8512000 8512 -8503 -2885117 -343225 -3228342 3228342 9163965 9164 51217402 51226566 51226566 1961349 1961349 784100 2745449 21432 21432 8568 30000 -25663 -25663 -10259 -35922 -764544 -764544 -305647 -1070191 1069250 1069250 -66650864 -66650864 -8238460 -74889324 28265289 28265 204762770 -40823 -117799610 86950602 28114184 115064786 28265289 28265 204762770 -40823 -117799610 86950602 28114184 115064786 17456490 17457 33871847 33889304 33889304 166655 166655 55256 221911 -910067 -17070 -927137 -1272853 -2199990 28287920 28287920 -383063 27904857 454355 454355 150645 605000 -14314 -14314 -4746 -19060 -14314 -14314 -4746 -19060 -930005 -930005 -308351 -1238356 246750 246750 -7110137 -7110137 -964347 -8074484 45721779 45722 266633480 -1002212 -124909747 140767243 25139975 165907218 45721779 45722 266633480 -1002212 -124909747 140767243 25139975 165907218 -30994705 -92771369 533820 85354 529418 284730 450000 50871869 134192 421754 2617896 1842128 -21773223 -35972445 6500573 2218988 -446104 68502 -1185251 -387435 87390 5420208 -4878334 198375 767987 -830294 8412 7466912 2419797 -10880 -37368 -8845706 -1217298 1746279 306438 -663252 -1302086 -554937 -263584 -31553 -1017400 -28331829 -6485979 694878 210319 220712 6057493 11081491 1082225 8479968 19308318 103809 110718 2480000 1235953 327603 840000 -15031318 -28743359 6213000 73157884 2975194 280000 73750 68502 1398250 216867 695635 5545495 2622400 5996133 77237040 -37367014 42007702 -199339 -802048 60802179 31735479 23235826 72941133 22605541 67944590 630285 4996543 23235826 72941133 2420 17659 446757 777773 -56969 1134969 256928 10003689 2279872 16557582 450000 -50770192 3895 57190499 6213000 64226566 27904857 605000 95000 <p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zD3WMIFHnN99" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82D_zaqex64szzE3">NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Nature of Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alset Inc. (the “Company” or “AEI”), formerly known as Alset EHome International Inc. and HF Enterprises Inc., was incorporated in the State of Delaware on March 7, 2018 and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20220930__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zfVt84P8IoZh" title="Issuance of shares of common stock">1,000</span> shares of common stock was issued to Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company. On October 4, 2022, through a merger transaction, the Company was reincorporated in Texas. AEI is a diversified holding company principally engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities and consumer products with operations in the United States, Singapore, Hong Kong, Australia and South Korea. The Company manages its principal businesses primarily through its subsidiary, Alset International Limited (“Alset International”, f.k.a. Singapore eDevelopment Limited), a company publicly traded on the Singapore Stock Exchange.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has four operating segments based on the products and services we offer, which include three of our principal businesses – real estate, digital transformation technology and biohealth – as well as a fourth category consisting of certain other business activities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1000 <p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zpftYFWb10ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_82D_zuYefbA0mp83">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zVxQq4hR6eeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Basis of Presentation and Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and following the requirements of the Securities and Exchange Commission (“SEC”) for interim reporting. These interim financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or any other interim periods or for any other future years. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Form 10-K for the year ended December 31, 2021 filed on March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include all accounts of the Company and its majority owned and controlled subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting common stock and controls operations. All intercompany transactions and balances among consolidated subsidiaries have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_zKfBMRZGyJBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s condensed consolidated financial statements include the financial position, results of operations and cash flows of the following entities as of September 30, 2022 and December 31, 2021, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyo1FjZCicJ5" style="display: none">SCHEDULE OF SUBSIDIARIES</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Attributable interest as of,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of subsidiary consolidated under AEI</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">State or other jurisdiction of incorporation or organization</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zGjvZnRTrBNk" style="width: 29%; text-align: left">Alset Global Pte. Ltd.</td><td style="width: 2%"> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zWZIZRtAKZl4" style="width: 29%" title="State or other jurisdiction of incorporation or organization">Singapore</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zec2OsgiSNs1" style="width: 16%; text-align: right" title="Ownership percentage">100</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zM1tjpEDFoE1" style="width: 16%; text-align: right" title="Ownership percentage">100</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zuRzv2hTpzR1" style="text-align: left">Alset Business Development Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_z2WEF4aTxRt7" title="State or other jurisdiction of incorporation or organization">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zXDLfBXzCzwe" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zzcp8gYKMrAa" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_ztnYyfQLy1o" style="text-align: left">Global eHealth Limited</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zMl5gbAncEi1" style="text-align: left" title="State or other jurisdiction of incorporation or organization">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zA8sJKCmcyHh" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zpudo3tzpxZd" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zspl1BoXj4U6" style="text-align: left">Alset International Limited</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zyggjgjOCAk5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zd6SSqD6gvQ5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zsCIjt6hPvAe" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zYzZG8Oo5B3k" style="text-align: left">Singapore Construction &amp; Development Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zSwXrLSaT5M4">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zhJJcsHtGZba" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zoE9fi0Jsgah" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_z0D7sOJ7Zuld" style="text-align: left">Art eStudio Pte. Ltd.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_zM3BSEe1trae">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_fKCop_znvJoK4Tu2Jf" style="text-align: right">43.6</td><td style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_fKCop_z4nzkPQv2mkd" style="text-align: right">39.2</td><td style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z4vO8Ft0MZ26" style="text-align: left">Singapore Construction Pte. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z9bUvZyxpxD6">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z6pQoTpt35Pd" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z4H0bFuhOCu1" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zXBZI9F3mkn4" style="text-align: left">Global BioMedical Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zqaO2kC4hIO3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zMeBy9cCeCYf" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zKTGVJrmzyv7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zh6sSemR1Ag4" style="text-align: left">Alset Innovation Pte. Ltd.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zLWzabOjrRef">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zcYso7WpNa7l" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_z9uHJYijIhD5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zUYHnjQXYog8" style="text-align: left">Health Wealth Happiness Pte. Ltd.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zEEMYbNqGMd9">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zG8W9aCvj8ee" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zyqonfb5DVm4" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zJKGaw7IUDQe" style="text-align: left">SeD Capital Pte. Ltd.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zkYzIgivKMe5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zisAC5TeqHh7" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zaInywzKyIa7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zKGAbqmZsRX2" style="text-align: left">LiquidValue Asset Management Pte. Ltd.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_z9L5u4CQcYVc">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zfulsvizA1H6" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zmGSTiY5izBg" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zaNycvIhygDl" style="text-align: left">Alset Solar Limited</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_za2SfRaN69a8" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zfve6mtbhjl5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zqw9EWeo8SU5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_z7alaIhk7a0b" style="text-align: left">Alset F&amp;B One Pte. Ltd</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zcGhlReUrGye">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zjGrofxmGI9g" style="text-align: right">76.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zeCLghZpR8S2" style="text-align: right">69.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_ztQBZ2dXrSde" style="text-align: left">Global TechFund of Fund Pte. Ltd.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zYZLebo191f8">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zy9FcJqwC0wl" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zn12zYn81RRj" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zkdYUmWQhJRa" style="text-align: left">Singapore eChainLogistic Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_z3rg5M5Ta3C3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zEY5IiQ0dsB9" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zZkbD0QvDGt5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98C_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zx5jAMk96Dgk" style="text-align: left">BMI Capital Partners International Limited.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zNZER6L3U8U2" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zLfn1c0foS65" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zaYjAaAvfIDc" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zbJk8Cp9y4L7" style="text-align: left">SeD Perth Pty. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zO6z95J2W3m7">Australia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zX9WYc5Qyyoj" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zdQ6Cm4cf87g" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zR4k8yzLa7Rg" style="text-align: left">SeD Intelligent Home Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_z2iQnAKflSfg" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zaWsX8VGM3M1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zRfBDXd8cscf" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zBt4dwdctTq5" style="text-align: left">LiquidValue Development Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zk7A1WQXDae3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zYbKeJ8FZb4g" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zTTSv2lyHvIi" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zWUnQmi1dOfc" style="text-align: left">Alset EHome Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zbql4JjirPml" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zalP5UIbyerh" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_z9rgK2LA6w4h" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zAMhiQnBza0b" style="text-align: left">SeD USA, LLC</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zJRGQIfYlrOf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zzMzKak2kHuh" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zMMVlGuZDj5b" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zuT9ydk8nbKh" style="text-align: left">150 Black Oak GP, Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zpZnoSZNSLga" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zPtmL4bDttBi" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_z7R3BBnyoesg" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zxP70f3dovh1" style="text-align: left">SeD Development USA Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zpaty3Q1FS7c" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zWfytqmcJ9if" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zaE4jG2AEq71" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zsC4KNpuzot8" style="text-align: left">150 CCM Black Oak, Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_z27ZYmeBpRCd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zWW3NiZFEMm8" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zgsZF5zNve79" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zuOzeKl2Rk1a" style="text-align: left">SeD Texas Home, LLC</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_z7pjvnkuMQxj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zazcZcDWSIlg" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zIwXkCT4SiZd" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zy3vl9fB8MFl" style="text-align: left">SeD Ballenger, LLC</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zu8wiaj81TK6" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zWV2RjiuOTpa" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zF0M6O58vQ74" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_zClMWBVmISjh" style="text-align: left">SeD Maryland Development, LLC</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_znIEJzglACw9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_zTbBEeSXuU8b" style="text-align: right">71.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_z32yBSTWLEG1" style="text-align: right">64.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zLia3L92BtBi" style="text-align: left">SeD Development Management, LLC</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_z9dl51I8oZZ9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zXaV2nYd8ohl" style="text-align: right">72.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zCdxpE1WRqNd" style="text-align: right">65.3</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_zuCM0wPSuXn9" style="text-align: left">SeD Builder, LLC</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_zygqjMADI039" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_z3CxPywaY0U1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_z3iKHPyxDuz2" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_z6rOoSvDH0Kf" style="text-align: left">GigWorld Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_z6opJSrJdFql" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_ziR9xMqfYzNf" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_zjZf4hvqZnEf" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zcFwXePedo39" style="text-align: left">HotApp BlockChain Pte. Ltd.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zoI8SiErQJd7">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zCRNdPzXB6F6" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zbgzfZN20EBf" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zCKjlDPq510d" style="text-align: left">HotApp International Limited</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zh4Gba00hR6j" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zLRVlCn9uRG5" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zQ1iktQUr7Rk" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zHbxawYDa6n5" style="text-align: left">HWH International, Inc. (Delaware)</td><td> </td> <td id="xdx_98A_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zl7HZkxkF46d" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zPG3hrzHqYV1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zt5UisTpF1ng" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zif6g0AC7LNl" style="text-align: left">Health Wealth &amp; Happiness Inc.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_z5PAA0VnJ1S8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zbq8GpKhqFn5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zdrtBq77GMGc" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zcznXKI9mSP8" style="text-align: left">HWH Multi-Strategy Investment, Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zs0GC8QM9pq8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zpFvklj1Ilgb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zySaZRttdMCb" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_z9LQl9XX3OK3" style="text-align: left">SeD REIT Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_z99HBeapOOfg" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_zGvs8tXMSzm9" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_zcBwjg7FjRQf" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zbea4qVKk30e" style="text-align: left">Gig Stablecoin Inc.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zDpXrgF6qkFd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zGGewq2UxiG5" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zAeK7g75Yl0a" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zYTmTH1k8VEc" style="text-align: left">HWH World Inc. (Delaware)</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_z0TqVuNODn1g" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zdV22smwFi7b" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zjF9wumbIPeg" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_z3Hk7tIdICXc" style="text-align: left">HWH World Pte. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zZahR4qqXo3j">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zkRrTs8dpeE4" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zh4kgbbDiJWj" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zhe7wg3gShdf" style="text-align: left">UBeauty Limited</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zIP6bEduRrU7" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zfc1oxZRHBY2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zvbpqiIEC1t8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zHXmJvfIbenk" style="text-align: left">WeBeauty Korea Inc</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zouJjylkVqV6">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zsyT5wBM4Pvl" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zuWFrQH4heli" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zitK5lkTWHx" style="text-align: left">HWH World Limited</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zDTkUj5CCjP" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_z4pATjEEmou3" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zqTZ48O5t1a6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_z2j174EcCFxk" style="text-align: left">HWH World Inc.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_zlU9mvajSMHe">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_znKvbF7JVWj" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_zeLjb8mUNhw6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_z4WUnkVpiz49" style="text-align: left">Alset BioHealth Pte. Ltd.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_zI80XH8GrUBe">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_z8dYrCMpaVad" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1511">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_zCEdqMtbrz3c" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zZK5J8rGfSba" style="text-align: left">Alset Energy Pte. Ltd.</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_z6IEUUjUNbI6">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zxl6RoWbXhU8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1515">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zFLSDY3rSBE3" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zThjyXb8VBY2" style="text-align: left">GDC REIT Inc. (f.k.a. Alset Payment Inc.)</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zzDRkEgwxP72" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_z67rAx3Yfeb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zKxF0cZQFFd8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_ztz9krDjbNZ7" style="text-align: left">Alset World Pte. Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zao4EUleZHh9">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zjLSdZ0qsQRl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1523">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zYxtt4wiNDfh" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_zQmE290rUilf" style="text-align: left">BioHealth Water Inc.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_zyUE1Cgn5yda" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_z2I7geUVuxy3" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_z7fffX8q2qo7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zXEtYPRRZAGi" style="width: 29%; text-align: left">Impact BioHealth Pte. Ltd.</td><td style="width: 2%"> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zUbFYWbj2r2k" style="width: 29%">Singapore</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zsiMMlMbyrab" style="width: 16%; text-align: right">85.4</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_z9ECiHi1Bu86" style="width: 16%; text-align: right">76.8</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zHjfTBnsv24j" style="text-align: left">American Home REIT Inc.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zW0tb7ovWSGc" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_z4UrMFO5dyt" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zglJFjXxoAH9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zn726lamWYog" style="text-align: left">Alset Solar Inc.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zJrSLonEJ9Vd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zBWEimVqild4" style="text-align: right">68.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zFwBB9xOlml3" style="text-align: right">61.5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zHgTxPQO98H2" style="text-align: left">HWH KOR Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zOHP3kMmKXm4" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zG4JyY5c0bvb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_z93HGy8RU3Vi" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zoRlgM2SHJi1" style="text-align: left">Open House Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_ze9hUf371t7f" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zwhfTX1jMEAh" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zgl4k1QRcHh9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_zRgzKmOYjoYe" style="text-align: left">Open Rental Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_z0gewfgGum8h" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_znetYc4qfea8" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_zSKwPSZx2EY9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_z8AvJlAisFw7" style="text-align: left">Hapi Cafe Inc. (Nevada)</td><td> </td> <td id="xdx_98A_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zEnCaLD0YeNk" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zVdXDXNkqATk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zLqYWcLxsKW9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zizeQhvFmW2g" style="text-align: left">Global Solar REIT Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization._c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zEuglecY6LSk" style="text-align: left" title="State or other jurisdiction of incorporation or organization">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zvdDTVYwgjjf" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zARHTGFSdeRa" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_z4DpJJYSvQDk" style="text-align: left">OpenBiz Inc.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zs1k78nlsGG8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zm7s9gkXxwBg" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zmWkqGpz9Wvd" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_z4ovMM46PHa4" style="text-align: left">Hapi Cafe Inc. (Texas)</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_ziodkPffcvD2" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_zwhH72aHjC61" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_zGx04eC9zmy3" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98C_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zTfNRNbDKXa7" style="text-align: left">HWH (S) Pte. Ltd.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zghztcntyPF2">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zmtkXpQ8iBha" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zzpvXIZLLjq7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zMI1ig5COWDi" style="text-align: left">True Partner International Limited</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zunIVDx8hjTc" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zrjk5mmIgDT9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zpjbc64S16Jk" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zJ5wg3ae57Q4" style="text-align: left">LiquidValue Development Pte. Ltd.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_znQyryMbPddg">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zr2ysal9kGqk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zJOXNHjZwF5f" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zMRshS4FffKf" style="text-align: left">LiquidValue Development Limited</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zB1j3dyQgaTj" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_z48mnHH83bJj" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zyLY60tGJKUf" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zujbySfnKbs6" style="text-align: left">EPowerTech Inc.</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zAZseqYA0hbj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zoTfSYXpkbo4" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zajAEyALz3r9" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_za8jrxjyNIUl" style="text-align: left">Alset EPower Inc.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zn4a2NVN3qf6" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zkmosgzP3Iee" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zflF2g8mmBD1" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zVAfEyNyodI8" style="text-align: left">AHR Asset Management Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zdfbI9w3rLO4" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_ziUaIXkawgP2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zgjFHaXFcmR6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98B_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zXiXMO9rWKac" style="text-align: left">HWH World Inc. (Nevada)</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zKcaDjtCyRoc" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zcYO5iNsXs4b" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_z9nad746l2re" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zVBry3rryz5k" style="text-align: left">Alset F&amp;B Holdings Pte. Ltd.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zLMF2zj5ji0b">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zzrcVRaEfbch" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zo0wtFIeace9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_zrPuU32qm196" style="text-align: left">Credas Capital Pte. Ltd.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_zd9cDrRf1Wzd">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_fKCop_zxa5djgidPIh" style="text-align: right">42.7</td><td id="xdx_F2A_zxJkt8SxVRF5" style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_fKCop_zGqXEnD9jUR1" style="text-align: right">38.4</td><td id="xdx_F29_zWz5fv7nygMa" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_z2CO6DbPkR5b" style="text-align: left">Credas Capital GmbH</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_zUWfYzgtZ3N7">Switzerland</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_fKCop_zjQnFfSbRAd9" style="text-align: right">42.7</td><td id="xdx_F25_zkaa148HqTse" style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_fKCop_zGwgAxLBydLh" style="text-align: right">38.4</td><td id="xdx_F23_zOFEHLHkBvAh" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zmgQZE8pc5Gc" style="text-align: left">Smart Reward Express Limited</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zR2kMC3WbIEf" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zwolIpA8uy91" style="text-align: right">50.0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_fKCop_zAMdTZPxDi0b" style="text-align: right">38.3</td><td id="xdx_F20_znhqL38LCOW3" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zJM3retDgzUe" style="text-align: left">AHR Texas Two LLC</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zv0WezpGeyUa" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_za9ZBHA7V002" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zYCwSj1MjJu4" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zKoKXvWmBcTd" style="text-align: left">AHR Black Oak One LLC</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zZ4gpcOAsv8b" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zvUTAlbmOJqf" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zhZSpDuJBrr8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zlNNm1tpB0ob" style="text-align: left">Hapi Air Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zfzbfVKhBbv3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zcU7N22UaKck" style="text-align: right">92.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zBSo8TTXGkrc" style="text-align: right">88.4</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_z7GVN1ZoriCd" style="text-align: left">AHR Texas Three, LLC</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_ziTeYsJXC4j5" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_zO0Fqu0AhkZg" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_z2F5h1ZsGp3h" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zn1nbm114St" style="text-align: left">Alset Capital Pte. Ltd.</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zxdgO5a0vQM3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zjun7QNAohfd" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zITAcnX316bi" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zoRXxDozRAUe" style="text-align: left">Hapi Cafe Korea, Inc.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zZsh6gslXj5c">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zjuIUSe6Dlta" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zMTfYBs2kpu6" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zTWmiveZh3l8" style="text-align: left">Green Energy Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zfOOkhu32Tik" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zhq3uMW5U1O1" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zwUTHTlEg1Gl" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zmd5xEy2p7pd" style="text-align: left">Green Energy Management Inc.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zQJ5OQOGSEhf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zhhOAurAwnFk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zhURnsGUuFCf" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_znk5ayFEKKa4" style="text-align: left">Alset Metaverse Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zxBc09YKg7E1" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zcyd5OiiQvLe" style="text-align: right">97.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zgLXraoTrIdc" style="text-align: right">95.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zIS4ZGuIxYgf" style="text-align: left">Alset Management Group Inc.</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zdSI2lETipD3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_z08L1RiwRRba" style="text-align: right">83.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zZfYRbmJEkY7" style="text-align: right">88.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_znS1jIMEiVXj" style="text-align: left">Alset Acquisition Sponsor, LLC</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zVWFKe8iv2l" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zoMdojxfJdj7" style="text-align: right">93.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zi83EtLj15Y7" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zTQEWoQZkTk5" style="text-align: left">Alset Capital Acquisition Corp.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zb9IrVRTKnQ3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zI1lsC7tyEd6" style="text-align: right">23.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zi5gLfm3m5J7" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zya1GZfZGyIe" style="text-align: left">Alset Spac Group Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zb2Wa6QHbur9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zJXg5FwnCvKf" style="text-align: right">93.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zsdevVgNZiVk" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zhTzeI5dM6f2" style="text-align: left">Alset Mining Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zp0qS1uSHfK5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zRnIROiEbf0f" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_z8kkjWdMtAt8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zJcU4ngQm0y6" style="text-align: left">Alset Inc.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zcSsvkAi2xHf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zPD9DG97uGK6" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zzL9RL7Hvare" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1677">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zjnmJX1xlP8g" style="text-align: left">Hapi Travel Pte. Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zqxHYoVEbewb">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zUvCZjOzq6Z9" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zMHFGasFSP9h" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_z29hNEdedcw4" style="text-align: left">Hapi WealthBuilder Pte. Ltd.</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_zzmkkzJtg1oj">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_zmyMJCIYFMBd" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_ztWo29saqIj4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1685">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zmpaZ4PbHRf" style="text-align: left">HWH Marketplace Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_z4IdO7qDdxL2">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zsp5i3bKuKZ2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zvBJj2XgNQ9f" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1689">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zSLRjIVOFblb" style="text-align: left">HWH International Inc. (Nevada)</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zp29tBAfsMI" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zyBdMLx3Xjfc" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zfP9VnTe24a6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1693">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zxzyrbtxCBgc" style="text-align: left">Hapi Cafe SG Pte. Ltd.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zcfqBZRRTDE8">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_z5KtB6mNEeXa" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zThWbvvQ00Oe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1697">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zn7MQrmFqAJa" style="text-align: left">Alset Reits Inc.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zHvszszHJcRl" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zXeXESXHk2ac" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zClWFGmNH4Ec" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1701">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zr7qGUQ61hJd" style="text-align: left">Robotic gHome Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zidbhee6z8d3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zG8MJFoTJCki" style="text-align: right">76.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zMNDgdUtgDlb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1705">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_zWdv5Wtt6tU7" style="text-align: left">HWH Merger Sub, Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_z10RFJ51zIyj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_zm4ld7j66fy8" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_ztuUVns9Y67e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_z0Vqv7NuFKT4" style="text-align: left">Alset Home REIT Inc.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zWFeaJuc7Wrj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zdTKPFkWUM09" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zTWHmYtrBvZg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1713">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zP5yrppr4Ya3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zHMr5x5REU4c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.</span></td></tr> </table> <p id="xdx_8A1_zzyBEetHN4pa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84C_eus-gaap--UseOfEstimates_zCX2R8oAqJC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, valuation of real estate assets, allocation of development costs and capitalized interest to sold lots, fair value of the investments, the valuation allowance of deferred taxes, and contingencies. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In our property development business, land acquisition costs are allocated to each lot based on the area method, the size of the lot compared to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot compared to the total size of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--PurchaseTransactionPolicy_zCftiG2lL4Pb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Transactions between Entities under Common Control</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On March 12, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company, for four proposed transactions, consisting of (i) purchase of certain warrants (the “Warrants”) to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AlsetInternationalLimitedMember_pdd" title="Number of warrant purchased">1,500,000,000</span> shares of Alset International Limited, which was valued at $<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstanding_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AlsetInternationalLimitedMember_pdp0" title="Warrants and rights outstanding">28,363,966</span>; (ii) purchase of all of the issued and outstanding stock of LiquidValue Development Pte Ltd. (“LVD”), which was valued at $<span id="xdx_90E_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20210309__20210312__srt--ConsolidatedEntitiesAxis__custom--LiquidValueDevelopmentPteLtdMember_zAuXGcsB3QI1" title="Stock repurchased during period, value">173,395</span>; (iii) purchase of <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--TruePartnerCapitalHoldingLimitedMember_zlq25OQmQI43" title="Stock repurchased during period, shares">62,122,908</span> ordinary shares in True Partner Capital Holding Limited (HKG: 8657) (“True Partner”), which was valued at $<span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodValue_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--TruePartnerCapitalHoldingLimitedMember_pp0p0" title="Stock repurchased during period, value">6,729,629</span>; and (iv) purchase of <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpIncMember_pdd" title="Stock repurchased during period, shares">4,775,523</span> shares of the common stock of American Pacific Bancorp Inc. (“APB”), which was valued at $<span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpIncMember_pp0p0" title="Stock repurchased during period, value">28,653,138</span>. The total amount of above four transactions was $<span id="xdx_908_eus-gaap--AccountsPayableCurrent_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Accounts payable, current">63,920,129</span>, payable on the Closing Date by the Company, in the convertible promissory notes (“Alset CPNs”), which, subject to the terms and conditions of the Alset CPNs and the Company’s shareholder approval, shall be convertible into shares of the Company’s common stock (“AEI Common Stock”), par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Common stock, par value">0.001</span> per share, at the conversion price of AEI’s Stock Market Price. AEI’s Stock Market Price was $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Shares issued per share">5.59</span> per share, equivalent to the average of the five closing per share prices of AEI’s Common Stock preceding January 4, 2021 as quoted by Bloomberg L.P. The above four acquisitions from Chan Heng Fai were transactions between entities under common control.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 15, 2020, American Pacific Bancorp (which subsequently became a majority-owned subsidiary of the Company) entered into an acquisition agreement to acquire <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20201014__20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HengfengFinanceLimitedMember_zQZrRWWkbxs8" title="Stock purchased upon acquisitions">3,500,001</span> common shares of HengFeng Finance Limited (“HFL”), representing <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HengfengFinanceLimitedMember_zBHVte6z20m9" title="Equity method investment, ownership percentage">100</span>% of the common shares of HFL, in consideration for $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20201014__20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HengfengFinanceLimitedMember_zUC6T2z3jXel" title="Purchase price">1,500,000</span>, to be satisfied by the issuance and allotment of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20201014__20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember_zCI1WvXIBHWl" title="Shares issued during acquisition">250,000</span> shares of the Class A Common Stock of American Pacific Bancorp. HFL is incorporated in Hong Kong with limited liability. The principal activities of HFL are money lending, securities trading and investment. This transaction closed on April 21, 2021. This transaction between the Company and Chan Heng Fai is under common control of Chan Heng Fai.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The common control transactions resulted in the following basis of accounting for the financial reporting periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition of the Warrants and True Partner stock were accounted for prospectively as of March 12, 2021 and they did not represent a change in reporting entity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition of LVD, APB and HFL was under common control and was consolidated in accordance with ASC 850-50. The consolidated financial statements were retrospectively adjusted for the acquisition of LVD, APB and HFL, and the operating results of LVD, APB and HFL as of January 1, 2020 for comparative purposes.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">AEI’s stock price was $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_c20210312_pdd" title="Shares issued per share">10.03</span> on March 12, 2021, the commitment date. The Beneficial Conversion Feature (“BCF”) intrinsic value was $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20210309__20210312_pp0p0" title="Beneficial conversion feature value">50,770,192</span> for the four convertible promissory notes and was recorded as debt discount of convertible notes after these transactions. The debt discount attributable to the BCF is amortized over the period from issuance to the date that the debt becomes convertible using the effective interest method. If the debt is converted, the discount is amortized to finance the cost in full immediately. On May 13, 2021 and June 14, 2021 all Alset CPNs of $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210511__20210513__dei--LegalEntityAxis__custom--AlsetCPNMember_zlM8UCIMnkwj" title="Debt conversion instrument, amount">63,920,128</span> and accrued interest of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210614__dei--LegalEntityAxis__custom--AlsetCPNMember_zmfSCQxVpwp7" title="Accrued interest">306,438</span> were converted into <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210509__20210614__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__dei--LegalEntityAxis__custom--AlsetCPNMember_zoNBCADQIKFh" title="Debt conversion instrument, shares issued">2,123</span> shares of Series B preferred stock and <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210509__20210614__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--AlsetCPNMember_zdENEbHnCEZi" title="Debt conversion instrument, shares issued">9,163,965</span> shares of common stock of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zy3lO7OFbyR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with a maturity of three months or less at the date of acquisition to be cash equivalents. Cash and cash equivalents include cash on hand and at the bank and short-term deposits with financial institutions that are readily convertible to a known amount of cash and are subject to an insignificant risk of changes in values. There were <span id="xdx_900_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20220930_z6lMek0THMck" title="Cash equivalents"><span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_zkmpfg9vXKag" title="Cash equivalents">no</span></span> cash equivalents as of September 30, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zIDkUBjRgiE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Restricted Cash</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a condition to the loan agreement with the Manufacturers and Traders Trust Company (“M&amp;T Bank”), the Company was required to maintain a minimum of $<span id="xdx_905_ecustom--DepositSecuringLoan_iI_pp0p0_c20220930__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember__srt--RangeAxis__srt--MinimumMember_zjOwI0FrJQzd" title="Deposit securing the loan">2,600,000</span> in an interest-bearing account maintained by the lender as additional security for the loan. The funds were required to remain as collateral for the loan until the loan is paid off in full and the loan agreement terminated. On March 15, 2022 approximately $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20220314__20220315__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zcRLnPuWBBK6" title="Line of credit collateral">2,300,000</span> was released from collateral, leaving approximately $<span id="xdx_90C_ecustom--LineOfCreditFacilityCollateralOutstanding_c20220314__20220315__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zbQEwBJTp991" title="Line of credit facility collateral outstanding">300,000</span> as collateral for outstanding letters of credit. The Company also has an escrow account with M&amp;T Bank to deposit a portion of cash proceeds from lot sales. The funds in the escrow account were specifically to be used for the payment of the loan from M&amp;T Bank. The funds were required to remain in the escrow account for the loan payment until the loan agreement terminates. In May 2022 the funds from this escrow account were released and the account closed. As of September 30, 2022 and December 31, 2021, the total balance of these two accounts was $<span id="xdx_908_eus-gaap--EscrowDeposit_iI_pp0p0_c20220930__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zMk1Nh2SKxqc" title="Escrow Deposit">309,145</span> and $<span id="xdx_90C_eus-gaap--EscrowDeposit_c20211231__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_pp0p0" title="Escrow Deposit">4,399,984</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a condition to the loan agreement with National Australian Bank Limited in conjunction with the Perth project, an Australian real estate development project, the Company was required to maintain Australian Dollar <span id="xdx_903_ecustom--CollateralDeposit_iI_uAUD_c20220930__srt--StatementGeographicalAxis__country--AU_zXVEM9w5ujb6" title="Collateral deposit">50,000</span>, in a non-interest-bearing account. As of December 31, 2021, the account balance was $<span id="xdx_903_ecustom--CollateralDeposit_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--CreditFacilityAxis__custom--NationalAustralianBankLimitedMember_zzGnjyRzSYwf" title="Collateral deposit">36,316</span>. In February 2022 the Company repaid the loan and the funds were subsequently released.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company puts money into brokerage accounts specifically for equity investment. As of September 30, 2022 and December 31, 2021, the cash balance in these brokerage accounts was $<span id="xdx_90B_eus-gaap--RestrictedCash_iI_pp0p0_c20220930__us-gaap--DebtInstrumentAxis__custom--BrokerageMember_zLlPNrITArYc" title="Restricted cash">321,140</span> and $<span id="xdx_909_eus-gaap--RestrictedCash_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--BrokerageMember_zmfySAY46Xrk" title="Restricted cash">304,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zqx6whqb7sKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Account Receivables and Allowance for Doubtful Accounts</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account receivables is stated at amounts due from buyers, contractors, and all third parties, net of an allowance for doubtful accounts. As of September 30, 2022 and December 31, 2021, the balance of account receivables was $<span id="xdx_905_eus-gaap--AccountsReceivableNetCurrent_iI_pp0p0_c20220930_ztEWz1apdDi7" title="Account receivables">171,380</span> and $<span id="xdx_904_eus-gaap--AccountsReceivableNetCurrent_c20211231_pp0p0" title="Account receivables">39,622</span>, respectively. Approximately $<span id="xdx_902_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930_zPcB28e4y6k1" title="Accounts receivable, net">0</span> and $<span id="xdx_90F_eus-gaap--AccountsReceivableNet_c20211231_pp0p0" title="Accounts receivable, net">2,500</span> of account receivables as of September 30, 2022 and December 31, 2021, respectively, was from DSS with a merchant agreement, under which the Company uses DSS credit card platform to collect money from our direct sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company monitors its account receivables balances on a monthly basis to ensure that they are collectible. On a quarterly basis, the Company uses its historical experience to estimate its allowance for doubtful account receivables. The Company’s allowance for doubtful accounts represents an estimate of the losses expected to be incurred based on specifically identified accounts as well as nonspecific amount, when determined appropriate. Generally, the amount of the allowance is primarily decided by division management’s historical experience, the delinquency trends, the resolution rates, the aging of receivables, the credit quality indicators and financial health of specific customers. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, the allowance was $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20220930_zvjdtKoKPis2" title="Accounts receivable, allowance of doubtful accounts"><span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20211231_zTqqwLzr3T25" title="Accounts receivable, allowance of doubtful accounts">0</span></span>.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zM91tAGU2XN2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method and includes all costs in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs necessary to make the sale. As of December 31, 2021, inventory consisted of finished goods from HWH World Inc. As of September 30, 2022, inventory consisted of finished goods from HWH World Inc. and Hapi Cafe Korea Inc. The Company continuously evaluates the need for reserve for obsolescence and possible price concessions required to write-down inventories to net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84D_ecustom--InvestmentSecuritiesPolicyTextBlock_zMREcJn1romi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Investment Securities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investment Securities at Fair Value</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records all equity investments with readily determinable fair values at fair value calculated by the publicly traded stock price at the close of the reporting period. Amarantus BioScience Holdings (“AMBS”) and True Partner Capital Holding Limited (“True Partner”) are publicly traded companies. The Company does not have significant influence over AMBS and True Partner, as the Company is the beneficial owner of approximately <span id="xdx_902_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmarantusBioScienceHoldingsMember_zo5057sXn95g" title="Ownership in fair value investment rate">4.3</span>% of the common shares of AMBS and as of December 31, 2021 held <span id="xdx_904_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TrustPartnerMember_zztnrg3bd528" title="Ownership in fair value investment rate">15.5</span>% of True Partner. On May 17, 2022 the Company sold its investment in True Partner to DSS Inc. These securities’ fair values are determined by reference to quoted stock prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2021 a subsidiary of the Company acquired <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210410__20210412__dei--LegalEntityAxis__custom--ValueExchangeInternationalMember_zNIoh29zfOZe" title="Stock acquisitions, shares">6,500,000</span> common shares of Value Exchange International, Inc. (“Value Exchange International”), an OTC listed company, for an aggregate subscription price of $<span id="xdx_903_ecustom--CostOfInvestmentInSecuritiesAtFairValue_iI_pp0p0_c20210412__dei--LegalEntityAxis__custom--ValueExchangeInternationalMember_zbdSDkgFZR6" title="Cost of investment in securities at fair value">650,000</span>. As of September 30, 2022, the Company, through subsidiaries, owned approximately <span id="xdx_901_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ValueExchangeInternationalMember_zgtr0mLZAUU4" title="Ownership in fair value investment rate">18.1</span>% of Value Exchange International. The stock’s fair value was determined by reference to quoted stock prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the year ended December 31, 2021, the Company’s subsidiaries established a portfolio of trading securities. The objective is to generate profits on short-term differences in market prices. The Company does not have significant influence over any trading securities in our portfolio and fair value of these trading securities are determined by reference to quoted stock prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has elected the fair value option for the equity securities noted below that would otherwise be accounted for under the equity method of accounting. Holista CollTech Limited (“Holista”), DSS, Inc. (“DSS”) and American Premium Mining Corporation (“APM” formerly known as American Premium Water Corp.) are publicly traded companies and the fair value of such securities are determined by reference to quoted stock prices. The Company has significant influence but does not have a controlling interest in these investments, and therefore, the Company’s investment could be accounted for under the equity method of accounting or elect fair value accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has significant influence over DSS. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, the Company owned approximately <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DocumentSecuritiesSystemsIncMember_z4VQKEwK9595" title="Ownership percentage">45.18</span>% and <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DocumentSecuritiesSystemsIncMember_zuN9CyuEdBba" title="Ownership percentage">24.9</span>% of the common stock of DSS, respectively. Our CEO is a stockholder and the Chairman of the Board of Directors of DSS. Chan Tung Moe, our Co-Chief Executive Officer and the son of Chan Heng Fai, is also a director of DSS. William Wu, Wong Shui Yeung and Joanne Wong Hiu Pan, directors of the Company, are each also directors of DSS.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has significant influence over Holista as the Company and its CEO are the beneficial owner of approximately <span id="xdx_905_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HolistaCollTechLimitedMember_znlf5mM35MEc" title="Ownership in fair value investment rate">15.5</span>% of the outstanding shares of Holista and our CEO held a position on Holista’s Board of Directors until June of 2021.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has significant influence over APM as the Company is the beneficial owner of approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumWaterCorpMember_zqYfCv4iFqi7" title="Investment securities cost at fair value ownership percentage">0.8</span>% of the common shares of APM and two officers of the Company and one member of our Board also serve on APM’s Board of Directors.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of American Medical REIT Inc. (“AMRE”), a related party private company, in conjunction with the Company lending two $<span id="xdx_903_eus-gaap--NotesReceivableRelatedParties_iI_c20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z5T8hRfS1Jve" title="Notes receivable, related parties"><span id="xdx_90B_eus-gaap--NotesReceivableRelatedParties_iI_c20211029__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zhmRXzpYYe65" title="Notes receivable, related parties">200,000</span></span> promissory notes. For further details on this transaction, refer to Note 8 - Related Party Transactions, <i>Note Receivable from a Related Party Company</i>. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, AMRE was a private company. Based on management’s analysis, the fair value of the AMRE warrants was $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20210101__20211231__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zCQ5Ke9NURU3" title="Fair value of warrants">0</span> as of December 31, 2021. In March 2022 both loans, together with warrants were converted into common shares of AMRE. After the conversion, the Company owns approximately <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalREITIncMember_z5jfvHNTjccb" title="Ownership percentage">15.8</span>% of AMRE.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company held a stock option to purchase <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20220101__20220930__dei--LegalEntityAxis__custom--VivacitasMember_zO4AVwyE4hvc" title="Number of shares purchased">250,000</span> shares of Vivacitas common stock at $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220930__dei--LegalEntityAxis__custom--VivacitasMember_zGhKWIsGVEyk" title="Common stock, par value">1</span> per share at any time prior to the date of a public offering by Vivacitas. As of December 31, 2020, Vivacitas was a private company. Based on management’s analysis, the fair value of the Vivacitas stock option was $<span id="xdx_90B_ecustom--FairValueOfStockOption_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--VivacitasMember_zRw05PZHXKm2" title="Fair value of stock option">0</span> as of December 31, 2020. On March 18, 2021 the Company sold the subsidiary holding the ownership and stock option in Vivacitas to an indirect subsidiary of DSS. For further details on this transaction, refer to Note 8 - Related Party Transactions, <i>Sale of Investment in Vivacitas to DSS</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for certain of its investments in funds without readily determinable fair values in accordance with ASU No. 2015-07, <i>Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent)</i> (“2015-07”). In the first six months of 2022 the Company invested <span style="background-color: white">$<span id="xdx_90E_eus-gaap--Investments_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NovumAlphaFundMember_ztlPWxQ9PCv4" title="Invested amount">100,000</span> in Class A Shares of Novum Alpha Global Opportunity Digital Asset Fund I SP, a segregated portfolio of Novum Alpha SPC (“Novum Alpha Fund”).</span> This fund invests in long-short digital assets. The Company subscribed in participating shares which are redeemable and non-voting. The Company closed the fund in July 2022 recording $<span id="xdx_905_eus-gaap--GainLossOnInvestments_c20220701__20220731_zgGnUyuO9pVb" title="Investment loss">74,827</span> loss on this investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2021 BMI Capital Partners International Limited (“BMI”) entered into loan agreement with Liquid Value Asset Management Limited (“LVAML”), a subsidiary of DSS, pursuant to which BMI agreed to lend $<span id="xdx_907_eus-gaap--LoansAndLeasesReceivableImpairedCommitmentToLend_iI_c20220930__dei--LegalEntityAxis__custom--LiquidValueAssetManagementLimitedMember_zw8K5mu19SS5" title="Loan lend">3,000,000</span> to LVAML. The loan has variable interest rate and matures on October 12, 2022, with automatic three-month extension. The purpose of the loan is to purchase a portfolio of trading securities by LVAM. BMI participates in the losses and gains from portfolio based on the calculations included in the loan agreement. As of September 30, 2022 and December 31, 2021 LVAML owes $<span id="xdx_900_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--LiquidValueAssetManagementLimitedMember_z5bdR4sPFXT" title="Investment at fair value">3,032,185</span> and $<span id="xdx_906_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--LiquidValueAssetManagementLimitedMember_zsqTlUmpwNHk" title="Investment at fair value">2,987,039</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investment Securities at Cost</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in equity securities without readily determinable fair values are measured at cost minus impairment adjusted by observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These investments are measured at fair value on a nonrecurring basis when there are events or changes in circumstances that may have a significant adverse effect. An impairment loss is recognized in the condensed consolidated statements of comprehensive income equal to the amount by which the carrying value exceeds the fair value of the investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company had an equity holding in Vivacitas Oncology Inc. (“Vivacitas”), a private company that is currently not listed on an exchange. We measured Vivacitas at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Our ownership in Vivacitas was sold on March 18, 2021 to DSS for $<span id="xdx_904_eus-gaap--GainOnSaleOfInvestments_pp0p0_c20210316__20210318__dei--LegalEntityAxis__custom--DocumentSecuritiesSystemsIncMember_zDGnVz6sYeUb" title="Gain on sale of investments">2,480,000</span>. The difference of $<span id="xdx_905_ecustom--CostMethodInvestmentOriginalCost_iI_pp0p0_c20210318__dei--LegalEntityAxis__custom--DocumentSecuritiesSystemsIncMember_zTD8STrfUwI3" title="Cost method investments, original cost">2,279,872</span> between the selling price and our original investment cost was recorded as additional paid capital considering a related party transaction. For further details on this transaction, refer to Note 8 – Related Party Transactions, <i>Sale of Investment in Vivacitas to DSS</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On September 8, 2020, the Company acquired <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200906__20200908__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NervotecPteLtdMember_z8CnIlrlrmx" title="Shares issued for acquisition">1,666</span> shares, approximately <span id="xdx_900_ecustom--OwnershipInInvestmentAtCostRate_iI_pid_dp_uPure_c20200908__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NervotecPteLtdMember_z0TfujlsPtlk" title="Ownership in investment at cost">1.45</span>% ownership, from Nervotec Pte Ltd (“Nervotec”), a private company, at the purchase price of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200906__20200908__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NervotecPteLtdMember_zGZqAmOJYC08" title="Cost of stock">37,826</span>. The Company applied ASC 321 and measured Nervotec at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On September 30, 2020, the Company acquired <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200928__20200930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HytenGlobalThailandCoLtdMember_zpUo0g7oyWq3" title="Shares issued for acquisition">3,800</span> shares, representing the ownership of approximately <span id="xdx_900_ecustom--OwnershipInInvestmentAtCostRate_iI_pid_dp_uPure_c20200930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HytenGlobalThailandCoLtdMember_zIUNmZkJeLWh" title="Ownership in investment at cost">19</span>%, from HWH World Company Limited (f.k.a. Hyten Global (Thailand) Co., Ltd.) (“HWH World Co.”), a private company, at a purchase price of $<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HytenGlobalThailandCoLtdMember_zWOSQLIk5aC4" title="Cost of stock">42,562</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During 2021, the Company invested $<span id="xdx_90B_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KBeautyResearchLabCoLtdMember_zwDxLv8wRFj1" title="Cost method investments, original cost">19,609</span> in K Beauty Research Lab Co., Ltd (“K Beauty”) for <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KBeautyResearchLabCoLtdMember_zf26qMrBR1mh" title="Ownership percentage">18</span>% of such company. K Beauty was established for sourcing, developing and producing variety of Korea-made beauty products as well as Korea - originated beauty contents for the purpose of distribution to HWH’s membership distribution channel.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There has been no indication of impairment or changes in observable prices via transactions of similar securities and investments are still carried at cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity Method Investment</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company accounts for equity investment in entities with significant influence under equity-method accounting. Under this method, the Group’s pro rata share of income (loss) from investment is recognized in the condensed consolidated statements of comprehensive income. Dividends received reduce the carrying amount of the investment. When the Company’s share of loss in an equity-method investee equals or exceeds its carrying value of the investment in that entity, the equity method investment can be reduced below zero based on losses, if the Company either is liable for the obligations of the investee or provides for losses in excess of the investment when imminent return to profitable operations by the investee appears to be assured. Otherwise, the Company does not recognize its share of equity method losses exceeding its carrying amount of the investment, but discloses the losses in the footnotes. Equity-method investment is reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other-than-temporary. In making this determination, factors are evaluated in determining whether a loss in value should be recognized. These include consideration of the intent and ability of the Group to hold investment and the ability of the investee to sustain an earnings capacity, justifying the carrying amount of the investment. Impairment losses are recognized in other expense when a decline in value is deemed to be other-than-temporary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>American Medical REIT Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">LiquidValue Asset Management Pte. Ltd. (“LiquidValue”), a subsidiary of the Company, owns <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalREITIncMember_zxepeKpF5en9" title="Ownership percentage">15.8</span>% of American Medical REIT Inc. (“AMRE”) as of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022, a company concentrating on medical real estate. AMRE acquires state-of-the-art, purpose-built healthcare facilities and leases them to leading clinical operators with dominant market share under secure triple net leases. AMRE targets hospitals (both Critical Access and Specialty Surgical), Physician Group Practices, Ambulatory Surgical Centers, and other licensed medical treatment facilities. Chan Heng Fai, our Chairman and CEO, is the executive chairman and director of AMRE. DSS, of which we own 45.2% and have significant influence over, owns 80.8% of AMRE. Therefore, the Company has significant influence on AMRE.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Joint Venture with Novum</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On April 20, 2021, one of Company’s indirect subsidiaries, SeD Capital Pte. Ltd. (“SeD Capital”), entered into a joint venture agreement with a digital asset management firm Novum Alpha Pte Ltd (“Novum”). Pursuant to this agreement, SeD Capital will own <span id="xdx_900_ecustom--JointVenturePaidUpCapital_iI_pid_dp_uPure_c20210420__dei--LegalEntityAxis__custom--SeDCapitalPteLtdMember__us-gaap--AwardTypeAxis__custom--NovumAlphaPteLtdMember_zkevwjed1k1a" title="Joint venture">50</span>% of the issued and paid-up capital in the joint venture company, Credas Capital Pte. Ltd. (“Credas”) with the remaining <span id="xdx_906_ecustom--JointVenturePaidUpCapital_iI_pid_dp_uPure_c20210420__dei--LegalEntityAxis__custom--SeDCapitalPteLtdMember__us-gaap--AwardTypeAxis__custom--CredasCapitalPteLtdMember_zKeIGDqZd6w9" title="Joint venture">50</span>% shareholding stake held by Novum. On the condensed consolidated balance sheet, the prorate loss from Credas was not recorded as a liability because the Company is not liable for the obligations of Credas and has not committed to provide additional financial support.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>American Pacific Bancorp, Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Securities Purchase Agreement from March 12, 2021 the Company purchased of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210309__20210312__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Purchase of stock">4,775,523</span> shares of the common stock of American Pacific Bancorp Inc. (“APB”) and gained majority ownership in that entity. APB was consolidated into the Company under common control accounting (See Transactions between Entities under Common Control for details). On September 8, 2021 APB sold <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210907__20210908__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonStockMember_zhubJIRbuLej" title="Purchase of stock">6,666,700</span> shares of Series A Common Stock to <span style="background-color: white">DSS, Inc.</span> for $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210907__20210908__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonStockMember_pdp0" title="Stock cost">40,000,200</span> cash. <span id="xdx_90E_eus-gaap--DeconsolidationRelatedPartyDescription_c20210907__20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zea8ChmGa2I9" title="Deconsolidation description">As a result of the new share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3% and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $<span id="xdx_90D_eus-gaap--DeconsolidationGainOrLossAmount_pn5n6_c20210907__20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zGy5Z8JJRbUk" title="Gain on deconsolidation">28.2</span> million.</span> The gain represents the difference between the fair value of retained equity method investment of $<span id="xdx_904_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zYmKabB1oduj" title="Equity method investement">30.8</span> million and $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pn5n6_c20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zDhEAlzNuJEi" title="Cost of investment">2.6</span> million, the Company’s investment percentage of carrying amount of APB’s net assets of $<span id="xdx_90E_eus-gaap--AssetsNet_iI_pn5n6_c20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_z4iN6QIq0fNd" title="Net assets">2.9</span> million. Considering the transaction was between related parties, the Company recorded the gain as additional paid in capital in its equity. From September 8 to December 31, 2021, the investment loss was $<span id="xdx_907_eus-gaap--GainLossOnInvestments_pp0p0_c20210907__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_z3zCZqiQnER8" title="Investment gain (loss)">51,999</span>. During three and nine months ended September 30, 2022 the investment gain was $<span id="xdx_903_eus-gaap--GainLossOnInvestments_c20220701__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zE2b2o8PvwJk" title="Investment gain (loss)">419,005</span> and $<span id="xdx_901_eus-gaap--GainLossOnInvestments_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zbgw2yowr8T3" title="Investment gain (loss)">579,026</span>, respectively. As of September 30, 2022 and December 31, 2021, the investment in APB was $<span id="xdx_900_eus-gaap--Investments_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zclnQwxOH0rd" title="Investments">31,380,155</span> and $<span id="xdx_90B_eus-gaap--Investments_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_z3zz26tQ02Xc" title="Investments">30,801,129</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Alset Capital Acquisition Corp.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, Alset Capital Acquisition Corp. (“Alset Capital”), a special purpose acquisition company (SPAC) sponsored by the Company and certain affiliates, closed its initial public offering of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220202__20220203__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_z8qih1MchJ1e">7,500,000</span> units at $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20220203__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zwcOAzQ4jCLf">10.00</span> per unit (the “Offering”). At the same time the exercise of underwriters’ over-allotment option of additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220202__20220203__us-gaap--BusinessAcquisitionAxis__custom--AlsetCapitalAcquisitionCorpMember_zM2n85K02jK5">1,125,000</span> units closed. The Company is majority owner of Alset Acquisition Sponsor, LLC, the sponsor (the “Sponsor”) of Alset Capital. On February 3, 2022, the Sponsor purchased <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220202__20220203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zZvk9kbbtnFf">473,750</span> units pursuant to a private placement for a purchase price of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220202__20220203__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgIpH5L66X6e" title="Purchase price of private placement amount">4,737,500</span>. Previously, the Sponsor had purchased <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220202__20220203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhHXQJnjzjm" title="Issuance of shares of common stock">2,156,250</span> shares of Class B common stock pursuant to a private placement for a purchase price of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220202__20220203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpN5PpWjeEaf" title="Purchase price of stock">25,000</span>. After the Offering the Company holds <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220203__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCropMember_z4MbC2RvcQb4">23.4</span>% of Alset Capital. Chan Heng Fai, the Chairman and CEO of the Company, is the CEO and director of Alset Capital. In June 2022, the Company made an adjustment of $<span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_c20220630__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zEnx7rYzjlJ4" title="Additional paid in capital">2,830,961</span> to Additional Paid in Capital and the fair value of investment in Alset Capital, and reversed the previously recorded unrealized loss of $<span id="xdx_90A_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20220601__20220630__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zxQIp20fR206" title="Unrealized loss on securities investment">237,578</span>, because of the change of valuation methods of the investment on Class B Common Stock and units the company held. Initially, the Company used market trading prices of Class A common stock and units to calculate the fair value of these investment securities and recorded $<span id="xdx_902_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20220301__20220331__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zPqVGFHF2zG6">237,578</span> unrealized loss on security investment during three months ended March 31, 2022. In June 2022, the Company determined the fair value of Class B common shares and units by using a put option model and a Monte Carlo simulation considering some restrictions and risks related to these securities the Company held. During the nine months ended September 30, 2022, the Company recorded investment loss of $<span id="xdx_900_eus-gaap--GainLossOnInvestments_pp0p0_c20220101__20220930__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zmyMdlCSJRNc" title="Investment gain (loss)">82,582</span> by equity method. On September 30, 2022 the Company purchased the remaining <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SponsorMember_zZU3M0EGTXM1" title="Ownership percentage">10</span>% ownership in the Sponsor for $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220901__20220930__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zWXmtqZNnyBe" title="Number of shares issued, value">476,250</span> and currently owns <span id="xdx_904_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zZZqskQ3jTOc" title="Ownership percentage">100</span>% of it. The Company’s investment in Alset Capital was $<span id="xdx_90D_eus-gaap--EquitySecuritiesFvNiCurrentAndNoncurrent_iI_c20220930_zBdbI9W5tSh6" title="Investment in capital">21,232,707</span> as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ketomei Pte Ltd</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 10, 2021 the Company’s indirect subsidiary Hapi Cafe Inc. (“Hapi Cafe”) lent $<span id="xdx_909_eus-gaap--OtherShortTermBorrowings_iI_c20210610__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zfBKSUMYua9b" title="Amount lent">76,723</span> to Ketomei Pte Ltd (“Ketomei”). On March 21, 2022 Hapi Cafe entered into an agreement pursuant to which the principal of the loan together with accrued interest were converted into an investment in Ketomei. At the same time, Hapi Cafe invested an additional $<span id="xdx_908_ecustom--AdditionalInvestment_c20220601__20220610__dei--LegalEntityAxis__custom--KetomeiPteLtdMember_z19yzXIixGP6" title="Additional investment">179,595</span> in Ketomei. After the conversion and fund investment the Company now holds <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220610__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_ziROQjiqHGMe" title="Ownership percentage">28</span>% of Ketomei. Ketomei is in the business of selling cooked food and drinks. During three and nine months ended September 30, 2022 the investment loss was $<span id="xdx_903_eus-gaap--GainLossOnInvestments_c20220701__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zXv3hhDHMZlc" title="Gain on loss on investment">5,937</span> and $<span id="xdx_903_eus-gaap--GainLossOnInvestments_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zRjCPVO1IwK" title="Gain on loss on investment">38,996</span>, respectively. Investment in Ketomei was $<span id="xdx_90E_eus-gaap--Investments_iI_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zROtsJe2chi4" title="Investment">217,321</span> at September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investment in Debt Securities</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt securities are reported at fair value, with unrealized gains and losses (other than impairment losses) recognized in accumulated other comprehensive income or loss. Realized gains and losses on debt securities are recognized in the net income in the condensed consolidated statements of comprehensive income. The Company monitors its investments for other-than-temporary impairment by considering factors including, but not limited to, current economic and market conditions, the operating performance of the companies including current earnings trends and other company-specific information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invested $<span id="xdx_900_eus-gaap--Investments_iI_pp0p0_c20220930__us-gaap--DebtInstrumentAxis__custom--SharingServicesConvertibleNoteMember_zrhp1PBOhWR" title="Invested amount">50,000</span> in a convertible promissory note of Sharing Services Global Corporation (“Sharing Services Convertible Note”), a company quoted on the US OTC market. The value of the convertible note is estimated by management using a Black-Scholes valuation model. The fair value of the note was $<span id="xdx_901_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20211231_zN0qzt853wi3" title="Convertible debt, fair value disclosures">9,799</span> on December 31, 2021. The note was redeemed on July 14, 2022 and $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220714__us-gaap--DebtInstrumentAxis__custom--SharingServicesConvertibleNoteMember_zHmsVWMMVAi5" title="debt face amount">50,000</span> principal together with $<span id="xdx_902_eus-gaap--InterestReceivable_iI_pp0p0_c20220714__us-gaap--DebtInstrumentAxis__custom--SharingServicesConvertibleNoteMember_zTBVtcyMbN2e" title="Iinterests receivable">28,636</span> accrued interests were received from Sharing Services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 26, 2021, the Company invested approximately $<span id="xdx_905_eus-gaap--Investments_iI_pp0p0_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zMmmwcVITHge" title="Invested amount">88,599</span> in the convertible note of Vector Com Co., Ltd (“Vector Com”), a private company in South Korea. The interest rate is <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zltrgMCbffSh" title="Debt instrument, interest percentage">2</span>% per annum and maturity is <span id="xdx_907_eus-gaap--DebtInstrumentTerm_dc_c20210224__20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zGVO1EtVy1Vd" title="Debt instrument, term">two years</span>. The conversion price is approximately $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zYndEqO1vUv5" title="Debt instrument, convertible, conversion price">21.26</span> per common share of Vector Com. As of September 30, 2022, our management estimated the fair value of the note to be $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zwDdwWlFUzG8" title="Debt instrument, face amount">88,599</span>, the initial transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ConsolidationVariableInterestEntityPolicy_zGKqTkscJie4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span><span><span id="xdx_86F_zkkw1XEtwlc2">Variable Interest Entity</span></span></span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Under Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 810, <i>Consolidation</i>, when a reporting entity is the primary beneficiary of an entity that is a variable interest entity (“VIE”), as defined in ASC 810, the VIE must be consolidated into the financial statements of the reporting entity. The determination of which owner is the primary beneficiary of a VIE requires management to make significant estimates and judgments about the rights, obligations, and economic interests of each interest holder in the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company evaluates its interests in VIEs on an ongoing basis and consolidates any VIE in which it has a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>HWH World Company Limited</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">HWH World Co. is a direct sales company in Thailand. The Company has a <span id="xdx_900_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--HWHWorldMember_zuOW1RrfLTxl" title="Ownership percentage">19</span>% ownership and loaned $<span id="xdx_902_eus-gaap--ProceedsFromPaymentsForLongTermLoansForRelatedParties_pp0p0_c20220101__20220930__srt--OwnershipAxis__custom--HWHWorldMember_z6GpaCSjOZj2" title="Payment of related parties">187,500</span> with zero interest and due on demand, to HWH World Co. The current level of equity in HWH World Co. is not sufficient to determine if HWH World Co. can operate on its own without additional subordinated financial support. The Company has a variable interest in HWH World Co., however, the Company is not deemed to absorb losses or receive benefits that could potentially be significant to HWH World Co. Ltd. The Company does not also have the ultimate power over the activities which can impact VIE’s economic performance, like developing company budgets or overseeing and controlling the management. The power to direct the activities are held by the manager in Thailand who owns <span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--HWHWorldCoMember_zrGYxNSePlmd" title="Ownership percentage">51</span>% of the HWH World Co. Therefore, the Company is not a primary beneficiary of this VIE and does not consolidate it. On </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021 variable interest and amount receivable in the non-consolidated VIE was $<span id="xdx_902_eus-gaap--ReceivablesNetCurrent_iI_pp0p0_c20220930__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_zeWBeXl3NY2l" title="Receivables, Net, Current">236,699</span> and $<span id="xdx_90E_eus-gaap--ReceivablesNetCurrent_iI_pp0p0_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_zDMzr7Tie1n9" title="Receivables, Net, Current">236,699</span>, respectively, which represents the Company’s maximum risk of loss from non-consolidated VIE. The Company applied ASC 321 and measured HWH World Co. investment at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>American Medical REIT Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In 2021 the Company owned <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_z2rtQ4UgO4L9" title="Onwership percentage">3.4</span>% of AMRE and made a loan in the amount of $<span id="xdx_90A_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zqt3glYhFvp">8,350,000</span> to AMRE, as well as two loans of $<span id="xdx_90E_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanMedicalReitIcbMember_zBH6sg3wt2Oc">200,000</span> each, all with <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zxMEAZhWvE7e">8</span>% per annum interest rate. One of the $<span id="xdx_900_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_pp0p0_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanMedicalReitIcbMember_zIZXcm72HxVl">200,000</span> loans was due on March 3, 2022, the other one is due on October 29, 2024. The $<span id="xdx_905_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20231129__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4kgVMW6Bdkf">8,350,000</span> loan is due on November 29, 2023. The Company has a variable interest in AMRE. However, the Company is not deemed to absorb losses or receive benefits that could potentially be significant to AMRE. The Company does not also have the ultimate power over the activities which can impact VIE’s economic performance, like developing company budgets or overseeing and controlling the management. The power to direct these activities are held by the AMRE’s largest shareholder which owns approximately <span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--AMREAndAMREManagementMember_zk63aDcSlrfh">80.8</span>% of AMRE and AMRE’s management team. Therefore, the Company is not a primary beneficiary of this VIE and does not consolidate it. In March 2022, the Company converted both $<span id="xdx_90E_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zGvQpQlhY3Bc" title="Notes payable related parties">200,000</span> loans and accrued interests, together with accompanying warrants into AMRE common shares. After the conversion the Company owns <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AMREAndAMREManagementMember_z8pgDJLCq1ka">15.8</span>% of AMRE. On July 12, 2022, pursuant to Assignment and Assumption Agreement from February 25, 2022, as amended on July 12, 2022, the Company sold the $<span id="xdx_90B_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20220712__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zVLpmV7t0uya">8,350,000</span> loan, together with accrued interest, to DSS for a purchase price of <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220711__20220712__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__dei--LegalEntityAxis__custom--DocumentSecuritiesSystemsIncMember_zn7HtDZrGSXa">21,366,177</span> shares of DSS’s common stock. The loss from this transaction of $<span id="xdx_90D_eus-gaap--DebtAndEquitySecuritiesRealizedGainLoss_c20220711__20220712__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_znTs2PawVkhf" title="Transaction loss">1,089,675</span> was calculated as the difference between the face value of promissory note together with accrued interest and the fair value of DSS stock on July 12, 2022, and was recorded under Other Expense in Statement of Operations. From July 12 to September 30, 2022, DSS stock was valued under fair market value and a loss of $<span id="xdx_907_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220713__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_z9gws52VzVe9" title="Unrealized loss on security investment">2,157,984</span> was booked as unrealized loss on security investment. On </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021 variable interest and amount receivable in the non-consolidated VIE was $<span id="xdx_90D_eus-gaap--ReceivablesNetCurrent_iI_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_zuphySQKFKs3" title="Receivables net">0</span> and $<span id="xdx_907_eus-gaap--ReceivablesNetCurrent_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_zGYiyGbK8uIb" title="Receivables net">8,901,285</span>, respectively, which represents the Company’s maximum risk of loss from non-consolidated VIE.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--RealEstatePolicyTextBlock_z4TYwptN89ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_z5U2WNpwHpK7">Real Estate Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Real estate assets are recorded at cost, except when real estate assets are acquired that meet the definition of a business combination in accordance with Financial Accounting Standards Board (“FASB”) ASC 805 - <i>“Business Combinations”,</i> which acquired assets are recorded at fair value. Interest, property taxes, insurance and other incremental costs (including salaries) directly related to a project are capitalized during the construction period of major facilities and land improvements. The capitalization period begins when activities to develop the parcel commence and ends when the asset constructed is completed. The capitalized costs are recorded as part of the asset to which they relate and are reduced when lots are sold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalized construction costs of approximately $<span id="xdx_90E_ecustom--CapitalizedConstructionCosts_pn5n6_c20220701__20220930_ztshdaHoCkC8" title="Capitalized construction costs">2.9</span> million and $<span id="xdx_903_ecustom--CapitalizedConstructionCosts_pn5n6_c20210701__20210930_zj0UldqyJrS2" title="Capitalized construction costs">1.8</span> million for the three months ended September 30, 2022 and 2021, respectively. The Company capitalized construction costs of approximately $<span id="xdx_905_ecustom--CapitalizedConstructionCosts_pn5n6_c20220101__20220930_zChwiyhxcxB2" title="Capitalized construction costs">5.9</span> million and $<span id="xdx_90F_ecustom--CapitalizedConstructionCosts_pn5n6_c20210101__20210930_z4eLOIFDuWEl" title="Capitalized construction costs">3.2</span> million for the nine months ended September 30, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s policy is to obtain an independent third-party valuation for each major project in the United States as part of our assessment of identifying potential triggering events for impairment. Management may use the market comparison method to value other relatively small projects, such as the project in Perth, Australia. In addition to the annual assessment of potential triggering events in accordance with ASC 360 – <i>Property Plant and Equipment</i> (“ASC 360”), the Company applies a fair value-based impairment test to the net book value assets on an annual basis and on an interim basis if certain events or circumstances indicate that an impairment loss may have occurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not record impairment on any of its projects during the three and nine months ended on September 30, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Properties under development</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properties under development are properties being constructed for sale in the ordinary course of business, rather than to be held for the Company’s own use, rental or capital appreciation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rental Properties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Rental properties are acquired with the intent to be rented to tenants. During the nine months ended </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and the year ended December 31, 2021, the Company signed multiple purchase agreements to acquire 23 and 109 homes, respectively. By </span>September <span style="background-color: white">30, 2022, all of the 132 homes were closed with an aggregate purchase cost of $<span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20220101__20220930_zM7pLrX0Znfa" title="Payments for rent">30,998,258</span>. These homes are located in Montgomery and Harris Counties, Texas. All of these purchased homes are properties of our rental business.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Investments in Single-Family Residential Properties</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company accounts for its investments in single-family residential properties as asset acquisitions and records these acquisitions at their purchase price. The purchase price is allocated between land, building, improvements and existing leases based upon their relative fair values at the date of acquisition. The purchase price for purposes of this allocation is inclusive of acquisition costs which typically include legal fees, title fees, property inspection and valuation fees, as well as other closing costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building improvements and buildings are depreciated over estimated useful lives of approximately <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220930__srt--RangeAxis__srt--MinimumMember_zoHHJfbCFl9i" title="Property, plant and equipment, useful life years">10</span> to <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220930__srt--RangeAxis__srt--MaximumMember_zcJIGmuOhzBh" title="Property, plant and equipment, useful life years">27.5</span> years, respectively, using the straight-line method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company assesses its investments in single-family residential properties for impairment whenever events or changes in business circumstances indicate that carrying amounts of the assets may not be fully recoverable. When such events occur, management determines whether there has been impairment by comparing the asset’s carrying value with its fair value. Should impairment exist, the asset is written down to its estimated fair value. The Company did not recognize any impairment losses during three and nine months ended </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and 2021.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zhlqb7gdzAPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zyovi7gUmXO2">Revenue Recognition and Cost of Revenue</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 606 - <i>Revenue from Contracts with Customers</i> (“ASC 606”), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers. The Company adopted this new standard on January 1, 2018 under the modified retrospective method. The adoption of this new standard did not have a material effect on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which the determination of revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which the Company expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, performance obligations are satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following represents the Company’s revenue recognition policies by Segments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Real Estate</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Property Sales</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s main business is land development. The Company purchases land and develops it for building into residential communities. The developed lots are sold to builders (customers) for the construction of new homes. The builders enter into sales contracts with the Company before they take the lots. The prices and timeline are determined and agreed upon in the contracts. The builders do the inspections to make sure all conditions and requirements in contracts are met before purchasing the lots. A detailed breakdown of the five-step process for the revenue recognition of the Ballenger project, which represented approximately <span id="xdx_902_ecustom--ConcentrationRiskPercentage_pid_dp_uPure_c20220101__20220930__us-gaap--AwardTypeAxis__custom--BallengerProjectsMember_zKKq6ocSKtw4" title="Risk percentage">18</span>% and <span id="xdx_907_ecustom--ConcentrationRiskPercentage_pid_dp_uPure_c20210101__20210930__us-gaap--AwardTypeAxis__custom--BallengerProjectsMember_zMDyQUUOaMll" title="Risk percentage">70</span>%, respectively, of the Company’s revenue in the nine months ended on September 30, 2022 and 2021, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract with a customer.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has signed agreements with the builders for developing the raw land to ready to build lots. The contract has agreed upon prices, timelines, and specifications for what is to be provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance obligations of the Company include delivering developed lots to the customer, which are required to meet certain specifications that are outlined in the contract. The customer inspects all lots prior to accepting title to ensure all specifications are met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine the transaction price.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transaction price per lot is fixed and specified in the contract. Any subsequent change orders or price changes are required to be approved by both parties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate the transaction price to performance obligations in the contract.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each lot or a group of lots is considered to be a separate performance obligation, for which the specified price in the contract is allocated to.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize revenue when (or as) the entity satisfies a performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The builders do the inspections to make sure all conditions/requirements are met before taking title of lots. The Company recognizes revenue at a point in time when title is transferred. The Company does not have further performance obligations or continuing involvement once title is transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Rental Revenue</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases real estate properties to its tenants under leases that are predominately classified as operating leases, in accordance with ASC 842, Leases (“ASC 842”). Real estate rental revenue is comprised of minimum base rent and revenue from the collection of lease termination fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent from tenants is recorded in accordance with the terms of each lease agreement on a straight-line basis over the initial term of the lease. Rental revenue recognition begins when the tenant controls the space and continues through the term of the related lease. Generally, at the end of the lease term, the Company provides the tenant with a one-year renewal option, including mostly the same terms and conditions provided under the initial lease term, subject to rent increases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company defers rental revenue related to lease payments received from tenants in advance of their due dates. These amounts are presented within deferred revenues and other payables on the Company’s condensed consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental revenue is subject to an evaluation for collectability on several factors, including payment history, the financial strength of the tenant and any guarantors, historical operations and operating trends of the property, and current economic conditions. If our evaluation of these factors indicates that it is not probable that we will recover substantially all of the receivable, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis (as applicable) or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. For the nine months ended September 30, 2022, the Company did not recognize any deferred revenue and collected all rents due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Sale of the Front Foot Benefit Assessments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We have established a front foot benefit (“FFB”) assessment on all of the NVR lots. This is a 30-year annual assessment allowed in Frederick County which requires homeowners to reimburse the developer for the costs of installing public water and sewer to the lots. These assessments become effective as homes are settled, at which time we can sell the collection rights to investors who will pay an upfront lump sum, enabling us to more quickly realize the revenue. The selling prices range from $<span id="xdx_905_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember__srt--RangeAxis__srt--MinimumMember_zyv53dj2ayd7" title="Proceeds from sale of property, plant, and equipment">3,000</span> to $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember__srt--RangeAxis__srt--MaximumMember_zUJ5b7KbGU6" title="Proceeds from sale of property, plant, and equipment">4,500</span> per home depending the type of the home. Our total revenue from the front foot benefit assessment is approximately $1 million. To recognize revenue of the FFB assessment, both our and NVR’s performance obligation have to be satisfied. Our performance obligation is completed once we complete the construction of water and sewer facility and close the lot sales with NVR, which inspects these water and sewer facility prior to close lot sales to ensure all specifications are met. NVR’s performance obligation is to sell homes they build to homeowners. Our FFB revenue is recognized on quarterly basis after NVR closes sales of homes to homeowners. The agreement with these FFB investors is not subject to amendment by regulatory agencies and thus our revenue from the FFB assessment is not either. During the three months ended on </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and 2021, we recognized revenue of $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20220701__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_z54pcvYBi9b6" title="Revenue recognized">9,968</span> and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_zTnfp7ZlyND" title="Revenue recognized">182,813</span> from the FFB assessments, respectively. During the nine months ended on </span>September <span style="background-color: white">30, 2022 and 2021, we recognized revenue of $<span id="xdx_907_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_zcZIci3m3zK7" title="Revenue recognized">126,055</span> and $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_zAVnkeKXuFgc" title="Revenue recognized">431,458</span> from the FFB assessments, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cost of Revenues</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Real Estate</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost of Real Estate Sale </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the costs of real estate sales are from our land development business. Land acquisition costs are allocated to each lot based on the area method, the size of the lot comparing to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot comparing to the total size of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost of Rental Revenue </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of rental revenue consists primarily of the costs associated with management and leasing fees to our management company, repairs and maintenance, depreciation and other related administrative costs. Utility expenses are paid directly by tenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Biohealth</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product Direct Sales</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s net sales consist of product sales. The Company’s performance obligation is to transfer its products to its third-party independent distributors (“Distributors”). The Company generally recognizes revenue when product is shipped to its Distributors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s Distributors may receive distributor allowances, which are comprised of discounts, rebates and wholesale commission payments from the Company. Distributor allowances resulting from the Company’s sales of its products to its Distributors are recorded against net sales because the distributor allowances represent discounts from the suggested retail price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to distributor allowances, the Company compensates its sales leader Distributors with leadership incentives for services rendered, relating to the development, retention, and management of their sales organizations. Leadership incentives are payable based on achieved sales volume, which are recorded in general and administrative expenses. The Company recognizes revenue when it ships products. The Company receives the net sales price in cash or through credit card payments at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a Distributor returns a product to the Company on a timely basis, he/she may obtain a replacement product from the Company for such returned products. In addition, the Company maintains a buyback program pursuant to which it will repurchase products sold to a Distributor who has decided to leave the business. Allowances for product returns, primarily in connection with the Company’s buyback program, are provided at the time the sale is recorded. This accrual is based upon historical return rates for each country and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Membership</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company collects an annual membership fee from its Distributors. The fee is fixed, paid in full at the time of joining the membership and non-refundable. The membership provides the member access to purchase products at a discount, access to certain back-office services, receive commissions for signing up new members, and attend corporate events. The Company recognizes revenue associated with the membership over the period of the membership. Before the membership fee is recognized as revenue, it is recorded as deferred revenue. Deferred revenue relating to membership was $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--DeferredRevenueMember_zemtK6yKCUBj" title="Deferred revenue">65,091</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--DeferredRevenueMember_zaKK6N5Qex1k" title="Deferred revenue">728,343</span> at September 30, 2022 and December 31, 2021, respectively. During 2021, the Company temporarily suspended the sale of its membership as it is focusing on developing new market strategy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Businesses</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Killiney Kopitiam’s Franchise</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through Alset F&amp;B One Pte. Ltd. (“Alset F&amp;B”), acquired a restaurant franchise license at the end of 2021 and has since commenced operations. This license will allow Alset F&amp;B to operate a Killiney Kopitiam restaurant in Singapore. Killiney Kopitiam is a Singapore-based chain of mass-market, traditional kopitiam style service cafes selling toast products, soft-boiled eggs and coffee.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Remaining performance obligations</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, there were no remaining performance obligations or continuing involvement, as all service obligations within the other business activities segment have been completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84F_eus-gaap--CompensationRelatedCostsPolicyTextBlock_z90b09dBtO6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zCtN7vLUw9Gh">Stock-Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective January 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services. During the three and nine months ended on September 30, 2022 and 2021, the Company recorded $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220701__20220930_zFQ41PlckIj4" title="Stock-based compensation"><span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220101__20220930_zshB3ihMTGfl" title="Stock-based compensation">0</span></span> and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930_z8VuuRJ6qH2d" title="Stock-based compensation"><span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210930_zLuRWfHi10r2" title="Stock-based compensation">73,292</span></span> as stock-based compensation expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zwA4XR6UcYe6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Foreign currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Functional and reporting currency</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items included in the financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (“functional currency”). The financial statements of the Company are presented in U.S. dollars (the “reporting currency”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional and reporting currency of the Company is the United States dollar (“U.S. dollar”). The financial records of the Company’s subsidiaries located in Singapore, Hong Kong, Australia and South Korea are maintained in their local currencies, the Singapore Dollar (S$), Hong Kong Dollar (HK$), Australian Dollar (“AUD”) and South Korean Won (“KRW”), which are also the functional currencies of these entities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transactions in foreign currencies</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions in currencies other than the functional currency during the periods are converted into functional currency at the applicable rates of exchange prevailing when the transactions occurred. Transaction gains and losses are recognized in the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of the Company’s foreign currency transaction gains or losses come from the effects of foreign exchange rate changes on the intercompany loans between Singapore entities and U.S. entities. The Company recorded foreign exchange gain of $<span id="xdx_906_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20220701__20220930_zn02ZGNYCdxj" title="Foreign currency transaction gain loss">132,092</span> and $<span id="xdx_902_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20210701__20210930_zrmxD58iOYz9" title="Foreign currency transaction gain loss">578,903</span> loss during the three months ended on September 30, 2022 and 2021, respectively. The Company recorded foreign exchange gain of $<span id="xdx_90A_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20220101__20220930_zFnyYAOPPBPb" title="Foreign currency transaction gain loss">2,617,896</span> and $<span id="xdx_901_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20210101__20210930_zStpZOMy0p67" title="Foreign currency transaction gain loss">1,842,128</span> during the nine months ended on September 30, 2022 and 2021, respectively. The foreign currency transactional gains and losses are recorded in operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Translation of consolidated entities’ financial statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at the rates of exchange ruling at the balance sheet date. The Company’s entities with functional currency of S$, HK$, AUD and KRW, translate their operating results and financial positions into the U.S. dollar, the Company’s reporting currency. Assets and liabilities are translated using the exchange rates in effect on the balance sheet date. Revenue, expense, gains and losses are translated using the average rate for the year. Translation adjustments are reported as cumulative translation adjustments and are shown as a separate component of comprehensive income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded other comprehensive gain of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220701__20220930_zOVJ9G9CcwS8" title="Other comprehensive loss">520,339</span> from foreign currency translation for the three months ended September 30, 2022 and $<span id="xdx_907_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210701__20210930_zHXLx0KrK1Il" title="Other comprehensive loss">1,238,356</span> loss for the three months ended September 30, 2021, in accumulated other comprehensive loss. The Company recorded other comprehensive loss of $<span id="xdx_90C_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20220930_zbqni1MCKKZ4" title="Other comprehensive loss">3,729,724</span> from foreign currency translation for the nine months ended September 30, 2022 and $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20210930_zZxB1YejpBJ3" title="Other comprehensive loss">4,077,987</span> loss for the nine months ended September 30, 2021, in accumulated other comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_ecustom--NoncontrollingInterestPolicyTextBlock_zXS1Vc9LF8R1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zfMm8iiMqzv6">Non-controlling interests</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling interests represent the equity in subsidiary not attributable, directly or indirectly, to owners of the Company, and are presented separately in the condensed consolidated statements of operation and comprehensive income, and within equity in the Condensed Consolidated Balance Sheets, separately from equity attributable to owners of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 30, 2022 and December 31, 2021, the aggregate non-controlling interests in the Company were $<span id="xdx_908_eus-gaap--MinorityInterest_iI_pp0p0_c20220930_zSVPhBBTXYte" title="Non controlling interest">12,015,513</span> and $<span id="xdx_906_eus-gaap--MinorityInterest_iI_pp0p0_c20211231_z3aCVU91BEif" title="Non controlling interest">21,912,268</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--CapitalizedFinancingCostsPolicyTextBlock_zMGQuZIgex5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zLm3hXna9z1l">Capitalized Financing Costs</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing costs, such as loan origination fee, administration fee, interests, and other related financing costs should be capitalized and recorded on the balance sheet, if these financing activities are directly associated with the development of real estate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized financing costs are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If the allocation of capitalized financing costs based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on an area method, which uses the size of the lots compared to the total project area and allocates costs based on their size.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, the capitalized financing costs were $<span id="xdx_905_ecustom--CapitalizedFinancingCosts_iI_pp0p0_c20220930_zSkViU2MMnSf" title="Capitalized financing costs"><span id="xdx_903_ecustom--CapitalizedFinancingCosts_iI_pp0p0_c20211231_zyAoJQqbjR9d" title="Capitalized financing costs">3,247,739</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--BeneficialConversionFeaturesPolicyTextBlock_zTOzFdICfmbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zwvJ1eCuRwe4">Beneficial Conversion Features</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates the conversion feature for whether it was beneficial as described in ASC 470-30. The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the shares of common stock at the commitment date to be received upon conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zL699vuPPze8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zDjOktgdNmv6">Recent Accounting Pronouncements</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting pronouncement adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.” ASU 2021-08 requires the company acquiring contract assets and contract liabilities obtained in a business combination to recognize and measure them in accordance with ASC 606, “Revenue from Contracts with Customers”. At the acquisition date, the company acquiring the business should record related revenue, as if it had originated the contract. Before the update such amounts were recognized by the acquiring company at fair value. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company plans to adopt these requirements prospectively, effective on the first day of the year 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting pronouncement not yet adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years, and a modified retrospective approach is required, with a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. In November of 2019, the FASB issued ASU 2019-10, which delayed the implementation of ASU 2016-13 to fiscal years beginning after December 15, 2022 for smaller reporting companies. The Company is currently evaluating the impact of ASU 2016-13 on its future consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FASB issued ASU 2020-04, <i>Reference Rate Reform (Topic 848): Facilitation of Reference Rate Reform on Financial Reporting</i>. The amendments in this update provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The Company’s line of credit agreement provides procedures for determining a replacement or alternative rate in the event that LIBOR is unavailable. The amendments in this update are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-04 on its future consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued <i>ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)</i> which simplifies the accounting for convertible instruments. The guidance removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2023 for smaller reporting companies, including interim periods within those fiscal years. Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 on its future consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zVxQq4hR6eeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Basis of Presentation and Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and following the requirements of the Securities and Exchange Commission (“SEC”) for interim reporting. These interim financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or any other interim periods or for any other future years. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Form 10-K for the year ended December 31, 2021 filed on March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements include all accounts of the Company and its majority owned and controlled subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting common stock and controls operations. All intercompany transactions and balances among consolidated subsidiaries have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_zKfBMRZGyJBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s condensed consolidated financial statements include the financial position, results of operations and cash flows of the following entities as of September 30, 2022 and December 31, 2021, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyo1FjZCicJ5" style="display: none">SCHEDULE OF SUBSIDIARIES</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Attributable interest as of,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of subsidiary consolidated under AEI</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">State or other jurisdiction of incorporation or organization</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zGjvZnRTrBNk" style="width: 29%; text-align: left">Alset Global Pte. Ltd.</td><td style="width: 2%"> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zWZIZRtAKZl4" style="width: 29%" title="State or other jurisdiction of incorporation or organization">Singapore</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zec2OsgiSNs1" style="width: 16%; text-align: right" title="Ownership percentage">100</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zM1tjpEDFoE1" style="width: 16%; text-align: right" title="Ownership percentage">100</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zuRzv2hTpzR1" style="text-align: left">Alset Business Development Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_z2WEF4aTxRt7" title="State or other jurisdiction of incorporation or organization">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zXDLfBXzCzwe" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zzcp8gYKMrAa" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_ztnYyfQLy1o" style="text-align: left">Global eHealth Limited</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zMl5gbAncEi1" style="text-align: left" title="State or other jurisdiction of incorporation or organization">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zA8sJKCmcyHh" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zpudo3tzpxZd" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zspl1BoXj4U6" style="text-align: left">Alset International Limited</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zyggjgjOCAk5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zd6SSqD6gvQ5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zsCIjt6hPvAe" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zYzZG8Oo5B3k" style="text-align: left">Singapore Construction &amp; Development Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zSwXrLSaT5M4">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zhJJcsHtGZba" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zoE9fi0Jsgah" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_z0D7sOJ7Zuld" style="text-align: left">Art eStudio Pte. Ltd.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_zM3BSEe1trae">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_fKCop_znvJoK4Tu2Jf" style="text-align: right">43.6</td><td style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_fKCop_z4nzkPQv2mkd" style="text-align: right">39.2</td><td style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z4vO8Ft0MZ26" style="text-align: left">Singapore Construction Pte. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z9bUvZyxpxD6">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z6pQoTpt35Pd" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z4H0bFuhOCu1" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zXBZI9F3mkn4" style="text-align: left">Global BioMedical Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zqaO2kC4hIO3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zMeBy9cCeCYf" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zKTGVJrmzyv7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zh6sSemR1Ag4" style="text-align: left">Alset Innovation Pte. Ltd.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zLWzabOjrRef">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zcYso7WpNa7l" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_z9uHJYijIhD5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zUYHnjQXYog8" style="text-align: left">Health Wealth Happiness Pte. Ltd.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zEEMYbNqGMd9">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zG8W9aCvj8ee" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zyqonfb5DVm4" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zJKGaw7IUDQe" style="text-align: left">SeD Capital Pte. Ltd.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zkYzIgivKMe5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zisAC5TeqHh7" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zaInywzKyIa7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zKGAbqmZsRX2" style="text-align: left">LiquidValue Asset Management Pte. Ltd.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_z9L5u4CQcYVc">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zfulsvizA1H6" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zmGSTiY5izBg" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zaNycvIhygDl" style="text-align: left">Alset Solar Limited</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_za2SfRaN69a8" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zfve6mtbhjl5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zqw9EWeo8SU5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_z7alaIhk7a0b" style="text-align: left">Alset F&amp;B One Pte. Ltd</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zcGhlReUrGye">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zjGrofxmGI9g" style="text-align: right">76.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zeCLghZpR8S2" style="text-align: right">69.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_ztQBZ2dXrSde" style="text-align: left">Global TechFund of Fund Pte. Ltd.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zYZLebo191f8">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zy9FcJqwC0wl" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zn12zYn81RRj" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zkdYUmWQhJRa" style="text-align: left">Singapore eChainLogistic Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_z3rg5M5Ta3C3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zEY5IiQ0dsB9" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zZkbD0QvDGt5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98C_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zx5jAMk96Dgk" style="text-align: left">BMI Capital Partners International Limited.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zNZER6L3U8U2" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zLfn1c0foS65" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zaYjAaAvfIDc" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zbJk8Cp9y4L7" style="text-align: left">SeD Perth Pty. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zO6z95J2W3m7">Australia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zX9WYc5Qyyoj" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zdQ6Cm4cf87g" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zR4k8yzLa7Rg" style="text-align: left">SeD Intelligent Home Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_z2iQnAKflSfg" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zaWsX8VGM3M1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zRfBDXd8cscf" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zBt4dwdctTq5" style="text-align: left">LiquidValue Development Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zk7A1WQXDae3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zYbKeJ8FZb4g" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zTTSv2lyHvIi" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zWUnQmi1dOfc" style="text-align: left">Alset EHome Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zbql4JjirPml" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zalP5UIbyerh" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_z9rgK2LA6w4h" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zAMhiQnBza0b" style="text-align: left">SeD USA, LLC</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zJRGQIfYlrOf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zzMzKak2kHuh" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zMMVlGuZDj5b" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zuT9ydk8nbKh" style="text-align: left">150 Black Oak GP, Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zpZnoSZNSLga" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zPtmL4bDttBi" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_z7R3BBnyoesg" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zxP70f3dovh1" style="text-align: left">SeD Development USA Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zpaty3Q1FS7c" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zWfytqmcJ9if" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zaE4jG2AEq71" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zsC4KNpuzot8" style="text-align: left">150 CCM Black Oak, Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_z27ZYmeBpRCd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zWW3NiZFEMm8" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zgsZF5zNve79" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zuOzeKl2Rk1a" style="text-align: left">SeD Texas Home, LLC</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_z7pjvnkuMQxj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zazcZcDWSIlg" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zIwXkCT4SiZd" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zy3vl9fB8MFl" style="text-align: left">SeD Ballenger, LLC</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zu8wiaj81TK6" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zWV2RjiuOTpa" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zF0M6O58vQ74" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_zClMWBVmISjh" style="text-align: left">SeD Maryland Development, LLC</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_znIEJzglACw9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_zTbBEeSXuU8b" style="text-align: right">71.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_z32yBSTWLEG1" style="text-align: right">64.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zLia3L92BtBi" style="text-align: left">SeD Development Management, LLC</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_z9dl51I8oZZ9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zXaV2nYd8ohl" style="text-align: right">72.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zCdxpE1WRqNd" style="text-align: right">65.3</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_zuCM0wPSuXn9" style="text-align: left">SeD Builder, LLC</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_zygqjMADI039" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_z3CxPywaY0U1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_z3iKHPyxDuz2" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_z6rOoSvDH0Kf" style="text-align: left">GigWorld Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_z6opJSrJdFql" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_ziR9xMqfYzNf" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_zjZf4hvqZnEf" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zcFwXePedo39" style="text-align: left">HotApp BlockChain Pte. Ltd.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zoI8SiErQJd7">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zCRNdPzXB6F6" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zbgzfZN20EBf" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zCKjlDPq510d" style="text-align: left">HotApp International Limited</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zh4Gba00hR6j" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zLRVlCn9uRG5" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zQ1iktQUr7Rk" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zHbxawYDa6n5" style="text-align: left">HWH International, Inc. (Delaware)</td><td> </td> <td id="xdx_98A_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zl7HZkxkF46d" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zPG3hrzHqYV1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zt5UisTpF1ng" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zif6g0AC7LNl" style="text-align: left">Health Wealth &amp; Happiness Inc.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_z5PAA0VnJ1S8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zbq8GpKhqFn5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zdrtBq77GMGc" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zcznXKI9mSP8" style="text-align: left">HWH Multi-Strategy Investment, Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zs0GC8QM9pq8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zpFvklj1Ilgb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zySaZRttdMCb" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_z9LQl9XX3OK3" style="text-align: left">SeD REIT Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_z99HBeapOOfg" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_zGvs8tXMSzm9" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_zcBwjg7FjRQf" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zbea4qVKk30e" style="text-align: left">Gig Stablecoin Inc.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zDpXrgF6qkFd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zGGewq2UxiG5" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zAeK7g75Yl0a" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zYTmTH1k8VEc" style="text-align: left">HWH World Inc. (Delaware)</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_z0TqVuNODn1g" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zdV22smwFi7b" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zjF9wumbIPeg" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_z3Hk7tIdICXc" style="text-align: left">HWH World Pte. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zZahR4qqXo3j">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zkRrTs8dpeE4" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zh4kgbbDiJWj" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zhe7wg3gShdf" style="text-align: left">UBeauty Limited</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zIP6bEduRrU7" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zfc1oxZRHBY2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zvbpqiIEC1t8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zHXmJvfIbenk" style="text-align: left">WeBeauty Korea Inc</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zouJjylkVqV6">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zsyT5wBM4Pvl" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zuWFrQH4heli" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zitK5lkTWHx" style="text-align: left">HWH World Limited</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zDTkUj5CCjP" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_z4pATjEEmou3" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zqTZ48O5t1a6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_z2j174EcCFxk" style="text-align: left">HWH World Inc.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_zlU9mvajSMHe">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_znKvbF7JVWj" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_zeLjb8mUNhw6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_z4WUnkVpiz49" style="text-align: left">Alset BioHealth Pte. Ltd.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_zI80XH8GrUBe">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_z8dYrCMpaVad" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1511">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_zCEdqMtbrz3c" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zZK5J8rGfSba" style="text-align: left">Alset Energy Pte. Ltd.</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_z6IEUUjUNbI6">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zxl6RoWbXhU8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1515">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zFLSDY3rSBE3" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zThjyXb8VBY2" style="text-align: left">GDC REIT Inc. (f.k.a. Alset Payment Inc.)</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zzDRkEgwxP72" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_z67rAx3Yfeb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zKxF0cZQFFd8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_ztz9krDjbNZ7" style="text-align: left">Alset World Pte. Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zao4EUleZHh9">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zjLSdZ0qsQRl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1523">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zYxtt4wiNDfh" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_zQmE290rUilf" style="text-align: left">BioHealth Water Inc.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_zyUE1Cgn5yda" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_z2I7geUVuxy3" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_z7fffX8q2qo7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zXEtYPRRZAGi" style="width: 29%; text-align: left">Impact BioHealth Pte. Ltd.</td><td style="width: 2%"> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zUbFYWbj2r2k" style="width: 29%">Singapore</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zsiMMlMbyrab" style="width: 16%; text-align: right">85.4</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_z9ECiHi1Bu86" style="width: 16%; text-align: right">76.8</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zHjfTBnsv24j" style="text-align: left">American Home REIT Inc.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zW0tb7ovWSGc" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_z4UrMFO5dyt" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zglJFjXxoAH9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zn726lamWYog" style="text-align: left">Alset Solar Inc.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zJrSLonEJ9Vd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zBWEimVqild4" style="text-align: right">68.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zFwBB9xOlml3" style="text-align: right">61.5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zHgTxPQO98H2" style="text-align: left">HWH KOR Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zOHP3kMmKXm4" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zG4JyY5c0bvb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_z93HGy8RU3Vi" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zoRlgM2SHJi1" style="text-align: left">Open House Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_ze9hUf371t7f" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zwhfTX1jMEAh" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zgl4k1QRcHh9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_zRgzKmOYjoYe" style="text-align: left">Open Rental Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_z0gewfgGum8h" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_znetYc4qfea8" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_zSKwPSZx2EY9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_z8AvJlAisFw7" style="text-align: left">Hapi Cafe Inc. (Nevada)</td><td> </td> <td id="xdx_98A_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zEnCaLD0YeNk" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zVdXDXNkqATk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zLqYWcLxsKW9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zizeQhvFmW2g" style="text-align: left">Global Solar REIT Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization._c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zEuglecY6LSk" style="text-align: left" title="State or other jurisdiction of incorporation or organization">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zvdDTVYwgjjf" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zARHTGFSdeRa" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_z4DpJJYSvQDk" style="text-align: left">OpenBiz Inc.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zs1k78nlsGG8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zm7s9gkXxwBg" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zmWkqGpz9Wvd" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_z4ovMM46PHa4" style="text-align: left">Hapi Cafe Inc. (Texas)</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_ziodkPffcvD2" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_zwhH72aHjC61" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_zGx04eC9zmy3" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98C_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zTfNRNbDKXa7" style="text-align: left">HWH (S) Pte. Ltd.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zghztcntyPF2">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zmtkXpQ8iBha" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zzpvXIZLLjq7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zMI1ig5COWDi" style="text-align: left">True Partner International Limited</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zunIVDx8hjTc" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zrjk5mmIgDT9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zpjbc64S16Jk" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zJ5wg3ae57Q4" style="text-align: left">LiquidValue Development Pte. Ltd.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_znQyryMbPddg">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zr2ysal9kGqk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zJOXNHjZwF5f" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zMRshS4FffKf" style="text-align: left">LiquidValue Development Limited</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zB1j3dyQgaTj" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_z48mnHH83bJj" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zyLY60tGJKUf" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zujbySfnKbs6" style="text-align: left">EPowerTech Inc.</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zAZseqYA0hbj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zoTfSYXpkbo4" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zajAEyALz3r9" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_za8jrxjyNIUl" style="text-align: left">Alset EPower Inc.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zn4a2NVN3qf6" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zkmosgzP3Iee" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zflF2g8mmBD1" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zVAfEyNyodI8" style="text-align: left">AHR Asset Management Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zdfbI9w3rLO4" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_ziUaIXkawgP2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zgjFHaXFcmR6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98B_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zXiXMO9rWKac" style="text-align: left">HWH World Inc. (Nevada)</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zKcaDjtCyRoc" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zcYO5iNsXs4b" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_z9nad746l2re" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zVBry3rryz5k" style="text-align: left">Alset F&amp;B Holdings Pte. Ltd.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zLMF2zj5ji0b">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zzrcVRaEfbch" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zo0wtFIeace9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_zrPuU32qm196" style="text-align: left">Credas Capital Pte. Ltd.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_zd9cDrRf1Wzd">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_fKCop_zxa5djgidPIh" style="text-align: right">42.7</td><td id="xdx_F2A_zxJkt8SxVRF5" style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_fKCop_zGqXEnD9jUR1" style="text-align: right">38.4</td><td id="xdx_F29_zWz5fv7nygMa" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_z2CO6DbPkR5b" style="text-align: left">Credas Capital GmbH</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_zUWfYzgtZ3N7">Switzerland</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_fKCop_zjQnFfSbRAd9" style="text-align: right">42.7</td><td id="xdx_F25_zkaa148HqTse" style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_fKCop_zGwgAxLBydLh" style="text-align: right">38.4</td><td id="xdx_F23_zOFEHLHkBvAh" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zmgQZE8pc5Gc" style="text-align: left">Smart Reward Express Limited</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zR2kMC3WbIEf" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zwolIpA8uy91" style="text-align: right">50.0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_fKCop_zAMdTZPxDi0b" style="text-align: right">38.3</td><td id="xdx_F20_znhqL38LCOW3" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zJM3retDgzUe" style="text-align: left">AHR Texas Two LLC</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zv0WezpGeyUa" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_za9ZBHA7V002" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zYCwSj1MjJu4" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zKoKXvWmBcTd" style="text-align: left">AHR Black Oak One LLC</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zZ4gpcOAsv8b" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zvUTAlbmOJqf" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zhZSpDuJBrr8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zlNNm1tpB0ob" style="text-align: left">Hapi Air Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zfzbfVKhBbv3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zcU7N22UaKck" style="text-align: right">92.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zBSo8TTXGkrc" style="text-align: right">88.4</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_z7GVN1ZoriCd" style="text-align: left">AHR Texas Three, LLC</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_ziTeYsJXC4j5" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_zO0Fqu0AhkZg" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_z2F5h1ZsGp3h" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zn1nbm114St" style="text-align: left">Alset Capital Pte. Ltd.</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zxdgO5a0vQM3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zjun7QNAohfd" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zITAcnX316bi" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zoRXxDozRAUe" style="text-align: left">Hapi Cafe Korea, Inc.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zZsh6gslXj5c">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zjuIUSe6Dlta" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zMTfYBs2kpu6" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zTWmiveZh3l8" style="text-align: left">Green Energy Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zfOOkhu32Tik" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zhq3uMW5U1O1" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zwUTHTlEg1Gl" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zmd5xEy2p7pd" style="text-align: left">Green Energy Management Inc.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zQJ5OQOGSEhf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zhhOAurAwnFk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zhURnsGUuFCf" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_znk5ayFEKKa4" style="text-align: left">Alset Metaverse Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zxBc09YKg7E1" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zcyd5OiiQvLe" style="text-align: right">97.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zgLXraoTrIdc" style="text-align: right">95.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zIS4ZGuIxYgf" style="text-align: left">Alset Management Group Inc.</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zdSI2lETipD3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_z08L1RiwRRba" style="text-align: right">83.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zZfYRbmJEkY7" style="text-align: right">88.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_znS1jIMEiVXj" style="text-align: left">Alset Acquisition Sponsor, LLC</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zVWFKe8iv2l" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zoMdojxfJdj7" style="text-align: right">93.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zi83EtLj15Y7" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zTQEWoQZkTk5" style="text-align: left">Alset Capital Acquisition Corp.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zb9IrVRTKnQ3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zI1lsC7tyEd6" style="text-align: right">23.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zi5gLfm3m5J7" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zya1GZfZGyIe" style="text-align: left">Alset Spac Group Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zb2Wa6QHbur9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zJXg5FwnCvKf" style="text-align: right">93.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zsdevVgNZiVk" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zhTzeI5dM6f2" style="text-align: left">Alset Mining Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zp0qS1uSHfK5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zRnIROiEbf0f" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_z8kkjWdMtAt8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zJcU4ngQm0y6" style="text-align: left">Alset Inc.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zcSsvkAi2xHf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zPD9DG97uGK6" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zzL9RL7Hvare" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1677">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zjnmJX1xlP8g" style="text-align: left">Hapi Travel Pte. Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zqxHYoVEbewb">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zUvCZjOzq6Z9" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zMHFGasFSP9h" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_z29hNEdedcw4" style="text-align: left">Hapi WealthBuilder Pte. Ltd.</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_zzmkkzJtg1oj">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_zmyMJCIYFMBd" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_ztWo29saqIj4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1685">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zmpaZ4PbHRf" style="text-align: left">HWH Marketplace Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_z4IdO7qDdxL2">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zsp5i3bKuKZ2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zvBJj2XgNQ9f" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1689">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zSLRjIVOFblb" style="text-align: left">HWH International Inc. (Nevada)</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zp29tBAfsMI" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zyBdMLx3Xjfc" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zfP9VnTe24a6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1693">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zxzyrbtxCBgc" style="text-align: left">Hapi Cafe SG Pte. Ltd.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zcfqBZRRTDE8">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_z5KtB6mNEeXa" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zThWbvvQ00Oe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1697">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zn7MQrmFqAJa" style="text-align: left">Alset Reits Inc.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zHvszszHJcRl" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zXeXESXHk2ac" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zClWFGmNH4Ec" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1701">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zr7qGUQ61hJd" style="text-align: left">Robotic gHome Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zidbhee6z8d3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zG8MJFoTJCki" style="text-align: right">76.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zMNDgdUtgDlb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1705">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_zWdv5Wtt6tU7" style="text-align: left">HWH Merger Sub, Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_z10RFJ51zIyj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_zm4ld7j66fy8" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_ztuUVns9Y67e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_z0Vqv7NuFKT4" style="text-align: left">Alset Home REIT Inc.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zWFeaJuc7Wrj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zdTKPFkWUM09" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zTWHmYtrBvZg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1713">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zP5yrppr4Ya3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zHMr5x5REU4c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.</span></td></tr> </table> <p id="xdx_8A1_zzyBEetHN4pa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_892_eus-gaap--ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_zKfBMRZGyJBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s condensed consolidated financial statements include the financial position, results of operations and cash flows of the following entities as of September 30, 2022 and December 31, 2021, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zyo1FjZCicJ5" style="display: none">SCHEDULE OF SUBSIDIARIES</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Attributable interest as of,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of subsidiary consolidated under AEI</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">State or other jurisdiction of incorporation or organization</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">September 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zGjvZnRTrBNk" style="width: 29%; text-align: left">Alset Global Pte. Ltd.</td><td style="width: 2%"> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zWZIZRtAKZl4" style="width: 29%" title="State or other jurisdiction of incorporation or organization">Singapore</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zec2OsgiSNs1" style="width: 16%; text-align: right" title="Ownership percentage">100</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetGlobalPteLtdMember_zM1tjpEDFoE1" style="width: 16%; text-align: right" title="Ownership percentage">100</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zuRzv2hTpzR1" style="text-align: left">Alset Business Development Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_z2WEF4aTxRt7" title="State or other jurisdiction of incorporation or organization">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zXDLfBXzCzwe" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBusinessDevelopmentPteLtdMember_zzcp8gYKMrAa" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_ztnYyfQLy1o" style="text-align: left">Global eHealth Limited</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zMl5gbAncEi1" style="text-align: left" title="State or other jurisdiction of incorporation or organization">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zA8sJKCmcyHh" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobaleHealthLimitedMember_zpudo3tzpxZd" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zspl1BoXj4U6" style="text-align: left">Alset International Limited</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zyggjgjOCAk5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zd6SSqD6gvQ5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalIncMember_zsCIjt6hPvAe" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zYzZG8Oo5B3k" style="text-align: left">Singapore Construction &amp; Development Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zSwXrLSaT5M4">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zhJJcsHtGZba" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionDevelopmentPteLtdMember_zoE9fi0Jsgah" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_z0D7sOJ7Zuld" style="text-align: left">Art eStudio Pte. Ltd.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_zM3BSEe1trae">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_fKCop_znvJoK4Tu2Jf" style="text-align: right">43.6</td><td style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ArtEStudioPteLtdMember_fKCop_z4nzkPQv2mkd" style="text-align: right">39.2</td><td style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z4vO8Ft0MZ26" style="text-align: left">Singapore Construction Pte. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z9bUvZyxpxD6">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z6pQoTpt35Pd" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeConstructionPteLtdMember_z4H0bFuhOCu1" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zXBZI9F3mkn4" style="text-align: left">Global BioMedical Pte. Ltd.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zqaO2kC4hIO3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zMeBy9cCeCYf" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalBioMedicalPteLtdMember_zKTGVJrmzyv7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zh6sSemR1Ag4" style="text-align: left">Alset Innovation Pte. Ltd.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zLWzabOjrRef">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_zcYso7WpNa7l" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInnovationPteLtdMember_z9uHJYijIhD5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zUYHnjQXYog8" style="text-align: left">Health Wealth Happiness Pte. Ltd.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zEEMYbNqGMd9">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zG8W9aCvj8ee" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessPteLtdMember_zyqonfb5DVm4" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zJKGaw7IUDQe" style="text-align: left">SeD Capital Pte. Ltd.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zkYzIgivKMe5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zisAC5TeqHh7" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDCapitalPteLtdMember_zaInywzKyIa7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zKGAbqmZsRX2" style="text-align: left">LiquidValue Asset Management Pte. Ltd.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_z9L5u4CQcYVc">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zfulsvizA1H6" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueAssetManagementPteLtdMember_zmGSTiY5izBg" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zaNycvIhygDl" style="text-align: left">Alset Solar Limited</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_za2SfRaN69a8" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zfve6mtbhjl5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarLimitedMember_zqw9EWeo8SU5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_z7alaIhk7a0b" style="text-align: left">Alset F&amp;B One Pte. Ltd</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zcGhlReUrGye">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zjGrofxmGI9g" style="text-align: right">76.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBOnePteLtdMember_zeCLghZpR8S2" style="text-align: right">69.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_ztQBZ2dXrSde" style="text-align: left">Global TechFund of Fund Pte. Ltd.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zYZLebo191f8">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zy9FcJqwC0wl" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalTechFundOfFundPteLtdMember_zn12zYn81RRj" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zkdYUmWQhJRa" style="text-align: left">Singapore eChainLogistic Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_z3rg5M5Ta3C3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zEY5IiQ0dsB9" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SingaporeEChainLogisticPteLtdMember_zZkbD0QvDGt5" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98C_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zx5jAMk96Dgk" style="text-align: left">BMI Capital Partners International Limited.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zNZER6L3U8U2" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zLfn1c0foS65" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BMICapitalPartnersInternationalLimitedMember_zaYjAaAvfIDc" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zbJk8Cp9y4L7" style="text-align: left">SeD Perth Pty. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zO6z95J2W3m7">Australia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zX9WYc5Qyyoj" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zdQ6Cm4cf87g" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zR4k8yzLa7Rg" style="text-align: left">SeD Intelligent Home Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_z2iQnAKflSfg" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zaWsX8VGM3M1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDIntelligentHomeIncMember_zRfBDXd8cscf" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zBt4dwdctTq5" style="text-align: left">LiquidValue Development Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zk7A1WQXDae3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zYbKeJ8FZb4g" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentIncMember_zTTSv2lyHvIi" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zWUnQmi1dOfc" style="text-align: left">Alset EHome Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zbql4JjirPml" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_zalP5UIbyerh" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEHomeIncMember_z9rgK2LA6w4h" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zAMhiQnBza0b" style="text-align: left">SeD USA, LLC</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zJRGQIfYlrOf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zzMzKak2kHuh" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDUSALLCMember_zMMVlGuZDj5b" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zuT9ydk8nbKh" style="text-align: left">150 Black Oak GP, Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zpZnoSZNSLga" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_zPtmL4bDttBi" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyBlackOakGPIncMember_z7R3BBnyoesg" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zxP70f3dovh1" style="text-align: left">SeD Development USA Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zpaty3Q1FS7c" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zWfytqmcJ9if" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentUSAIncMember_zaE4jG2AEq71" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zsC4KNpuzot8" style="text-align: left">150 CCM Black Oak, Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_z27ZYmeBpRCd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zWW3NiZFEMm8" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OneHundredFiftyCCMBlackOakLtdMember_zgsZF5zNve79" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zuOzeKl2Rk1a" style="text-align: left">SeD Texas Home, LLC</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_z7pjvnkuMQxj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zazcZcDWSIlg" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDTexasHomeLLCMember_zIwXkCT4SiZd" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zy3vl9fB8MFl" style="text-align: left">SeD Ballenger, LLC</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zu8wiaj81TK6" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zWV2RjiuOTpa" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBallengerLLCMember_zF0M6O58vQ74" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_zClMWBVmISjh" style="text-align: left">SeD Maryland Development, LLC</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_znIEJzglACw9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_zTbBEeSXuU8b" style="text-align: right">71.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDMarylandDevelopmentLLCMember_z32yBSTWLEG1" style="text-align: right">64.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zLia3L92BtBi" style="text-align: left">SeD Development Management, LLC</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_z9dl51I8oZZ9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zXaV2nYd8ohl" style="text-align: right">72.6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDDevelopmentManagementLLCMember_zCdxpE1WRqNd" style="text-align: right">65.3</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_zuCM0wPSuXn9" style="text-align: left">SeD Builder, LLC</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_zygqjMADI039" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_z3CxPywaY0U1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDBuilderLLCMember_z3iKHPyxDuz2" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_z6rOoSvDH0Kf" style="text-align: left">GigWorld Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_z6opJSrJdFql" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_ziR9xMqfYzNf" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigWorldIncMember_zjZf4hvqZnEf" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zcFwXePedo39" style="text-align: left">HotApp BlockChain Pte. Ltd.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zoI8SiErQJd7">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zCRNdPzXB6F6" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppBlockChainPte.LtdMember_zbgzfZN20EBf" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zCKjlDPq510d" style="text-align: left">HotApp International Limited</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zh4Gba00hR6j" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zLRVlCn9uRG5" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HotAppInternationalLimitedMember_zQ1iktQUr7Rk" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zHbxawYDa6n5" style="text-align: left">HWH International, Inc. (Delaware)</td><td> </td> <td id="xdx_98A_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zl7HZkxkF46d" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zPG3hrzHqYV1" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncMember_zt5UisTpF1ng" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zif6g0AC7LNl" style="text-align: left">Health Wealth &amp; Happiness Inc.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_z5PAA0VnJ1S8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zbq8GpKhqFn5" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HealthWealthHappinessIncMember_zdrtBq77GMGc" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zcznXKI9mSP8" style="text-align: left">HWH Multi-Strategy Investment, Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zs0GC8QM9pq8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zpFvklj1Ilgb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMultiStrategyInvestmentIncMember_zySaZRttdMCb" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_z9LQl9XX3OK3" style="text-align: left">SeD REIT Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_z99HBeapOOfg" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_zGvs8tXMSzm9" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDREITIncMember_zcBwjg7FjRQf" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zbea4qVKk30e" style="text-align: left">Gig Stablecoin Inc.</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zDpXrgF6qkFd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zGGewq2UxiG5" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GigStablecoinIncMember_zAeK7g75Yl0a" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zYTmTH1k8VEc" style="text-align: left">HWH World Inc. (Delaware)</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_z0TqVuNODn1g" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zdV22smwFi7b" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncMember_zjF9wumbIPeg" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_z3Hk7tIdICXc" style="text-align: left">HWH World Pte. Ltd.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zZahR4qqXo3j">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zkRrTs8dpeE4" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldPteLtdMember_zh4kgbbDiJWj" style="text-align: right">76.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zhe7wg3gShdf" style="text-align: left">UBeauty Limited</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zIP6bEduRrU7" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zfc1oxZRHBY2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--UBeautyLimitedMember_zvbpqiIEC1t8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zHXmJvfIbenk" style="text-align: left">WeBeauty Korea Inc</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zouJjylkVqV6">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zsyT5wBM4Pvl" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--WeBeautyKoreaIncMember_zuWFrQH4heli" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zitK5lkTWHx" style="text-align: left">HWH World Limited</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zDTkUj5CCjP" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_z4pATjEEmou3" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldLimitedMember_zqTZ48O5t1a6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_z2j174EcCFxk" style="text-align: left">HWH World Inc.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_zlU9mvajSMHe">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_znKvbF7JVWj" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncOneMember_zeLjb8mUNhw6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_z4WUnkVpiz49" style="text-align: left">Alset BioHealth Pte. Ltd.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_zI80XH8GrUBe">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_z8dYrCMpaVad" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1511">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetBioHealthPteLtdMember_zCEdqMtbrz3c" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zZK5J8rGfSba" style="text-align: left">Alset Energy Pte. Ltd.</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_z6IEUUjUNbI6">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zxl6RoWbXhU8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1515">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEnergyPteLtdMember_zFLSDY3rSBE3" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zThjyXb8VBY2" style="text-align: left">GDC REIT Inc. (f.k.a. Alset Payment Inc.)</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zzDRkEgwxP72" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_z67rAx3Yfeb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GDCREITIncMember_zKxF0cZQFFd8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_ztz9krDjbNZ7" style="text-align: left">Alset World Pte. Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zao4EUleZHh9">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zjLSdZ0qsQRl" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1523">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetWorldPteLtdMember_zYxtt4wiNDfh" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_zQmE290rUilf" style="text-align: left">BioHealth Water Inc.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_zyUE1Cgn5yda" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_z2I7geUVuxy3" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioHealthWaterIncMember_z7fffX8q2qo7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zXEtYPRRZAGi" style="width: 29%; text-align: left">Impact BioHealth Pte. Ltd.</td><td style="width: 2%"> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zUbFYWbj2r2k" style="width: 29%">Singapore</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_zsiMMlMbyrab" style="width: 16%; text-align: right">85.4</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ImpactBioHealthPte.LtdMember_z9ECiHi1Bu86" style="width: 16%; text-align: right">76.8</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zHjfTBnsv24j" style="text-align: left">American Home REIT Inc.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zW0tb7ovWSGc" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_z4UrMFO5dyt" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanHomeREITIncMember_zglJFjXxoAH9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zn726lamWYog" style="text-align: left">Alset Solar Inc.</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zJrSLonEJ9Vd" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zBWEimVqild4" style="text-align: right">68.3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSolarIncMember_zFwBB9xOlml3" style="text-align: right">61.5</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zHgTxPQO98H2" style="text-align: left">HWH KOR Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zOHP3kMmKXm4" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_zG4JyY5c0bvb" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHKORIncMember_z93HGy8RU3Vi" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zoRlgM2SHJi1" style="text-align: left">Open House Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_ze9hUf371t7f" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zwhfTX1jMEAh" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenHouseIncMember_zgl4k1QRcHh9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_zRgzKmOYjoYe" style="text-align: left">Open Rental Inc.</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_z0gewfgGum8h" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_znetYc4qfea8" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenRentalIncMember_zSKwPSZx2EY9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_z8AvJlAisFw7" style="text-align: left">Hapi Cafe Inc. (Nevada)</td><td> </td> <td id="xdx_98A_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zEnCaLD0YeNk" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zVdXDXNkqATk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncNevadaMember_zLqYWcLxsKW9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zizeQhvFmW2g" style="text-align: left">Global Solar REIT Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization._c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zEuglecY6LSk" style="text-align: left" title="State or other jurisdiction of incorporation or organization">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zvdDTVYwgjjf" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GlobalSolarREITIncMember_zARHTGFSdeRa" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_z4DpJJYSvQDk" style="text-align: left">OpenBiz Inc.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zs1k78nlsGG8" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zm7s9gkXxwBg" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--OpenBizIncMember_zmWkqGpz9Wvd" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_z4ovMM46PHa4" style="text-align: left">Hapi Cafe Inc. (Texas)</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_ziodkPffcvD2" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_zwhH72aHjC61" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeIncTexasMember_zGx04eC9zmy3" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98C_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zTfNRNbDKXa7" style="text-align: left">HWH (S) Pte. Ltd.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zghztcntyPF2">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zmtkXpQ8iBha" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHSPteLtdMember_zzpvXIZLLjq7" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zMI1ig5COWDi" style="text-align: left">True Partner International Limited</td><td> </td> <td id="xdx_980_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zunIVDx8hjTc" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zrjk5mmIgDT9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1576">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TruePartnerInternationalLimitedMember_zpjbc64S16Jk" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zJ5wg3ae57Q4" style="text-align: left">LiquidValue Development Pte. Ltd.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_znQyryMbPddg">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zr2ysal9kGqk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember_zJOXNHjZwF5f" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zMRshS4FffKf" style="text-align: left">LiquidValue Development Limited</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zB1j3dyQgaTj" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_z48mnHH83bJj" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentLimitedMember_zyLY60tGJKUf" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zujbySfnKbs6" style="text-align: left">EPowerTech Inc.</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zAZseqYA0hbj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zoTfSYXpkbo4" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--EPowerIncMember_zajAEyALz3r9" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_za8jrxjyNIUl" style="text-align: left">Alset EPower Inc.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zn4a2NVN3qf6" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zkmosgzP3Iee" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetEPowerIncMember_zflF2g8mmBD1" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zVAfEyNyodI8" style="text-align: left">AHR Asset Management Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zdfbI9w3rLO4" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_ziUaIXkawgP2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRAssetManagementIncMember_zgjFHaXFcmR6" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98B_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zXiXMO9rWKac" style="text-align: left">HWH World Inc. (Nevada)</td><td> </td> <td id="xdx_982_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zKcaDjtCyRoc" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_zcYO5iNsXs4b" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldIncNevadaMember_z9nad746l2re" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zVBry3rryz5k" style="text-align: left">Alset F&amp;B Holdings Pte. Ltd.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zLMF2zj5ji0b">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zzrcVRaEfbch" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetFBHoldingsPteIncMember_zo0wtFIeace9" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_zrPuU32qm196" style="text-align: left">Credas Capital Pte. Ltd.</td><td> </td> <td id="xdx_98E_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_zd9cDrRf1Wzd">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_fKCop_zxa5djgidPIh" style="text-align: right">42.7</td><td id="xdx_F2A_zxJkt8SxVRF5" style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalPteLtdMember_fKCop_zGqXEnD9jUR1" style="text-align: right">38.4</td><td id="xdx_F29_zWz5fv7nygMa" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_z2CO6DbPkR5b" style="text-align: left">Credas Capital GmbH</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_zUWfYzgtZ3N7">Switzerland</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_fKCop_zjQnFfSbRAd9" style="text-align: right">42.7</td><td id="xdx_F25_zkaa148HqTse" style="text-align: left">*</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--CredasCapitalGmbhMember_fKCop_zGwgAxLBydLh" style="text-align: right">38.4</td><td id="xdx_F23_zOFEHLHkBvAh" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zmgQZE8pc5Gc" style="text-align: left">Smart Reward Express Limited</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zR2kMC3WbIEf" style="text-align: left">Hong Kong</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_zwolIpA8uy91" style="text-align: right">50.0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SmartRewardExpressLimitedMember_fKCop_zAMdTZPxDi0b" style="text-align: right">38.3</td><td id="xdx_F20_znhqL38LCOW3" style="text-align: left">*</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_984_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zJM3retDgzUe" style="text-align: left">AHR Texas Two LLC</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zv0WezpGeyUa" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_za9ZBHA7V002" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasTwoLLCMember_zYCwSj1MjJu4" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zKoKXvWmBcTd" style="text-align: left">AHR Black Oak One LLC</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zZ4gpcOAsv8b" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zvUTAlbmOJqf" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRBlackOakOneLLCMember_zhZSpDuJBrr8" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zlNNm1tpB0ob" style="text-align: left">Hapi Air Inc.</td><td> </td> <td id="xdx_98F_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zfzbfVKhBbv3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zcU7N22UaKck" style="text-align: right">92.7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiAirIncMember_zBSo8TTXGkrc" style="text-align: right">88.4</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_z7GVN1ZoriCd" style="text-align: left">AHR Texas Three, LLC</td><td> </td> <td id="xdx_986_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_ziTeYsJXC4j5" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_zO0Fqu0AhkZg" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AHRTexasThreeLLCMember_z2F5h1ZsGp3h" style="text-align: right">76.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zn1nbm114St" style="text-align: left">Alset Capital Pte. Ltd.</td><td> </td> <td id="xdx_984_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zxdgO5a0vQM3">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zjun7QNAohfd" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalPteLtdMember_zITAcnX316bi" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zoRXxDozRAUe" style="text-align: left">Hapi Cafe Korea, Inc.</td><td> </td> <td id="xdx_983_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zZsh6gslXj5c">Korea</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zjuIUSe6Dlta" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeKoreaIncMember_zMTfYBs2kpu6" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zTWmiveZh3l8" style="text-align: left">Green Energy Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zfOOkhu32Tik" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zhq3uMW5U1O1" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyIncMember_zwUTHTlEg1Gl" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zmd5xEy2p7pd" style="text-align: left">Green Energy Management Inc.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zQJ5OQOGSEhf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zhhOAurAwnFk" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GreenEnergyManagementIncMember_zhURnsGUuFCf" style="text-align: right">100</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_znk5ayFEKKa4" style="text-align: left">Alset Metaverse Inc.</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zxBc09YKg7E1" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zcyd5OiiQvLe" style="text-align: right">97.2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMetaverseIncMember_zgLXraoTrIdc" style="text-align: right">95.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zIS4ZGuIxYgf" style="text-align: left">Alset Management Group Inc.</td><td> </td> <td id="xdx_987_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zdSI2lETipD3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_z08L1RiwRRba" style="text-align: right">83.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetManagementGroupIncMember_zZfYRbmJEkY7" style="text-align: right">88.2</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_981_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_znS1jIMEiVXj" style="text-align: left">Alset Acquisition Sponsor, LLC</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zVWFKe8iv2l" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zoMdojxfJdj7" style="text-align: right">93.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetAcquisitionSponsorLLCMember_zi83EtLj15Y7" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_982_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zTQEWoQZkTk5" style="text-align: left">Alset Capital Acquisition Corp.</td><td> </td> <td id="xdx_985_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zb9IrVRTKnQ3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zI1lsC7tyEd6" style="text-align: right">23.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCorpMember_zi5gLfm3m5J7" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zya1GZfZGyIe" style="text-align: left">Alset Spac Group Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zb2Wa6QHbur9" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zJXg5FwnCvKf" style="text-align: right">93.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetSpacGroupIncMember_zsdevVgNZiVk" style="text-align: right">79.6</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zhTzeI5dM6f2" style="text-align: left">Alset Mining Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zp0qS1uSHfK5">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_zRnIROiEbf0f" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetMiningPteLtdMember_z8kkjWdMtAt8" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zJcU4ngQm0y6" style="text-align: left">Alset Inc.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zcSsvkAi2xHf" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zPD9DG97uGK6" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetIncMember_zzL9RL7Hvare" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1677">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_989_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zjnmJX1xlP8g" style="text-align: left">Hapi Travel Pte. Ltd.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zqxHYoVEbewb">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zUvCZjOzq6Z9" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiTravelPteLtdMember_zMHFGasFSP9h" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1681">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98D_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_z29hNEdedcw4" style="text-align: left">Hapi WealthBuilder Pte. Ltd.</td><td> </td> <td id="xdx_989_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_zzmkkzJtg1oj">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_zmyMJCIYFMBd" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiWealthBuilderPteLtdMember_ztWo29saqIj4" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1685">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_988_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zmpaZ4PbHRf" style="text-align: left">HWH Marketplace Pte. Ltd.</td><td> </td> <td id="xdx_98D_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_z4IdO7qDdxL2">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zsp5i3bKuKZ2" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMarketingPlacePteLtdMember_zvBJj2XgNQ9f" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1689">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zSLRjIVOFblb" style="text-align: left">HWH International Inc. (Nevada)</td><td> </td> <td id="xdx_988_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zp29tBAfsMI" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zyBdMLx3Xjfc" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHInternationalIncNevadaMember_zfP9VnTe24a6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1693">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98E_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zxzyrbtxCBgc" style="text-align: left">Hapi Cafe SG Pte. Ltd.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zcfqBZRRTDE8">Singapore</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_z5KtB6mNEeXa" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HapiCafeSGPteMember_zThWbvvQ00Oe" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1697">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_987_ecustom--NameOfSubsidiary_c20220101__20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zn7MQrmFqAJa" style="text-align: left">Alset Reits Inc.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zHvszszHJcRl" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zXeXESXHk2ac" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetReitsIncMember_zClWFGmNH4Ec" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1701">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_986_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zr7qGUQ61hJd" style="text-align: left">Robotic gHome Inc.</td><td> </td> <td id="xdx_98B_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zidbhee6z8d3" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zG8MJFoTJCki" style="text-align: right">76.9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--RoboticgHomeIncMember_zMNDgdUtgDlb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1705">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_98F_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_zWdv5Wtt6tU7" style="text-align: left">HWH Merger Sub, Inc.</td><td> </td> <td id="xdx_98C_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_z10RFJ51zIyj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_zm4ld7j66fy8" style="text-align: right">85.4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHMergerSubIncMember_ztuUVns9Y67e" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_ecustom--NameOfSubsidiary_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_z0Vqv7NuFKT4" style="text-align: left">Alset Home REIT Inc.</td><td> </td> <td id="xdx_981_ecustom--StateOrOtherJurisdictionOfIncorporationOrOrganization_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zWFeaJuc7Wrj" style="text-align: left">United States of America</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zdTKPFkWUM09" style="text-align: right">100</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetHomeREITIncMember_zTWHmYtrBvZg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1713">-</span></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F02_zP5yrppr4Ya3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zHMr5x5REU4c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.</span></td></tr> </table> Alset Global Pte. Ltd. Singapore 1 1 Alset Business Development Pte. Ltd. Singapore 1 1 Global eHealth Limited Hong Kong 1 1 Alset International Limited Singapore 0.854 0.768 Singapore Construction & Development Pte. Ltd. Singapore 0.854 0.768 Art eStudio Pte. Ltd. Singapore 0.436 0.392 Singapore Construction Pte. Ltd. Singapore 0.854 0.768 Global BioMedical Pte. Ltd. Singapore 0.854 0.768 Alset Innovation Pte. Ltd. Singapore 0.854 0.768 Health Wealth Happiness Pte. Ltd. Singapore 0.854 0.768 SeD Capital Pte. Ltd. Singapore 0.854 0.768 LiquidValue Asset Management Pte. Ltd. Singapore 0.854 0.768 Alset Solar Limited Hong Kong 0.854 0.768 Alset F&B One Pte. Ltd Singapore 0.769 0.692 Global TechFund of Fund Pte. Ltd. Singapore 1 0.768 Singapore eChainLogistic Pte. Ltd. Singapore 1 0.768 BMI Capital Partners International Limited. Hong Kong 0.854 0.768 SeD Perth Pty. Ltd. Australia 0.854 0.768 SeD Intelligent Home Inc. United States of America 0.854 0.768 LiquidValue Development Inc. United States of America 0.854 0.768 Alset EHome Inc. United States of America 0.854 0.768 SeD USA, LLC United States of America 0.854 0.768 150 Black Oak GP, Inc. United States of America 0.854 0.768 SeD Development USA Inc. United States of America 0.854 0.768 150 CCM Black Oak, Ltd. United States of America 0.854 0.768 SeD Texas Home, LLC United States of America 0.854 0.768 SeD Ballenger, LLC United States of America 0.854 0.768 SeD Maryland Development, LLC United States of America 0.714 0.642 SeD Development Management, LLC United States of America 0.726 0.653 SeD Builder, LLC United States of America 0.854 0.768 GigWorld Inc. United States of America 1 0.766 HotApp BlockChain Pte. Ltd. Singapore 1 0.766 HotApp International Limited Hong Kong 1 0.766 HWH International, Inc. (Delaware) United States of America 0.854 0.768 Health Wealth & Happiness Inc. United States of America 0.854 0.768 HWH Multi-Strategy Investment, Inc. United States of America 0.854 0.768 SeD REIT Inc. United States of America 0.854 0.768 Gig Stablecoin Inc. United States of America 1 0.766 HWH World Inc. (Delaware) United States of America 1 0.766 HWH World Pte. Ltd. Singapore 0.854 0.766 UBeauty Limited Hong Kong 0.854 0.768 WeBeauty Korea Inc Korea 0.854 0.768 HWH World Limited Hong Kong 0.854 0.768 HWH World Inc. Korea 0.854 0.768 Alset BioHealth Pte. Ltd. Singapore 0.768 Alset Energy Pte. Ltd. Singapore 0.768 GDC REIT Inc. (f.k.a. Alset Payment Inc.) United States of America 0.854 0.768 Alset World Pte. Ltd. Singapore 0.768 BioHealth Water Inc. United States of America 0.854 0.768 Impact BioHealth Pte. Ltd. Singapore 0.854 0.768 American Home REIT Inc. United States of America 0.854 0.768 Alset Solar Inc. United States of America 0.683 0.615 HWH KOR Inc. United States of America 0.854 0.768 Open House Inc. United States of America 1 0.768 Open Rental Inc. United States of America 1 0.768 Hapi Cafe Inc. (Nevada) United States of America 1 0.768 Global Solar REIT Inc. United States of America 1 0.768 OpenBiz Inc. United States of America 1 0.768 Hapi Cafe Inc. (Texas) United States of America 0.854 1 HWH (S) Pte. Ltd. Singapore 0.854 0.768 True Partner International Limited Hong Kong 1 LiquidValue Development Pte. Ltd. Singapore 1 1 LiquidValue Development Limited Hong Kong 1 1 EPowerTech Inc. United States of America 1 1 Alset EPower Inc. United States of America 1 1 AHR Asset Management Inc. United States of America 0.854 0.768 HWH World Inc. (Nevada) United States of America 0.854 0.768 Alset F&B Holdings Pte. Ltd. Singapore 0.854 0.768 Credas Capital Pte. Ltd. Singapore 0.427 0.384 Credas Capital GmbH Switzerland 0.427 0.384 Smart Reward Express Limited Hong Kong 0.500 0.383 AHR Texas Two LLC United States of America 0.854 0.768 AHR Black Oak One LLC United States of America 0.854 0.768 Hapi Air Inc. United States of America 0.927 0.884 AHR Texas Three, LLC United States of America 0.854 0.768 Alset Capital Pte. Ltd. Singapore 1 1 Hapi Cafe Korea, Inc. Korea 0.854 1 Green Energy Inc. United States of America 1 1 Green Energy Management Inc. United States of America 1 1 Alset Metaverse Inc. United States of America 0.972 0.956 Alset Management Group Inc. United States of America 0.834 0.882 Alset Acquisition Sponsor, LLC United States of America 0.934 0.796 Alset Capital Acquisition Corp. United States of America 0.234 0.796 Alset Spac Group Inc. United States of America 0.934 0.796 Alset Mining Pte. Ltd. Singapore 0.854 Alset Inc. United States of America 1 Hapi Travel Pte. Ltd. Singapore 0.854 Hapi WealthBuilder Pte. Ltd. Singapore 0.854 HWH Marketplace Pte. Ltd. Singapore 0.854 HWH International Inc. (Nevada) United States of America 0.854 Hapi Cafe SG Pte. Ltd. Singapore 0.854 Alset Reits Inc. United States of America 1 Robotic gHome Inc. United States of America 0.769 HWH Merger Sub, Inc. United States of America 0.854 Alset Home REIT Inc. United States of America 1 <p id="xdx_84C_eus-gaap--UseOfEstimates_zCX2R8oAqJC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, valuation of real estate assets, allocation of development costs and capitalized interest to sold lots, fair value of the investments, the valuation allowance of deferred taxes, and contingencies. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In our property development business, land acquisition costs are allocated to each lot based on the area method, the size of the lot compared to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot compared to the total size of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--PurchaseTransactionPolicy_zCftiG2lL4Pb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Transactions between Entities under Common Control</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On March 12, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company, for four proposed transactions, consisting of (i) purchase of certain warrants (the “Warrants”) to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AlsetInternationalLimitedMember_pdd" title="Number of warrant purchased">1,500,000,000</span> shares of Alset International Limited, which was valued at $<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstanding_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AlsetInternationalLimitedMember_pdp0" title="Warrants and rights outstanding">28,363,966</span>; (ii) purchase of all of the issued and outstanding stock of LiquidValue Development Pte Ltd. (“LVD”), which was valued at $<span id="xdx_90E_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20210309__20210312__srt--ConsolidatedEntitiesAxis__custom--LiquidValueDevelopmentPteLtdMember_zAuXGcsB3QI1" title="Stock repurchased during period, value">173,395</span>; (iii) purchase of <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--TruePartnerCapitalHoldingLimitedMember_zlq25OQmQI43" title="Stock repurchased during period, shares">62,122,908</span> ordinary shares in True Partner Capital Holding Limited (HKG: 8657) (“True Partner”), which was valued at $<span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodValue_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--TruePartnerCapitalHoldingLimitedMember_pp0p0" title="Stock repurchased during period, value">6,729,629</span>; and (iv) purchase of <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpIncMember_pdd" title="Stock repurchased during period, shares">4,775,523</span> shares of the common stock of American Pacific Bancorp Inc. (“APB”), which was valued at $<span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodValue_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpIncMember_pp0p0" title="Stock repurchased during period, value">28,653,138</span>. The total amount of above four transactions was $<span id="xdx_908_eus-gaap--AccountsPayableCurrent_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Accounts payable, current">63,920,129</span>, payable on the Closing Date by the Company, in the convertible promissory notes (“Alset CPNs”), which, subject to the terms and conditions of the Alset CPNs and the Company’s shareholder approval, shall be convertible into shares of the Company’s common stock (“AEI Common Stock”), par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Common stock, par value">0.001</span> per share, at the conversion price of AEI’s Stock Market Price. AEI’s Stock Market Price was $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Shares issued per share">5.59</span> per share, equivalent to the average of the five closing per share prices of AEI’s Common Stock preceding January 4, 2021 as quoted by Bloomberg L.P. The above four acquisitions from Chan Heng Fai were transactions between entities under common control.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 15, 2020, American Pacific Bancorp (which subsequently became a majority-owned subsidiary of the Company) entered into an acquisition agreement to acquire <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20201014__20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HengfengFinanceLimitedMember_zQZrRWWkbxs8" title="Stock purchased upon acquisitions">3,500,001</span> common shares of HengFeng Finance Limited (“HFL”), representing <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HengfengFinanceLimitedMember_zBHVte6z20m9" title="Equity method investment, ownership percentage">100</span>% of the common shares of HFL, in consideration for $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20201014__20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HengfengFinanceLimitedMember_zUC6T2z3jXel" title="Purchase price">1,500,000</span>, to be satisfied by the issuance and allotment of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20201014__20201015__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpMember_zCI1WvXIBHWl" title="Shares issued during acquisition">250,000</span> shares of the Class A Common Stock of American Pacific Bancorp. HFL is incorporated in Hong Kong with limited liability. The principal activities of HFL are money lending, securities trading and investment. This transaction closed on April 21, 2021. This transaction between the Company and Chan Heng Fai is under common control of Chan Heng Fai.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The common control transactions resulted in the following basis of accounting for the financial reporting periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition of the Warrants and True Partner stock were accounted for prospectively as of March 12, 2021 and they did not represent a change in reporting entity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquisition of LVD, APB and HFL was under common control and was consolidated in accordance with ASC 850-50. The consolidated financial statements were retrospectively adjusted for the acquisition of LVD, APB and HFL, and the operating results of LVD, APB and HFL as of January 1, 2020 for comparative purposes.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">AEI’s stock price was $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_c20210312_pdd" title="Shares issued per share">10.03</span> on March 12, 2021, the commitment date. The Beneficial Conversion Feature (“BCF”) intrinsic value was $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20210309__20210312_pp0p0" title="Beneficial conversion feature value">50,770,192</span> for the four convertible promissory notes and was recorded as debt discount of convertible notes after these transactions. The debt discount attributable to the BCF is amortized over the period from issuance to the date that the debt becomes convertible using the effective interest method. If the debt is converted, the discount is amortized to finance the cost in full immediately. On May 13, 2021 and June 14, 2021 all Alset CPNs of $<span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210511__20210513__dei--LegalEntityAxis__custom--AlsetCPNMember_zlM8UCIMnkwj" title="Debt conversion instrument, amount">63,920,128</span> and accrued interest of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210614__dei--LegalEntityAxis__custom--AlsetCPNMember_zmfSCQxVpwp7" title="Accrued interest">306,438</span> were converted into <span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210509__20210614__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__dei--LegalEntityAxis__custom--AlsetCPNMember_zoNBCADQIKFh" title="Debt conversion instrument, shares issued">2,123</span> shares of Series B preferred stock and <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210509__20210614__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--AlsetCPNMember_zdENEbHnCEZi" title="Debt conversion instrument, shares issued">9,163,965</span> shares of common stock of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1500000000 28363966 173395 62122908 6729629 4775523 28653138 63920129 0.001 5.59 3500001 1 1500000 250000 10.03 50770192 63920128 306438 2123 9163965 <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zy3lO7OFbyR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with a maturity of three months or less at the date of acquisition to be cash equivalents. Cash and cash equivalents include cash on hand and at the bank and short-term deposits with financial institutions that are readily convertible to a known amount of cash and are subject to an insignificant risk of changes in values. There were <span id="xdx_900_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20220930_z6lMek0THMck" title="Cash equivalents"><span id="xdx_90D_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_zkmpfg9vXKag" title="Cash equivalents">no</span></span> cash equivalents as of September 30, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zIDkUBjRgiE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Restricted Cash</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a condition to the loan agreement with the Manufacturers and Traders Trust Company (“M&amp;T Bank”), the Company was required to maintain a minimum of $<span id="xdx_905_ecustom--DepositSecuringLoan_iI_pp0p0_c20220930__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember__srt--RangeAxis__srt--MinimumMember_zjOwI0FrJQzd" title="Deposit securing the loan">2,600,000</span> in an interest-bearing account maintained by the lender as additional security for the loan. The funds were required to remain as collateral for the loan until the loan is paid off in full and the loan agreement terminated. On March 15, 2022 approximately $<span id="xdx_90D_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20220314__20220315__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zcRLnPuWBBK6" title="Line of credit collateral">2,300,000</span> was released from collateral, leaving approximately $<span id="xdx_90C_ecustom--LineOfCreditFacilityCollateralOutstanding_c20220314__20220315__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zbQEwBJTp991" title="Line of credit facility collateral outstanding">300,000</span> as collateral for outstanding letters of credit. The Company also has an escrow account with M&amp;T Bank to deposit a portion of cash proceeds from lot sales. The funds in the escrow account were specifically to be used for the payment of the loan from M&amp;T Bank. The funds were required to remain in the escrow account for the loan payment until the loan agreement terminates. In May 2022 the funds from this escrow account were released and the account closed. As of September 30, 2022 and December 31, 2021, the total balance of these two accounts was $<span id="xdx_908_eus-gaap--EscrowDeposit_iI_pp0p0_c20220930__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zMk1Nh2SKxqc" title="Escrow Deposit">309,145</span> and $<span id="xdx_90C_eus-gaap--EscrowDeposit_c20211231__us-gaap--CreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_pp0p0" title="Escrow Deposit">4,399,984</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a condition to the loan agreement with National Australian Bank Limited in conjunction with the Perth project, an Australian real estate development project, the Company was required to maintain Australian Dollar <span id="xdx_903_ecustom--CollateralDeposit_iI_uAUD_c20220930__srt--StatementGeographicalAxis__country--AU_zXVEM9w5ujb6" title="Collateral deposit">50,000</span>, in a non-interest-bearing account. As of December 31, 2021, the account balance was $<span id="xdx_903_ecustom--CollateralDeposit_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--CreditFacilityAxis__custom--NationalAustralianBankLimitedMember_zzGnjyRzSYwf" title="Collateral deposit">36,316</span>. In February 2022 the Company repaid the loan and the funds were subsequently released.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company puts money into brokerage accounts specifically for equity investment. As of September 30, 2022 and December 31, 2021, the cash balance in these brokerage accounts was $<span id="xdx_90B_eus-gaap--RestrictedCash_iI_pp0p0_c20220930__us-gaap--DebtInstrumentAxis__custom--BrokerageMember_zLlPNrITArYc" title="Restricted cash">321,140</span> and $<span id="xdx_909_eus-gaap--RestrictedCash_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--BrokerageMember_zmfySAY46Xrk" title="Restricted cash">304,570</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2600000 2300000 300000 309145 4399984 50000 36316 321140 304570 <p id="xdx_847_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_zqx6whqb7sKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Account Receivables and Allowance for Doubtful Accounts</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account receivables is stated at amounts due from buyers, contractors, and all third parties, net of an allowance for doubtful accounts. As of September 30, 2022 and December 31, 2021, the balance of account receivables was $<span id="xdx_905_eus-gaap--AccountsReceivableNetCurrent_iI_pp0p0_c20220930_ztEWz1apdDi7" title="Account receivables">171,380</span> and $<span id="xdx_904_eus-gaap--AccountsReceivableNetCurrent_c20211231_pp0p0" title="Account receivables">39,622</span>, respectively. Approximately $<span id="xdx_902_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20220930_zPcB28e4y6k1" title="Accounts receivable, net">0</span> and $<span id="xdx_90F_eus-gaap--AccountsReceivableNet_c20211231_pp0p0" title="Accounts receivable, net">2,500</span> of account receivables as of September 30, 2022 and December 31, 2021, respectively, was from DSS with a merchant agreement, under which the Company uses DSS credit card platform to collect money from our direct sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company monitors its account receivables balances on a monthly basis to ensure that they are collectible. On a quarterly basis, the Company uses its historical experience to estimate its allowance for doubtful account receivables. The Company’s allowance for doubtful accounts represents an estimate of the losses expected to be incurred based on specifically identified accounts as well as nonspecific amount, when determined appropriate. Generally, the amount of the allowance is primarily decided by division management’s historical experience, the delinquency trends, the resolution rates, the aging of receivables, the credit quality indicators and financial health of specific customers. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, the allowance was $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20220930_zvjdtKoKPis2" title="Accounts receivable, allowance of doubtful accounts"><span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_c20211231_zTqqwLzr3T25" title="Accounts receivable, allowance of doubtful accounts">0</span></span>.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 171380 39622 0 2500 0 0 <p id="xdx_845_eus-gaap--InventoryPolicyTextBlock_zM91tAGU2XN2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method and includes all costs in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs necessary to make the sale. As of December 31, 2021, inventory consisted of finished goods from HWH World Inc. As of September 30, 2022, inventory consisted of finished goods from HWH World Inc. and Hapi Cafe Korea Inc. The Company continuously evaluates the need for reserve for obsolescence and possible price concessions required to write-down inventories to net realizable value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84D_ecustom--InvestmentSecuritiesPolicyTextBlock_zMREcJn1romi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Investment Securities</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investment Securities at Fair Value</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records all equity investments with readily determinable fair values at fair value calculated by the publicly traded stock price at the close of the reporting period. Amarantus BioScience Holdings (“AMBS”) and True Partner Capital Holding Limited (“True Partner”) are publicly traded companies. The Company does not have significant influence over AMBS and True Partner, as the Company is the beneficial owner of approximately <span id="xdx_902_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmarantusBioScienceHoldingsMember_zo5057sXn95g" title="Ownership in fair value investment rate">4.3</span>% of the common shares of AMBS and as of December 31, 2021 held <span id="xdx_904_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TrustPartnerMember_zztnrg3bd528" title="Ownership in fair value investment rate">15.5</span>% of True Partner. On May 17, 2022 the Company sold its investment in True Partner to DSS Inc. These securities’ fair values are determined by reference to quoted stock prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 12, 2021 a subsidiary of the Company acquired <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210410__20210412__dei--LegalEntityAxis__custom--ValueExchangeInternationalMember_zNIoh29zfOZe" title="Stock acquisitions, shares">6,500,000</span> common shares of Value Exchange International, Inc. (“Value Exchange International”), an OTC listed company, for an aggregate subscription price of $<span id="xdx_903_ecustom--CostOfInvestmentInSecuritiesAtFairValue_iI_pp0p0_c20210412__dei--LegalEntityAxis__custom--ValueExchangeInternationalMember_zbdSDkgFZR6" title="Cost of investment in securities at fair value">650,000</span>. As of September 30, 2022, the Company, through subsidiaries, owned approximately <span id="xdx_901_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ValueExchangeInternationalMember_zgtr0mLZAUU4" title="Ownership in fair value investment rate">18.1</span>% of Value Exchange International. The stock’s fair value was determined by reference to quoted stock prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During the year ended December 31, 2021, the Company’s subsidiaries established a portfolio of trading securities. The objective is to generate profits on short-term differences in market prices. The Company does not have significant influence over any trading securities in our portfolio and fair value of these trading securities are determined by reference to quoted stock prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has elected the fair value option for the equity securities noted below that would otherwise be accounted for under the equity method of accounting. Holista CollTech Limited (“Holista”), DSS, Inc. (“DSS”) and American Premium Mining Corporation (“APM” formerly known as American Premium Water Corp.) are publicly traded companies and the fair value of such securities are determined by reference to quoted stock prices. The Company has significant influence but does not have a controlling interest in these investments, and therefore, the Company’s investment could be accounted for under the equity method of accounting or elect fair value accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has significant influence over DSS. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, the Company owned approximately <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DocumentSecuritiesSystemsIncMember_z4VQKEwK9595" title="Ownership percentage">45.18</span>% and <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DocumentSecuritiesSystemsIncMember_zuN9CyuEdBba" title="Ownership percentage">24.9</span>% of the common stock of DSS, respectively. Our CEO is a stockholder and the Chairman of the Board of Directors of DSS. Chan Tung Moe, our Co-Chief Executive Officer and the son of Chan Heng Fai, is also a director of DSS. William Wu, Wong Shui Yeung and Joanne Wong Hiu Pan, directors of the Company, are each also directors of DSS.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has significant influence over Holista as the Company and its CEO are the beneficial owner of approximately <span id="xdx_905_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HolistaCollTechLimitedMember_znlf5mM35MEc" title="Ownership in fair value investment rate">15.5</span>% of the outstanding shares of Holista and our CEO held a position on Holista’s Board of Directors until June of 2021.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company has significant influence over APM as the Company is the beneficial owner of approximately <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumWaterCorpMember_zqYfCv4iFqi7" title="Investment securities cost at fair value ownership percentage">0.8</span>% of the common shares of APM and two officers of the Company and one member of our Board also serve on APM’s Board of Directors.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of American Medical REIT Inc. (“AMRE”), a related party private company, in conjunction with the Company lending two $<span id="xdx_903_eus-gaap--NotesReceivableRelatedParties_iI_c20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z5T8hRfS1Jve" title="Notes receivable, related parties"><span id="xdx_90B_eus-gaap--NotesReceivableRelatedParties_iI_c20211029__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zhmRXzpYYe65" title="Notes receivable, related parties">200,000</span></span> promissory notes. For further details on this transaction, refer to Note 8 - Related Party Transactions, <i>Note Receivable from a Related Party Company</i>. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, AMRE was a private company. Based on management’s analysis, the fair value of the AMRE warrants was $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20210101__20211231__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zCQ5Ke9NURU3" title="Fair value of warrants">0</span> as of December 31, 2021. In March 2022 both loans, together with warrants were converted into common shares of AMRE. After the conversion, the Company owns approximately <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalREITIncMember_z5jfvHNTjccb" title="Ownership percentage">15.8</span>% of AMRE.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company held a stock option to purchase <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20220101__20220930__dei--LegalEntityAxis__custom--VivacitasMember_zO4AVwyE4hvc" title="Number of shares purchased">250,000</span> shares of Vivacitas common stock at $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220930__dei--LegalEntityAxis__custom--VivacitasMember_zGhKWIsGVEyk" title="Common stock, par value">1</span> per share at any time prior to the date of a public offering by Vivacitas. As of December 31, 2020, Vivacitas was a private company. Based on management’s analysis, the fair value of the Vivacitas stock option was $<span id="xdx_90B_ecustom--FairValueOfStockOption_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--VivacitasMember_zRw05PZHXKm2" title="Fair value of stock option">0</span> as of December 31, 2020. On March 18, 2021 the Company sold the subsidiary holding the ownership and stock option in Vivacitas to an indirect subsidiary of DSS. For further details on this transaction, refer to Note 8 - Related Party Transactions, <i>Sale of Investment in Vivacitas to DSS</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for certain of its investments in funds without readily determinable fair values in accordance with ASU No. 2015-07, <i>Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent)</i> (“2015-07”). In the first six months of 2022 the Company invested <span style="background-color: white">$<span id="xdx_90E_eus-gaap--Investments_iI_pp0p0_c20220630__us-gaap--DebtInstrumentAxis__custom--NovumAlphaFundMember_ztlPWxQ9PCv4" title="Invested amount">100,000</span> in Class A Shares of Novum Alpha Global Opportunity Digital Asset Fund I SP, a segregated portfolio of Novum Alpha SPC (“Novum Alpha Fund”).</span> This fund invests in long-short digital assets. The Company subscribed in participating shares which are redeemable and non-voting. The Company closed the fund in July 2022 recording $<span id="xdx_905_eus-gaap--GainLossOnInvestments_c20220701__20220731_zgGnUyuO9pVb" title="Investment loss">74,827</span> loss on this investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 13, 2021 BMI Capital Partners International Limited (“BMI”) entered into loan agreement with Liquid Value Asset Management Limited (“LVAML”), a subsidiary of DSS, pursuant to which BMI agreed to lend $<span id="xdx_907_eus-gaap--LoansAndLeasesReceivableImpairedCommitmentToLend_iI_c20220930__dei--LegalEntityAxis__custom--LiquidValueAssetManagementLimitedMember_zw8K5mu19SS5" title="Loan lend">3,000,000</span> to LVAML. The loan has variable interest rate and matures on October 12, 2022, with automatic three-month extension. The purpose of the loan is to purchase a portfolio of trading securities by LVAM. BMI participates in the losses and gains from portfolio based on the calculations included in the loan agreement. As of September 30, 2022 and December 31, 2021 LVAML owes $<span id="xdx_900_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--LiquidValueAssetManagementLimitedMember_z5bdR4sPFXT" title="Investment at fair value">3,032,185</span> and $<span id="xdx_906_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--LiquidValueAssetManagementLimitedMember_zsqTlUmpwNHk" title="Investment at fair value">2,987,039</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investment Securities at Cost</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in equity securities without readily determinable fair values are measured at cost minus impairment adjusted by observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These investments are measured at fair value on a nonrecurring basis when there are events or changes in circumstances that may have a significant adverse effect. An impairment loss is recognized in the condensed consolidated statements of comprehensive income equal to the amount by which the carrying value exceeds the fair value of the investment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company had an equity holding in Vivacitas Oncology Inc. (“Vivacitas”), a private company that is currently not listed on an exchange. We measured Vivacitas at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Our ownership in Vivacitas was sold on March 18, 2021 to DSS for $<span id="xdx_904_eus-gaap--GainOnSaleOfInvestments_pp0p0_c20210316__20210318__dei--LegalEntityAxis__custom--DocumentSecuritiesSystemsIncMember_zDGnVz6sYeUb" title="Gain on sale of investments">2,480,000</span>. The difference of $<span id="xdx_905_ecustom--CostMethodInvestmentOriginalCost_iI_pp0p0_c20210318__dei--LegalEntityAxis__custom--DocumentSecuritiesSystemsIncMember_zTD8STrfUwI3" title="Cost method investments, original cost">2,279,872</span> between the selling price and our original investment cost was recorded as additional paid capital considering a related party transaction. For further details on this transaction, refer to Note 8 – Related Party Transactions, <i>Sale of Investment in Vivacitas to DSS</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On September 8, 2020, the Company acquired <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200906__20200908__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NervotecPteLtdMember_z8CnIlrlrmx" title="Shares issued for acquisition">1,666</span> shares, approximately <span id="xdx_900_ecustom--OwnershipInInvestmentAtCostRate_iI_pid_dp_uPure_c20200908__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NervotecPteLtdMember_z0TfujlsPtlk" title="Ownership in investment at cost">1.45</span>% ownership, from Nervotec Pte Ltd (“Nervotec”), a private company, at the purchase price of $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200906__20200908__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NervotecPteLtdMember_zGZqAmOJYC08" title="Cost of stock">37,826</span>. The Company applied ASC 321 and measured Nervotec at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On September 30, 2020, the Company acquired <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200928__20200930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HytenGlobalThailandCoLtdMember_zpUo0g7oyWq3" title="Shares issued for acquisition">3,800</span> shares, representing the ownership of approximately <span id="xdx_900_ecustom--OwnershipInInvestmentAtCostRate_iI_pid_dp_uPure_c20200930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HytenGlobalThailandCoLtdMember_zIUNmZkJeLWh" title="Ownership in investment at cost">19</span>%, from HWH World Company Limited (f.k.a. Hyten Global (Thailand) Co., Ltd.) (“HWH World Co.”), a private company, at a purchase price of $<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HytenGlobalThailandCoLtdMember_zWOSQLIk5aC4" title="Cost of stock">42,562</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During 2021, the Company invested $<span id="xdx_90B_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KBeautyResearchLabCoLtdMember_zwDxLv8wRFj1" title="Cost method investments, original cost">19,609</span> in K Beauty Research Lab Co., Ltd (“K Beauty”) for <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KBeautyResearchLabCoLtdMember_zf26qMrBR1mh" title="Ownership percentage">18</span>% of such company. K Beauty was established for sourcing, developing and producing variety of Korea-made beauty products as well as Korea - originated beauty contents for the purpose of distribution to HWH’s membership distribution channel.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There has been no indication of impairment or changes in observable prices via transactions of similar securities and investments are still carried at cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity Method Investment</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company accounts for equity investment in entities with significant influence under equity-method accounting. Under this method, the Group’s pro rata share of income (loss) from investment is recognized in the condensed consolidated statements of comprehensive income. Dividends received reduce the carrying amount of the investment. When the Company’s share of loss in an equity-method investee equals or exceeds its carrying value of the investment in that entity, the equity method investment can be reduced below zero based on losses, if the Company either is liable for the obligations of the investee or provides for losses in excess of the investment when imminent return to profitable operations by the investee appears to be assured. Otherwise, the Company does not recognize its share of equity method losses exceeding its carrying amount of the investment, but discloses the losses in the footnotes. Equity-method investment is reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other-than-temporary. In making this determination, factors are evaluated in determining whether a loss in value should be recognized. These include consideration of the intent and ability of the Group to hold investment and the ability of the investee to sustain an earnings capacity, justifying the carrying amount of the investment. Impairment losses are recognized in other expense when a decline in value is deemed to be other-than-temporary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>American Medical REIT Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">LiquidValue Asset Management Pte. Ltd. (“LiquidValue”), a subsidiary of the Company, owns <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalREITIncMember_zxepeKpF5en9" title="Ownership percentage">15.8</span>% of American Medical REIT Inc. (“AMRE”) as of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022, a company concentrating on medical real estate. AMRE acquires state-of-the-art, purpose-built healthcare facilities and leases them to leading clinical operators with dominant market share under secure triple net leases. AMRE targets hospitals (both Critical Access and Specialty Surgical), Physician Group Practices, Ambulatory Surgical Centers, and other licensed medical treatment facilities. Chan Heng Fai, our Chairman and CEO, is the executive chairman and director of AMRE. DSS, of which we own 45.2% and have significant influence over, owns 80.8% of AMRE. Therefore, the Company has significant influence on AMRE.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Joint Venture with Novum</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On April 20, 2021, one of Company’s indirect subsidiaries, SeD Capital Pte. Ltd. (“SeD Capital”), entered into a joint venture agreement with a digital asset management firm Novum Alpha Pte Ltd (“Novum”). Pursuant to this agreement, SeD Capital will own <span id="xdx_900_ecustom--JointVenturePaidUpCapital_iI_pid_dp_uPure_c20210420__dei--LegalEntityAxis__custom--SeDCapitalPteLtdMember__us-gaap--AwardTypeAxis__custom--NovumAlphaPteLtdMember_zkevwjed1k1a" title="Joint venture">50</span>% of the issued and paid-up capital in the joint venture company, Credas Capital Pte. Ltd. (“Credas”) with the remaining <span id="xdx_906_ecustom--JointVenturePaidUpCapital_iI_pid_dp_uPure_c20210420__dei--LegalEntityAxis__custom--SeDCapitalPteLtdMember__us-gaap--AwardTypeAxis__custom--CredasCapitalPteLtdMember_zKeIGDqZd6w9" title="Joint venture">50</span>% shareholding stake held by Novum. On the condensed consolidated balance sheet, the prorate loss from Credas was not recorded as a liability because the Company is not liable for the obligations of Credas and has not committed to provide additional financial support.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>American Pacific Bancorp, Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Securities Purchase Agreement from March 12, 2021 the Company purchased of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210309__20210312__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Purchase of stock">4,775,523</span> shares of the common stock of American Pacific Bancorp Inc. (“APB”) and gained majority ownership in that entity. APB was consolidated into the Company under common control accounting (See Transactions between Entities under Common Control for details). On September 8, 2021 APB sold <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210907__20210908__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonStockMember_zhubJIRbuLej" title="Purchase of stock">6,666,700</span> shares of Series A Common Stock to <span style="background-color: white">DSS, Inc.</span> for $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210907__20210908__us-gaap--StatementClassOfStockAxis__custom--SeriesACommonStockMember_pdp0" title="Stock cost">40,000,200</span> cash. <span id="xdx_90E_eus-gaap--DeconsolidationRelatedPartyDescription_c20210907__20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zea8ChmGa2I9" title="Deconsolidation description">As a result of the new share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3% and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $<span id="xdx_90D_eus-gaap--DeconsolidationGainOrLossAmount_pn5n6_c20210907__20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zGy5Z8JJRbUk" title="Gain on deconsolidation">28.2</span> million.</span> The gain represents the difference between the fair value of retained equity method investment of $<span id="xdx_904_eus-gaap--EquityMethodInvestments_iI_pn5n6_c20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zYmKabB1oduj" title="Equity method investement">30.8</span> million and $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtCost_iI_pn5n6_c20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zDhEAlzNuJEi" title="Cost of investment">2.6</span> million, the Company’s investment percentage of carrying amount of APB’s net assets of $<span id="xdx_90E_eus-gaap--AssetsNet_iI_pn5n6_c20210908__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_z4iN6QIq0fNd" title="Net assets">2.9</span> million. Considering the transaction was between related parties, the Company recorded the gain as additional paid in capital in its equity. From September 8 to December 31, 2021, the investment loss was $<span id="xdx_907_eus-gaap--GainLossOnInvestments_pp0p0_c20210907__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_z3zCZqiQnER8" title="Investment gain (loss)">51,999</span>. During three and nine months ended September 30, 2022 the investment gain was $<span id="xdx_903_eus-gaap--GainLossOnInvestments_c20220701__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zE2b2o8PvwJk" title="Investment gain (loss)">419,005</span> and $<span id="xdx_901_eus-gaap--GainLossOnInvestments_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zbgw2yowr8T3" title="Investment gain (loss)">579,026</span>, respectively. As of September 30, 2022 and December 31, 2021, the investment in APB was $<span id="xdx_900_eus-gaap--Investments_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_zclnQwxOH0rd" title="Investments">31,380,155</span> and $<span id="xdx_90B_eus-gaap--Investments_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPacificBancorpIncMember_z3zz26tQ02Xc" title="Investments">30,801,129</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Alset Capital Acquisition Corp.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, Alset Capital Acquisition Corp. (“Alset Capital”), a special purpose acquisition company (SPAC) sponsored by the Company and certain affiliates, closed its initial public offering of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220202__20220203__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_z8qih1MchJ1e">7,500,000</span> units at $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20220203__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zwcOAzQ4jCLf">10.00</span> per unit (the “Offering”). At the same time the exercise of underwriters’ over-allotment option of additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220202__20220203__us-gaap--BusinessAcquisitionAxis__custom--AlsetCapitalAcquisitionCorpMember_zM2n85K02jK5">1,125,000</span> units closed. The Company is majority owner of Alset Acquisition Sponsor, LLC, the sponsor (the “Sponsor”) of Alset Capital. On February 3, 2022, the Sponsor purchased <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220202__20220203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zZvk9kbbtnFf">473,750</span> units pursuant to a private placement for a purchase price of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20220202__20220203__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgIpH5L66X6e" title="Purchase price of private placement amount">4,737,500</span>. Previously, the Sponsor had purchased <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220202__20220203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhHXQJnjzjm" title="Issuance of shares of common stock">2,156,250</span> shares of Class B common stock pursuant to a private placement for a purchase price of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220202__20220203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpN5PpWjeEaf" title="Purchase price of stock">25,000</span>. After the Offering the Company holds <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220203__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCropMember_z4MbC2RvcQb4">23.4</span>% of Alset Capital. Chan Heng Fai, the Chairman and CEO of the Company, is the CEO and director of Alset Capital. In June 2022, the Company made an adjustment of $<span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_c20220630__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zEnx7rYzjlJ4" title="Additional paid in capital">2,830,961</span> to Additional Paid in Capital and the fair value of investment in Alset Capital, and reversed the previously recorded unrealized loss of $<span id="xdx_90A_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20220601__20220630__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zxQIp20fR206" title="Unrealized loss on securities investment">237,578</span>, because of the change of valuation methods of the investment on Class B Common Stock and units the company held. Initially, the Company used market trading prices of Class A common stock and units to calculate the fair value of these investment securities and recorded $<span id="xdx_902_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20220301__20220331__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zPqVGFHF2zG6">237,578</span> unrealized loss on security investment during three months ended March 31, 2022. In June 2022, the Company determined the fair value of Class B common shares and units by using a put option model and a Monte Carlo simulation considering some restrictions and risks related to these securities the Company held. During the nine months ended September 30, 2022, the Company recorded investment loss of $<span id="xdx_900_eus-gaap--GainLossOnInvestments_pp0p0_c20220101__20220930__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zmyMdlCSJRNc" title="Investment gain (loss)">82,582</span> by equity method. On September 30, 2022 the Company purchased the remaining <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SponsorMember_zZU3M0EGTXM1" title="Ownership percentage">10</span>% ownership in the Sponsor for $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220901__20220930__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zWXmtqZNnyBe" title="Number of shares issued, value">476,250</span> and currently owns <span id="xdx_904_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--AlsetCapitalAcquisitionCorpMember_zZZqskQ3jTOc" title="Ownership percentage">100</span>% of it. The Company’s investment in Alset Capital was $<span id="xdx_90D_eus-gaap--EquitySecuritiesFvNiCurrentAndNoncurrent_iI_c20220930_zBdbI9W5tSh6" title="Investment in capital">21,232,707</span> as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ketomei Pte Ltd</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 10, 2021 the Company’s indirect subsidiary Hapi Cafe Inc. (“Hapi Cafe”) lent $<span id="xdx_909_eus-gaap--OtherShortTermBorrowings_iI_c20210610__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zfBKSUMYua9b" title="Amount lent">76,723</span> to Ketomei Pte Ltd (“Ketomei”). On March 21, 2022 Hapi Cafe entered into an agreement pursuant to which the principal of the loan together with accrued interest were converted into an investment in Ketomei. At the same time, Hapi Cafe invested an additional $<span id="xdx_908_ecustom--AdditionalInvestment_c20220601__20220610__dei--LegalEntityAxis__custom--KetomeiPteLtdMember_z19yzXIixGP6" title="Additional investment">179,595</span> in Ketomei. After the conversion and fund investment the Company now holds <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220610__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_ziROQjiqHGMe" title="Ownership percentage">28</span>% of Ketomei. Ketomei is in the business of selling cooked food and drinks. During three and nine months ended September 30, 2022 the investment loss was $<span id="xdx_903_eus-gaap--GainLossOnInvestments_c20220701__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zXv3hhDHMZlc" title="Gain on loss on investment">5,937</span> and $<span id="xdx_903_eus-gaap--GainLossOnInvestments_c20220101__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zRjCPVO1IwK" title="Gain on loss on investment">38,996</span>, respectively. Investment in Ketomei was $<span id="xdx_90E_eus-gaap--Investments_iI_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--KetomeiPteLtdMember_zROtsJe2chi4" title="Investment">217,321</span> at September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investment in Debt Securities</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt securities are reported at fair value, with unrealized gains and losses (other than impairment losses) recognized in accumulated other comprehensive income or loss. Realized gains and losses on debt securities are recognized in the net income in the condensed consolidated statements of comprehensive income. The Company monitors its investments for other-than-temporary impairment by considering factors including, but not limited to, current economic and market conditions, the operating performance of the companies including current earnings trends and other company-specific information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invested $<span id="xdx_900_eus-gaap--Investments_iI_pp0p0_c20220930__us-gaap--DebtInstrumentAxis__custom--SharingServicesConvertibleNoteMember_zrhp1PBOhWR" title="Invested amount">50,000</span> in a convertible promissory note of Sharing Services Global Corporation (“Sharing Services Convertible Note”), a company quoted on the US OTC market. The value of the convertible note is estimated by management using a Black-Scholes valuation model. The fair value of the note was $<span id="xdx_901_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_c20211231_zN0qzt853wi3" title="Convertible debt, fair value disclosures">9,799</span> on December 31, 2021. The note was redeemed on July 14, 2022 and $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220714__us-gaap--DebtInstrumentAxis__custom--SharingServicesConvertibleNoteMember_zHmsVWMMVAi5" title="debt face amount">50,000</span> principal together with $<span id="xdx_902_eus-gaap--InterestReceivable_iI_pp0p0_c20220714__us-gaap--DebtInstrumentAxis__custom--SharingServicesConvertibleNoteMember_zTBVtcyMbN2e" title="Iinterests receivable">28,636</span> accrued interests were received from Sharing Services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 26, 2021, the Company invested approximately $<span id="xdx_905_eus-gaap--Investments_iI_pp0p0_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zMmmwcVITHge" title="Invested amount">88,599</span> in the convertible note of Vector Com Co., Ltd (“Vector Com”), a private company in South Korea. The interest rate is <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zltrgMCbffSh" title="Debt instrument, interest percentage">2</span>% per annum and maturity is <span id="xdx_907_eus-gaap--DebtInstrumentTerm_dc_c20210224__20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zGVO1EtVy1Vd" title="Debt instrument, term">two years</span>. The conversion price is approximately $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zYndEqO1vUv5" title="Debt instrument, convertible, conversion price">21.26</span> per common share of Vector Com. As of September 30, 2022, our management estimated the fair value of the note to be $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zwDdwWlFUzG8" title="Debt instrument, face amount">88,599</span>, the initial transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.043 0.155 6500000 650000 0.181 0.4518 0.249 0.155 0.008 200000 200000 0 0.158 250000 1 0 100000 74827 3000000 3032185 2987039 2480000 2279872 1666 0.0145 37826 3800 0.19 42562 19609 0.18 0.158 0.50 0.50 4775523 6666700 40000200 As a result of the new share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3% and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $28.2 million. 28200000 30800000 2600000 2900000 51999 419005 579026 31380155 30801129 7500000 10.00 1125000 473750 4737500 2156250 25000 0.234 2830961 237578 237578 82582 0.10 476250 1 21232707 76723 179595 0.28 5937 38996 217321 50000 9799 50000 28636 88599 0.02 P2Y 21.26 88599 <p id="xdx_84A_eus-gaap--ConsolidationVariableInterestEntityPolicy_zGKqTkscJie4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span><span><span id="xdx_86F_zkkw1XEtwlc2">Variable Interest Entity</span></span></span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Under Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 810, <i>Consolidation</i>, when a reporting entity is the primary beneficiary of an entity that is a variable interest entity (“VIE”), as defined in ASC 810, the VIE must be consolidated into the financial statements of the reporting entity. The determination of which owner is the primary beneficiary of a VIE requires management to make significant estimates and judgments about the rights, obligations, and economic interests of each interest holder in the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company evaluates its interests in VIEs on an ongoing basis and consolidates any VIE in which it has a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>HWH World Company Limited</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">HWH World Co. is a direct sales company in Thailand. The Company has a <span id="xdx_900_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--HWHWorldMember_zuOW1RrfLTxl" title="Ownership percentage">19</span>% ownership and loaned $<span id="xdx_902_eus-gaap--ProceedsFromPaymentsForLongTermLoansForRelatedParties_pp0p0_c20220101__20220930__srt--OwnershipAxis__custom--HWHWorldMember_z6GpaCSjOZj2" title="Payment of related parties">187,500</span> with zero interest and due on demand, to HWH World Co. The current level of equity in HWH World Co. is not sufficient to determine if HWH World Co. can operate on its own without additional subordinated financial support. The Company has a variable interest in HWH World Co., however, the Company is not deemed to absorb losses or receive benefits that could potentially be significant to HWH World Co. Ltd. The Company does not also have the ultimate power over the activities which can impact VIE’s economic performance, like developing company budgets or overseeing and controlling the management. The power to direct the activities are held by the manager in Thailand who owns <span id="xdx_906_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--HWHWorldCoMember_zrGYxNSePlmd" title="Ownership percentage">51</span>% of the HWH World Co. Therefore, the Company is not a primary beneficiary of this VIE and does not consolidate it. On </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021 variable interest and amount receivable in the non-consolidated VIE was $<span id="xdx_902_eus-gaap--ReceivablesNetCurrent_iI_pp0p0_c20220930__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_zeWBeXl3NY2l" title="Receivables, Net, Current">236,699</span> and $<span id="xdx_90E_eus-gaap--ReceivablesNetCurrent_iI_pp0p0_c20211231__srt--ConsolidatedEntitiesAxis__us-gaap--VariableInterestEntityPrimaryBeneficiaryMember_zDMzr7Tie1n9" title="Receivables, Net, Current">236,699</span>, respectively, which represents the Company’s maximum risk of loss from non-consolidated VIE. The Company applied ASC 321 and measured HWH World Co. investment at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>American Medical REIT Inc.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In 2021 the Company owned <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_z2rtQ4UgO4L9" title="Onwership percentage">3.4</span>% of AMRE and made a loan in the amount of $<span id="xdx_90A_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zqt3glYhFvp">8,350,000</span> to AMRE, as well as two loans of $<span id="xdx_90E_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanMedicalReitIcbMember_zBH6sg3wt2Oc">200,000</span> each, all with <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zxMEAZhWvE7e">8</span>% per annum interest rate. One of the $<span id="xdx_900_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_pp0p0_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanMedicalReitIcbMember_zIZXcm72HxVl">200,000</span> loans was due on March 3, 2022, the other one is due on October 29, 2024. The $<span id="xdx_905_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20231129__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4kgVMW6Bdkf">8,350,000</span> loan is due on November 29, 2023. The Company has a variable interest in AMRE. However, the Company is not deemed to absorb losses or receive benefits that could potentially be significant to AMRE. The Company does not also have the ultimate power over the activities which can impact VIE’s economic performance, like developing company budgets or overseeing and controlling the management. The power to direct these activities are held by the AMRE’s largest shareholder which owns approximately <span id="xdx_90D_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20220930__srt--OwnershipAxis__custom--AMREAndAMREManagementMember_zk63aDcSlrfh">80.8</span>% of AMRE and AMRE’s management team. Therefore, the Company is not a primary beneficiary of this VIE and does not consolidate it. In March 2022, the Company converted both $<span id="xdx_90E_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zGvQpQlhY3Bc" title="Notes payable related parties">200,000</span> loans and accrued interests, together with accompanying warrants into AMRE common shares. After the conversion the Company owns <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AMREAndAMREManagementMember_z8pgDJLCq1ka">15.8</span>% of AMRE. On July 12, 2022, pursuant to Assignment and Assumption Agreement from February 25, 2022, as amended on July 12, 2022, the Company sold the $<span id="xdx_90B_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20220712__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zVLpmV7t0uya">8,350,000</span> loan, together with accrued interest, to DSS for a purchase price of <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220711__20220712__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__dei--LegalEntityAxis__custom--DocumentSecuritiesSystemsIncMember_zn7HtDZrGSXa">21,366,177</span> shares of DSS’s common stock. The loss from this transaction of $<span id="xdx_90D_eus-gaap--DebtAndEquitySecuritiesRealizedGainLoss_c20220711__20220712__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_znTs2PawVkhf" title="Transaction loss">1,089,675</span> was calculated as the difference between the face value of promissory note together with accrued interest and the fair value of DSS stock on July 12, 2022, and was recorded under Other Expense in Statement of Operations. From July 12 to September 30, 2022, DSS stock was valued under fair market value and a loss of $<span id="xdx_907_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220713__20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_z9gws52VzVe9" title="Unrealized loss on security investment">2,157,984</span> was booked as unrealized loss on security investment. On </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021 variable interest and amount receivable in the non-consolidated VIE was $<span id="xdx_90D_eus-gaap--ReceivablesNetCurrent_iI_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_zuphySQKFKs3" title="Receivables net">0</span> and $<span id="xdx_907_eus-gaap--ReceivablesNetCurrent_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember_zGYiyGbK8uIb" title="Receivables net">8,901,285</span>, respectively, which represents the Company’s maximum risk of loss from non-consolidated VIE.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.19 187500 0.51 236699 236699 0.034 8350000 200000 0.08 200000 8350000 0.808 200000 0.158 8350000 21366177 1089675 2157984 0 8901285 <p id="xdx_841_eus-gaap--RealEstatePolicyTextBlock_z4TYwptN89ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_z5U2WNpwHpK7">Real Estate Assets</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Real estate assets are recorded at cost, except when real estate assets are acquired that meet the definition of a business combination in accordance with Financial Accounting Standards Board (“FASB”) ASC 805 - <i>“Business Combinations”,</i> which acquired assets are recorded at fair value. Interest, property taxes, insurance and other incremental costs (including salaries) directly related to a project are capitalized during the construction period of major facilities and land improvements. The capitalization period begins when activities to develop the parcel commence and ends when the asset constructed is completed. The capitalized costs are recorded as part of the asset to which they relate and are reduced when lots are sold.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalized construction costs of approximately $<span id="xdx_90E_ecustom--CapitalizedConstructionCosts_pn5n6_c20220701__20220930_ztshdaHoCkC8" title="Capitalized construction costs">2.9</span> million and $<span id="xdx_903_ecustom--CapitalizedConstructionCosts_pn5n6_c20210701__20210930_zj0UldqyJrS2" title="Capitalized construction costs">1.8</span> million for the three months ended September 30, 2022 and 2021, respectively. The Company capitalized construction costs of approximately $<span id="xdx_905_ecustom--CapitalizedConstructionCosts_pn5n6_c20220101__20220930_zChwiyhxcxB2" title="Capitalized construction costs">5.9</span> million and $<span id="xdx_90F_ecustom--CapitalizedConstructionCosts_pn5n6_c20210101__20210930_z4eLOIFDuWEl" title="Capitalized construction costs">3.2</span> million for the nine months ended September 30, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s policy is to obtain an independent third-party valuation for each major project in the United States as part of our assessment of identifying potential triggering events for impairment. Management may use the market comparison method to value other relatively small projects, such as the project in Perth, Australia. In addition to the annual assessment of potential triggering events in accordance with ASC 360 – <i>Property Plant and Equipment</i> (“ASC 360”), the Company applies a fair value-based impairment test to the net book value assets on an annual basis and on an interim basis if certain events or circumstances indicate that an impairment loss may have occurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not record impairment on any of its projects during the three and nine months ended on September 30, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Properties under development</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properties under development are properties being constructed for sale in the ordinary course of business, rather than to be held for the Company’s own use, rental or capital appreciation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rental Properties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Rental properties are acquired with the intent to be rented to tenants. During the nine months ended </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and the year ended December 31, 2021, the Company signed multiple purchase agreements to acquire 23 and 109 homes, respectively. By </span>September <span style="background-color: white">30, 2022, all of the 132 homes were closed with an aggregate purchase cost of $<span id="xdx_908_eus-gaap--PaymentsForRent_pp0p0_c20220101__20220930_zM7pLrX0Znfa" title="Payments for rent">30,998,258</span>. These homes are located in Montgomery and Harris Counties, Texas. All of these purchased homes are properties of our rental business.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Investments in Single-Family Residential Properties</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company accounts for its investments in single-family residential properties as asset acquisitions and records these acquisitions at their purchase price. The purchase price is allocated between land, building, improvements and existing leases based upon their relative fair values at the date of acquisition. The purchase price for purposes of this allocation is inclusive of acquisition costs which typically include legal fees, title fees, property inspection and valuation fees, as well as other closing costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building improvements and buildings are depreciated over estimated useful lives of approximately <span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220930__srt--RangeAxis__srt--MinimumMember_zoHHJfbCFl9i" title="Property, plant and equipment, useful life years">10</span> to <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220930__srt--RangeAxis__srt--MaximumMember_zcJIGmuOhzBh" title="Property, plant and equipment, useful life years">27.5</span> years, respectively, using the straight-line method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company assesses its investments in single-family residential properties for impairment whenever events or changes in business circumstances indicate that carrying amounts of the assets may not be fully recoverable. When such events occur, management determines whether there has been impairment by comparing the asset’s carrying value with its fair value. Should impairment exist, the asset is written down to its estimated fair value. The Company did not recognize any impairment losses during three and nine months ended </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and 2021.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2900000 1800000 5900000 3200000 30998258 P10Y P27Y6M <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zhlqb7gdzAPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_868_zyovi7gUmXO2">Revenue Recognition and Cost of Revenue</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 606 - <i>Revenue from Contracts with Customers</i> (“ASC 606”), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity’s contracts to provide goods or services to customers. The Company adopted this new standard on January 1, 2018 under the modified retrospective method. The adoption of this new standard did not have a material effect on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which the determination of revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which the Company expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, performance obligations are satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following represents the Company’s revenue recognition policies by Segments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Real Estate</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Property Sales</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s main business is land development. The Company purchases land and develops it for building into residential communities. The developed lots are sold to builders (customers) for the construction of new homes. The builders enter into sales contracts with the Company before they take the lots. The prices and timeline are determined and agreed upon in the contracts. The builders do the inspections to make sure all conditions and requirements in contracts are met before purchasing the lots. A detailed breakdown of the five-step process for the revenue recognition of the Ballenger project, which represented approximately <span id="xdx_902_ecustom--ConcentrationRiskPercentage_pid_dp_uPure_c20220101__20220930__us-gaap--AwardTypeAxis__custom--BallengerProjectsMember_zKKq6ocSKtw4" title="Risk percentage">18</span>% and <span id="xdx_907_ecustom--ConcentrationRiskPercentage_pid_dp_uPure_c20210101__20210930__us-gaap--AwardTypeAxis__custom--BallengerProjectsMember_zMDyQUUOaMll" title="Risk percentage">70</span>%, respectively, of the Company’s revenue in the nine months ended on September 30, 2022 and 2021, is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the contract with a customer.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has signed agreements with the builders for developing the raw land to ready to build lots. The contract has agreed upon prices, timelines, and specifications for what is to be provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify the performance obligations in the contract.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance obligations of the Company include delivering developed lots to the customer, which are required to meet certain specifications that are outlined in the contract. The customer inspects all lots prior to accepting title to ensure all specifications are met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine the transaction price.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transaction price per lot is fixed and specified in the contract. Any subsequent change orders or price changes are required to be approved by both parties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate the transaction price to performance obligations in the contract.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each lot or a group of lots is considered to be a separate performance obligation, for which the specified price in the contract is allocated to.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize revenue when (or as) the entity satisfies a performance obligation.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The builders do the inspections to make sure all conditions/requirements are met before taking title of lots. The Company recognizes revenue at a point in time when title is transferred. The Company does not have further performance obligations or continuing involvement once title is transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Rental Revenue</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases real estate properties to its tenants under leases that are predominately classified as operating leases, in accordance with ASC 842, Leases (“ASC 842”). Real estate rental revenue is comprised of minimum base rent and revenue from the collection of lease termination fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent from tenants is recorded in accordance with the terms of each lease agreement on a straight-line basis over the initial term of the lease. Rental revenue recognition begins when the tenant controls the space and continues through the term of the related lease. Generally, at the end of the lease term, the Company provides the tenant with a one-year renewal option, including mostly the same terms and conditions provided under the initial lease term, subject to rent increases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company defers rental revenue related to lease payments received from tenants in advance of their due dates. These amounts are presented within deferred revenues and other payables on the Company’s condensed consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental revenue is subject to an evaluation for collectability on several factors, including payment history, the financial strength of the tenant and any guarantors, historical operations and operating trends of the property, and current economic conditions. If our evaluation of these factors indicates that it is not probable that we will recover substantially all of the receivable, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis (as applicable) or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. For the nine months ended September 30, 2022, the Company did not recognize any deferred revenue and collected all rents due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Sale of the Front Foot Benefit Assessments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We have established a front foot benefit (“FFB”) assessment on all of the NVR lots. This is a 30-year annual assessment allowed in Frederick County which requires homeowners to reimburse the developer for the costs of installing public water and sewer to the lots. These assessments become effective as homes are settled, at which time we can sell the collection rights to investors who will pay an upfront lump sum, enabling us to more quickly realize the revenue. The selling prices range from $<span id="xdx_905_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember__srt--RangeAxis__srt--MinimumMember_zyv53dj2ayd7" title="Proceeds from sale of property, plant, and equipment">3,000</span> to $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember__srt--RangeAxis__srt--MaximumMember_zUJ5b7KbGU6" title="Proceeds from sale of property, plant, and equipment">4,500</span> per home depending the type of the home. Our total revenue from the front foot benefit assessment is approximately $1 million. To recognize revenue of the FFB assessment, both our and NVR’s performance obligation have to be satisfied. Our performance obligation is completed once we complete the construction of water and sewer facility and close the lot sales with NVR, which inspects these water and sewer facility prior to close lot sales to ensure all specifications are met. NVR’s performance obligation is to sell homes they build to homeowners. Our FFB revenue is recognized on quarterly basis after NVR closes sales of homes to homeowners. The agreement with these FFB investors is not subject to amendment by regulatory agencies and thus our revenue from the FFB assessment is not either. During the three months ended on </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and 2021, we recognized revenue of $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20220701__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_z54pcvYBi9b6" title="Revenue recognized">9,968</span> and $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_zTnfp7ZlyND" title="Revenue recognized">182,813</span> from the FFB assessments, respectively. During the nine months ended on </span>September <span style="background-color: white">30, 2022 and 2021, we recognized revenue of $<span id="xdx_907_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_zcZIci3m3zK7" title="Revenue recognized">126,055</span> and $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--FrontFootBenefitAssessmentsMember_zAVnkeKXuFgc" title="Revenue recognized">431,458</span> from the FFB assessments, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cost of Revenues</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Real Estate</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost of Real Estate Sale </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the costs of real estate sales are from our land development business. Land acquisition costs are allocated to each lot based on the area method, the size of the lot comparing to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot comparing to the total size of all lots in the project.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost of Rental Revenue </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of rental revenue consists primarily of the costs associated with management and leasing fees to our management company, repairs and maintenance, depreciation and other related administrative costs. Utility expenses are paid directly by tenants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Biohealth</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product Direct Sales</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s net sales consist of product sales. The Company’s performance obligation is to transfer its products to its third-party independent distributors (“Distributors”). The Company generally recognizes revenue when product is shipped to its Distributors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s Distributors may receive distributor allowances, which are comprised of discounts, rebates and wholesale commission payments from the Company. Distributor allowances resulting from the Company’s sales of its products to its Distributors are recorded against net sales because the distributor allowances represent discounts from the suggested retail price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to distributor allowances, the Company compensates its sales leader Distributors with leadership incentives for services rendered, relating to the development, retention, and management of their sales organizations. Leadership incentives are payable based on achieved sales volume, which are recorded in general and administrative expenses. The Company recognizes revenue when it ships products. The Company receives the net sales price in cash or through credit card payments at the point of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a Distributor returns a product to the Company on a timely basis, he/she may obtain a replacement product from the Company for such returned products. In addition, the Company maintains a buyback program pursuant to which it will repurchase products sold to a Distributor who has decided to leave the business. Allowances for product returns, primarily in connection with the Company’s buyback program, are provided at the time the sale is recorded. This accrual is based upon historical return rates for each country and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual Membership</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company collects an annual membership fee from its Distributors. The fee is fixed, paid in full at the time of joining the membership and non-refundable. The membership provides the member access to purchase products at a discount, access to certain back-office services, receive commissions for signing up new members, and attend corporate events. The Company recognizes revenue associated with the membership over the period of the membership. Before the membership fee is recognized as revenue, it is recorded as deferred revenue. Deferred revenue relating to membership was $<span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--DeferredRevenueMember_zemtK6yKCUBj" title="Deferred revenue">65,091</span> and $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pp0p0_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--DeferredRevenueMember_zaKK6N5Qex1k" title="Deferred revenue">728,343</span> at September 30, 2022 and December 31, 2021, respectively. During 2021, the Company temporarily suspended the sale of its membership as it is focusing on developing new market strategy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Businesses</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Killiney Kopitiam’s Franchise</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through Alset F&amp;B One Pte. Ltd. (“Alset F&amp;B”), acquired a restaurant franchise license at the end of 2021 and has since commenced operations. This license will allow Alset F&amp;B to operate a Killiney Kopitiam restaurant in Singapore. Killiney Kopitiam is a Singapore-based chain of mass-market, traditional kopitiam style service cafes selling toast products, soft-boiled eggs and coffee.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Remaining performance obligations</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, there were no remaining performance obligations or continuing involvement, as all service obligations within the other business activities segment have been completed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0.18 0.70 3000 4500 9968 182813 126055 431458 65091 728343 <p id="xdx_84F_eus-gaap--CompensationRelatedCostsPolicyTextBlock_z90b09dBtO6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86F_zCtN7vLUw9Gh">Stock-Based Compensation</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective January 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services. During the three and nine months ended on September 30, 2022 and 2021, the Company recorded $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220701__20220930_zFQ41PlckIj4" title="Stock-based compensation"><span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220101__20220930_zshB3ihMTGfl" title="Stock-based compensation">0</span></span> and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930_z8VuuRJ6qH2d" title="Stock-based compensation"><span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20210930_zLuRWfHi10r2" title="Stock-based compensation">73,292</span></span> as stock-based compensation expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 73292 73292 <p id="xdx_843_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zwA4XR6UcYe6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Foreign currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Functional and reporting currency</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items included in the financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (“functional currency”). The financial statements of the Company are presented in U.S. dollars (the “reporting currency”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional and reporting currency of the Company is the United States dollar (“U.S. dollar”). The financial records of the Company’s subsidiaries located in Singapore, Hong Kong, Australia and South Korea are maintained in their local currencies, the Singapore Dollar (S$), Hong Kong Dollar (HK$), Australian Dollar (“AUD”) and South Korean Won (“KRW”), which are also the functional currencies of these entities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transactions in foreign currencies</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions in currencies other than the functional currency during the periods are converted into functional currency at the applicable rates of exchange prevailing when the transactions occurred. Transaction gains and losses are recognized in the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The majority of the Company’s foreign currency transaction gains or losses come from the effects of foreign exchange rate changes on the intercompany loans between Singapore entities and U.S. entities. The Company recorded foreign exchange gain of $<span id="xdx_906_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20220701__20220930_zn02ZGNYCdxj" title="Foreign currency transaction gain loss">132,092</span> and $<span id="xdx_902_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20210701__20210930_zrmxD58iOYz9" title="Foreign currency transaction gain loss">578,903</span> loss during the three months ended on September 30, 2022 and 2021, respectively. The Company recorded foreign exchange gain of $<span id="xdx_90A_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20220101__20220930_zFnyYAOPPBPb" title="Foreign currency transaction gain loss">2,617,896</span> and $<span id="xdx_901_ecustom--ForeignCurrencyTransactionGainLossBeforeTaxes_pp0p0_c20210101__20210930_zStpZOMy0p67" title="Foreign currency transaction gain loss">1,842,128</span> during the nine months ended on September 30, 2022 and 2021, respectively. The foreign currency transactional gains and losses are recorded in operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Translation of consolidated entities’ financial statements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at the rates of exchange ruling at the balance sheet date. The Company’s entities with functional currency of S$, HK$, AUD and KRW, translate their operating results and financial positions into the U.S. dollar, the Company’s reporting currency. Assets and liabilities are translated using the exchange rates in effect on the balance sheet date. Revenue, expense, gains and losses are translated using the average rate for the year. Translation adjustments are reported as cumulative translation adjustments and are shown as a separate component of comprehensive income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded other comprehensive gain of $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220701__20220930_zOVJ9G9CcwS8" title="Other comprehensive loss">520,339</span> from foreign currency translation for the three months ended September 30, 2022 and $<span id="xdx_907_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210701__20210930_zHXLx0KrK1Il" title="Other comprehensive loss">1,238,356</span> loss for the three months ended September 30, 2021, in accumulated other comprehensive loss. The Company recorded other comprehensive loss of $<span id="xdx_90C_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20220101__20220930_zbqni1MCKKZ4" title="Other comprehensive loss">3,729,724</span> from foreign currency translation for the nine months ended September 30, 2022 and $<span id="xdx_90A_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c20210101__20210930_zZxB1YejpBJ3" title="Other comprehensive loss">4,077,987</span> loss for the nine months ended September 30, 2021, in accumulated other comprehensive loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 132092 578903 2617896 1842128 520339 1238356 3729724 4077987 <p id="xdx_840_ecustom--NoncontrollingInterestPolicyTextBlock_zXS1Vc9LF8R1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zfMm8iiMqzv6">Non-controlling interests</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling interests represent the equity in subsidiary not attributable, directly or indirectly, to owners of the Company, and are presented separately in the condensed consolidated statements of operation and comprehensive income, and within equity in the Condensed Consolidated Balance Sheets, separately from equity attributable to owners of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 30, 2022 and December 31, 2021, the aggregate non-controlling interests in the Company were $<span id="xdx_908_eus-gaap--MinorityInterest_iI_pp0p0_c20220930_zSVPhBBTXYte" title="Non controlling interest">12,015,513</span> and $<span id="xdx_906_eus-gaap--MinorityInterest_iI_pp0p0_c20211231_z3aCVU91BEif" title="Non controlling interest">21,912,268</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 12015513 21912268 <p id="xdx_849_ecustom--CapitalizedFinancingCostsPolicyTextBlock_zMGQuZIgex5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_860_zLm3hXna9z1l">Capitalized Financing Costs</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing costs, such as loan origination fee, administration fee, interests, and other related financing costs should be capitalized and recorded on the balance sheet, if these financing activities are directly associated with the development of real estate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized financing costs are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If the allocation of capitalized financing costs based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on an area method, which uses the size of the lots compared to the total project area and allocates costs based on their size.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, the capitalized financing costs were $<span id="xdx_905_ecustom--CapitalizedFinancingCosts_iI_pp0p0_c20220930_zSkViU2MMnSf" title="Capitalized financing costs"><span id="xdx_903_ecustom--CapitalizedFinancingCosts_iI_pp0p0_c20211231_zyAoJQqbjR9d" title="Capitalized financing costs">3,247,739</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3247739 3247739 <p id="xdx_84A_ecustom--BeneficialConversionFeaturesPolicyTextBlock_zTOzFdICfmbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zwvJ1eCuRwe4">Beneficial Conversion Features</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates the conversion feature for whether it was beneficial as described in ASC 470-30. The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the shares of common stock at the commitment date to be received upon conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zL699vuPPze8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zDjOktgdNmv6">Recent Accounting Pronouncements</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting pronouncement adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.” ASU 2021-08 requires the company acquiring contract assets and contract liabilities obtained in a business combination to recognize and measure them in accordance with ASC 606, “Revenue from Contracts with Customers”. At the acquisition date, the company acquiring the business should record related revenue, as if it had originated the contract. Before the update such amounts were recognized by the acquiring company at fair value. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company plans to adopt these requirements prospectively, effective on the first day of the year 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounting pronouncement not yet adopted</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years, and a modified retrospective approach is required, with a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. In November of 2019, the FASB issued ASU 2019-10, which delayed the implementation of ASU 2016-13 to fiscal years beginning after December 15, 2022 for smaller reporting companies. The Company is currently evaluating the impact of ASU 2016-13 on its future consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FASB issued ASU 2020-04, <i>Reference Rate Reform (Topic 848): Facilitation of Reference Rate Reform on Financial Reporting</i>. The amendments in this update provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The Company’s line of credit agreement provides procedures for determining a replacement or alternative rate in the event that LIBOR is unavailable. The amendments in this update are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU 2020-04 on its future consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued <i>ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)</i> which simplifies the accounting for convertible instruments. The guidance removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2023 for smaller reporting companies, including interim periods within those fiscal years. Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06 on its future consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_803_eus-gaap--ConcentrationRiskDisclosureTextBlock_zbenJJNG6mPf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_82E_zBiuq84vtNqg">CONCENTRATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at various financial institutions in different countries. These balances are usually secured by the central banks’ insurance companies. At times, these balances may exceed the insurance limits. As of September 30, 2022 and December 31, 2021, uninsured cash and restricted cash balances were $<span id="xdx_905_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20220930_z25nu33Cpxma" title="Uninsured cash">20,252,709</span> and $<span id="xdx_90A_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20211231_zM27tvBhsBt3" title="Uninsured cash">57,905,303</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended September 30, 2021, two customers accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z9b5NtMOzA78" title="Concentration risk, percentage">95</span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zmFJgkYLGrRk" title="Concentration risk, percentage">5</span>% of the Company’s property development revenue. For the nine months ended September 30, 2022, three customers accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zJe1WNN2ovEj" title="Concentration risk, percentage">42</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zYEP7PQ3aKpf" title="Concentration risk, percentage">10</span>%, and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zn5R6fKFOJM4" title="Concentration risk, percentage">48</span>% of the Company’s property development revenue. For the nine months ended September 30, 2021, two customers accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zI1SyadWLIW3" title="Concentration risk, percentage">96</span>%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zOdPAfgvbsoe" title="Concentration risk, percentage">4</span>% of the Company’s property development revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 20252709 57905303 0.95 0.05 0.42 0.10 0.48 0.96 0.04 <p id="xdx_804_eus-gaap--SegmentReportingDisclosureTextBlock_z36ZgWaU5ha6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82D_z0YhW4cA0oGk">SEGMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: real estate, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_ztcbak5fHlb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the nine months ended September 30, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zjg7yW8M1wx1" style="display: none">SCHEDULE OF SEGMENT INFORMATION</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_zNwxOqQi21je" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zOyMRqjHJG51" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zRxe2f4n3YS3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zBQfBZIpQW48" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zZZdj5GNCly3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Real Estate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Digital Transformation Technology</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Biohealth Business</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Nine Months Ended on September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_ztmQXVXIDJxc" style="vertical-align: bottom; background-color: White"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,494,707</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,066</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">771,847</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">319,862</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,600,482</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di_zpfjD1pcaXE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cost of Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,880,914</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,574</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(512,931</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(80,177</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,478,596</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--GrossProfit_zNA3C2U6zM25" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross Margin</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">613,793</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">258,916</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">239,685</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,121,886</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherGeneralExpense_iN_pp0p0_di_zsXPzbXgXqPj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Operating Expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,988,323</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(255,764</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(587,051</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,669,563</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,500,701</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingIncomeLoss_zuu7cdUw7alk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating Loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,374,530</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(246,272</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(328,135</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,429,878</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,378,815</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_zv3Vq25w7FA9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Income (Expense)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,505</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,359,913</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,535,998</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,677,529</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(25,546,935</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zKNCRdcaqrm7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net Loss Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,348,025</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,606,185</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,864,133</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(24,107,407</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(30,925,750</td><td style="text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_zGGRlVGBXq24" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zgGyndprZeMl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zK3w1Fjd2aA6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zPcAw2KFTsn" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210101__20210930_zKG3mZKqtfM9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Real Estate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Digital Transformation Technology</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Biohealth Business</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Nine Months Ended on September 30, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zaDOlzOJfIH2" style="vertical-align: bottom; background-color: White"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">12,026,069</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,919,844</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2138">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,945,913</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di_z5MfjbyGgWVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cost of Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,291,698</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2142">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(218,507</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2144">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,510,205</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--GrossProfit_zkWnjTwSDZ3e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross Margin</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,734,371</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,701,337</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,435,708</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherGeneralExpense_iN_pp0p0_di_zwF1ouC2lpmi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Operating Expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(901,236</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(173,594</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,451,152</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,940,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,466,414</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--OperatingIncomeLoss_zqbwxrUGjFFc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating (Loss) Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,833,135</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(173,594</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,250,185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,940,432</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,030,706</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,063</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">403,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,960,503</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,727,340</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(87,293,906</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zEQ8mJMbBUj4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net Loss Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,824,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">229,406</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,710,318</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,667,772</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(92,324,612</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash and Restricted Cash</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_zFzzt2b3E99k" style="text-align: right" title="Cash and restricted cash">2,678,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zR46UapuSML1" style="text-align: right" title="Cash and restricted cash">389,118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zwXtcYDbhsya" style="text-align: right" title="Cash and restricted cash">1,698,868</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zsjdgcKb90Kf" style="text-align: right" title="Cash and restricted cash">18,469,310</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930_zpzicL6e2Sr8" style="text-align: right" title="Cash and restricted cash">23,235,826</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_z6ReYAhZ65x3" style="text-align: right" title="Total assets">49,820,288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zoeDZK1B7Bx8" style="text-align: right" title="Total assets">1,273,132</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zQOBrSJRtlPh" style="text-align: right" title="Total assets">6,074,039</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zCTW9GFdUy1g" style="text-align: right" title="Total assets">107,497,047</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Assets_iI_pp0p0_c20220930_z1RseKn10Y2h" style="text-align: right" title="Total assets">164,664,506</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash and Restricted Cash</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_pp0p0" style="text-align: right" title="Cash and restricted cash">7,493,921</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_pp0p0" style="text-align: right" title="Cash and restricted cash">245,780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_pp0p0" style="text-align: right" title="Cash and restricted cash">2,629,464</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Cash and restricted cash">50,433,014</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231_pp0p0" style="text-align: right" title="Cash and restricted cash">60,802,179</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_pp0p0" style="text-align: right" title="Total assets">55,465,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_pp0p0" style="text-align: right" title="Total assets">2,199,466</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_pp0p0" style="text-align: right" title="Total assets">11,056,779</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Total assets">115,488,298</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="text-align: right" title="Total assets">184,210,143</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zzrSuyhExc89" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_ztcbak5fHlb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the nine months ended September 30, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zjg7yW8M1wx1" style="display: none">SCHEDULE OF SEGMENT INFORMATION</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_zNwxOqQi21je" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zOyMRqjHJG51" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zRxe2f4n3YS3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20220930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zBQfBZIpQW48" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220930_zZZdj5GNCly3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Real Estate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Digital Transformation Technology</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Biohealth Business</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Nine Months Ended on September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_ztmQXVXIDJxc" style="vertical-align: bottom; background-color: White"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,494,707</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,066</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">771,847</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">319,862</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,600,482</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di_zpfjD1pcaXE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cost of Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,880,914</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,574</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(512,931</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(80,177</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,478,596</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--GrossProfit_zNA3C2U6zM25" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross Margin</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">613,793</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">258,916</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">239,685</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,121,886</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherGeneralExpense_iN_pp0p0_di_zsXPzbXgXqPj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Operating Expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,988,323</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(255,764</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(587,051</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,669,563</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,500,701</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--OperatingIncomeLoss_zuu7cdUw7alk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating Loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,374,530</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(246,272</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(328,135</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,429,878</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,378,815</td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_zv3Vq25w7FA9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Income (Expense)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,505</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,359,913</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,535,998</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,677,529</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(25,546,935</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zKNCRdcaqrm7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net Loss Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,348,025</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,606,185</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,864,133</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(24,107,407</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(30,925,750</td><td style="text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_zGGRlVGBXq24" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zgGyndprZeMl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zK3w1Fjd2aA6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210101__20210930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zPcAw2KFTsn" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210101__20210930_zKG3mZKqtfM9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Real Estate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Digital Transformation Technology</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Biohealth Business</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Nine Months Ended on September 30, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zaDOlzOJfIH2" style="vertical-align: bottom; background-color: White"> <td style="width: 35%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">12,026,069</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,919,844</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2138">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,945,913</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--CostOfGoodsAndServicesSold_iN_pp0p0_di_z5MfjbyGgWVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cost of Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,291,698</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2142">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(218,507</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2144">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,510,205</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--GrossProfit_zkWnjTwSDZ3e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross Margin</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,734,371</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,701,337</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,435,708</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherGeneralExpense_iN_pp0p0_di_zwF1ouC2lpmi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Operating Expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(901,236</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(173,594</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,451,152</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,940,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,466,414</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--OperatingIncomeLoss_zqbwxrUGjFFc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Operating (Loss) Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,833,135</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(173,594</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,250,185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,940,432</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,030,706</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,063</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">403,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,960,503</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,727,340</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(87,293,906</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_zEQ8mJMbBUj4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net Loss Before Income Tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,824,072</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">229,406</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(32,710,318</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(62,667,772</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(92,324,612</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash and Restricted Cash</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_zFzzt2b3E99k" style="text-align: right" title="Cash and restricted cash">2,678,530</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zR46UapuSML1" style="text-align: right" title="Cash and restricted cash">389,118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zwXtcYDbhsya" style="text-align: right" title="Cash and restricted cash">1,698,868</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zsjdgcKb90Kf" style="text-align: right" title="Cash and restricted cash">18,469,310</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_pp0p0_c20220930_zpzicL6e2Sr8" style="text-align: right" title="Cash and restricted cash">23,235,826</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_z6ReYAhZ65x3" style="text-align: right" title="Total assets">49,820,288</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_zoeDZK1B7Bx8" style="text-align: right" title="Total assets">1,273,132</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_zQOBrSJRtlPh" style="text-align: right" title="Total assets">6,074,039</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20220930__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_zCTW9GFdUy1g" style="text-align: right" title="Total assets">107,497,047</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Assets_iI_pp0p0_c20220930_z1RseKn10Y2h" style="text-align: right" title="Total assets">164,664,506</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash and Restricted Cash</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_pp0p0" style="text-align: right" title="Cash and restricted cash">7,493,921</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_pp0p0" style="text-align: right" title="Cash and restricted cash">245,780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_pp0p0" style="text-align: right" title="Cash and restricted cash">2,629,464</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Cash and restricted cash">50,433,014</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c20211231_pp0p0" style="text-align: right" title="Cash and restricted cash">60,802,179</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--RealEstateSegmentMember_pp0p0" style="text-align: right" title="Total assets">55,465,600</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--DigitalTransformationTechnologyMember_pp0p0" style="text-align: right" title="Total assets">2,199,466</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--BiohealthBusinessMember_pp0p0" style="text-align: right" title="Total assets">11,056,779</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Assets_c20211231__us-gaap--StatementBusinessSegmentsAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Total assets">115,488,298</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="text-align: right" title="Total assets">184,210,143</td><td style="text-align: left"> </td></tr> </table> 2494707 14066 771847 319862 3600482 1880914 4574 512931 80177 2478596 613793 9492 258916 239685 1121886 1988323 255764 587051 3669563 6500701 -1374530 -246272 -328135 -3429878 -5378815 26505 -1359913 -3535998 -20677529 -25546935 -1348025 -1606185 -3864133 -24107407 -30925750 12026069 4919844 16945913 8291698 218507 8510205 3734371 4701337 8435708 901236 173594 3451152 8940432 13466414 2833135 -173594 1250185 -8940432 -5030706 -9063 403000 -33960503 -53727340 -87293906 2824072 229406 -32710318 -62667772 -92324612 2678530 389118 1698868 18469310 23235826 49820288 1273132 6074039 107497047 164664506 7493921 245780 2629464 50433014 60802179 55465600 2199466 11056779 115488298 184210143 <p id="xdx_805_eus-gaap--RealEstateDisclosureTextBlock_zJAemF4F5OR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_824_znAXFSdgwZO1">REAL ESTATE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfRealEstatePropertiesTableTextBlock_zDNuqoJWWPK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, real estate assets consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zR65L5qUknQ5" style="display: none">SCHEDULE OF REAL ESTATE ASSETS</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220930_zdLVqkhhnqpk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20211231_z79nwdEKaYvd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--DevelopmentInProcess_iI_pp0p0_maREIPAzIgL_z3pq0S8dRsnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Construction in Progress</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12,155,652</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,597,023</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LandAvailableForDevelopment_iI_pp0p0_maREIPAzIgL_zisTnZl8uVX3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Land Held for Development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,943,126</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,098,104</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RentalProperties_iI_pp0p0_maREIPAzIgL_zONc4pvhMC8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Rental Properties, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,485,036</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,820,253</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RealEstateInvestmentPropertyAtCost_iTI_pp0p0_mtREIPAzIgL_z9N50rhL6hUd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 2.5pt">Total Real Estate Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">51,583,814</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,515,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zF9kLUNqoAM8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Single family residential properties</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, the Company owned <span id="xdx_90C_eus-gaap--NumberOfRealEstateProperties_iI_uInteger_c20220930__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zzYm7roM62Ue" title="Number of Homes">132</span> and <span id="xdx_900_eus-gaap--NumberOfRealEstateProperties_iI_uInteger_c20211231__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zi3v8jhamuDi" title="Number of Homes">109</span> Single Family Residential Properties (“SFRs”), respectively. The Company’s aggregate investment in those SFRs was $<span id="xdx_909_eus-gaap--RealEstateInvestmentPropertyNet_iI_pn5n6_c20220930_z5ZWf5xzqJI1" title="Aggregate investment">31</span> million. Depreciation expense was $<span id="xdx_907_eus-gaap--DepreciationAndAmortization_c20220701__20220930_zdmqdVvrF278" title="Depreciation">161,182</span> and $<span id="xdx_90F_eus-gaap--DepreciationAndAmortization_c20210701__20210930_z75HUUUXkbZh" title="Depreciation">38,533</span> in the three months ended </span>September <span style="background-color: white">30, 2022 and 2021, respectively. Depreciation expense was $<span id="xdx_908_eus-gaap--DepreciationAndAmortization_c20220101__20220930_zaaakSWZI8H7" title="Depreciation">474,936</span> and $<span id="xdx_90D_eus-gaap--DepreciationAndAmortization_c20210101__20210930_z6frBub5cjPd" title="Depreciation">53,755</span> in the nine months ended </span>September <span style="background-color: white">30, 2022 and 2021, respectively. These homes are located in Montgomery and Harris Counties, Texas.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--OtherRealEstateRollForwardTableTextBlock_zSfWLGkmS5tb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the summary of our SRFs as of September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zoiZL4QVWZq1" style="display: none">SUMMARY OF SINGLE FAMILY RESIDENTIAL PROPERTIES</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Homes</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate investment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average Investment per Home</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">SFRs</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--NumberOfRealEstateProperties_iI_uInteger_c20220930__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zsnwB43wLsNi" style="width: 14%; text-align: right" title="Number of Homes">132</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RealEstateInvestmentPropertyNet_iI_pp0p0_c20220930__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zZ55pUpsWv1i" style="width: 14%; text-align: right" title="Aggregate investment">30,998,258</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--AverageInvestmentPerHome_pp0p0_c20220101__20220930__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zrspKrk8wuUg" style="width: 14%; text-align: right" title="Average Investment Per Home">234,835</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zBr3pz862eMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfRealEstatePropertiesTableTextBlock_zDNuqoJWWPK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, real estate assets consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zR65L5qUknQ5" style="display: none">SCHEDULE OF REAL ESTATE ASSETS</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220930_zdLVqkhhnqpk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20211231_z79nwdEKaYvd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--DevelopmentInProcess_iI_pp0p0_maREIPAzIgL_z3pq0S8dRsnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Construction in Progress</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">12,155,652</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,597,023</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LandAvailableForDevelopment_iI_pp0p0_maREIPAzIgL_zisTnZl8uVX3" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Land Held for Development</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,943,126</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,098,104</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RentalProperties_iI_pp0p0_maREIPAzIgL_zONc4pvhMC8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Rental Properties, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,485,036</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">24,820,253</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--RealEstateInvestmentPropertyAtCost_iTI_pp0p0_mtREIPAzIgL_z9N50rhL6hUd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: justify; padding-bottom: 2.5pt">Total Real Estate Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">51,583,814</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,515,380</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12155652 8597023 7943126 7098104 31485036 24820253 51583814 40515380 132 109 31000000 161182 38533 474936 53755 <p id="xdx_896_eus-gaap--OtherRealEstateRollForwardTableTextBlock_zSfWLGkmS5tb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the summary of our SRFs as of September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zoiZL4QVWZq1" style="display: none">SUMMARY OF SINGLE FAMILY RESIDENTIAL PROPERTIES</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Homes</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate investment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Average Investment per Home</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">SFRs</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--NumberOfRealEstateProperties_iI_uInteger_c20220930__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zsnwB43wLsNi" style="width: 14%; text-align: right" title="Number of Homes">132</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RealEstateInvestmentPropertyNet_iI_pp0p0_c20220930__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zZ55pUpsWv1i" style="width: 14%; text-align: right" title="Aggregate investment">30,998,258</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--AverageInvestmentPerHome_pp0p0_c20220101__20220930__srt--MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis__srt--SingleFamilyMember_zrspKrk8wuUg" style="width: 14%; text-align: right" title="Average Investment Per Home">234,835</td><td style="width: 1%; text-align: left"> </td></tr> </table> 132 30998258 234835 <p id="xdx_80F_ecustom--BuilderDepositsTextBlock_zLnXq8Ni0N5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_822_zpBRLQabLUO3">BUILDER DEPOSITS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2015, SeD Maryland Development, LLC (“SeD Maryland”) entered into lot purchase agreements with NVR, Inc. (“NVR”) relating to the sale of single-family home and townhome lots to NVR in the Ballenger Run Project. The purchase agreements were amended three times thereafter. Based on the agreements, NVR was entitled to purchase <span id="xdx_900_ecustom--NumberOfBuilderDepositsShares_iI_c20151130__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_z6PdMkR3UBgk" title="Number of lots">479</span> lots for a price of approximately $<span id="xdx_901_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pp0p0_c20151129__20151130__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zDQ1ALtVhsf3" title="Purchase Price">64,000,000</span>, which escalated <span id="xdx_909_ecustom--PercentageOfIncreaseInPriceOfLots_iI_pid_dp_uPure_c20151130__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zA8yDaaGoKb5" title="Percentage of increase in price of lots">3</span>% annually after June 1, 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the agreements, NVR was required to give a deposit in the amount of $<span id="xdx_90B_eus-gaap--SecurityDepositLiability_iI_pp0p0_c20151130__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_za5IEUqlY0o2" title="Security deposit liability">5,600,000</span>. Upon the sale of lots to NVR, <span id="xdx_906_ecustom--PercentageOfPaymentDeposit_iI_pip0_dp_c20151130__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zVCCIvJaxTDk" title="Security deposit liability">9.9</span>% of the purchase price is taken as payback of the deposit. A violation of the agreements by NVR would cause NVR to forfeit the deposit. On January 3, 2019 and April 28, 2020, NVR gave SeD Maryland two more deposits in the amounts of $<span id="xdx_908_eus-gaap--SecurityDepositLiability_iI_pp0p0_c20190103__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zJHsZOi1eHNl" title="Security deposit liability">100,000</span> and $<span id="xdx_905_eus-gaap--SecurityDepositLiability_c20200428__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_pp0p0" title="Security deposit liability">220,000</span>, respectively, based on the 3rd Amendment to the Lot Purchase Agreement. On September 30, 2022 and December 31, 2021, there was $<span id="xdx_901_eus-gaap--SecurityDepositLiability_iI_pp0p0_c20220930__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zlnc5Ihd7637" title="Security deposit liability">0</span> and $<span id="xdx_908_eus-gaap--SecurityDepositLiability_iI_pp0p0_c20211231__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zGWS9TwvEjUe" title="Security deposit liability">31,553</span> held on deposit, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 479 64000000 0.03 5600000 0.099 100000 220000 0 31553 <p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zN1cpz8vhy6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_828_zdkCv1jrkrZe">NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfDebtTableTextBlock_zErjtH1iMaal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, notes payable consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zuL3hhlYrlv8" style="display: none">SCHEDULE OF NOTES PAYABLE</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220930_z2RtcnH2XN5c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20211231_zpu7l3dLu0Jj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--PPPLoanMember_z2ej6E1C8E3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">PPP Loan</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">68,502</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_z1IxBKXc8j7f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Australia Loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">162,696</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--HirePurchaseOneMember_z2lxej4NGvqg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Hire Purchase 1</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--HirePurchaseTwoMember_zd0GqxQLFIGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Hire Purchase 2</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">122,050</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2289">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayable_iI_zW9lJyoTIw6f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">193,645</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">317,671</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zoXDwwADmFtk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>M&amp;T Bank Loan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 17, 2019, SeD Maryland Development LLC entered into a Development Loan Agreement with Manufacturers and Traders Trust Company (“M&amp;T Bank”) in the principal amount not to exceed at any one time outstanding the sum of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20190417__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zXYscaryyFyd" title="Debt instrument, face amount">8,000,000</span>, with a cumulative loan advance amount of $<span id="xdx_900_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pp0p0_c20190417__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zb552Ey1avfd" title="Line of credit maximum capacity">18,500,000</span>. The line of credit bears interest rate of LIBOR plus 375 basis points. SeD Maryland Development LLC was also provided with a Letter of Credit (“L/C”) Facility in an aggregate amount of up to $<span id="xdx_90C_eus-gaap--LineOfCredit_c20190417__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_pp0p0" title="Long-term line of credit">900,000</span>. The L/C commission will be <span id="xdx_907_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20190415__20190417__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_zhkTEg2lYJI4" title="Line of credit facility, interest rate">1.5</span>% per annum on the face amount of the L/C. Other standard lender fees will apply in the event the L/C is drawn down. The loan is a revolving line of credit. The L/C Facility is not a revolving loan, and amounts advanced and repaid may not be re-borrowed. Repayment of the Loan Agreement is secured by $<span id="xdx_902_eus-gaap--LineOfCreditFacilityCollateralFeesAmount_c20190415__20190417__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_pp0p0" title="Line of credit facility, collateral fees, amount">2,600,000</span> collateral fund and a Deed of Trust issued to the Lender on the property owned by SeD Maryland. As of September 30, 2022, the <span id="xdx_909_eus-gaap--LineOfCreditFacilityRevolvingCreditConversionToTermLoanDescription_c20220101__20220930__dei--LegalEntityAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember_z10J8LutBFJ6" title="Line of credit facility, revolving credit conversion to term loan, description">outstanding balance of the revolving loan was $0</span>. As part of the transaction, the Company incurred loan origination fees and closing fees in the amount of $<span id="xdx_90A_eus-gaap--LoanProcessingFee_pp0p0_c20220101__20220930_zowGOvTc66El" title="Loan processing fee">381,823</span> and capitalized it into construction in process. On March 15, 2022, approximately $<span id="xdx_90C_ecustom--CollateralFee_pp0p0_c20220309__20220315_zNOe1t7Om1Pc" title="Collateral fee">2,300,000</span> was released from collateral, leaving approximately $<span id="xdx_90D_eus-gaap--LineOfCredit_iI_pp0p0_c20220315_za5cXSnvLsXf" title="Long-term line of credit">300,000</span> as collateral for outstanding letters of credit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 18, 2020, Alset EHome Inc. (“Alset EHome”), a wholly owned subsidiary of LiquidValue Development Inc., entered into a Loan Agreement with Manufacturers and Traders Trust Company (the “Lender”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Loan Agreement, the Lender provided a non-revolving loan to Alset EHome in an aggregate amount of up to $<span id="xdx_908_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pp0p0_c20200618__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_z8jTBcbg94w7" title="Line of credit maximum capacity">2,990,000</span> (the “Loan”). The line of credit bears interest rate of LIBOR plus 375 basis points. Repayment of the Loan is secured by a Deed of Trust issued to the Lender on the property owned by certain subsidiaries of Alset EHome. The maturity date of this Loan is <span id="xdx_90C_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20200615__20200618__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zPpDAUFTFBk4" title="Line of credit facility, expiration date">July 1, 2022</span>. LiquidValue Development Inc. and one of its subsidiaries are guarantors of this Loan. The guarantors are required to maintain during the term of the loan a combined minimum net worth in an aggregate amount equal to not less than $<span id="xdx_909_eus-gaap--LineOfCredit_iI_pp0p0_c20200618__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember__srt--RangeAxis__srt--MinimumMember_z7qhmUanGa5d" title="Long-term line of credit">20,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, Alset EHome borrowed $<span id="xdx_90C_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20200101__20201231__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_z8B3F7bnMSri" title="Proceeds from lines of credit">664,810</span> from M&amp;T Bank, incurring at the same time a loan origination fees of $<span id="xdx_900_eus-gaap--LoanProcessingFee_c20200101__20201231__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_pp0p0" title="Loan processing fee">61,679</span> which were amortized over the term of the loan. As of December 31, 2020, the remaining unamortized debt discount was $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20201231__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_ze5m3ltLuFlh" title="Debt instrument, unamortized discount">42,906</span>. The loan in the amount of $<span id="xdx_90F_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20210527__20210528__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zoFy5ETArlIe" title="Proceeds from lines of credit">664,810</span>, together with all accrued interest of $<span id="xdx_909_eus-gaap--LineOfCreditFacilityIncreaseAccruedInterest_pp0p0_c20210527__20210528__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zrvcUyloxdgl" title="Line of credit facility, increase, accrued interest">25,225</span>, was paid off on May 28, 2021. The loan was closed in June 2021. Additionally, the debt discount of $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20210101__20211231__dei--LegalEntityAxis__custom--AlsetEHomeIncMember__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--LineOfCreditFacilityAxis__custom--ManufacturersAndTradersTrustCompanyMember_zrepNtnXUYbb" title="Amortization of debt discount">42,907</span> was fully amortized during the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Paycheck Protection Program Loan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 11, 2021, the Company entered into a five year note with M&amp;T Bank with a principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210211__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_zLN0gsCxpWs6" title="Debt instrument, face amount">68,502</span> pursuant to the Paycheck Protection Program (“PPP Term Note”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan was evidenced by a promissory note. The PPP Term Note had a fixed annual rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210211__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_zM9OCK5c0zUi" title="Debt instrument, interest rate, stated percentage">1.00</span>%, with the first sixteen months of principal and interest deferred until we applied for loan forgiveness. The PPP Term Note was subject to acceleration upon the occurrence of an event of default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The PPP Term Note was unsecured and guaranteed by the United States Small Business Administration. The Company applied to M&amp;T Bank for forgiveness of the PPP Term Note, with the amount which may be forgiven equal to at least <span id="xdx_903_ecustom--PercentageOfForgivenDebtAmount_iI_pid_dp_uPure_c20210211__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_zLvkmexs409g" title="Percentage of forgiven debt amount">60</span>% of payroll costs and other eligible payments incurred by the Company, calculated in accordance with the terms of the CARES Act. In April 2022 the Company received confirmation that the PPP Loan was fully forgiven.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Australia Loan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 7, 2017, SeD Perth Pty Ltd (“SeD Perth”) entered into a loan agreement with National Australian Bank Limited (the “Australia Loan”) for the purpose of funding land development. The loan facility provides SeD Perth with access to funding of up to approximately $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20170107__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_z7kYyIXfrbYe" title="Debt instrument, face amount">460,000</span> and matures on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20170105__20170107__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_zRmAmhTT1qMa" title="Debt instrument, maturity date">December 31, 2018</span>. The Australia Loan is secured by both the land under development and a pledged deposit of $<span id="xdx_90A_eus-gaap--Deposits_iI_pp0p0_c20170107__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_zpT0lAioDE94" title="Deposits">36,059</span>. This loan is denominated in AUD. Personal guarantees amounting to approximately $<span id="xdx_90C_eus-gaap--GuaranteesFairValueDisclosure_c20170107__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_pp0p0" title="Personal guarantee">500,000</span> have been provided by our CEO, Chan Heng Fai and by Rajen Manicka, the CEO of Holista CollTech and Co-founder of iGalen Inc. The interest rate on the Australia Loan is based on the weighted average interest rates applicable to each of the business markets facility components as defined within the loan agreement, ranging from <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210930__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember__srt--RangeAxis__srt--MinimumMember_zZYp1D0KoO6e" title="Debt instrument, interest rate, stated percentage">4.12</span>% to <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210930__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember__srt--RangeAxis__srt--MaximumMember_zH0nsZDUcyZ5" title="Debt instrument, interest rate, stated percentage">4.86</span>% per annum for the nine months ended September 30, 2021. On September 7, 2017 the Australia Loan was amended to reduce the maximum borrowing capacity to approximately $<span id="xdx_909_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pp0p0_c20170907__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_zfF2nEkfe56b" title="Line of credit facility, maximum borrowing capacity">179,000</span>. During 2020, the terms of the Australia Loan were amended to reflect an extended maturity date of <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20200101__20201231__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember__us-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_zeCdlIFPaGGg" title="Debt instrument, maturity date">April 30, 2022</span>. This was accounted for as a debt modification. The Company did not pay fees to the National Australian Bank Limited for the modification of the loan agreement. In February 2022, SeD Perth repaid the loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Singapore Car Loans</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 17, 2021, Alset International Limited entered into an agreement with Hong Leong Finance Limited to purchase a car for business. The total purchase price of the car, including associated charges, was approximately $<span id="xdx_90A_ecustom--PurchasePriceAssociatedCharges_iI_pp0p0_c20210517__dei--LegalEntityAxis__custom--HongLeongFinanceLimitedMember_zvYfNHuE7LYk" title="Associated charges">184,596</span>. Alset International paid an initial deposit of $<span id="xdx_904_eus-gaap--DepositAssets_iI_pp0p0_c20210517__dei--LegalEntityAxis__custom--HongLeongFinanceLimitedMember_zUTRaM5P2CO" title="Initial deposit">78,640</span>, and would make monthly instalment of approximately $<span id="xdx_908_ecustom--MonthlyInstalment_c20210516__20210517__dei--LegalEntityAxis__custom--HongLeongFinanceLimitedMember_zhzv6OUWjKC7" title="Monthly instalment">1,300</span>, including interest of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210517__dei--LegalEntityAxis__custom--HongLeongFinanceLimitedMember_znIu3QsiBjql" title="Debt instrument, interest rate, stated percentage">1.88</span>% per annum, for the <span id="xdx_90B_eus-gaap--DebtInstrumentTerm_dtM_c20210516__20210517__dei--LegalEntityAxis__custom--HongLeongFinanceLimitedMember_z9Z37cFgSCHi" title="Debt instrument, term">84</span> months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 22, 2022 Alset International entered into an agreement with United Overseas Bank Limited to purchase additional car for business. The total purchase price of the car, including associated charges, was approximately $<span id="xdx_906_ecustom--PurchasePriceAssociatedCharges_iI_pp0p0_c20220922__dei--LegalEntityAxis__custom--UnitedOverseasBankLimitedMember_zwcs6ssyfepk" title="Associated charges">182,430</span>. Alset International paid an initial deposit of $<span id="xdx_90B_eus-gaap--DepositAssets_iI_pp0p0_c20220922__dei--LegalEntityAxis__custom--UnitedOverseasBankLimitedMember_zyGNE7VJaWu1" title="Initial deposit">66,020</span> and would make monthly installments of approximately $<span id="xdx_90D_ecustom--MonthlyInstalment_c20220920__20220922__dei--LegalEntityAxis__custom--UnitedOverseasBankLimitedMember_zwczxTrw1N86" title="Monthly instalment">1,472</span>, including interest of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220922__dei--LegalEntityAxis__custom--UnitedOverseasBankLimitedMember_zVpGH4gAErYh" title="Debt instrument, interest rate, stated percentage">1.88</span>% per annum, for the <span id="xdx_909_eus-gaap--DebtInstrumentTerm_dtM_c20220920__20220922__us-gaap--TypeOfArrangementAxis__custom--HirePurchaseAgreementMember_zevAmewxNCW2" title="Debt instrument, term">84</span> months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_eus-gaap--ScheduleOfDebtTableTextBlock_zErjtH1iMaal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, notes payable consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zuL3hhlYrlv8" style="display: none">SCHEDULE OF NOTES PAYABLE</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220930_z2RtcnH2XN5c" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">September 30,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20211231_zpu7l3dLu0Jj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2021</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--PPPLoanMember_z2ej6E1C8E3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">PPP Loan</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">68,502</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--AustraliaLoanMember_z1IxBKXc8j7f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Australia Loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">162,696</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--HirePurchaseOneMember_z2lxej4NGvqg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Hire Purchase 1</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">71,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86,473</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--HirePurchaseTwoMember_zd0GqxQLFIGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Hire Purchase 2</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">122,050</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2289">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NotesPayable_iI_zW9lJyoTIw6f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total notes payable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">193,645</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">317,671</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 68502 162696 71595 86473 122050 193645 317671 8000000 18500000 900000 0.015 2600000 outstanding balance of the revolving loan was $0 381823 2300000 300000 2990000 2022-07-01 20000000 664810 61679 42906 664810 25225 42907 68502 0.0100 0.60 460000 2018-12-31 36059 500000 0.0412 0.0486 179000 2022-04-30 184596 78640 1300 0.0188 P84M 182430 66020 1472 0.0188 P84M <p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zhgkO7iGs01i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_823_zhaKhC2q5rA">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Personal Guarantees by Directors</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022 and December 31, 2021, a director of the Company had provided personal guarantees amounting to approximately $<span id="xdx_90E_ecustom--PersonalGuarantees_pp0p0_c20220101__20220930__srt--TitleOfIndividualAxis__custom--DirectorsMember_zpnfzfoBe8H6" title="Personal guarantees">0</span> and $<span id="xdx_90E_ecustom--PersonalGuarantees_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DirectorsMember_z6vdaju74H48" title="Personal guarantees">500,000</span>, respectively, to secure external loans from financial institutions for AEI and the consolidated entities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchase of Shares and Warrants from APM</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 17, 2020, the Company purchased <span id="xdx_903_ecustom--NumberOfSharesPurchased_c20200716__20200717__us-gaap--RelatedPartyTransactionAxis__custom--AmericanMedicalREITIncMember_zq9pHLjAlLIe" title="Number of shares purchased">122,039,000</span> shares, approximately <span id="xdx_90F_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_pid_dp_c20200717__us-gaap--RelatedPartyTransactionAxis__custom--AmericanMedicalREITIncMember_zH5bgmQaBnL" title="Onwership percentage">9.99</span>% ownership, and warrants to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200717__us-gaap--RelatedPartyTransactionAxis__custom--AmericanMedicalREITIncMember_z6hzkFTb1Pr6" title="Class of warrant or right purchased">1,220,390,000</span> shares with an exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200717__us-gaap--RelatedPartyTransactionAxis__custom--AmericanMedicalREITIncMember_z8TUKGR5PcE7" title="Class of warrant or right, exercise price of warrants or rights">0.0001</span> per share, from <span style="background-color: white">APM</span>, for an aggregate purchase price of $<span id="xdx_90C_eus-gaap--PaymentsToAcquireEquitySecuritiesFvNi_pp0p0_c20200716__20200717__us-gaap--RelatedPartyTransactionAxis__custom--AmericanMedicalREITIncMember_zMIduELPwhef" title="Payments to acquire equity securities, FV-NI">122,039</span>. We value the <span style="background-color: white">APM </span>warrants under level 3 category through a Black Scholes option pricing model and the fair value of the APM warrants were $<span id="xdx_909_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20200716__20200717__us-gaap--RelatedPartyTransactionAxis__custom--AmericanMedicalREITIncMember_zOY3f6F7xYI8" title="Fair value of warrants">860,342</span> as of July 17, 2020, the purchase date, $<span id="xdx_90E_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--AmericanPremiumWaterCorpMember_zqftOsU4zy74" title="Investment">517,965</span> as of September 30, 2022 and $<span id="xdx_903_eus-gaap--InvestmentsFairValueDisclosure_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--AmericanPremiumWaterCorpMember_zfNJA15x2bu5" title="Investment">1,009,854</span> as of December 31, 2021. The difference of $<span id="xdx_909_ecustom--Contribution_pp0p0_c20220101__20220930__dei--LegalEntityAxis__custom--AmericanPremiumWaterCorpMember_zd7U4Dx7b5v" title="Contribution">945,769</span> of fair value of stock and warrants, total $<span id="xdx_905_ecustom--Contribution_pp0p0_c20220101__20220930__us-gaap--FairValueByAssetClassAxis__custom--StockAndWarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumWaterCorpMember_zWBljD5hSj2f" title="Contribution">1,067,808</span> and the purchase price $<span id="xdx_909_eus-gaap--PaymentsToAcquireEquitySecuritiesFvNi_pp0p0_c20200716__20200717__us-gaap--RelatedPartyTransactionAxis__custom--AmericanMedicalREITIncMember_zPdvhaBu0LV5" title="Payments to acquire equity securities, FV-NI">122,039</span>, was recorded as additional paid in capital at December 31, 2021, as it was a related party transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sale of Investment in Vivacitas to DSS</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 18, 2021, the Company sold its equity investment in Vivacitas, a U.S.-based biopharmaceutical company, consisting of <span id="xdx_909_ecustom--GainOnSaleOfSharesInvestment_pid_c20210316__20210318__us-gaap--RelatedPartyTransactionAxis__custom--DocumentSecuritiesSystemsIncMember_zxvOT7Mk0na5" title="Gain on sale of shares investment">2,480,000</span> shares of common stock and an option to purchase <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20210316__20210318__us-gaap--RelatedPartyTransactionAxis__custom--VivacitasMember_ztBngpqkmyo4" title="Number of shares purchased">250,000</span> shares of Vivacitas common stock at $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210318__us-gaap--RelatedPartyTransactionAxis__custom--VivacitasMember_z42GjIxLN26e" title="Common stock, par value">1</span> per share at any time prior to the date of a public offering, to a subsidiary of DSS for $<span id="xdx_90A_eus-gaap--GainOnSaleOfInvestments_pp0p0_c20210316__20210318__us-gaap--RelatedPartyTransactionAxis__custom--DocumentSecuritiesSystemsIncMember_zzFyCwoyyr9" title="Gain on sale of shares investment">2,480,000</span>. Chan Heng Fai, our Chairman, CEO and founder, serves as a director of Vivacitas and as the Executive Chairman of DSS. After this transaction, we do not own any investment in Vivacitas. Our original cost of common stock and stock option of Vivacitas was $<span id="xdx_90C_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20210318__us-gaap--RelatedPartyTransactionAxis__custom--DocumentSecuritiesSystemsIncMember_zG4fRov0x8Li" title="Owned fair value">200,128</span>. We did not recognize gain or loss in this transaction. The difference of $<span id="xdx_905_ecustom--CostMethodInvestmentOriginalCost_iI_pp0p0_c20210318__us-gaap--RelatedPartyTransactionAxis__custom--DocumentSecuritiesSystemsIncMember_znLksNcEz8H9" title="Original cost">2,279,872</span> between the selling price and our original investment cost was recorded as additional paid capital, reflecting that it was a related party transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchase and Sale of Stock in True Partners Capital Holding Limited</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 12, 2021, the Company purchased <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210309__20210312__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnersCapitalHoldingLimitedMember_zQHAXHekalDb" title="Purchase of stock">62,122,908</span> ordinary shares of True Partners Capital Holding Limited for $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20210309__20210312__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnersCapitalHoldingLimitedMember_zXVp2GnWSkZ" title="Stock cost">6,729,629</span> from a related party. The fair market value of such stock on the acquisition date was $<span id="xdx_903_eus-gaap--EquityFairValueDisclosure_iI_pp0p0_c20210312__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnersCapitalHoldingLimitedMember_zyk5ziRPiEVh" title="Equity, fair value disclosure">10,003,689</span>. The difference between the purchase price and the fair market value of $<span id="xdx_90D_ecustom--AdjustmentsToAdditionalPaidInCapitalPurchaseStockOfTruePartnerFromRelatedParty_pp0p0_c20210309__20210312__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnersCapitalHoldingLimitedMember_zDEcYtk74ZIb" title="Additional paid in capital adjustment">3,274,060</span> was recorded as an equity transaction on Company’s condensed consolidated statement of stockholders’ equity at December 31, 2021. Pursuant to a Stock Purchase Agreement from February 2022, the Company sold <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220516__20220517__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnersCapitalHoldingLimitedMember_zCOpX7J8Xv33" title="Purchase of stock">62,122,908</span> shares of True Partner to DSS Inc. (through the transfer of subsidiary and otherwise), for a purchase price of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220516__20220517__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnersCapitalHoldingLimitedMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zR0zD9P3Agz9" title="Purchase of stock">17,570,948</span> shares of common stock of DSS. DSS shareholders approved the Stock Purchase Agreement on May 17, 2022 (which is deemed to be the effective date of this transaction). The transaction loss of $<span id="xdx_90C_ecustom--TransactionLoss_pp0p0_c20220516__20220517__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnersCapitalHoldingLimitedMember_z3EXIPB7M8He" title="Transaction loss">446,104</span>, which is the difference between the fair value of True Partner stock and fair value of DSS stock at the agreement’s effective date, was recorded as other expense in the Company’s Statement of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Notes Payable</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chan Heng Fai provided an interest-free, due on demand advance to LiquidValue Development Pte. Ltd. and its subsidiary LiquidValue Development Limited for the general operations of such entities. As of September 30, 2022 and December 31, 2021, the outstanding balance was approximately $<span id="xdx_90D_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--LiquidValueDevelopmentPteLtdMember_zGlda2DDZdj4" title="Notes payable">0</span>, and $<span id="xdx_906_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--LiquidValueDevelopmentPteLtdMember_zpWKWBO4dCk9" title="Notes payable">820,113</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chan Heng Fai provided an interest-free, due on demand advance to Alset Inc. for the Company’s general operations. The advance was paid back during the year ended December 31, 2021 and as of September 30, 2022 and December 31, 2021, the outstanding balance was $<span id="xdx_909_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220930_z1xkgcQ0Ixij" title="Notes payable"><span id="xdx_904_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231_zZ8UbItSE8L1" title="Notes payable">0</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chan Heng Fai provided an interest-free, due on demand advance to SeD Perth Pty. Ltd. for its general operations. As of September 30, 2022 and December 31, 2021, the outstanding balance was $<span id="xdx_908_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember_zq9k2T6cRVHd" title="Notes payable">12,088</span> and $<span id="xdx_907_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--SeDPerthPtyLtdMember_zbXNkgpaJxo3" title="Notes payable">13,546</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 20, 2020, the Company acquired <span id="xdx_900_eus-gaap--StockRepurchasedDuringPeriodShares_c20200819__20200820__dei--LegalEntityAxis__custom--ChanHengFaiMember_zFI7cHGdbqO3" title="Stock repurchased during period, value">30,000,000</span> common shares from Chan Heng Fai in exchange for a two-year non-interest bearing note of $<span id="xdx_90B_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20200820__dei--LegalEntityAxis__custom--ChanHengFaiMember_zxd7EBeZMscd" title="Notes payable">1,333,429</span>. During the year ended December 31, 2021, the Company paid back all $<span id="xdx_901_ecustom--NotesPayablePaidBackAmount_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--ChanHengFaiMember_zvxi3P3oBmC9" title="Notes payable paid back amount">1,333,429</span> and as of September 30, 2022 and December 31, 2021 the amount outstanding was $<span id="xdx_90C_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--ChanHengFaiMember_z7G5DwcKpF24" title="Notes payable"><span id="xdx_908_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--ChanHengFaiMember_z4v1g9EMzu9a" title="Notes payable">0</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 12, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company, for four proposed transactions, consisting of (i) purchase of certain warrants (the “Warrants”) to purchase <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AlsetInternationalLimitedMember_zVYo3UymeZd1" title="Number of warrant purchased">1,500,000,000</span> shares of Alset International Limited, which was valued at $<span id="xdx_905_eus-gaap--WarrantsAndRightsOutstanding_iI_pdp0_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AlsetInternationalLimitedMember_zM8dbT5ou2i3" title="Warrants and rights outstanding">28,363,966</span>; (ii) purchase of all of the issued and outstanding stock of LiquidValue Development Pte Ltd. (“LVD”), which was valued at $<span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--LiquidValueDevelopmentPteLtdMember_zrZ15GXZLM9b" title="Stock repurchased during period, value">173,395</span>; (iii) purchase of <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--TruePartnerCapitalHoldingLimitedMember_zzdYu5I77xie" title="Stock repurchased during period, value">62,122,908</span> ordinary shares in True Partner Capital Holding Limited (HKG: 8657) (“True Partner”), which was valued at $<span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--TruePartnerCapitalHoldingLimitedMember_zPB1fW3FyUPa" title="Stock repurchased during period, value">6,729,629</span>; and (iv) purchase of <span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodShares_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpIncMember_zj4XprBc8vc5" title="Stock repurchased during period, value">4,775,523</span> shares of the common stock of American Pacific Bancorp Inc. (“APB”), which was valued at $<span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20210309__20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--AmericanPacificBancorpIncMember_zKZJnH5A9Y52" title="Stock repurchased during period, value">28,653,138</span>. The total amount of above four transactions was $<span id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zF4z2YV1HSTl" title="Accounts payable, current">63,920,129</span>, payable on the Closing Date by the Company, in the convertible promissory notes (“Alset CPNs”), which, subject to the terms and conditions of the Alset CPNs and the Company’s shareholder approval, shall be convertible into shares of the Company’s common stock (“AEI Common Stock”), at par value of $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEjZgkYwfUE4" title="Common stock, par value">0.001</span> per share, at the conversion price of AEI’s Stock Market Price. AEI’s Stock Market Price was $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20210312__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zdAVhFUlB4c3" title="Shares price">5.59</span> per share, equivalent to the average of the five closing per share prices of AEI Common Stock preceding January 4, 2021 as quoted by Bloomberg L.P. AEI’s stock price was $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20210312_zaSopYM0gRU4" title="Shares price">10.03</span> on March 12, 2021, the commitment date. The Beneficial Conversion Feature (“BCF”) intrinsic value was $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_pp0p0_c20210309__20210312_zPCHAUsEy5U6" title="Beneficial conversion feature value">50,770,192</span> for the four convertible promissory notes and was recorded as debt discount of convertible notes after the transaction. On May 13 and June 14, 2021 all Alset CPNs of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210511__20210513__dei--LegalEntityAxis__custom--AlsetCPNMember_zPDuLqQi4gqh" title="Debt conversion, converted instrument, amount"><span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210611__20210614__dei--LegalEntityAxis__custom--AlsetCPNMember_zdvvu88B8Iah" title="Debt conversion, converted instrument, amount">63,920,128</span></span> and accrued interests of $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210513__dei--LegalEntityAxis__custom--AlsetCPNMember_z3GWyEt4vQrc" title="Interest payable"><span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20210614__dei--LegalEntityAxis__custom--AlsetCPNMember_z3Pbvld16Enj" title="Interest payable">306,438</span></span> were converted into <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210511__20210513__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__dei--LegalEntityAxis__custom--AlsetCPNMember_zoK83TN8OJx9" title="Debt conversion, converted instrument, shares issued"><span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210611__20210614__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__dei--LegalEntityAxis__custom--AlsetCPNMember_ze0Z18Qrb3cb" title="Debt conversion, converted instrument, shares issued">2,123</span></span> shares of Series B preferred stock and <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210511__20210513__dei--LegalEntityAxis__custom--AlsetCPNMember_zSv1mAGqmFg3" title="Debt conversion, converted instrument, shares issued"><span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210611__20210614__dei--LegalEntityAxis__custom--AlsetCPNMember_zzKnB3IpJOOf" title="Debt conversion, converted instrument, shares issued">9,163,965</span></span> shares of common stock of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 14, 2021, the Company borrowed S$<span id="xdx_904_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_uSGD_c20210514__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zVQe26GfgAQ1" title="Notes payable">7,395,472</span> Singapore Dollars (equal to approximately $<span id="xdx_905_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20210514__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_ztdonJBJbb67" title="Notes payable">5,545,495</span> U.S. Dollars) from Chan Heng Fai. The unpaid principal amount of the Loan is due and payable on May 14, 2022 and the Loan has no interest. The loan was paid back in full during 2021 and the outstanding balance was $<span id="xdx_90C_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220930__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zpg9nfk0ihfj" title="Notes payable"><span id="xdx_908_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_z8ZFagQHqPha" title="Notes payable">0</span></span> as of September 30, 2022 and December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management Fees</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MacKenzie Equity Partners, LLC, an entity owned by Charles MacKenzie, the Chief Development Officer of the Company, has had a consulting agreement with a majority-owned subsidiary of the Company since 2015. Pursuant to the terms of the agreement, as amended on January 1, 2018, the Company’s subsidiary paid a monthly fee of $<span id="xdx_90D_eus-gaap--ProfessionalFees_pp0p0_c20171230__20180101__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zoQayscCg9Ua" title="Professional fees">20,000</span> for consulting services. Pursuant to an agreement entered into in June of 2022, the Company’s subsidiary has paid $<span id="xdx_901_eus-gaap--ProfessionalFees_pp0p0_c20220601__20220630__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zjz5onqfIg9h" title="Professional fees">25,000</span> per month for consulting services, effective as of January 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_pp0p0_c20220101__20220930__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zWhrc3xfPd5d" title="Related party transaction description">In addition, MacKenzie Equity Partners will be paid certain bonuses, including (i) a sum of $50,000 on June 30, 2022; (ii) a sum of $50,000 upon the successful financing of 100 homes owned by American Housing REIT Inc. with an entity not affiliated with SeD Development Management LLC (a subsidiary of the Company); and (iii) a sum of $50,000 upon the successful leasing of 30 homes in the Alset of Black Oak development</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred expenses of $<span id="xdx_907_eus-gaap--ProfessionalFees_pp0p0_c20210701__20210930__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zyogyUqXPzF9" title="Professional fees">60,000</span> and $<span id="xdx_906_eus-gaap--ProfessionalFees_pp0p0_c20210101__20210930__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zQamzoEKzw47" title="Professional fees">240,000</span> in the three and nine months ended September 30, 2021, respectively, and $<span id="xdx_900_eus-gaap--ProfessionalFees_pp0p0_c20220701__20220930__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zbK9mQgc2Sgc" title="Professional fees">75,000</span> and $<span id="xdx_900_eus-gaap--ProfessionalFees_pp0p0_c20220101__20220930__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zlPQpOqsqztc" title="Professional fees">275,000</span> in the three and nine months ended September 30, 2022, respectively, which were capitalized as part of Real Estate on the balance sheet as the services relate to property and project management. In 2021, MacKenzie Equity Partners was paid a bonus payment of $<span id="xdx_901_ecustom--EquityPartnersAdditionalBonusGranted_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--MacKenzieEquityPartnersMember_zs8DiqGdrbEd" title="Equity partners additional bonus granted">120,000</span>. In June 2022, MacKenzie Equity Partners was paid an additional $<span id="xdx_90E_ecustom--AdditionalBonusPayment_iI_pp0p0_c20220930__srt--TitleOfIndividualAxis__custom--MacKenzieEquityPartnersMember_zXWtTAmj3d4k" title="Additional bonus payment">50,000</span> bonus payment (as described above). On September 30, 2022 and December 31, 2021, the Company owed this related party $<span id="xdx_907_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_zzoL8wI0jIuf" title="Due to related party">25,000</span> and $<span id="xdx_90A_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__dei--LegalEntityAxis__custom--MacKenzieEquityPartnersMember_z5p9g8H01jJg" title="Due to related party">80,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Notes Receivable from Related Party</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2, 2020 and on October 29, 2021, LiquidValue Asset Management Pte. Ltd. (“LiquidValue”) received two $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zLPtrUa1rPh5">200,000</span> Promissory Notes and on October 29, 2021 Alset International received $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211029__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z6gqvenMwbJe">8,350,000</span> Promissory Note from American Medical REIT Inc. (“AMRE”), a company which is <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember__srt--RangeAxis__srt--MaximumMember_zjA7VyC189f8">15.8</span>% owned by LiquidValue as of September 30, 2022. Chan Heng Fai and Chan Tung Moe are directors of American Medical REIT Inc. The notes carry interest rates of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zvAw137b9KM1">8</span>% and are <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDateDescription_c20200229__20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zxG1nGVPUlGe" title="Debt maturity date description">payable in two</span>, three years and 25 months, respectively. LiquidValue also received warrants to purchase AMRE shares at the exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z3xkPl47D5V5" title="Exercise price">5.00</span> per share. <span id="xdx_908_ecustom--IpoPriceDescription_c20200229__20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zTcetbWi0rf4" title="Ipo price, description">The amount of the warrants equals to the note principal divided by the exercise price. If AMRE goes to IPO in the future and IPO price is less than $10.00 per share, the exercise price shall be adjusted downward to fifty percent (50%) of the IPO price</span>. In March 2022 the Company converted two $<span id="xdx_905_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_c20220331__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zkaTIIksABb" title="Notes payable related parties">200,000</span> loans, together with associated warrants into <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20220301__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zeG64R5nDDt4" title="Shares conversion of convertible securities">167,938</span> common shares of AMRE, and increased its ownership in AMRE from <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember__srt--RangeAxis__srt--MinimumMember_zOEYH1U7QHn2">3.4</span>% to <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--LiquidValueDevelopmentPteLtdMember__srt--RangeAxis__srt--MaximumMember_zimaIIImyi62">15.8</span>%. <span style="background-color: white">On July 12, 2022, pursuant to Assignment and Assumption Agreement from February 25, 2022, as amended on July 12, 2022, the Company sold the $<span id="xdx_907_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20220712__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanMedicalReitIcbMember__us-gaap--ShortTermDebtTypeAxis__custom--LoanOneMember_zjLOQ9WCpLwc" title="Loans and leases receivable related parties">8,350,000</span> loan, together with accrued interest, to DSS for a purchase price of<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220711__20220712__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__dei--LegalEntityAxis__custom--DocumentSecuritiesSystemsIncMember_zDW9Bc21fRG1" title="Shares purchase price"> 21,366,177</span> shares of DSS’s common stock. The loss from this transaction of $<span id="xdx_907_ecustom--TransactionLoss_c20220711__20220712__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zk9LZKsAJAA4" title="Transaction loss">1,089,675</span> was calculated as the difference between the face value of promissory note together with accrued interest and the fair value of DSS stock on July 12, 2022, and was recorded under Other Expense in Statement of Operations. From July 12 to September 30, 2022, DSS stock was valued under fair market value and a loss of $<span id="xdx_90F_eus-gaap--MarketableSecuritiesUnrealizedGainLoss_c20220713__20220930__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zkmcQcDWRGva" title="Unrealized loss on security investment">2,157,984</span> was booked as unrealized loss on security investment. </span>As of December 31, 2021, the fair market value of the warrants was $<span id="xdx_905_eus-gaap--WarrantsAndRightsOutstanding_iI_c20211231__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zwYHosYb3fr3" title="Fair value of warrants">0</span>. The Company accrued $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20220930__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zQjQN9vAIhId" title="Interest payable">0</span> and $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20211231__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zCuWwXouWYHg" title="Interest payable">130,000</span> interest income as of September 30, 2022 and December 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 24, 2017, SeD Capital Pte Ltd, a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20210124__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SeDPerthPtyLtdMember_zDjNMUHwJaS3" title="Equity method investment, ownership percentage">100</span>% owned subsidiary of Alset International lent $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20170124__srt--ConsolidatedEntitiesAxis__custom--SeDCapitalPteLtdMember__dei--LegalEntityAxis__custom--IGalenInternationalMember_zojCyRLUNI7f" title="Principal amount">350,000</span> to iGalen Inc.<span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20170123__20170124__srt--ConsolidatedEntitiesAxis__custom--SeDCapitalPteLtdMember__dei--LegalEntityAxis__custom--IGalenInternationalMember_zrqnI6VZlS6i" title="Debt instrument maturity date description"> The term of the loan was two years, with an interest rate of 3% per annum for the first year and 5% per annum for the second year. The expiration term was renewed as due on demand after two years with 5% per annum interest rate.</span> As of December 31, 2020, the outstanding principal was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20201231__srt--ConsolidatedEntitiesAxis__custom--SeDCapitalPteLtdMember__dei--LegalEntityAxis__custom--IGalenInternationalMember_zcxEucfRR8c3" title="Debt instrument face amount">350,000</span> and accrued interest $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20201231__srt--ConsolidatedEntitiesAxis__custom--SeDCapitalPteLtdMember__dei--LegalEntityAxis__custom--IGalenInternationalMember_z2ARajGt7ha5" title="Interest payable">61,555</span>. On December 31, 2021, the management of the Company evaluated the financial and the operation results of iGalen and concluded that possibility to repay this loan is not probable, and the principal and accrued interest total of $<span id="xdx_90F_eus-gaap--InterestExpense_pp0p0_c20211201__20211231__srt--ConsolidatedEntitiesAxis__custom--SeDCapitalPteLtdMember__dei--LegalEntityAxis__custom--IGalenInternationalMember_zpf2IDJdpvA8" title="Interest expenses">412,754</span> was recorded as bad debt expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022, the Company provided advances for operation of $<span id="xdx_903_ecustom--AdvancesForOperations_pp0p0_c20220101__20220930__dei--LegalEntityAxis__custom--HWHWorldCoMember_zzcbo2Xgjco1" title="Advances for operations">236,699</span> to HWH World Co., a direct sales company in Thailand of which the Company holds approximately <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HWHWorldCoMember_zOtJkvouagBh" title="Equity method investment, ownership percentage">19</span>% ownership.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the first quarter of 2022, a subsidiary of the Company made a non-interest bearing advance in the amount of $<span id="xdx_90C_eus-gaap--EquityMethodInvestmentAggregateCost_iI_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInvestmentPteLTDMember__srt--TitleOfIndividualAxis__custom--OneOfOurDirectorMember_zlvkdNt6cvA8" title="Equity method investment aggregate cost">476,250</span> on behalf of Alset Investment Pte. Ltd., a company <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInvestmentPteLTDMember__srt--TitleOfIndividualAxis__custom--OneOfOurDirectorMember_zgKcGuMdieXf" title="Ownership percentage">100</span>% owned by one of our directors. Such advance was made in connection with a private placement into Alset Capital Acquisition Corp. by its sponsor, Alset Acquisition Sponsor, LLC. On September 30, 2022 Alset Investment repaid all balance due of $<span id="xdx_90C_eus-gaap--EquityMethodInvestmentAggregateCost_iI_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInvestmentPteLTDMember__srt--TitleOfIndividualAxis__custom--OneOfOurDirectorMember_zoXK1U8IT0n2" title="Equity method investment aggregate cost">476,250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2022, Alset International Limited, a subsidiary of the Company, entered into a stock purchase agreement with one of our directors and paid $<span id="xdx_90B_eus-gaap--PaymentsToAcquireEquityMethodInvestments_c20220101__20220630__srt--TitleOfIndividualAxis__custom--OneOfOurDirectorMember_zMJWHOrpmUF2" title="Equity method investments">1,746,279</span> to one of our directors as the consideration for purchase of <span id="xdx_90E_ecustom--CommonSharesOfValueExchange_iI_c20220630__srt--TitleOfIndividualAxis__srt--DirectorMember_z6zlVfK3XG8e" title="Common shares of value exchange">7,276,163</span> common shares of Value Exchange International. This transaction was terminated under the agreement of both parties thereafter. The director agreed to fully refund the amount of $<span id="xdx_90F_eus-gaap--DueFromOfficersOrStockholders_iI_c20221231__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1tA40Zv6kCk" title="Receivable from director">1,746,279</span> or to work on a new stock sale deal with the Company in the fourth quarter of 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company paid some operating expenses for Alset Capital Acquisition Corp., a special purpose acquisition company of which the Company holds <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCropMember_zgFu4HNAZIN8" title="Equity method investment, ownership percentage">23.4</span>%. The advances are interest free with no set repayment terms. As of September 30, 2022 and December 31, 2021, the balance of these advances was $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetCapitalAcquisitionCropMember_zyXMFHmo47I1" title="Principal amount"><span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInvestmentPteLTDMember_zXE8w4cYryrd" title="Principal amount">0</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2022 Hapi Café Inc. entered into binding term sheet (the “First Term Sheet”) with Ketomei Pte Ltd and Tong Leok Siong Constant, pursuant to which Hapi Café lent Ketomei $<span id="xdx_907_eus-gaap--DebtConversionOriginalDebtAmount1_c20220727__20220728__dei--LegalEntityAxis__custom--HapiCafeIncMember_zDEQNp6bIMlc" title="Debt conversion original debt amount">41,750</span>. This loan has a <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220628__dei--LegalEntityAxis__custom--HapiCafeIncMember_zpim4DyenV65" title="Debt interest rate">0</span>% interest rate for the first 60 days and an interest rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20220727__20220728__dei--LegalEntityAxis__custom--HapiCafeIncMember_zpkyTBMaeeI6" title="Debt interest rate">8</span>% per annum afterwards. On August 4, 2022 the same parties entered into another binding term sheet (the “Second Term Sheet”) pursuant to which Hapi Café agreed to lend Ketomei up to S$<span id="xdx_900_ecustom--LentAgreed_uSGD_c20220803__20220804__dei--LegalEntityAxis__custom--HapiCafeIncMember_zGXKTSLyIgMl" title="Lend agreed">360,000</span> Singapore Dollars (equal to approximately $<span id="xdx_90F_ecustom--LentAgreed_c20220803__20220804__dei--LegalEntityAxis__custom--HapiCafeIncMember_z9Ivl9QsdD31" title="Lend agreed">250,500</span> US Dollars) pursuant to a convertible loan, with a term of 12 months. After the initial 12 months, the interest on such loan will be <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220728__dei--LegalEntityAxis__custom--HapiCafeIncMember_zLrUm0LjrVr6" title="Debt interest rate">8</span>%. In addition, pursuant to the Second Term Sheet, the July 28, 2022 loan was modified to include conversion rights. In August 2022, Ketomei drew $<span id="xdx_90D_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20220831__dei--LegalEntityAxis__custom--KetomeiDrewMember_z1Ps4223O1i2">29,922</span> from the loan. As of September 30, 2022, Ketomei owed $<span id="xdx_909_eus-gaap--LoansAndLeasesReceivableRelatedParties_iI_c20220930__dei--LegalEntityAxis__custom--HapiCafeIncMember_zFsSmRsBZvzk">71,672</span> to Hapi Cafe.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loan to Employees</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 24, 2020, American Pacific Bancorp. Inc. lent $<span id="xdx_90A_eus-gaap--DueToOfficersOrStockholdersCurrentAndNoncurrent_iI_pp0p0_c20201124__srt--TitleOfIndividualAxis__custom--ChanTungMoeMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zqH0DfySZXcg" title="Due to officer">560,000</span> to Chan Tung Moe, an officer of one of the subsidiaries of the Company and son of Chan Heng Fai, Chairman and Chief Executive Officer of the Company, bearing interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201124__srt--TitleOfIndividualAxis__custom--ChanTungMoeMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zgN62ejB7Wql" title="Debt instrument, interest percentage">6</span>%, with a maturity date of <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20201122__20201124__srt--TitleOfIndividualAxis__custom--ChanTungMoeMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zOctqDnoPV02" title="Debt instrument maturity date">November 23, 2023</span>. <span id="xdx_90E_eus-gaap--DebtInstrumentDescription_c20201122__20201124__srt--TitleOfIndividualAxis__custom--ChanTungMoeMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zcRbY04NQBKf" title="Debt instrument description">This loan was secured by an irrevocable letter of instruction on 80,000 shares of Alset Inc</span>. On November 24, 2020, American Pacific Bancorp. Inc. lent $<span id="xdx_90D_eus-gaap--DueToOfficersOrStockholdersCurrentAndNoncurrent_iI_pp0p0_c20201124__srt--TitleOfIndividualAxis__custom--LimShengHonDannyMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zpwFgJXZ8XGk" title="Due to officer">280,000</span> to Lim Sheng Hon Danny, an employee of one of the subsidiaries of the Company, bearing interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201124__srt--TitleOfIndividualAxis__custom--ChanTungMoeMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zXyyXTSMKGua" title="Debt instrument, interest rate, stated percentage">6</span>%, with a maturity date of <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20201122__20201124__srt--TitleOfIndividualAxis__custom--ChanTungMoeMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zzeSfxTOfe42" title="Debt instrument maturity date">November 23, 2023</span>. <span id="xdx_90B_eus-gaap--DebtInstrumentDescription_c20201122__20201124__srt--TitleOfIndividualAxis__custom--LimShengHonDannyMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zQdWIA1pw9Cb" title="Debt instrument description">This loan was secured by an irrevocable letter of instruction on 40,000 shares of Alset Inc</span>. Subsequent to the making of these loans, the Company acquired the majority of the issued and outstanding common stock of American Pacific Bancorp. During the year ended December 31, 2021, both principal and interest, $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--ChanTungMoeMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zcXkoqvq2uph" title="Debt interest and principal">840,000</span> and $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--LimShengHongMember__dei--LegalEntityAxis__custom--AmericanPacificBancorpIncMember_zPFQB4w0hhK5" title="Debt interest and principal">28,031</span>, of both loans to Chan Tung Moe and Lim Sheng Hong, were fully paid off.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0 500000 122039000 0.0999 1220390000 0.0001 122039 860342 517965 1009854 945769 1067808 122039 2480000 250000 1 2480000 200128 2279872 62122908 6729629 10003689 3274060 62122908 17570948 446104 0 820113 0 0 12088 13546 30000000 1333429 1333429 0 0 1500000000 28363966 173395 62122908 6729629 4775523 28653138 63920129 0.001 5.59 10.03 50770192 63920128 63920128 306438 306438 2123 2123 9163965 9163965 7395472 5545495 0 0 20000 25000 In addition, MacKenzie Equity Partners will be paid certain bonuses, including (i) a sum of $50,000 on June 30, 2022; (ii) a sum of $50,000 upon the successful financing of 100 homes owned by American Housing REIT Inc. with an entity not affiliated with SeD Development Management LLC (a subsidiary of the Company); and (iii) a sum of $50,000 upon the successful leasing of 30 homes in the Alset of Black Oak development 60000 240000 75000 275000 120000 50000 25000 80000 200000 8350000 0.158 0.08 payable in two 5.00 The amount of the warrants equals to the note principal divided by the exercise price. If AMRE goes to IPO in the future and IPO price is less than $10.00 per share, the exercise price shall be adjusted downward to fifty percent (50%) of the IPO price 200000 167938 0.034 0.158 8350000 21366177 1089675 2157984 0 0 130000 1 350000 The term of the loan was two years, with an interest rate of 3% per annum for the first year and 5% per annum for the second year. The expiration term was renewed as due on demand after two years with 5% per annum interest rate. 350000 61555 412754 236699 0.19 476250 1 476250 1746279 7276163 1746279 0.234 0 0 41750 0 0.08 360000 250500 0.08 29922 71672 560000 0.06 2023-11-23 This loan was secured by an irrevocable letter of instruction on 80,000 shares of Alset Inc 280000 0.06 2023-11-23 This loan was secured by an irrevocable letter of instruction on 40,000 shares of Alset Inc 840000 28031 <p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zX7UOltj1Jw6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_82F_zb9jLdTPgpsh">EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 14, 2021, the Company filed an amendment (the “Amendment”) to its Third Amended and Restated Certificate of Incorporation, as amended, to increase the Company’s authorized share capital. The Amendment increased the Company’s authorized share capital to <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220930_z2euP6BAxv96" title="Common stock, shares authorized">250,000,000</span> common shares and <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220930_z9RQMnKgefal" title="Preferred stock, shares authorized">25,000,000</span> preferred shares, from <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210614_zdi3MakTml85" title="Common stock, shares authorized">20,000,000</span> common shares and <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210614_zUSt0wySz7Wf" title="Preferred stock, shares authorized">5,000,000</span> preferred shares, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has designated<span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zXxw1ZsH3Lc" title="Preferred stock, shares authorized"> 6,380</span> preferred shares as Series A Preferred Stock and <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zwuI9RDw2Owc" title="Preferred stock, shares authorized">2,132</span> as Series B Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of the Series A Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock, par value $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210614__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8MwiWX7PPS7" title="Preferred stock par value">0.001</span> per share (“Common Stock”) when, as and if paid on shares of Common Stock. Each holder of outstanding Series A Preferred Stock is entitled to vote equal to the number of whole shares of Common Stock into which each share of the Series A Preferred Stock is convertible. Holders of Series A Preferred Stock are entitled, upon liquidation of the Company, to receive the same amount that a holder of Series A Preferred Stock would receive if the Series A Preferred Stock were fully converted into Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders of the Series B Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock par value $<span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210614__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zFITlhNmtIt2" title="Preferred stock par value">0.001</span> per share (“Common Stock”) when, as and if paid on shares of Common Stock. Each holder of outstanding Series B Preferred Stock is entitled to vote equal to the number of whole shares of Common Stock into which each share of the Series B Preferred Stock is convertible. Holders of Series B Preferred Stock are entitled, upon liquidation of the Company, to receive the same amount that a holder of Series B Preferred Stock would receive if the Series B Preferred Stock were fully converted into Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company analyzed the Preferred stock and the embedded conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option should be classified as equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 19, 2021, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20210118__20210119_zuqfvK3O47hg" title="Stock issued during period, shares, issued for services">10,000</span> shares of its common stock as compensation for public relations services at a fair value of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210118__20210119_zqpMzs8l9KW9" title="Stock issued during period, value, issued for services">60,900</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 3, 2021, the Company entered into a Loan and Exchange Agreement with its Chief Executive Officer, Chan Heng Fai pursuant to which he loaned the Company his shares of Common Stock of the Company by exchanging <span id="xdx_90A_ecustom--StockPurchased_pid_c20210427__20210503__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zPNa63H2tCLk" title="Stock purchased">6,380,000</span> shares of common stock which he owned for an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20210427__20210503__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zEq8uZKYp6n1" title="Stock issued during period, shares, other">6,380</span> shares of the Company’s newly designated Series A Convertible Preferred Stock. Effective upon the filing of the Amendment in June 2021, the Company issued an entity owned by Chan Heng Fai<span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zv96QTaiaOWl" title="Conversion of stock, shares converted"> 6,380,000</span> shares of common stock upon the automatic conversion of all <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zZKKBwvnkXch" title="Debt conversion instrument, shares issued">6,380</span> outstanding shares of the Company’s Series A Convertible Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 12, 2021, the Company entered into an Exchange Agreement with Chan Heng Fai, pursuant to which he converted a note in the amount of $<span id="xdx_90D_eus-gaap--DebtConversionOriginalDebtAmount1_c20210511__20210512__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zFzHgx4Q91J7" title="Debt conversion original debt amount">13,000,000</span> for<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210511__20210512__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zdC7x0Mn9bw3" title="Debt conversion converted instrument shares issued"> 2,132</span> shares of the Company’s newly designated Series B Preferred Stock. Effective upon the filing of the Amendment in June 2021, the Company issued Chan Heng Fai <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zEeGTw2RiZ3d" title="Conversion of stock shares converted">2,132,000</span> shares of common stock upon the automatic conversion of all <span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20210601__20210630__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zuUA3BKeX5X8" title="Debt conversion converted instrument shares issued">2,132</span> outstanding shares of the Company’s Series B Convertible Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 10, 2021, the Company entered into an underwriting agreement with Aegis Capital Corp., as the sole book-running manager and representative of the underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “May Offering”) of (i) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210509__20210510__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_ze4XAq8D2o3l" title="Stock issued during period, shares, new issues">4,700,637</span> common units (the “Common Units”), at a price to the public of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210510__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_ztcugVPUrHH9" title="Share price">5.07</span> per Common Unit, with each Common Unit consisting of (a) one share of common stock, par value $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210510__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zSbjgceLVux7" title="Preferred stock par vale">0.001</span> per share (the “Common Stock”), (b) one Series A warrant (the “Series A Warrant” and collectively, the “Series A Warrants”) to purchase one share of Common Stock with an initial exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210510__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_z7ChRGiazXW" title="Class of warrant exercies price">5.07</span> per whole share, exercisable until the fifth anniversary of the issuance date, and (c) one Series B warrant (the “Series B Warrant” and collectively, the “Series B Warrants” and together with the Series A Warrants, the “Warrants”) to purchase one-half share of Common Stock with an initial exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210510__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_ziFeaD6kPnoj" title="Class of warrant exercies price">6.59</span> per whole share, exercisable until the fifth anniversary of the issuance date and (ii) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210509__20210510__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zoTGPD4HcTI" title="Stock issued during period, shares, new issues">1,611,000</span> pre-funded units (the “Pre-funded Units”), at a price to the public of $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210510__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zL5MoxVMSer2" title="Share price">5.06</span> per Pre-funded Unit, with each Pre-funded Unit consisting of (a) one pre-funded warrant (the “Pre-funded Warrant” and collectively, the “Pre-funded Warrants”) to purchase one share of Common Stock, (b) one Series A Warrant and (c) one Series B Warrant. The shares of Common Stock, the Pre-funded Warrants, and the Warrants were offered together, but the securities contained in the Common Units and the Pre-funded Units were issued separately. Following the May Offering, all the investors exercised their Pre-funded Units and an additional <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210509__20210510__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zT0bFBdAYFUg" title="Stock issued during period, shares, new issues">1,611,000</span> shares of common stock and Series A and Series B Warrants were issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also granted the Underwriters a 45-day over-allotment option to purchase up to <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210509__20210510__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z8yu202OsKO" title="Number of shares purchased">808,363</span> additional shares of Common Stock and/or up to <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210510__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpPgKV1jiDT6" title="Warrants to purchase common stock">808,363</span> additional Series A Warrants to purchase <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210510__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zEZZgGBN8Um8" title="Warrants to purchase common stock">808,363</span> shares of Common Stock, and/or up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210509__20210510__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zMyZifMS7gP3" title="Number of shares purchased">808,363</span> additional Series B warrants to purchase <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210510__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zcm9ICyijGd3" title="Number of warrant purchased">404,181</span> shares of Common Stock. The May Offering, including the partial exercise of the Underwriters’ over-allotment option to purchase <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210509__20210510__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zuIbHiGWQe69" title="Number of shares purchased">808,363</span> Series A Warrants and <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210509__20210510__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zr643v6ztrn9" title="Number of shares purchased">808,363</span> Series B Warrants, closed on May 13, 2021. During the month of June 2021, Aegis exercised its option to purchase an additional <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210601__20210630__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ziLovtU1YuS1" title="Number of warrants issued">808,363</span> common shares at a price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__dei--LegalEntityAxis__custom--AegisCapitalCorpMember_zDEWI5YD02Z6" title="Share price">5.07</span> per common share and as of September 30, 2022 still holds <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__dei--LegalEntityAxis__custom--AegisCapitalCorpMember_zcwr4Ebyozt5" title="Class of warrant or right issued">808,363</span> Series B Warrants. Through September 30, 2022, investors exercised <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesAWarrantMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zdz0m6ti69Sc" title="Class of warrant or right issued">1,364,025</span> of Series A Warrants and <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--ClassOfWarrantOrRightAxis__custom--SeriesBWarrantMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zyJ7uWMxsOqe" title="Class of warrant or right issued">6,598</span> of Series B Warrants. As a result of the May Offering and subsequent exercise notice received for the pre-funded units and warrants, the Company issued <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210531_zGSQCusVBlMe" title="Class of warrant or right issued">8,487,324</span> common shares. As a result of the May Offering and subsequent exercise notice received for the pre-funded units and warrants, and the net proceeds to the Company were $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYRh1D1NW1k8" title="Proceeds from issuance of common stock">39,765,440</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred approximately $<span id="xdx_90D_ecustom--PaymentsForWarrantExercises_c20220101__20220930__srt--ConsolidatedEntitiesAxis__custom--AlsetInternationalLimitedMember_zDrdfhgZm635" title="Payments for warrant exercises">88,848</span> in expenses related to the May Offering and subsequent warrants exercises, including SEC fees, FINRA fees, auditor fees and filing fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfNetFundsReceivedOnOfferingAndWarrantsExercisedTableTextBlock_gL3SONFROOAWE-UZQ_zg8xcUA1BLFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents net funds received from the May Offering and warrants exercised as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/><span id="xdx_8B5_zYenlehAQ0h3" style="display: none">SCHEDULE OF NET FUNDS RECEIVED ON OFFERING AND WARRANTS EXERCISED</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount received</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zxOwDwYocJZi" style="width: 14%; text-align: right" title="Purchase of warrants, shares">4,700,637</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zPzzDu96TJg1" style="width: 14%; text-align: right" title="Warrants and rights outstanding">4,701</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_ziPhSUFVated" style="width: 14%; text-align: right" title="Amount received">29,145,056</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of Pre-Funded Units</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zzSYGNtnkdci" style="text-align: right" title="Purchase of warrants, shares">1,611,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zRsVXJoTcK4" style="text-align: right" title="Warrants and rights outstanding">1,611</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zDbiQdQqANra" style="text-align: right" title="Amount received">16,110</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Exercise of Underwriter’s Series A Warrants</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersSeriesAWarrantsMember_zM0iYuhKDFV5" style="text-align: right" title="Purchase of warrants, shares">808,363</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersSeriesAWarrantsMember_znsctgSIMI4" style="text-align: right" title="Warrants and rights outstanding">808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersSeriesAWarrantsMember_zAAAb7h1rjUb" style="text-align: right" title="Amount received">3,755,774</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Exercise of Series A and Series B Warrants</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfSeriesAAndSeriesBWarrantsMember_zC1oIrEWbbJ2" style="text-align: right" title="Purchase of warrants, shares">1,367,324</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfSeriesAAndSeriesBWarrantsMember_z4fN251l5Usj" style="text-align: right" title="Warrants and rights outstanding">1,367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfSeriesAAndSeriesBWarrantsMember_zAGcNCh5Pfg9" style="text-align: right" title="Amount received">6,937,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Offering Expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_987_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_ztQieqvfWxrb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase of warrants, shares"><span style="-sec-ix-hidden: xdx2ixbrl2731">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98F_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zHIkTfzZW3R1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and rights outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2733">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_985_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zba5fLJ37sv5" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount received">(88,848</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember_zGla7by3P2F" style="text-align: right" title="Purchase of warrants, shares">8,487,324</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember_zfVOtDFftFn3" style="text-align: right" title="Warrants and rights outstanding">8,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember_z0aI5gs8Peah" style="text-align: right" title="Amount received">39,765,439</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_zc4OgtnJ9e2i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 27, 2021, the Company entered into another underwriting agreement with Aegis Capital Corp., as the sole book-running manager and representative of the underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “July Offering”) of (i) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210726__20210727__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zVR9KTOCz2sa" title="Stock issued during period, shares, new issues">5,324,139</span> shares of common stock, par value $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210727__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zskAwHTP1Lvl" title="Preferred stock par value">0.001</span> per share (the “Common Stock”), at a price to the public of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20210727__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_z83lTfrn4sA4" title="Share price">2.12</span> per share of Common Stock and (ii) <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210726__20210727__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zdE4EhbZ7ZTl" title="Stock issued during period, shares, new issues">9,770,200</span> pre-funded warrants (the “Pre-funded Warrants”) to purchase<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210727__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_z6jvgb2jOCze" title="Number of warrant purchased"> 9,770,200</span> shares of Common Stock, at a price to the public of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20210727__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zVxuYea17sui" title="Share price">2.11</span> per Pre-funded Warrant. The Offering closed on July 30, 2021. As a result of the July Offering and subsequent exercise notice received for the pre-funded warrants, the net proceeds to the Company were $<span id="xdx_908_eus-gaap--ProceedsFromWarrantExercises_c20210728__20210730__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zxgKWeqTU6vd" title="Proceeds from warrant exercises">33,392,444</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted the Underwriters a 45-day over-allotment option to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210727__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zWPe4OcfdpHk" title="Number of warrants issued">2,264,150</span> additional shares of Common Stock. The Company also paid the Underwriters an underwriting discount equal to <span id="xdx_90A_ecustom--UnderwritingDiscountPercentage_iI_pid_dp_uPure_c20210727__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z9K3OUtHX9R5" title="Underwriting discount, percentage">7.0</span>% of the gross proceeds of the Offering and a non-accountable expense fee equal to <span id="xdx_908_ecustom--NonaccountableExpensePercentage_iI_pid_dp_uPure_c20210727__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zCXk7Kl5aYzf" title="Non-accountable expense, percentage">1.5</span>% of the gross proceeds of the Offering. In addition, the Company agreed to issue to the representative warrants (the “Representative’s Warrants”) to purchase a number of shares equal to <span id="xdx_90D_ecustom--PercentageOfWarrantsPurchased_iI_dp_uPure_c20210727__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVvEOxkvaap6" title="Percentage of warrants purchased">3.0</span>% of the aggregate number of shares (including shares underlying the Pre-funded Warrants) sold under in the Offering, or warrants to purchase up to an aggregate of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210727__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zwDbT6zoi5pi" title="Class of warrants or right issued">520,754</span> shares, assuming the Underwriters exercise their over-allotment option in full. The Representative’s Warrants have an exercise price equal to <span id="xdx_90D_ecustom--PercentageOfPublicOfferingPrice_pid_dp_uPure_c20210726__20210727__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zXVf0JD0XoA9" title="Percentage of public offering price">125</span>% of the public offering price, or $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20210727__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_z8wvmTYm5Wm5" title="Share price">2.65</span> per share, with an exercise period of <span id="xdx_901_ecustom--WarrantsIssuanceExercisePeriod_dtM_c20210726__20210727_z20EscE7xnSi" title="Warrants issuance excercise period">24</span> months from issuance. On September 9, 2021 the Underwriters exercised their over-allotment option and were issued<span id="xdx_906_ecustom--StockIssuedForWarrantExercise_c20210901__20210909__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z070NNb5Eibb" title="Stock issued for warrant exercise"> 2,264,150</span> shares of our Common Stock. On September 9, 2021 the Underwriters exercised the option and the Company received $<span id="xdx_902_eus-gaap--ProceedsFromWarrantExercises_c20210901__20210909__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z552otlzHlx4" title="Proceeds from warrant exercise">4,386,998</span> proceeds from this exercise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--WarantExerciseDescription_c20210901__20210909__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z5cmp7V44DP2" title="Warant exercise, description">The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering in lieu of Common Stock that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of the Company’s outstanding Common Stock (or, at the election of the purchaser, 9.99%). Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.01 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full</span>. All of the Pre-Funded Warrants were exercised during 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred approximately $<span id="xdx_902_eus-gaap--DeferredOfferingCosts_iI_c20211231__us-gaap--AwardDateAxis__custom--JulyOfferingMember_zxgrHZMMKY8a" title="Deferred offering costs">49,553</span> in expenses related to the July Offering and subsequent warrants exercises, including SEC fees, FINRA fees, auditor fees and filing fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C07_gL3SONFROOAWE-UZQ_zRcHMERyPki1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <div id="xdx_C0A_gL3SONFROOAWE-UZQ_z6ICy8Yxg0u"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents net funds received from the July Offering and warrants exercised as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount received</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zD0M0FTx94A" style="width: 14%; text-align: right" title="Number of offering and warrants exercised, shares">5,324,139</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_989_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zMMTh4ADEi7i" style="width: 14%; text-align: right" title="Warrants and rights outstanding">5,324</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zvMImUGfCLBb" style="width: 14%; text-align: right" title="Total">28,957,297</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of Pre-Funded Units</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_z7iGAcFyvKv6" style="text-align: right" title="Number of offering and warrants exercised, shares">9,770,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zPiUCwO7u40b" style="text-align: right" title="Warrants and rights outstanding">9,770</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_ztnjl7YatKW6" style="text-align: right" title="Total">97,702</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise of Underwriter’s Over-Allotment Option</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zGciKp7I9izb" style="text-align: right" title="Number of offering and warrants exercised, shares">2,264,150</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zY8FlOZi3Zo1" style="text-align: right" title="Warrants and rights outstanding">2,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zArUUsDJiCzb" style="text-align: right" title="Total">4,386,998</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Offering Expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_989_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zdmZzWiO0tT9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of offering and warrants exercised, shares"><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zuTtOaBizr8f" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and rights outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zXspT1K2kWbk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(49,553</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember_ztNdvlmGp053" style="text-align: right" title="Number of offering and warrants exercised, shares">17,358,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember_zEMLxciYZFTe" style="text-align: right" title="Warrants and rights outstanding">17,358</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember_z6GVMUfQhzgl" style="text-align: right" title="Total">33,392,444</td><td style="text-align: left"> </td></tr> </table> </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C04_gL3SONFROOAWE-UZQ_zrdeOVaPIWsa"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 5, 2021, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp., as the sole book-running manager and representative of the underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “December Offering”) of (i) <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211201__20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zXw1Oaazq7mi" title="Stock issued during period, shares, new issues">18,076,666</span> shares of common stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zaJvicInL67i" title="Common stock par value">0.001</span> per share (the “Common Stock”), at a price to the public of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zQsnMsG3z98e" title="Share price">0.60</span> per share of Common Stock and (ii) <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211205__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_znUMeBREcSJ3" title="Number of warrant purchased">31,076,666</span> pre-funded warrants (the “Pre-funded Warrants”) to purchase <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211205__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_z4oRvcmo1Lqg" title="Number of warrant purchased">31,076,666</span> shares of Common Stock, at a price to the public of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20211205__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zLrkuKz11pTl" title="Share price">0.599</span> per Pre-funded Warrant. The December Offering closed on December 8, 2021. As a result of the December Offering and subsequent exercise notice received for the pre-funded warrants, the net proceeds to the Company were $<span id="xdx_90D_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20211201__20211205__us-gaap--StatementEquityComponentsAxis__custom--PreFundedUnitsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zTzIKWNz9od1" title="Proceeds from warrant exercise">27,231,875</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted the Underwriters a 45-day over-allotment option to purchase up to <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zlGsOwtrybtl" title="Number of warrants issued">7,500,000</span> additional shares of Common Stock. The Company also paid the Underwriters an underwriting discount equal to <span id="xdx_904_ecustom--UnderwritingDiscountPercentage_iI_pid_dp_uPure_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z8dQu6Zqk0gi" title="Underwriting discount, percentage">7</span>% of the gross proceeds of the Offering and a non-accountable expense fee equal to <span id="xdx_905_ecustom--NonaccountableExpensePercentage_iI_pid_dp_uPure_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zDG4QtqvuyYb" title="Non-accountable expense, percentage">1</span>% of the gross proceeds of the Offering. On December 14, 2021, the Company consummated the sale of these <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zurdAiPdIhB5" title="Class of warrant or right issued">7,500,000</span> shares of Common Stock, representing <span id="xdx_908_ecustom--PercentageOfCommonStock_iI_dp_uPure_c20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zihRBbroFP9i" title="Percentage of commonStock">15</span>% of the shares of common stock and the shares underlying the Pre-funded Warrants sold in the offering, that were subject to the underwriters’ over-allotment option at a price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenOverAllotmentMember_zhAc73r5jrCl" title="Share price">0.60</span> per share, generating net proceeds of $<span id="xdx_907_eus-gaap--ProceedsFromWarrantExercises_c20211212__20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z3H8SETWBin6" title="Proceeds from warrant exercises">4,115,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted the Underwriters a 45-day over-allotment option to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zStnmiUGMsua" title="Number of warrants issued">7,500,000</span> additional shares of Common Stock. The Company also paid the Underwriters an underwriting discount equal to <span id="xdx_901_ecustom--UnderwritingDiscountPercentage_iI_pid_dp_uPure_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zocMc1ZbzOf9" title="Underwriting discount, percentage">7</span>% of the gross proceeds of the Offering and a non-accountable expense fee equal to <span id="xdx_907_ecustom--NonaccountableExpensePercentage_iI_pid_dp_uPure_c20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zHtpXwD5DF7d" title="Non-accountable expense, percentage">1</span>% of the gross proceeds of the Offering. On December 14, 2021, the Company consummated the sale of these <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zYPHQsnZI6wj" title="Class of warrant or right issued">7,500,000</span> shares of Common Stock, representing <span id="xdx_907_ecustom--PercentageOfCommonStock_iI_dp_uPure_c20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZO4bFaffaC8" title="Percentage of commonStock">15</span>% of the shares of common stock and the shares underlying the Pre-funded Warrants sold in the offering, that were subject to the underwriters’ over-allotment option at a price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenOverAllotmentMember_zaj19PFGwldc" title="Share price">0.60</span> per share, generating net proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromWarrantExercises_c20211212__20211214__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zm7jHxgk8Agc" title="Proceeds from warrant exercises">4,115,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarantExerciseDescription_c20211201__20211205__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zxuQ9Qhxeoyc" title="Warant exercise, description">The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering. Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.001 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full. At September 30, 2022, 31,076,666 warrants were exercised, some in cashless exercise transactions</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred approximately $<span id="xdx_906_eus-gaap--DeferredOfferingCosts_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zqmEpqqvQI84" title="Offering cost">40,621</span> in expenses related to the December Offering and subsequent warrants exercises, including SEC fees, FINRA fees, auditor fees and filing fees.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <div id="xdx_C09_gL3SONFROOAWE-UZQ_z8smGcU2EnS1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents net funds received from the December Offering and warrants exercised as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>received</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_982_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zhQEcv8DoeBc" style="width: 14%; text-align: right">18,923,334</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_z3cNNre5Jlcd" style="width: 14%; text-align: right">18,923</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_z3GceDZ3SW91" style="width: 14%; text-align: right">27,263,673</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of Pre-Funded Units</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_983_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zvjPNer0hhCf" style="text-align: right" title="Number of offering and warrants exercised, shares">15,223,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_z0i7ubWYX99h" style="text-align: right" title="Warrants and rights outstanding">15,223</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_982_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zJMD4qEwclrh" style="text-align: right" title="Total">8,823</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise of Underwriter’s Over-Allotment Option</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zcB0yO3icqMj" style="text-align: right" title="Number of offering and warrants exercised, shares">7,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98F_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zKYULVR9l13f" style="text-align: right" title="Warrants and rights outstanding">7,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zOjN1sGu28J3" style="text-align: right" title="Total">4,115,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Offering Expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zeRAhPBXPkS9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of offering and warrants exercised, shares"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zlrfOS7GWpG4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and rights outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zLB18bX1PGQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(40,621</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zvqCh8BTxiYf" style="text-align: right" title="Number of offering and warrants exercised, shares">41,646,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zfyiT7SGkOW" style="text-align: right" title="Number of offering and warrants exercised, par value">41,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zyupY6fA2bO4" style="text-align: right" title="Number of offering and warrants exercised, amount received">31,346,875</td><td style="text-align: left"> </td></tr> </table> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C05_gL3SONFROOAWE-UZQ_znyDr7N1MU51"> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 30, 2022, there were <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zf2W5NhVXf5e" title="Common stock, shares outstanding">148,507,188</span> common shares issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zrCn8BJhrqJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the warrant activity for the nine months ended September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zT2wjCcJze27" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Term</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Warrants Outstanding as of December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20220930_zFBW7y9w60gb" style="width: 10%; text-align: right" title="Number of common shares warrants outstanding, beginning balance">28,533,147</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePrice_iS_c20220101__20220930_zCHfLZPX4Sr5" style="width: 10%; text-align: right" title="Exercise price, beginning balance">1.79</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20220930_z3xYXyVa8lBe" title="Remaining contractual term outstanding, beginning balance">1.88</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueOutstanding_iS_c20220101__20220930_zB0KspqGAsvd" style="width: 10%; text-align: right" title="Aggregate intrinsic value, beginning"><span style="-sec-ix-hidden: xdx2ixbrl2894">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants Vested and exercisable at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedExercisableNumber_iS_c20220101__20220930_zo9yPtCAqpNj" style="text-align: right" title="Number of common shares warrants vested and exercisable, beginning">28,533,147</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentVestedAndExercisableWeightedAverageExercisePrice_iS_c20220101__20220930_z0P8v45vZ4Rf" style="text-align: right" title="Exercise price, vested and exercisable beginning balance">1.79</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentVetsedAndExercisableBeginningWeightedAverageRemainingContractualTerms_dtY_c20220101__20220930_zVp1YICUUcA9" title="Remaining contractual term exercisable, beginning balance">1.88</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueVestedAndExercisable_iS_c20220101__20220930_zMwPhry7RgJe" style="text-align: right" title="Aggregate intrinsic value, vested and exercisable beginning"><span style="-sec-ix-hidden: xdx2ixbrl2902">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20220930_zsQCwqmF79l" style="text-align: right" title="Number of common shares warrants granted"><span style="-sec-ix-hidden: xdx2ixbrl2904">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePriceGranted_c20220101__20220930_zMBWr3CGus6h" style="text-align: right" title="Exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl2906">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20220930_zNmlSBQMj0Be" style="text-align: right" title="Number of common shares warrants exercised">(15,843,378</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePriceExercised_c20220101__20220930_zkXsPrAEB66" style="text-align: right" title="Exercise price, exercised">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Forfeited, cancelled, expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20220101__20220930_zZ7N6nScFj2l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of common shares warrants forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl2912">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePriceForfeited_c20220101__20220930_zx9wTz9v3Ay9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl2914">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Warrants Outstanding as of September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20220930_zlHBA2EdbTD1" style="text-align: right" title="Number of common shares warrants outstanding, beginning balance">12,689,769</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePrice_iE_c20220101__20220930_znIcGCvFgibb" style="text-align: right" title="Exercise price, ending balance">4.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220930_zZ7XNV46qFKl" title="Remaining contractual term outstanding, ending balance">3.48</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueOutstanding_iE_c20220101__20220930_zXoVUUBwCXRg" style="text-align: right" title="Aggregate intrinsic value, ending"><span style="-sec-ix-hidden: xdx2ixbrl2922">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants Vested and exercisable at September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedExercisableNumber_iI_c20220930_zHsATgVUQnh5" style="text-align: right" title="Number of common shares warrants vested and exercisable, beginning">12,689,769</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentVestedAndExercisableWeightedAverageExercisePrice_iE_c20220101__20220930_znd3ZYUq6qk9" style="text-align: right" title="Exercise price, vested and exercisable ending balance">4.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentVetsedAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20220930_zMVYN5cRoBOb" title="Remaining contractual term exercisable, ending balance">3.48</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueVestedAndExercisable_iE_c20220101__20220930_zFMbDZi8IkG8" style="text-align: right" title="Aggregate intrinsic value, vested and exercisable ending"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A8_zyyK2YhwgQgk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>GigWorld Inc. Sale of Shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2021, the Company sold <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210101__20210630__dei--LegalEntityAxis__custom--GigWorldMember_z97E1mLqPhue" title="Purchase of stock">280,000</span> shares of GigWorld to international investors for the amount of $<span id="xdx_902_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210101__20210930__dei--LegalEntityAxis__custom--GigWorldMember_zRGsbWjfXdQ" title="Stock cost">280,000</span>, which was booked as addition paid-in capital. The Company held <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20220930__dei--LegalEntityAxis__custom--GigWorldMember_z5oBuZu8McSb" title="Common stock, shares outstanding">505,381,376</span> shares of the total outstanding shares <span id="xdx_904_ecustom--CommonStockSharesOutstandingBeforeSale_iI_c20220930__dei--LegalEntityAxis__custom--GigWorldMember_zprIALgNzBNj" title="Common stock, shares outstanding before sale">506,898,576</span> before the sale. After the sale, the Company still owns approximately <span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20220101__20220930__dei--LegalEntityAxis__custom--GigWorldMember_ztMutdNJkXr3" title="Ownership percentage">99</span>% of GigWorld’s total outstanding shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2021, the sales of GigWorld’s shares were de minimis compared to its outstanding shares and did not change the minority interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distribution to Minority Shareholder</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2021, SeD Maryland Development LLC Board approved the payment distribution plan to members and paid $<span id="xdx_90B_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c20220101__20220930_z7xypcCQT2Mg" title="Minority shareholder">1,398,250</span> in distribution to the minority shareholder.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes of Ownership of Alset International</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the year ended December 31, 2021, Alset International issued <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211231__dei--LegalEntityAxis__custom--AlsetInternationalLimitedMember_zGK8XEJSiNs6" title="Number of warrant purchased">1,721,303,416</span> common shares through warrants exercise with exercise price of approximately $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211231__dei--LegalEntityAxis__custom--AlsetInternationalLimitedMember_zADH4laA4Bgl" title="Exercise price of warrants or rights">0.04</span> per share and received $<span id="xdx_909_ecustom--RepaymentOfCashReceived_c20210101__20211231__dei--LegalEntityAxis__custom--AlsetInternationalLimitedMember_zagXeTCpHGu1" title="Cash received">60,300,464</span> cash, which included approximately $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfWarrants_pn6n6_c20210101__20211231__dei--LegalEntityAxis__custom--AlsetInternationalLimitedMember_zRRT617pdoHf" title="Proceeds from Issuance of Warrants">58</span> million from Alset Inc. to exercise its warrants to purchase Alset International common shares. The warrant exercise transactions between Alset Inc. and Alset International were intercompany transactions and only affected change in non-controlling interest on the condensed consolidated statements of stockholders’ equity. During the year ended December 31, 2021, the stock-based compensation expense of Alset International was $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_c20210101__20211231__dei--LegalEntityAxis__custom--AlsetInternationalLimitedMember__srt--TitleOfIndividualAxis__srt--OfficerMember_zhvSU52u3dHi" title="Share-Based Payment Arrangement, before Forfeiture">73,292</span> with the issuance of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationGross_c20210101__20211231__dei--LegalEntityAxis__custom--AlsetInternationalLimitedMember__srt--TitleOfIndividualAxis__srt--OfficerMember_zJXqBbHxm48k" title="Share-Based Payment Arrangement, before Forfeiture">1,500,000</span> shares to an officer. In nine months ended September 30, 2022 the Company purchased <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20220930__dei--LegalEntityAxis__custom--AlsetInternationalLimitedMember__srt--TitleOfIndividualAxis__srt--OfficerMember_zh85MOOBkfvl" title="Stock issued during period, shares, new issues">6,670,200</span> shares of Alset International from the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2022 the Company entered into a securities purchase agreement with Chan Heng Fai, pursuant to which the Company agreed to purchase from Chan Heng Fai <span id="xdx_904_ecustom--NumberOfSharesPurchased_pid_c20220116__20220117__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zKx99z6wUZ9k" title="Number of shares purchase">293,428,200</span> ordinary shares of Alset International for a purchase price of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220116__20220117__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zwFLCE9kALr1" title="Issuance of Common Stock, shares">29,468,977</span> newly issued shares of the Company’s common stock. On February 28, 2022, the Company and Chan Heng Fai entered into an amendment to this securities purchase agreement pursuant to which the Company shall purchase these <span id="xdx_903_ecustom--NumberOfSharesPurchased_pid_c20220227__20220228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zXwcewverswl" title="Number of shares purchase">293,428,200</span> ordinary shares of Alset International for a purchase price of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220227__20220228__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zXt8Xt8TMrC8" title="Issuance of Common Stock, shares">35,319,290</span> newly issued shares of the Company’s common stock. The closing of this transaction with Chan Heng Fai was subject to approval of the Nasdaq and the Company’s stockholders. These <span id="xdx_909_ecustom--NumberOfSharesPurchased_pid_c20220116__20220117__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zXi8k5rIEjVk" title="Number of shares purchase">293,428,200</span> ordinary shares of Alset International represent approximately <span id="xdx_900_ecustom--PercentageOfOrdinaryShares_pid_dp_uPure_c20220116__20220117__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zS7vaXADdLSc" title="Percentage of ordinary shares">8.4</span>% of the <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20220117_zm11bKrKblG6" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_c20220117_zkOEhhiyUlee" title="Common stock, shares outstanding">3,492,713,362</span></span> total issued and outstanding shares of Alset International. The Company had a Special Meeting of Stockholders to vote on the approval of this transaction on June 6, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to these transactions the Company’s ownership of Alset International changed from <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalLimitedMember_zYpro3SP5TE5" title="Attributable interest">76.8</span>% as of December 31, 2021 to <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlsetInternationalLimitedMember_zcY3D4pwNLpe" title="Attributable interest">85.4</span>% as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Promissory Note Converted into Shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 13, 2021 the Company entered into a Securities Purchase Agreement with Chan Heng Fai for the issuance and sale of a convertible promissory note in favor of Chan Heng Fai, in the principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20211213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zTqeZWCe5Ybg" title="Principal amount">6,250,000</span>. The note bears interest of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211213__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zReVxLKyU8R5" title="Debt instrument, interest rate, stated percentage">3</span>% per annum and was due on the earlier of December 31, 2024 or when declared due and payable by Chan Heng Fai. The note could be converted in part or whole into common shares of the Company at the conversion price of $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211213__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--ChanHengFaiMember_zTL14rz7sdn6" title="Conversion price">0.625</span> or into cash. The loan closed on January 26, 2022 after all closing conditions were met. Chan Heng Fai opted to convert all of the amount of such note into <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220126__20220127_z6AsazZ26UY6" title="Debt conversion, converted instrument, shares issued">10,000,000</span> shares of the Company’s common stock, which shares were issued on January 27, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration Statement on Form S-3</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 11, 2022 the Company filed a Registration Statement on Form S-3 using a “shelf” registration or continuous offering process. Under this shelf registration process, the Company may, from time to time, sell any combination of the securities (common stock, preferred stock, warrants, rights, units) described in the filed prospectus in one or more offerings up to a total aggregate offering price of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20220410__20220411__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLI6HFD67dXi" title="Stock issued during period value new issues">75,000,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000000 25000000 20000000 5000000 6380 2132 0.001 0.001 10000 60900 6380000 6380 6380000 6380 13000000 2132 2132000 2132 4700637 5.07 0.001 5.07 6.59 1611000 5.06 1611000 808363 808363 808363 808363 404181 808363 808363 808363 5.07 808363 1364025 6598 8487324 39765440 88848 <p id="xdx_89B_ecustom--ScheduleOfNetFundsReceivedOnOfferingAndWarrantsExercisedTableTextBlock_gL3SONFROOAWE-UZQ_zg8xcUA1BLFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents net funds received from the May Offering and warrants exercised as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/><span id="xdx_8B5_zYenlehAQ0h3" style="display: none">SCHEDULE OF NET FUNDS RECEIVED ON OFFERING AND WARRANTS EXERCISED</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount received</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zxOwDwYocJZi" style="width: 14%; text-align: right" title="Purchase of warrants, shares">4,700,637</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zPzzDu96TJg1" style="width: 14%; text-align: right" title="Warrants and rights outstanding">4,701</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_ziPhSUFVated" style="width: 14%; text-align: right" title="Amount received">29,145,056</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of Pre-Funded Units</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zzSYGNtnkdci" style="text-align: right" title="Purchase of warrants, shares">1,611,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zRsVXJoTcK4" style="text-align: right" title="Warrants and rights outstanding">1,611</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zDbiQdQqANra" style="text-align: right" title="Amount received">16,110</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Exercise of Underwriter’s Series A Warrants</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersSeriesAWarrantsMember_zM0iYuhKDFV5" style="text-align: right" title="Purchase of warrants, shares">808,363</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersSeriesAWarrantsMember_znsctgSIMI4" style="text-align: right" title="Warrants and rights outstanding">808</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersSeriesAWarrantsMember_zAAAb7h1rjUb" style="text-align: right" title="Amount received">3,755,774</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Exercise of Series A and Series B Warrants</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfSeriesAAndSeriesBWarrantsMember_zC1oIrEWbbJ2" style="text-align: right" title="Purchase of warrants, shares">1,367,324</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfSeriesAAndSeriesBWarrantsMember_z4fN251l5Usj" style="text-align: right" title="Warrants and rights outstanding">1,367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfSeriesAAndSeriesBWarrantsMember_zAGcNCh5Pfg9" style="text-align: right" title="Amount received">6,937,347</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Offering Expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_987_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_ztQieqvfWxrb" style="border-bottom: Black 2.5pt double; text-align: right" title="Purchase of warrants, shares"><span style="-sec-ix-hidden: xdx2ixbrl2731">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98F_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zHIkTfzZW3R1" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and rights outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2733">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_985_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zba5fLJ37sv5" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount received">(88,848</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember_zGla7by3P2F" style="text-align: right" title="Purchase of warrants, shares">8,487,324</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember_zfVOtDFftFn3" style="text-align: right" title="Warrants and rights outstanding">8,487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--MaysOfferingMember_z0aI5gs8Peah" style="text-align: right" title="Amount received">39,765,439</td><td style="text-align: left"> </td></tr> </table> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents net funds received from the July Offering and warrants exercised as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount received</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zD0M0FTx94A" style="width: 14%; text-align: right" title="Number of offering and warrants exercised, shares">5,324,139</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_989_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zMMTh4ADEi7i" style="width: 14%; text-align: right" title="Warrants and rights outstanding">5,324</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zvMImUGfCLBb" style="width: 14%; text-align: right" title="Total">28,957,297</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of Pre-Funded Units</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_z7iGAcFyvKv6" style="text-align: right" title="Number of offering and warrants exercised, shares">9,770,200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_982_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zPiUCwO7u40b" style="text-align: right" title="Warrants and rights outstanding">9,770</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98B_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_ztnjl7YatKW6" style="text-align: right" title="Total">97,702</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise of Underwriter’s Over-Allotment Option</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zGciKp7I9izb" style="text-align: right" title="Number of offering and warrants exercised, shares">2,264,150</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zY8FlOZi3Zo1" style="text-align: right" title="Warrants and rights outstanding">2,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zArUUsDJiCzb" style="text-align: right" title="Total">4,386,998</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Offering Expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_989_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zdmZzWiO0tT9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of offering and warrants exercised, shares"><span style="-sec-ix-hidden: xdx2ixbrl2799">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zuTtOaBizr8f" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and rights outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zXspT1K2kWbk" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(49,553</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember_ztNdvlmGp053" style="text-align: right" title="Number of offering and warrants exercised, shares">17,358,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember_zEMLxciYZFTe" style="text-align: right" title="Warrants and rights outstanding">17,358</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--JulyOfferingMember_z6GVMUfQhzgl" style="text-align: right" title="Total">33,392,444</td><td style="text-align: left"> </td></tr> </table>  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents net funds received from the December Offering and warrants exercised as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Par value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>received</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_982_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_zhQEcv8DoeBc" style="width: 14%; text-align: right">18,923,334</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_z3cNNre5Jlcd" style="width: 14%; text-align: right">18,923</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_988_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingMember_z3GceDZ3SW91" style="width: 14%; text-align: right">27,263,673</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercise of Pre-Funded Units</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_983_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zvjPNer0hhCf" style="text-align: right" title="Number of offering and warrants exercised, shares">15,223,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_z0i7ubWYX99h" style="text-align: right" title="Warrants and rights outstanding">15,223</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_982_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfPreFundedWarrantsMember_zJMD4qEwclrh" style="text-align: right" title="Total">8,823</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise of Underwriter’s Over-Allotment Option</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_984_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zcB0yO3icqMj" style="text-align: right" title="Number of offering and warrants exercised, shares">7,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98F_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zKYULVR9l13f" style="text-align: right" title="Warrants and rights outstanding">7,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ExerciseOfUnderwritersOverAllotmentOptionMember_zOjN1sGu28J3" style="text-align: right" title="Total">4,115,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Offering Expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_980_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zeRAhPBXPkS9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of offering and warrants exercised, shares"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_986_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zlrfOS7GWpG4" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants and rights outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_983_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember__us-gaap--SubsidiarySaleOfStockAxis__custom--OfferingExpensesMember_zLB18bX1PGQ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">(40,621</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Total</td><td> </td> <td style="text-align: left"> </td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zvqCh8BTxiYf" style="text-align: right" title="Number of offering and warrants exercised, shares">41,646,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_981_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zfyiT7SGkOW" style="text-align: right" title="Number of offering and warrants exercised, par value">41,647</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5FVCBGVU5EUyBSRUNFSVZFRCBPTiBPRkZFUklORyBBTkQgV0FSUkFOVFMgRVhFUkNJU0VEIChEZXRhaWxzKQA_" id="xdx_98D_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220101__20220930__us-gaap--AwardDateAxis__custom--DecembersOfferingMember_zyupY6fA2bO4" style="text-align: right" title="Number of offering and warrants exercised, amount received">31,346,875</td><td style="text-align: left"> </td></tr> </table>   4700637 4701 29145056 1611000 1611 16110 808363 808 3755774 1367324 1367 6937347 -88848 8487324 8487 39765439 5324139 0.001 2.12 9770200 9770200 2.11 33392444 2264150 0.070 0.015 0.030 520754 1.25 2.65 P24M 2264150 4386998 The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering in lieu of Common Stock that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of the Company’s outstanding Common Stock (or, at the election of the purchaser, 9.99%). Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.01 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full 49553 5324139 5324 28957297 9770200 9770 97702 2264150 2264 4386998 -49553 17358489 17358 33392444 18076666 0.001 0.60 31076666 31076666 0.599 27231875 7500000 0.07 0.01 7500000 0.15 0.60 4115000 7500000 0.07 0.01 7500000 0.15 0.60 4115000 The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering. Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.001 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full. At September 30, 2022, 31,076,666 warrants were exercised, some in cashless exercise transactions 40621 18923334 18923 27263673 15223333 15223 8823 7500000 7500 4115000 -40621 41646667 41647 31346875 148507188 <p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zrCn8BJhrqJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the warrant activity for the nine months ended September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zT2wjCcJze27" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Term</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Warrants Outstanding as of December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20220101__20220930_zFBW7y9w60gb" style="width: 10%; text-align: right" title="Number of common shares warrants outstanding, beginning balance">28,533,147</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePrice_iS_c20220101__20220930_zCHfLZPX4Sr5" style="width: 10%; text-align: right" title="Exercise price, beginning balance">1.79</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20220930_z3xYXyVa8lBe" title="Remaining contractual term outstanding, beginning balance">1.88</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueOutstanding_iS_c20220101__20220930_zB0KspqGAsvd" style="width: 10%; text-align: right" title="Aggregate intrinsic value, beginning"><span style="-sec-ix-hidden: xdx2ixbrl2894">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants Vested and exercisable at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedExercisableNumber_iS_c20220101__20220930_zo9yPtCAqpNj" style="text-align: right" title="Number of common shares warrants vested and exercisable, beginning">28,533,147</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentVestedAndExercisableWeightedAverageExercisePrice_iS_c20220101__20220930_z0P8v45vZ4Rf" style="text-align: right" title="Exercise price, vested and exercisable beginning balance">1.79</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentVetsedAndExercisableBeginningWeightedAverageRemainingContractualTerms_dtY_c20220101__20220930_zVp1YICUUcA9" title="Remaining contractual term exercisable, beginning balance">1.88</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueVestedAndExercisable_iS_c20220101__20220930_zMwPhry7RgJe" style="text-align: right" title="Aggregate intrinsic value, vested and exercisable beginning"><span style="-sec-ix-hidden: xdx2ixbrl2902">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20220930_zsQCwqmF79l" style="text-align: right" title="Number of common shares warrants granted"><span style="-sec-ix-hidden: xdx2ixbrl2904">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePriceGranted_c20220101__20220930_zMBWr3CGus6h" style="text-align: right" title="Exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl2906">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20220930_zNmlSBQMj0Be" style="text-align: right" title="Number of common shares warrants exercised">(15,843,378</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePriceExercised_c20220101__20220930_zkXsPrAEB66" style="text-align: right" title="Exercise price, exercised">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Forfeited, cancelled, expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_c20220101__20220930_zZ7N6nScFj2l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of common shares warrants forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl2912">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePriceForfeited_c20220101__20220930_zx9wTz9v3Ay9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl2914">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Warrants Outstanding as of September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20220101__20220930_zlHBA2EdbTD1" style="text-align: right" title="Number of common shares warrants outstanding, beginning balance">12,689,769</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentOutstandingWeightedAverageExercisePrice_iE_c20220101__20220930_znIcGCvFgibb" style="text-align: right" title="Exercise price, ending balance">4.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220930_zZ7XNV46qFKl" title="Remaining contractual term outstanding, ending balance">3.48</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueOutstanding_iE_c20220101__20220930_zXoVUUBwCXRg" style="text-align: right" title="Aggregate intrinsic value, ending"><span style="-sec-ix-hidden: xdx2ixbrl2922">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants Vested and exercisable at September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedExercisableNumber_iI_c20220930_zHsATgVUQnh5" style="text-align: right" title="Number of common shares warrants vested and exercisable, beginning">12,689,769</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentVestedAndExercisableWeightedAverageExercisePrice_iE_c20220101__20220930_znd3ZYUq6qk9" style="text-align: right" title="Exercise price, vested and exercisable ending balance">4.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentVetsedAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20220930_zMVYN5cRoBOb" title="Remaining contractual term exercisable, ending balance">3.48</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionEquityInstrumentAggregateIntrinsicValueVestedAndExercisable_iE_c20220101__20220930_zFMbDZi8IkG8" style="text-align: right" title="Aggregate intrinsic value, vested and exercisable ending"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></td><td style="text-align: left"> </td></tr> </table> 28533147 1.79 P1Y10M17D 28533147 1.79 P1Y10M17D 15843378 0.001 12689769 4.02 P3Y5M23D 12689769 4.02 P3Y5M23D 280000 280000 505381376 506898576 0.99 1398250 1721303416 0.04 60300464 58000000 73292 1500000 6670200 293428200 29468977 293428200 35319290 293428200 0.084 3492713362 3492713362 0.768 0.854 6250000 0.03 0.625 10000000 75000000 <p id="xdx_803_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zzttKfhYQPyf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.<span id="xdx_827_zNSfrjFj060c"> LEASE INCOME</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company generally rents its SFRs under lease agreements with a term of one or <span id="xdx_903_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dc_c20220930_z2YTY5giwLw1" title="Lessee, operating lease, term of contract">two years</span>. Future minimum rental revenue under existing leases on our properties at September 30, 2022 in each calendar year through the end of their terms are as follows:</span></p> <p id="xdx_897_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zQEzrgfgUOjb" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zR8nCIee7ne9" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20220930_zyshSqKw3twk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_maOLFMPzRQS_zELkt4VZDGdf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">552,644</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_maOLFMPzRQS_zFnpiohiDqlb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">856,590</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_maOLFMPzRQS_zvnKGDqFjH56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,450</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_mtOLFMPzRQS_zzxxCzDp0Cjj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Future Receipts</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,416,684</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zI1tamVFYVZg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property Management Agreements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into property management agreement with the property managers under which the property managers generally oversee and direct the leasing, management and advertising of the properties in our portfolio, including collecting rents and acting as liaison with the tenants. The Company pays its property managers a monthly property management fee for each property unit and a leasing fee. For the three months ended September 30, 2022 and 2021, property management fees incurred by the property managers were $<span id="xdx_90E_eus-gaap--ManagementFeeExpense_c20220701__20220930_zBnwVGS5juqd" title="Management Fee Expense">28,890</span> and $<span id="xdx_90D_eus-gaap--ManagementFeeExpense_c20210701__20210930_zmLbhEvmL2c5" title="Management Fee Expense">6,390</span>, respectively. For the nine months ended September 30, 2022 and 2021, property management fees incurred by the property managers were $<span id="xdx_90A_eus-gaap--ManagementFeeExpense_c20220101__20220930_zwrNawxZ1FEe" title="Management fee expense">60,390</span> and $<span id="xdx_90D_eus-gaap--ManagementFeeExpense_c20210101__20210930_z6AmqGI4alw6" title="Management fee expense">7,380</span>, respectively. For the three months ended September 30, 2022 and 2021, leasing fees incurred by the property managers were $<span id="xdx_901_ecustom--LeasingFeesIncurred_c20220701__20220930_zrD7Kg1wW4x2" title="Leasing fees incurred">36,420</span> and $<span id="xdx_900_ecustom--LeasingFeesIncurred_c20210701__20210930_zKtTHJDf03y6" title="Leasing fees incurred">31,580</span>, respectively. For the nine months ended September 30, 2022 and 2021, leasing fees incurred by the property managers were $<span id="xdx_90B_ecustom--LeasingFeesIncurred_c20220101__20220930_zjOm7Sy2VI9g" title="Leasing fees incurred">149,625</span> and $<span id="xdx_903_ecustom--LeasingFeesIncurred_c20210101__20210930_zeVkq2rVioe" title="Leasing fees incurred">47,805</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> P2Y <p id="xdx_897_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zQEzrgfgUOjb" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zR8nCIee7ne9" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20220930_zyshSqKw3twk" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_maOLFMPzRQS_zELkt4VZDGdf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">552,644</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_maOLFMPzRQS_zFnpiohiDqlb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">856,590</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_maOLFMPzRQS_zvnKGDqFjH56" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,450</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_mtOLFMPzRQS_zzxxCzDp0Cjj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total Future Receipts</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,416,684</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 552644 856590 7450 1416684 28890 6390 60390 7380 36420 31580 149625 47805 <p id="xdx_802_eus-gaap--ComprehensiveIncomeNoteTextBlock_zfgBWNa0CO21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_82B_zna8432oHFK8">ACCUMULATED OTHER COMPREHENSIVE INCOME</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z14f8SyC53w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following is a summary of the changes in the balances of accumulated other comprehensive income, net of tax:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_zDWkqPlU6P8e" style="display: none">SCHEDULE OF CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF TAX</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedNetUnrealizedInvestmentGainLossMember_zurVx3Ss4uDi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedTranslationAdjustmentMember_zkqaRwT6ZC05" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AociAttributableToNoncontrollingInterestMember_zKDKV9UdhIyj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B1_ztcDQOndlP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Gains and Losses on Security Investment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Foreign Currency Translations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change in Minority Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_435_c20220101__20220331_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zdYr0yvhO5nj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Balance at January 1, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(90,031</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(367,895</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">799,572</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">341,646</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_z7Om1b47DMz6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,027</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(499,967</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">459,069</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(47,925</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43A_c20220401__20220630_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zNB5OoIm9pg9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at March 31, 2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(97,058</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(867,862</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,258,641</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">293,721</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_zI5FdMMVqfzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(505</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,002,167</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,266,996</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">264,324</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43B_c20220701__20220930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zJ0sZ4vZR56a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at June 30, 2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(97,563</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(3,870,029</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,525,637</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">558,045</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_z7GfjiQae0Ik" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,642</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">370,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(486,134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(72,714</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_433_c20220701__20220930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_zSfoXeN3Itnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(54,921</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,499,251</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,039,503</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">485,331</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Gains and Losses on Security Investment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Foreign Currency Translations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change in Minority Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_432_c20210101__20210331_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zARgPs3pvJpg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Balance at January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(48,758</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,258,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(65,921</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,143,338</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_zhzdxNsb6j4k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,135</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,010,527</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(39,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,050,729</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43C_c20210401__20210630_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zT1NwiW9MYy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at March 31, 2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(49,893</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,247,490</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(104,988</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,092,609</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_zlwDHTxVX8ed" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other Comprehensive Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,663</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(764,544</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(343,225</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,133,432</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_439_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zQFKQa5uNELa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at June 30, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75,556</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(448,213</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,823</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43F_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zyM65QOAzCy8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at beginning</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75,556</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(448,213</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,823</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_z8SxrvI4qP8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other Comprehensive Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,314</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(930,005</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,070</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(961,389</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_431_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_zOQNoH92Iox" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at September 30, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(465,283</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,002,212</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43E_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_zolkmzRwg9Y4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at end</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(465,283</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,002,212</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AD_zpuDKGFjOEka" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z14f8SyC53w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following is a summary of the changes in the balances of accumulated other comprehensive income, net of tax:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_zDWkqPlU6P8e" style="display: none">SCHEDULE OF CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF TAX</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedNetUnrealizedInvestmentGainLossMember_zurVx3Ss4uDi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedTranslationAdjustmentMember_zkqaRwT6ZC05" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AociAttributableToNoncontrollingInterestMember_zKDKV9UdhIyj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B1_ztcDQOndlP9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Gains and Losses on Security Investment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Foreign Currency Translations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change in Minority Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_435_c20220101__20220331_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zdYr0yvhO5nj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Balance at January 1, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(90,031</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(367,895</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">799,572</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">341,646</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_z7Om1b47DMz6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,027</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(499,967</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">459,069</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(47,925</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43A_c20220401__20220630_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zNB5OoIm9pg9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at March 31, 2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(97,058</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(867,862</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,258,641</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">293,721</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_zI5FdMMVqfzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(505</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,002,167</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,266,996</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">264,324</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43B_c20220701__20220930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zJ0sZ4vZR56a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at June 30, 2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(97,563</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(3,870,029</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,525,637</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">558,045</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_z7GfjiQae0Ik" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,642</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">370,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(486,134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(72,714</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_433_c20220701__20220930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_zSfoXeN3Itnf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(54,921</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,499,251</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,039,503</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">485,331</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unrealized Gains and Losses on Security Investment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Foreign Currency Translations</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change in Minority Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_432_c20210101__20210331_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zARgPs3pvJpg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Balance at January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(48,758</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,258,017</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(65,921</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,143,338</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_zhzdxNsb6j4k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other Comprehensive Income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,135</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,010,527</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(39,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,050,729</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43C_c20210401__20210630_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zT1NwiW9MYy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at March 31, 2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(49,893</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,247,490</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(104,988</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,092,609</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_zlwDHTxVX8ed" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other Comprehensive Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,663</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(764,544</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(343,225</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,133,432</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_439_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zQFKQa5uNELa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at June 30, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75,556</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(448,213</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,823</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43F_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iS_zyM65QOAzCy8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at beginning</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(75,556</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(448,213</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,823</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_z8SxrvI4qP8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other Comprehensive Income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,314</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(930,005</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(17,070</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(961,389</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_431_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_zOQNoH92Iox" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at September 30, 2021</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(465,283</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,002,212</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43E_c20210701__20210930_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_iE_zolkmzRwg9Y4" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Balance at end</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(447,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(465,283</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,002,212</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> -90031 -367895 799572 341646 -7027 -499967 459069 -47925 -97058 -867862 1258641 293721 -505 -3002167 3266996 264324 -97563 -3870029 4525637 558045 42642 370778 -486134 -72714 -54921 -3499251 4039503 485331 -48758 2258017 -65921 2143338 -1135 -1010527 -39067 -1050729 -49893 1247490 -104988 1092609 -25663 -764544 -343225 -1133432 -75556 482946 -448213 -40823 -75556 482946 -448213 -40823 -14314 -930005 -17070 -961389 -89870 -447059 -465283 -1002212 -89870 -447059 -465283 -1002212 <p id="xdx_80C_eus-gaap--InvestmentTextBlock_znfli3tTXAlj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_82E_z1tGAX6KDLwe">INVESTMENTS MEASURED AT FAIR VALUE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zm5UWTpXoiV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the condensed consolidated balance sheet as of September 30, 2022 and December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zHB7C5R1LXO5" style="display: none">SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurement Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Investment Securities- Fair Value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_zx2okn4Xx927" style="width: 9%; text-align: right" title="Amount at Cost">76,264,051</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_za25j6qTIRT1" style="width: 9%; text-align: right" title="Investment securities fair value option">18,184,407</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zL64sSHY0mV7" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3110">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTGiPRNlknbj" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3112">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_z3cwy2JpgCK5" style="width: 9%; text-align: right" title="Amount at Fair Value">18,184,407</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Investment Securities- Trading</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_zEOZy2fT8vyb" style="text-align: right" title="Amount at Cost">2,387,149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMTTPDI2bEff" style="text-align: right" title="Investment securities trading">11,894,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zaDf6zVt1N75" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3120">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHJjKPaNmAel" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3122">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_ze82KAqlBXbi" style="text-align: right" title="Amount at Fair Value">11,894,002</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible Note Receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_zGDCpQgGnI7f" style="text-align: right" title="Amount at Cost">138,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCucmvmCqnH1" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3128">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8ghllf6Ht5b" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3130">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8HqjahkSg6a" style="text-align: right" title="Convertible note receivable">88,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_zc5BEPnM2Ps6" style="text-align: right" title="Amount at Fair Value">88,599</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants - American Premium Mining</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zgKzkXahSTEj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount at Cost">696,791</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoYwJZpRWHpg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3138">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zIuDrqKLINl7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zh41A4arEft3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants american premium water">517,965</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zhLzwrilRp8b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount at Fair Value">517,965</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Investments_iI_c20220930_zxwlMyoOmUDi" style="text-align: right" title="Total investment in securities at cost">79,486,590</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgSY1SLUUJs6" style="text-align: right" title="Total">30,078,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4ootrtVpE9h" style="text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl3150">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zyNHTxBlD7ue" style="text-align: right" title="Total">606,564</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930_z40RuKpbDjVi" style="text-align: right" title="Amount at Fair Value">30,684,973</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total Investment in securities at Fair Value</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--InvestmentAtFairValue_iI_c20220930_ztb5rHFzrQx6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total investment in securities at fair value">30,684,973</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurement Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">December 31, 2021</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Investment Securities- Fair Value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_zu7USrmMo4v4" style="width: 9%; text-align: right" title="Investment securities fair value option">72,000,301</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zFxV5fgll4f4" style="width: 9%; text-align: right" title="Investment securities fair value option">25,320,694</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQs9e46TgUoe" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3162">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOp5rEpAoVd" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3164">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_z6hWQbG8p2Gc" style="width: 9%; text-align: right" title="Amount at Fair Value">25,320,694</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Investment Securities- Trading</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_zzCHkdbIq1O1" style="text-align: right" title="Investment securities trading">9,809,778</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zjv0hUicNVX5" style="text-align: right" title="Investment securities trading">9,908,077</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhxcJt6nOcJj" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3172">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfMMrcwQhlHd" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3174">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_zKyh52aOWtc1" style="text-align: right" title="mount at Fair Value">9,908,077</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible Note Receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_ze8ImeAtQxK4" style="text-align: right" title="Convertible note receivable">138,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWKBI9SqeuOf" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3180">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQqZ4SFgdnd9" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zakSbwFIzHBb" style="text-align: right" title="Convertible note receivable">98,398</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_zvhoHXJau877" style="text-align: right" title="Amount at Fair Value">98,398</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants - American Premium Mining</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zuHa0jIqh9y1" style="text-align: right" title="Amount at Cost">696,791</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zPFmRT9Z1wab" style="text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9WqXWzr93I6" style="text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3192">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6frWJ6Uz3I3" style="text-align: right" title="Warrants american premium water">1,009,854</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zSg5QYPMt4Ud" style="text-align: right" title="Amount at Fair Value">1,009,854</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants - AMRE</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z8jDh2VRCHTj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3198">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfQoVxYSo61k" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3200">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zigBnlqpOnyd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3202">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPMEYXFOBFfh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3204">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z1NgoOIJKufk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount at Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl3206">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Investments_iI_c20211231_zGeqcX5EAsq" style="text-align: right" title="Total investment in securities at cost">82,645,469</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCNPSkFaFjRc" style="text-align: right" title="Total investment in securities at fair value">35,228,771</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwsPDUXt4mbh" style="text-align: right" title="Total investment in securities at fair value"><span style="-sec-ix-hidden: xdx2ixbrl3212">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zr6AhGdIyNV3" style="text-align: right" title="Total investment in securities at fair value">1,108,252</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231_zmAXCs28dOHk" style="text-align: right" title="Total investment in securities at fair value">36,337,023</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total Investment in securities at Fair Value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p id="xdx_98E_ecustom--InvestmentAtFairValue_iI_c20211231_zxavSJ3x982b" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Total investment in securities at fair value">36,337,023</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zD3awl5pxhM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized loss on investment securities for the nine months ended September 30, 2022 was $<span id="xdx_90C_eus-gaap--RealizedInvestmentGainsLosses_c20220101__20220930_z0gUAClpHlKg" title="Realized investment gains losses">6,500,573</span> and realized loss on investment securities for the nine months ended September 30, 2021 was $<span id="xdx_901_eus-gaap--RealizedInvestmentGainsLosses_c20210101__20210930_zueylCNtz9Le" title="Realized investment gains losses">2,218,988</span>. Unrealized loss on securities investment was $<span id="xdx_901_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20220101__20220930_zVWAKB8ruXUa" title="Unrealized loss on securities investment">21,773,223</span> and $<span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiUnrealizedLoss_c20210101__20210930_zbbFQvJ06usl" title="Unrealized loss on securities investment">35,972,445</span> in the nine months ended September 30, 2022 and 2021, respectively. These gains and losses were recorded directly to net income (loss). The change in fair value of the convertible note receivable in the nine months ended September 30, 2022 and 2021 was $<span id="xdx_907_ecustom--ChangeInFairValueOfConvertibleNoteReceivable_c20220101__20220930_zDtqA1HdRHkg" title="Change in fair value of convertible note receivable">40,201</span> and $<span id="xdx_90E_ecustom--ChangeInFairValueOfConvertibleNoteReceivable_c20210101__20210930_zAvjWX0EHpUk" title="Change in fair value of convertible note receivable">56,969</span>, respectively, and was recorded in condensed consolidated statements of stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For U.S. trading stocks, we use Bloomberg Market stock prices as the share prices to calculate fair value. For overseas stock, we use the stock price from the local stock exchange to calculate fair value. The following chart shows details of the fair value of equity security investment at September 30, 2022 and December 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"/><p id="xdx_894_ecustom--ScheduleOfFairValueOfEquitySecurityInvestmentTableTextBlock_znhXDa2EOUXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zViImwXT9128" style="display: none">SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Market Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">9/30/2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">9/30/2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Valuation</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 26%; font-weight: bold; text-align: center">DSS (Related Party)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3y2BttLs0d7" style="width: 10%; text-align: right" title="Share price">0.256</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAE87PN9Nm7b" style="width: 10%; text-align: right" title="Shares">62,812,264</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmn5uDwvkLE2" style="width: 10%; text-align: right" title="Market value">16,079,940</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 30%; text-align: left"><span id="xdx_90B_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHtvmzTBIIW6" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">AMBS (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIyEGPb2xxP1" style="text-align: right" title="Share price">0.004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z5HRuApNcI8d" style="text-align: right" title="Shares">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpsCGLbBXtff" style="text-align: right" title="Market value">74,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_908_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zx5TcJDfSbo8" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Holista (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3R8lqDh1Kz4" style="text-align: right" title="Share price">0.021</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zu14mkkG19J6" style="text-align: right" title="Shares">43,326,621</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3SCrYniTbT" style="text-align: right" title="Market value">923,988</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_904_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z66FFwrNbTH9" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">American Premium Mining (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJp5lAkHo4wh" style="text-align: right" title="Share price">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLAvUBF3uPhl" style="text-align: right" title="Shares">354,039,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zaTPKtlMTJ1e" style="text-align: right" title="Market value">389,443</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_90D_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zthMBp18e9kk" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Value Exchange</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z8UGD1blb5Bl" style="text-align: right" title="Share price">0.110</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQRHdP6NLpw2" style="text-align: right" title="Shares">6,518,512</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRuw83mgUAM5" style="text-align: right" title="Market value">717,036</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_90D_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0pFQkR2Gz02" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Trading Stocks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zif01R9UfsFd" style="text-align: right" title="Market value">11,894,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_904_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIqbHX5tSdAe" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="8" style="font-weight: bold; text-align: right">Total Level 1 Equity Securities</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQ4RIL4P1kXb" style="text-align: right" title="Market value">30,078,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Nervotech</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zMcEMigUd6F5" style="text-align: right" title="Shares">1,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zXk6EBBMGMZ3" style="text-align: right" title="Market value">35,958</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_906_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zyHUnlruc6Qi" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center">Hyten Global</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zZYBKSStrGs6" style="text-align: right" title="Shares">3,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zXpghP51zPHb" style="text-align: right" title="Market value">42,562</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_90A_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zcrrLvvm3Us4" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Ubeauty</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zccHCXrcwL69" style="padding-bottom: 1.5pt; text-align: right" title="Shares">3,600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zD14COm7yLa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">19,609</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt"><span id="xdx_908_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zz8HS3PACaYj" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="8" style="font-weight: bold; text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Equity Securities</b></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930_zW8KUZSvozfh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total equity securities">30,176,538</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Market Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">12/31/2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">12/31/2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Valuation</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 24%; font-weight: bold; text-align: center">DSS (Related Party)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmJTVzfulR11" style="width: 10%; text-align: right" title="Share price">0.672</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuUM5CwYl8ge" style="width: 10%; text-align: right" title="Shares">19,888,262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvybZhp3HCA2" style="width: 10%; text-align: right" title="Market value">13,364,912</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyzFIlHYcuD2" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">AMBS (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcJrFZ9EJ4c2" style="text-align: right" title="Share price">0.016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUyE36zhwnXi" style="text-align: right" title="Shares">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0nuF6aa2wil" style="text-align: right" title="Market value">328,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zEl5XNLwnJZe" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Holista (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMmjliZe5Dti" style="text-align: right" title="Share price">0.034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZyHRN466udk" style="text-align: right" title="Shares">43,626,621</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgYqPAOxqfLk" style="text-align: right" title="Market value">1,489,179</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztJH88zL9Shd" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">American Premium Mining (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6YiO0NJw7Z5" style="text-align: right" title="Share price">0.002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z7S0wIcQUdQ1" style="text-align: right" title="Shares">354,039,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zeNsbOeqsLp2" style="text-align: right" title="Market value">778,886</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvrWaqgj3Kal" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">True Partner</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2HBFu71Lym2" style="text-align: right" title="Share price">0.119</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyBMnXCkxYKh" style="text-align: right" title="Shares">62,122,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRy29OHgR1eg" style="text-align: right" title="Market value">7,409,717</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpidYkYMXOtj" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Value Exchange</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1sa6FUEfcE2" style="text-align: right" title="Share price">0.300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zw4L5xei1PRa" style="text-align: right" title="Shares">6,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zx8rnYcVRUUk" style="text-align: right" title="Market value">1,950,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvc8zPs451ce" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Trading Stocks</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zX04XMOlHTg5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">9,908,077</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zF3b3XXhLtC4" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="8" style="font-weight: bold; text-align: right; padding-bottom: 1.5pt; padding-left: 10pt"><p style="margin-top: 0; margin-bottom: 0">Total Level 1 Equity</p> <p style="margin-top: 0; margin-bottom: 0">Securities</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZqxHwH2Tt51" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">35,228,771</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Nervotech</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_ztcpmfudwD42" style="text-align: right" title="Shares">1,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zfZ6rYGPk3Q7" style="text-align: right" title="Market value">37,045</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zMZ2LQryE9zi" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center">Hyten Global</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_ztttYdSsX0Xh" style="text-align: right" title="Shares">3,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zGuJZFg2h5J1" style="text-align: right" title="Market value">42,562</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zQRtDNeysdP7" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Ubeauty</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_985_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zblS6xZgMNZh" style="padding-bottom: 1.5pt; text-align: right" title="Shares">3,600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zSINM19qdZQ8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">19,609</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_ztx7Dryq4Yzb" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="8" style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Equity Securities</b></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231_zjSSF5ixotg9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total equity securities">35,327,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zpFRKX0tKWXh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>DSS convertible preferred stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2021, Global BioMedical Pte Ltd. converted <span id="xdx_902_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20210930__us-gaap--StatementEquityComponentsAxis__custom--DSSConvertiblePreferredStockMember_ztQYq2uxKxH9" title="Preferred stock, convertible, shares issuable">42,575</span> preferred stock of DSS into <span id="xdx_903_eus-gaap--ConversionOfStockSharesIssued1_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__custom--DSSConvertiblePreferredStockMember_zkrXFvgptQO3" title="Conversion of stock, shares issued">6,570,170</span> common shares of DSS.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sharing Services Convertible Note</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zzJjhYU6LvUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Sharing Services Convertible Note under level 3 category as of December 31, 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zsqXUa3PsRH4" style="display: none">SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Dividend yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_901_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1Zzf298Qc01" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3380">-</span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_908_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z375uSfeSDK2" title="Measurement input">0.00</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zxwbs2qBf9v6" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3384">-</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdfG6b05LJn1" title="Measurement input">138.85</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zX2noI3yadD" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3388">-</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOsWNg5JT61k" title="Measurement input">3.25</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Contractual term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--DebtSecuritiesTradingMeasurementTerm_dtY_c20220101__20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYmpOWUAZvmb" title="Contractual term in years"><span style="-sec-ix-hidden: xdx2ixbrl3392">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--DebtSecuritiesTradingMeasurementTerm_dtY_c20210101__20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvQnPLvlbEzk" title="Contractual term in years">0.76</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">         <span id="xdx_90C_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uUSDPShares_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zf5WVh1KrDR6" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3396">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uUSDPShares_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcsGgxsBRcg3" title="Measurement input">0.15</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A8_ziwK7hAdNzth" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We assumed dividend yield rate is <span id="xdx_905_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zMGOiU9WL8V6" title="Debt securities, trading, measurement input">0.00</span>% in Sharing Services. The volatility is based on the historical volatility of the Sharing Services’ common stock. Risk-free interest rates were obtained from U.S. Treasury rates for the applicable periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in the observable input values would likely cause material changes in the fair value of the Company’s Level 3 financial instruments. A significant increase (decrease) in this likelihood would result in a higher (lower) fair value measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_hus-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zfIChM0C6Vg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below provides a summary of the changes in fair value which are recorded as other comprehensive income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_ze649j9XxJy3" style="display: none">SCHEDULE OF CHANGE IN FAIR VALUE</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Balance at January 1, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20220101__20220331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zQIbzPytLkej" style="width: 18%; text-align: right" title="Beginning balance">1,108,252</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20220101__20220331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zGfxpWMALLL4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(203,463</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at March 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20220401__20220630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zQ7Oy6Pm3UOf" style="text-align: right" title="Beginning balance">904,789</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20220401__20220630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zZ3v4HCgZVg9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(591</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at June 30, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20220701__20220930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zXzNWIpt9wFf" style="text-align: right" title="Beginning balance">904,198</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total gain</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20220701__20220930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zW0olso7TSD3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">49,915</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at September 30, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20220701__20220930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zqPAA8UGD5B" style="text-align: right" title="Ending balance">954,113</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Balance at January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20210331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zypMcW1sodZj" style="width: 18%; text-align: right" title="Beginning balance">66,978</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20210331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zGLqJ57Dc31l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(1,987</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at March 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210401__20210630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_ze3aQFtHYiQ" style="text-align: right" title="Beginning balance">64,991</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210401__20210630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zEHXzFSMMvOe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(35,922</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at June 30, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zYo5SudPboe5" style="text-align: right" title="Beginning balance">29,069</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zAai5pMNaEYd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(19,060</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at September 30, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zLjVFLo4K194" style="text-align: right" title="Ending balance">10,009</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A0_zwxnabGvklc1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Note was redeemed in July 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vector Com Convertible Bond</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 26, 2021, the Company invested approximately $<span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zlG7Gb51HWBe" title="Convertible debt">88,599</span> in the convertible bond of Vector Com Co., Ltd (“Vector Com”), a private company in South Korea. The interest rate is <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_z616w8uOikQ4" title="Debt instrument, interest rate, stated percentage">2</span>% per annum and maturity is <span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dc_c20210224__20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_z1CirDGmhZd9" title="Debt instrument, term">two years</span>. The conversion price is approximately $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210226__dei--LegalEntityAxis__custom--VectorComcoLtdMember_zmrkbkW1vzW3" title="Debt instrument, convertible, conversion price">21.26</span>, per common share of Vector Com. As of September 30, 2022, the management estimated that the fair value of this note remained unchanged from its initial purchase price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of AMRE, a related party private company, in conjunction with the Company lending two $<span id="xdx_90D_eus-gaap--NotesReceivableRelatedParties_iI_c20200302__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z1S9LsAO6IC3" title="Notes receivable, related parties"><span id="xdx_90B_eus-gaap--NotesReceivableRelatedParties_iI_c20211029__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zDNBoHFpcja2" title="Notes receivable, related parties">200,000</span></span> promissory notes. For further details on this transaction, refer to Note 8 - Related Party Transactions, <i>Note Receivable from a Related Party Company</i>. As of September 30, 2022 and December 31, 2021, AMRE was a private company. Based the management’s analysis, the fair value of the warrants was $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20220930__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zywUR3vxiSTi" title="Fair value of warrant"><span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_c20210101__20211231__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_zjuhVqYUuwPd" title="Fair value of warrant">0</span></span> as of December 31, 2021. All warrants were converted into common shares in March 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 17, 2020, the Company purchased <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200717__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zbdUud89g8dc" title="Number of warrant purchased">122,039,000</span> shares, approximately <span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20200717__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zhIR7p0PqRG5" title="Equity method investment, ownership percentage">9.99</span>% ownership, and <span id="xdx_906_ecustom--EquityMethodInvestmentNumberOfSharesAcquired_c20200716__20200717__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zZvcoxWKKcx1" title="Equity method investment number of shares acquired">1,220,390,000</span> warrants with an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200717__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zCL9w3bsQ2za" title="Class of warrant or right, exercise price of warrants or rights">0.0001</span> per share, from <span style="background-color: white">APM</span>, for an aggregated purchase price of $<span id="xdx_90E_eus-gaap--PaymentsToAcquireEquitySecuritiesFvNi_c20200716__20200717__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zDk1qV1jDD3a" title="Purchase of Investment Securities">122,039</span>. During 2021, the Company exercised <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20210101__20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zm19zfTFX2Gl" title="Number of warants exercised">232,000,000</span> of the warrants to purchase <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zntGDIlwuZHe" title="Number of warrant purchased">232,000,000</span> shares of <span style="background-color: white">APM</span> for the total consideration of $<span id="xdx_903_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesConsideration_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zYCG4PzNrrI5" title="Total consideration">232,000</span>, leaving the balance of outstanding warrants of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20211231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_zgUpTb3ECxoa" title="Warrant outstanding">988,390,000</span> at December 31, 2021. The Company did not exercise any warrants during nine months ended September 30, 2022. We value APB warrants under level 3 category through a Black Scholes option pricing model and the fair value of the warrants from <span style="background-color: white">APM</span> was $<span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20220930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_znA1IinuCIXe" title="Warrants and rights outstanding">517,965</span> as of September 30, 2022 and $<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AmericanPremiumMiningCorporationMember_z8hpn8rdQdKg" title="Fair value of warrants">1,009,854</span> as of December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--InvestmentTypeAxis__custom--APWWarrantsMember_zevPCs4IlUcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the <span style="background-color: white">APM</span> warrants under level 3 category as of September 30, 2022 and December 31, 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z7ZR6PFgQYn5" style="display: none">SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220930_zFL7phWnbcje" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20211231_zk88CCHdIRBi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z86wcdO1HEvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Stock Price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.0011</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.0022</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbAua87S68E9" style="vertical-align: bottom; background-color: White"> <td>Exercise price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd4maZPFTph3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.94</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.48</td><td style="text-align: left">%</td></tr> <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTNbjR89YUfc" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">167.9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186.5</td><td style="text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSXv956apQFe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Annualized volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">167.9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186.5</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zr406Q9x76md" title="Warrants and rights outstanding, term">7.81</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztnmfNwLQfn4" title="Warrants and rights outstanding, term">8.58</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AC_z6qdvehgOZIh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zm5UWTpXoiV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the condensed consolidated balance sheet as of September 30, 2022 and December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zHB7C5R1LXO5" style="display: none">SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurement Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Investment Securities- Fair Value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_zx2okn4Xx927" style="width: 9%; text-align: right" title="Amount at Cost">76,264,051</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_za25j6qTIRT1" style="width: 9%; text-align: right" title="Investment securities fair value option">18,184,407</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zL64sSHY0mV7" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3110">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTGiPRNlknbj" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3112">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_z3cwy2JpgCK5" style="width: 9%; text-align: right" title="Amount at Fair Value">18,184,407</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Investment Securities- Trading</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_zEOZy2fT8vyb" style="text-align: right" title="Amount at Cost">2,387,149</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMTTPDI2bEff" style="text-align: right" title="Investment securities trading">11,894,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zaDf6zVt1N75" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3120">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zHJjKPaNmAel" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3122">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_ze82KAqlBXbi" style="text-align: right" title="Amount at Fair Value">11,894,002</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible Note Receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_zGDCpQgGnI7f" style="text-align: right" title="Amount at Cost">138,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCucmvmCqnH1" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3128">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8ghllf6Ht5b" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3130">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8HqjahkSg6a" style="text-align: right" title="Convertible note receivable">88,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_zc5BEPnM2Ps6" style="text-align: right" title="Amount at Fair Value">88,599</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants - American Premium Mining</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--Investments_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zgKzkXahSTEj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount at Cost">696,791</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zoYwJZpRWHpg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3138">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zIuDrqKLINl7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zh41A4arEft3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants american premium water">517,965</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zhLzwrilRp8b" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount at Fair Value">517,965</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Investments_iI_c20220930_zxwlMyoOmUDi" style="text-align: right" title="Total investment in securities at cost">79,486,590</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgSY1SLUUJs6" style="text-align: right" title="Total">30,078,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4ootrtVpE9h" style="text-align: right" title="Total"><span style="-sec-ix-hidden: xdx2ixbrl3150">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zyNHTxBlD7ue" style="text-align: right" title="Total">606,564</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_iI_c20220930_z40RuKpbDjVi" style="text-align: right" title="Amount at Fair Value">30,684,973</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total Investment in securities at Fair Value</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--InvestmentAtFairValue_iI_c20220930_ztb5rHFzrQx6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total investment in securities at fair value">30,684,973</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurement Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Amount at</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">December 31, 2021</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Investment Securities- Fair Value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_zu7USrmMo4v4" style="width: 9%; text-align: right" title="Investment securities fair value option">72,000,301</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zFxV5fgll4f4" style="width: 9%; text-align: right" title="Investment securities fair value option">25,320,694</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQs9e46TgUoe" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3162">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOp5rEpAoVd" style="width: 9%; text-align: right" title="Investment securities fair value option"><span style="-sec-ix-hidden: xdx2ixbrl3164">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentSecuritiesFairValueMember_z6hWQbG8p2Gc" style="width: 9%; text-align: right" title="Amount at Fair Value">25,320,694</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Investment Securities- Trading</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_zzCHkdbIq1O1" style="text-align: right" title="Investment securities trading">9,809,778</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zjv0hUicNVX5" style="text-align: right" title="Investment securities trading">9,908,077</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zhxcJt6nOcJj" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3172">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfMMrcwQhlHd" style="text-align: right" title="Investment securities trading"><span style="-sec-ix-hidden: xdx2ixbrl3174">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__custom--InvestmentsSecuritiesTradingMember_zKyh52aOWtc1" style="text-align: right" title="mount at Fair Value">9,908,077</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible Note Receivable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_ze8ImeAtQxK4" style="text-align: right" title="Convertible note receivable">138,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWKBI9SqeuOf" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3180">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQqZ4SFgdnd9" style="text-align: right" title="Convertible note receivable"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zakSbwFIzHBb" style="text-align: right" title="Convertible note receivable">98,398</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--NotesReceivableMember_zvhoHXJau877" style="text-align: right" title="Amount at Fair Value">98,398</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants - American Premium Mining</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zuHa0jIqh9y1" style="text-align: right" title="Amount at Cost">696,791</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zPFmRT9Z1wab" style="text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9WqXWzr93I6" style="text-align: right" title="Warrants american premium mining"><span style="-sec-ix-hidden: xdx2ixbrl3192">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z6frWJ6Uz3I3" style="text-align: right" title="Warrants american premium water">1,009,854</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanPremiumMiningMember_zSg5QYPMt4Ud" style="text-align: right" title="Amount at Fair Value">1,009,854</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants - AMRE</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--Investments_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z8jDh2VRCHTj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3198">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zfQoVxYSo61k" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3200">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zigBnlqpOnyd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3202">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zPMEYXFOBFfh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants - AMRE"><span style="-sec-ix-hidden: xdx2ixbrl3204">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--AmericanMedicalREITIncMember_z1NgoOIJKufk" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount at Fair Value"><span style="-sec-ix-hidden: xdx2ixbrl3206">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total</td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Investments_iI_c20211231_zGeqcX5EAsq" style="text-align: right" title="Total investment in securities at cost">82,645,469</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zCNPSkFaFjRc" style="text-align: right" title="Total investment in securities at fair value">35,228,771</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zwsPDUXt4mbh" style="text-align: right" title="Total investment in securities at fair value"><span style="-sec-ix-hidden: xdx2ixbrl3212">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zr6AhGdIyNV3" style="text-align: right" title="Total investment in securities at fair value">1,108,252</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentsFairValueDisclosure_iI_c20211231_zmAXCs28dOHk" style="text-align: right" title="Total investment in securities at fair value">36,337,023</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total Investment in securities at Fair Value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p id="xdx_98E_ecustom--InvestmentAtFairValue_iI_c20211231_zxavSJ3x982b" style="font: 10pt Times New Roman, Times, Serif; margin: 0" title="Total investment in securities at fair value">36,337,023</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 76264051 18184407 18184407 2387149 11894002 11894002 138599 88599 88599 696791 517965 517965 79486590 30078409 606564 30684973 30684973 72000301 25320694 25320694 9809778 9908077 9908077 138599 98398 98398 696791 1009854 1009854 82645469 35228771 1108252 36337023 36337023 6500573 2218988 21773223 35972445 40201 56969 <p id="xdx_894_ecustom--ScheduleOfFairValueOfEquitySecurityInvestmentTableTextBlock_znhXDa2EOUXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zViImwXT9128" style="display: none">SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Market Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">9/30/2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">9/30/2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Valuation</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 26%; font-weight: bold; text-align: center">DSS (Related Party)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3y2BttLs0d7" style="width: 10%; text-align: right" title="Share price">0.256</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAE87PN9Nm7b" style="width: 10%; text-align: right" title="Shares">62,812,264</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmn5uDwvkLE2" style="width: 10%; text-align: right" title="Market value">16,079,940</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 30%; text-align: left"><span id="xdx_90B_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHtvmzTBIIW6" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">AMBS (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIyEGPb2xxP1" style="text-align: right" title="Share price">0.004</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z5HRuApNcI8d" style="text-align: right" title="Shares">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpsCGLbBXtff" style="text-align: right" title="Market value">74,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_908_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zx5TcJDfSbo8" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Holista (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3R8lqDh1Kz4" style="text-align: right" title="Share price">0.021</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zu14mkkG19J6" style="text-align: right" title="Shares">43,326,621</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3SCrYniTbT" style="text-align: right" title="Market value">923,988</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_904_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z66FFwrNbTH9" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">American Premium Mining (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJp5lAkHo4wh" style="text-align: right" title="Share price">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zLAvUBF3uPhl" style="text-align: right" title="Shares">354,039,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zaTPKtlMTJ1e" style="text-align: right" title="Market value">389,443</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_90D_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zthMBp18e9kk" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Value Exchange</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z8UGD1blb5Bl" style="text-align: right" title="Share price">0.110</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQRHdP6NLpw2" style="text-align: right" title="Shares">6,518,512</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRuw83mgUAM5" style="text-align: right" title="Market value">717,036</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_90D_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0pFQkR2Gz02" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Trading Stocks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zif01R9UfsFd" style="text-align: right" title="Market value">11,894,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_904_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIqbHX5tSdAe" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="8" style="font-weight: bold; text-align: right">Total Level 1 Equity Securities</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQ4RIL4P1kXb" style="text-align: right" title="Market value">30,078,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Nervotech</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zMcEMigUd6F5" style="text-align: right" title="Shares">1,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zXk6EBBMGMZ3" style="text-align: right" title="Market value">35,958</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_906_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zyHUnlruc6Qi" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center">Hyten Global</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zZYBKSStrGs6" style="text-align: right" title="Shares">3,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zXpghP51zPHb" style="text-align: right" title="Market value">42,562</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span id="xdx_90A_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zcrrLvvm3Us4" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Ubeauty</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_982_eus-gaap--InvestmentOwnedBalanceShares_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zccHCXrcwL69" style="padding-bottom: 1.5pt; text-align: right" title="Shares">3,600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zD14COm7yLa6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">19,609</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt"><span id="xdx_908_ecustom--FairValueMeasurementsValuationProcessDescription_c20220101__20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zz8HS3PACaYj" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="8" style="font-weight: bold; text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Equity Securities</b></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20220930_zW8KUZSvozfh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total equity securities">30,176,538</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Market Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">12/31/2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">12/31/2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Valuation</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 24%; font-weight: bold; text-align: center">DSS (Related Party)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmJTVzfulR11" style="width: 10%; text-align: right" title="Share price">0.672</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zuUM5CwYl8ge" style="width: 10%; text-align: right" title="Shares">19,888,262</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvybZhp3HCA2" style="width: 10%; text-align: right" title="Market value">13,364,912</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DocumentSecuritiesSystemsIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyzFIlHYcuD2" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">AMBS (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcJrFZ9EJ4c2" style="text-align: right" title="Share price">0.016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zUyE36zhwnXi" style="text-align: right" title="Shares">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0nuF6aa2wil" style="text-align: right" title="Market value">328,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmarantusBioScienceHoldingsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zEl5XNLwnJZe" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Holista (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMmjliZe5Dti" style="text-align: right" title="Share price">0.034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZyHRN466udk" style="text-align: right" title="Shares">43,626,621</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgYqPAOxqfLk" style="text-align: right" title="Market value">1,489,179</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HolistaCollTechLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztJH88zL9Shd" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">American Premium Mining (Related Party)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6YiO0NJw7Z5" style="text-align: right" title="Share price">0.002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z7S0wIcQUdQ1" style="text-align: right" title="Shares">354,039,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zeNsbOeqsLp2" style="text-align: right" title="Market value">778,886</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AmericanPremiumMiningMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvrWaqgj3Kal" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">True Partner</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2HBFu71Lym2" style="text-align: right" title="Share price">0.119</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyBMnXCkxYKh" style="text-align: right" title="Shares">62,122,908</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zRy29OHgR1eg" style="text-align: right" title="Market value">7,409,717</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TruePartnerCapitalHoldingLimitedMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpidYkYMXOtj" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Value Exchange</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1sa6FUEfcE2" style="text-align: right" title="Share price">0.300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zw4L5xei1PRa" style="text-align: right" title="Shares">6,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zx8rnYcVRUUk" style="text-align: right" title="Market value">1,950,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ValueExchangeInternationalIncMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvc8zPs451ce" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Trading Stocks</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zX04XMOlHTg5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">9,908,077</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TradingStocksMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zF3b3XXhLtC4" title="Fair value measurements, valuation processes, description">Investment in Securities at Fair Value</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="8" style="font-weight: bold; text-align: right; padding-bottom: 1.5pt; padding-left: 10pt"><p style="margin-top: 0; margin-bottom: 0">Total Level 1 Equity</p> <p style="margin-top: 0; margin-bottom: 0">Securities</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZqxHwH2Tt51" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">35,228,771</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center">Nervotech</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_ztcpmfudwD42" style="text-align: right" title="Shares">1,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zfZ6rYGPk3Q7" style="text-align: right" title="Market value">37,045</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NervotecPteLtdMember_zMZ2LQryE9zi" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: center">Hyten Global</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_ztttYdSsX0Xh" style="text-align: right" title="Shares">3,800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zGuJZFg2h5J1" style="text-align: right" title="Market value">42,562</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HytenGlobalMember_zQRtDNeysdP7" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Ubeauty</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td id="xdx_985_eus-gaap--InvestmentOwnedBalanceShares_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zblS6xZgMNZh" style="padding-bottom: 1.5pt; text-align: right" title="Shares">3,600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_zSINM19qdZQ8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Market value">19,609</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--FairValueMeasurementsValuationProcessDescription_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--UBeautyLimitedMember_ztx7Dryq4Yzb" title="Fair value measurements, valuation processes, description">Investment in Securities at Cost</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="8" style="text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Equity Securities</b></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--InvestmentOwnedAtFairValue_iI_c20211231_zjSSF5ixotg9" style="border-bottom: Black 2.5pt double; text-align: right" title="Total equity securities">35,327,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: center"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0.256 62812264 16079940 Investment in Securities at Fair Value 0.004 20000000 74000 Investment in Securities at Fair Value 0.021 43326621 923988 Investment in Securities at Fair Value 0.001 354039000 389443 Investment in Securities at Fair Value 0.110 6518512 717036 Investment in Securities at Fair Value 11894002 Investment in Securities at Fair Value 30078409 1666 35958 Investment in Securities at Cost 3800 42562 Investment in Securities at Cost 3600 19609 Investment in Securities at Cost 30176538 0.672 19888262 13364912 Investment in Securities at Fair Value 0.016 20000000 328000 Investment in Securities at Fair Value 0.034 43626621 1489179 Investment in Securities at Fair Value 0.002 354039000 778886 Investment in Securities at Fair Value 0.119 62122908 7409717 Investment in Securities at Fair Value 0.300 6500000 1950000 Investment in Securities at Fair Value 9908077 Investment in Securities at Fair Value 35228771 1666 37045 Investment in Securities at Cost 3800 42562 Investment in Securities at Cost 3600 19609 Investment in Securities at Cost 35327987 42575 6570170 <p id="xdx_897_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zzJjhYU6LvUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Sharing Services Convertible Note under level 3 category as of December 31, 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zsqXUa3PsRH4" style="display: none">SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Dividend yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_901_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1Zzf298Qc01" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3380">-</span></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_908_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z375uSfeSDK2" title="Measurement input">0.00</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zxwbs2qBf9v6" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3384">-</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdfG6b05LJn1" title="Measurement input">138.85</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zX2noI3yadD" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3388">-</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uPure_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOsWNg5JT61k" title="Measurement input">3.25</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Contractual term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--DebtSecuritiesTradingMeasurementTerm_dtY_c20220101__20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYmpOWUAZvmb" title="Contractual term in years"><span style="-sec-ix-hidden: xdx2ixbrl3392">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--DebtSecuritiesTradingMeasurementTerm_dtY_c20210101__20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvQnPLvlbEzk" title="Contractual term in years">0.76</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">         <span id="xdx_90C_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uUSDPShares_c20220930__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zf5WVh1KrDR6" title="Measurement input"><span style="-sec-ix-hidden: xdx2ixbrl3396">-</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--DebtSecuritiesTradingMeasurementInput_iI_pid_uUSDPShares_c20211231__dei--LegalEntityAxis__custom--SharingServicesIncMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcsGgxsBRcg3" title="Measurement input">0.15</span></td><td style="text-align: left"> </td></tr> </table> 0.00 138.85 3.25 P0Y9M3D 0.15 0.00 <p id="xdx_89A_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_hus-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zfIChM0C6Vg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below provides a summary of the changes in fair value which are recorded as other comprehensive income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2022 and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_ze649j9XxJy3" style="display: none">SCHEDULE OF CHANGE IN FAIR VALUE</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Balance at January 1, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20220101__20220331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zQIbzPytLkej" style="width: 18%; text-align: right" title="Beginning balance">1,108,252</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20220101__20220331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zGfxpWMALLL4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(203,463</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at March 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20220401__20220630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zQ7Oy6Pm3UOf" style="text-align: right" title="Beginning balance">904,789</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20220401__20220630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zZ3v4HCgZVg9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(591</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at June 30, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20220701__20220930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zXzNWIpt9wFf" style="text-align: right" title="Beginning balance">904,198</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total gain</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20220701__20220930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zW0olso7TSD3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">49,915</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at September 30, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20220701__20220930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zqPAA8UGD5B" style="text-align: right" title="Ending balance">954,113</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: justify">Balance at January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20210331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zypMcW1sodZj" style="width: 18%; text-align: right" title="Beginning balance">66,978</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20210331__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zGLqJ57Dc31l" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(1,987</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at March 31, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210401__20210630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_ze3aQFtHYiQ" style="text-align: right" title="Beginning balance">64,991</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210401__20210630__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zEHXzFSMMvOe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(35,922</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at June 30, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zYo5SudPboe5" style="text-align: right" title="Beginning balance">29,069</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Total losses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zAai5pMNaEYd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total losses">(19,060</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at September 30, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210701__20210930__us-gaap--InvestmentTypeAxis__custom--SharingServicesConvertibleNoteMember_zLjVFLo4K194" style="text-align: right" title="Ending balance">10,009</td><td style="text-align: left"> </td></tr> </table> 1108252 -203463 904789 -591 904198 49915 954113 66978 -1987 64991 -35922 29069 -19060 10009 88599 0.02 P2Y 21.26 200000 200000 0 0 122039000 0.0999 1220390000 0.0001 122039 232000000 232000000 232000 988390000 517965 1009854 <p id="xdx_897_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--InvestmentTypeAxis__custom--APWWarrantsMember_zevPCs4IlUcd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the <span style="background-color: white">APM</span> warrants under level 3 category as of September 30, 2022 and December 31, 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z7ZR6PFgQYn5" style="display: none">SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220930_zFL7phWnbcje" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20211231_zk88CCHdIRBi" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z86wcdO1HEvh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Stock Price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.0011</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.0022</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbAua87S68E9" style="vertical-align: bottom; background-color: White"> <td>Exercise price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.001</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zd4maZPFTph3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.94</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.48</td><td style="text-align: left">%</td></tr> <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zTNbjR89YUfc" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">167.9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186.5</td><td style="text-align: left">%</td></tr> <tr id="xdx_403_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_hus-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zSXv956apQFe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Annualized volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">167.9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">186.5</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year to maturity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20220930__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zr406Q9x76md" title="Warrants and rights outstanding, term">7.81</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztnmfNwLQfn4" title="Warrants and rights outstanding, term">8.58</span></td><td style="text-align: left"> </td></tr> </table> 0.0011 0.0022 0.001 0.001 3.94 1.48 167.9 186.5 167.9 186.5 P7Y9M21D P8Y6M29D <p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zsPFFaKS5WJ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_827_z9rmJ39Y52Nj">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lots Sales Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 23, 2015, SeD Maryland Development LLC completed the $<span id="xdx_908_eus-gaap--PaymentsToAcquireRealEstate_c20151122__20151123__us-gaap--TypeOfArrangementAxis__custom--LotsSalesAgreementMember__srt--OwnershipAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--BusinessAcquisitionAxis__custom--BallengerRunMember_zQ8nrSUWONad" title="Payments to Acquire Real Estate">15,700,000</span> acquisition of Ballenger Run, a <span id="xdx_907_eus-gaap--AreaOfLand_iI_pid_uAcre_c20151123__us-gaap--TypeOfArrangementAxis__custom--LotsSalesAgreementMember__srt--OwnershipAxis__custom--SeDMarylandDevelopmentLLCMember__us-gaap--BusinessAcquisitionAxis__custom--BallengerRunMember_zkKd4OIbA2M5" title="Area of land">197</span>-acre land sub-division development located in Frederick County, Maryland. Previously, on May 28, 2014, the RBG Family, LLC entered into a $<span id="xdx_907_eus-gaap--PaymentsToAcquireRealEstate_c20140527__20140528__us-gaap--TypeOfArrangementAxis__custom--LotsSalesAgreementMember__srt--OwnershipAxis__custom--RBGFamilyLLCMember__us-gaap--BusinessAcquisitionAxis__custom--BallengerRunMember_zML6ikAIIvwg" title="Payments to Acquire Real Estate">15,000,000</span> assignable real estate sales contract with NVR, by which RBG Family, LLC would facilitate the sale of the <span id="xdx_907_eus-gaap--AreaOfLand_iI_pid_uAcre_c20140528__us-gaap--TypeOfArrangementAxis__custom--LotsSalesAgreementMember__srt--OwnershipAxis__custom--RBGFamilyLLCMember__us-gaap--BusinessAcquisitionAxis__custom--BallengerRunMember_zrtk06xKi9xh" title="Area of land">197</span> acres of Ballenger Run to NVR. On December 10, 2014, NVR assigned this contract to SeD Maryland Development, LLC through execution of an assignment and assumption agreement and entered into a series of lot purchase agreements by which NVR would purchase 443 subdivided residential lots from SeD Maryland Development, LLC. <span id="xdx_904_ecustom--DescriptionOfRealEstateImprovements_c20181230__20181231__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zlzsr1ZZlRug" title="Description of real estate improvements">On December 31, 2018, SeD Maryland entered into the Third Amendment to the Lot Purchase Agreement for Ballenger Run with NVR. Pursuant to the Third Amendment, SeD Maryland will convert the 5.9 acre CCRC parcel to 36 lots (the 28 feet wide villa lot) and sell to NVR. SeD Maryland pursued the required zoning approval to change the number of such lots from 85 to 121, which was approved in July 2019. Subsequently, SeD Maryland Development signed Fourth Amendment to the Lot Purchase Agreement, pursuant to which NVR agreed to purchase all of the new 121 lots</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended on September 30, 2022 and 2021, NVR purchased <span id="xdx_906_ecustom--PurchaseOfLandLots_pid_uAcre_c20220701__20220930__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zm5MT7xZknC5" title="Purchase of land lots">0</span> and <span id="xdx_905_ecustom--PurchaseOfLandLots_pid_uAcre_c20210701__20210930__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zqmMHe8mpO6c" title="Purchase of land lots">18</span> lots, respectively. During the nine months ended on September 30, 2022 and 2021, NVR purchased <span id="xdx_904_ecustom--PurchaseOfLandLots_pid_uAcre_c20220101__20220930__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zEjjDu3rCIn4" title="Purchase of land lots">3</span> and <span id="xdx_907_ecustom--PurchaseOfLandLots_pid_uAcre_c20210101__20210930__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zmo4FBHWbr71" title="Purchase of land lots">76</span> lots, respectively. Through September 30, 2022 and December 31, 2021, NVR had purchased a total of <span id="xdx_906_ecustom--PurchaseOfLandLots_pid_uAcre_c20220701__20220930__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementOneMember_zZLlo8CWcwNg" title="Purchase of land lots">3</span> and <span id="xdx_905_ecustom--PurchaseOfLandLots_pid_uAcre_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementOneMember_z65Ltis7mN74" title="Purchase of land lots">476</span> lots, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain arrangements for the sale of buildable lots to NVR require the Company to credit NVR with an amount equal to one year of the FFB assessment. Under ASC 606, the credits to NVR are not in exchange for a distinct good or service and accordingly, the amount of the credit was recognized as the reduction of revenue. As of </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September <span style="background-color: white">30, 2022 and December 31, 2021, the accrued balance due to NVR was $</span><span id="xdx_903_eus-gaap--DebtAndCapitalLeaseObligations_iI_pid_uUSD_c20220930__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zs0RGTCUT3J5" title="Accrued balance">189,475</span> <span style="background-color: white">and $</span><span id="xdx_90B_eus-gaap--DebtAndCapitalLeaseObligations_iI_pid_uUSD_c20211231__us-gaap--TypeOfArrangementAxis__custom--LotPurchaseAgreementMember_zi75rZRVIzFb" title="Accrued balance">188,125</span><span style="background-color: white">, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases offices in Bethesda, Maryland, Magnolia, Texas, Singapore, Hong Kong and South Korea through leased spaces aggregating approximately <span id="xdx_90A_eus-gaap--AreaOfLand_iI_usqft_c20220930_zlUlkooI4yyd" title="Area of land">15,811</span> square feet, under leases expiring on various dates from October 2022 to August 2025. The leases have rental rates ranging from $<span id="xdx_901_eus-gaap--PaymentsForRent_c20220101__20220930__srt--RangeAxis__srt--MinimumMember_z1YGDGkwkH54" title="Payments for rent">2,300</span> to $<span id="xdx_909_eus-gaap--PaymentsForRent_c20220101__20220930__srt--RangeAxis__srt--MaximumMember_zKVCZh528OTh" title="Payments for rent">23,020</span> per month. Our total rent expense under these office leases was $<span id="xdx_903_eus-gaap--LeaseAndRentalExpense_c20220701__20220930_zBUIJ4CTd6Vd" title="Operating leases, rent expense">179,094</span> and $<span id="xdx_901_eus-gaap--LeaseAndRentalExpense_c20210701__20210930_zQjdqXRDBlO8" title="Operating leases, rent expense">140,685</span> in the three months ended September 30, 2022 and 2021, respectively. Our total rent expense under these office leases was $<span id="xdx_90A_eus-gaap--LeaseAndRentalExpense_c20220101__20220930_zWcd8hb1Xhui" title="Operating leases, rent expense">492,034</span> and $<span id="xdx_90F_eus-gaap--LeaseAndRentalExpense_c20210101__20210930_zp30n6ai4sVb" title="Operating leases, rent expense">405,677</span> in the nine months ended September 30, 2022 and 2021, respectively. The following table outlines the details of lease terms:</span></p> <p id="xdx_89B_ecustom--ScheduleOfOperatingAndRenewedLeaseTermsRental_zy7mRQxkjkT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zsuMPsE0QUr5" style="display: none">SCHEDULE OF OPERATING AND RENEWED LEASE TERMS RENTAL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office Location</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Term as of December 31, 2021</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore - AI</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--SG_zZsYs8WZBn3i" title="Lessee, operating lease, description">June 2022 to May 2023</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore – F&amp;B</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--SGFandBMember_zEn18UjBf0t7" title="Lessee, operating lease, description">October 2021 to October 2024</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore – Four Seasons Park</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--SingaporeFourSeasonsParkMember_zLsMnaRzd4G2" title="Lessee, operating lease, description">July 2022 to July 2024</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Kong</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--HK_zO6GxTnlYqIe" title="Lessee, operating lease, description">October 2020 to October 2022</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">South Korea</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--KRWMember_zmlrEeigfiBd" title="Lessee, operating lease, description">August 2022 to August 2025</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magnolia, Texas</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--TXMember_zB1TFFZ05pR2" title="Lessee, operating lease, description">May 2022 - on month to month basis</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bethesda, Maryland</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__stpr--MD_zWb6930fLWJ" title="Lessee, operating lease, description">January 2021 to March 2024</span></span></td></tr> </table> <p id="xdx_8AE_z2f504HSwY2b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company adopted ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) to recognize a right-of-use asset and a lease liability for all the leases with terms greater than twelve months. We elected the practical expedient to not recognize operating lease right-of-use assets and operating lease liabilities for lease agreements with terms less than 12 months. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. <span id="xdx_903_eus-gaap--LesseeOperatingLeaseDescription_c20220101__20220930_z6knQ96nBp12" title="Lessee, operating lease, description">As our leases do not provide a readily determinable implicit rates, we estimate our incremental borrowing rates to discount the lease payments based on information available at lease commencement. Our incremental borrowings rates are 3.9% in 2022 and 2021, which were used as the discount rates</span>. The balances of operating lease right-of-use assets and operating lease liabilities as of September 30, 2022 were $<span id="xdx_904_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20220930_z936uj5r4kH3" title="Operating lease, right-of-use asset">1,265,171</span> and $<span id="xdx_90D_eus-gaap--OperatingLeaseLiability_iI_c20220930_zs2PmWqNGY66" title="Operating lease, liability">1,278,157</span> respectively. The balances of operating lease right-of-use assets and operating lease liabilities as of December 31, 2021 were $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20211231_zi5PNRl3tIB4" title="Operating lease, right-of-use asset">659,620</span> and $<span id="xdx_902_eus-gaap--OperatingLeaseLiability_iI_c20211231_ztlD8Xv99gV5" title="Operating lease, liability">667,343</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQPkMdFSCf1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below summarizes future payments due under these leases as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended September 30:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z25DpVm31SU8" style="display: none">SCHEDULE OF LEASE PAYMENTS</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20220930_zN9LdNfgiZo9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPz2pt_zjgyNmlYMhj9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">645,572</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPz2pt_zKpqVwYucXIh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">516,273</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPz2pt_zhGyulZeMxY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,807</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPz2pt_z3zKkTQ5LKtc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Minimum Lease Payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,396,652</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zxesrr23WAd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Effect of Discounting</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(118,495</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zydoCV49DA22" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Present Value of Future Minimum Lease Payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,278,157</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_zYoNAQ3mYmO" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Current Obligations under Leases</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(619,355</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zKJfEqBlaNVi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term Lease Obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">658,802</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zlkyduicp4ll" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 15700000 197 15000000 197 On December 31, 2018, SeD Maryland entered into the Third Amendment to the Lot Purchase Agreement for Ballenger Run with NVR. Pursuant to the Third Amendment, SeD Maryland will convert the 5.9 acre CCRC parcel to 36 lots (the 28 feet wide villa lot) and sell to NVR. SeD Maryland pursued the required zoning approval to change the number of such lots from 85 to 121, which was approved in July 2019. Subsequently, SeD Maryland Development signed Fourth Amendment to the Lot Purchase Agreement, pursuant to which NVR agreed to purchase all of the new 121 lots 0 18 3 76 3 476 189475 188125 15811 2300 23020 179094 140685 492034 405677 <p id="xdx_89B_ecustom--ScheduleOfOperatingAndRenewedLeaseTermsRental_zy7mRQxkjkT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zsuMPsE0QUr5" style="display: none">SCHEDULE OF OPERATING AND RENEWED LEASE TERMS RENTAL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office Location</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Term as of December 31, 2021</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore - AI</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--SG_zZsYs8WZBn3i" title="Lessee, operating lease, description">June 2022 to May 2023</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore – F&amp;B</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--SGFandBMember_zEn18UjBf0t7" title="Lessee, operating lease, description">October 2021 to October 2024</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore – Four Seasons Park</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--SingaporeFourSeasonsParkMember_zLsMnaRzd4G2" title="Lessee, operating lease, description">July 2022 to July 2024</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Kong</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__country--HK_zO6GxTnlYqIe" title="Lessee, operating lease, description">October 2020 to October 2022</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">South Korea</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--KRWMember_zmlrEeigfiBd" title="Lessee, operating lease, description">August 2022 to August 2025</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magnolia, Texas</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__custom--TXMember_zB1TFFZ05pR2" title="Lessee, operating lease, description">May 2022 - on month to month basis</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bethesda, Maryland</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20211231__srt--StatementGeographicalAxis__stpr--MD_zWb6930fLWJ" title="Lessee, operating lease, description">January 2021 to March 2024</span></span></td></tr> </table> June 2022 to May 2023 October 2021 to October 2024 July 2022 to July 2024 October 2020 to October 2022 August 2022 to August 2025 May 2022 - on month to month basis January 2021 to March 2024 As our leases do not provide a readily determinable implicit rates, we estimate our incremental borrowing rates to discount the lease payments based on information available at lease commencement. Our incremental borrowings rates are 3.9% in 2022 and 2021, which were used as the discount rates 1265171 1278157 659620 667343 <p id="xdx_892_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQPkMdFSCf1c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below summarizes future payments due under these leases as of September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended September 30:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z25DpVm31SU8" style="display: none">SCHEDULE OF LEASE PAYMENTS</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20220930_zN9LdNfgiZo9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPz2pt_zjgyNmlYMhj9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">645,572</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPz2pt_zKpqVwYucXIh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">516,273</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPz2pt_zhGyulZeMxY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,807</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPz2pt_z3zKkTQ5LKtc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Minimum Lease Payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,396,652</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_zxesrr23WAd1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Effect of Discounting</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(118,495</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zydoCV49DA22" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Present Value of Future Minimum Lease Payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,278,157</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_di_zYoNAQ3mYmO" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Current Obligations under Leases</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(619,355</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zKJfEqBlaNVi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long-term Lease Obligations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">658,802</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 645572 516273 234807 1396652 118495 1278157 619355 658802 <p id="xdx_80C_eus-gaap--DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_zKJ4LXciBns8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.<span id="xdx_82F_zq4Wuxhm9XW2"> DIRECTORS AND EMPLOYEES’ BENEFITS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock Option plans AEI</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company previously reserved <span id="xdx_90D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20220930__us-gaap--PlanNameAxis__custom--IncentiveCompensationPlanMember_zU1476ZoXFPd" title="Capital shares reserved for future issuance">500,000</span> shares of common stock under the Incentive Compensation Plan for high-quality executives and other employees, officers, directors, consultants and other persons who provide services to the Company or its related entities. This plan is meant to enable such persons to acquire or increase a proprietary interest in the Company in order to strengthen the mutuality of interests between such persons and the Company’s shareholders, and providing such persons with performance incentives to expand their maximum efforts in the creation of shareholder value. As of September 30, 2022 and December 31, 2021, there have been no options granted. The reservation of shares under the Incentive Compensation Plan was cancelled in May of 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Alset International Stock Option plans</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 20, 2013, Alset International approved a Stock Option Plan (the “2013 Plan”). Employees, executive directors, and non-executive directors (including the independent directors) are eligible to participate in the 2013 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zFvEeSbFf7Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize stock option activity under the 2013 Plan for the nine months ended September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z5rLllKigv99" style="display: none">SCHEDULE OF OPTION ACTIVITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options for Common Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Remaining Contractual Term (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding as of January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zbJaSNwFz834" style="width: 10%; text-align: right" title="Options for common shares, Outstanding at beginning">1,061,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_z3CngUs1pkWa" style="width: 10%; text-align: right" title="Exercise price, vested and exercisable at beginning">0.09</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z0STKwhlBHCe" title="Remaining contractual term, outstanding at beginning">3.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20211231_zDUbdcbEMTwb" style="width: 10%; text-align: right" title="Aggregate intrinsic value, outstanding at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3589">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vested and exercisable at January 1, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iS_c20210101__20211231_zSmk30t5v7Kc" style="text-align: right" title="Options for common shares, vested and exercisable at beginning">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iS_c20210101__20211231_zX8bpK3rv294" style="text-align: right" title="Exercise price, outstanding at beginning">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_z9FaRsTZoxu2" title="Remaining contractual term, vested and exercisable at beginning">3.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_c20210101__20211231_zkXb9bEcjo77" style="text-align: right" title="Aggregate Intrinsic Value, vested and exercisable at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231_zw5nRdNYErCa" style="text-align: right" title="Options for common shares, granted"><span style="-sec-ix-hidden: xdx2ixbrl3599">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zadeBW2xKOyh" style="text-align: right" title="Exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl3601">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231_zx4lIVRK3gpk" style="text-align: right" title="Options for common shares, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3603">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zLqWe83wlVfe" style="text-align: right" title="Exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3605">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited, cancelled, expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20210101__20211231_z0vc42NYJsv9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Options for common shares, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3607">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zR9XMjrrcXf4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3609">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding as of December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220930_z0DECLUaiKv5" style="text-align: right" title="Options for common shares, oustanding at beginning">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220930_za1Q6vntZv3f" style="text-align: right" title="Exercise price, vested and exercisable at beginning">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220930_zIeGdlClmUm" title="Remaining contractual term, outstanding at beginning">2.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20220930_z3Fp3tfe8EPa" style="text-align: right" title="Aggregate Intrinsic Value, outstanding at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3617">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested and exercisable at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iS_c20220101__20220930_zcy885qjR21k" style="text-align: right" title="Options for common shares, vested and exercisable at beginning">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iS_c20220101__20220930_zMxpEPyogSS2" style="text-align: right" title="Exercise price, outstanding at beginning">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220930_zepxTeJtngyd" title="Remaining contractual term,vested and exercisable at beginning">2.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_pp0p0_c20220101__20220930_zlYEDvPZFMyl" style="text-align: right" title="Aggregate Intrinsic Value, vested and exercisable at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3625">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220930_zaaMxSklohOc" style="text-align: right" title="Options for common shares, granted"><span style="-sec-ix-hidden: xdx2ixbrl3627">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220930_zXzSUc87Sqn2" style="text-align: right" title="Exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl3629">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220930_z8wDwq9DytN3" style="text-align: right" title="Options for common shares, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3631">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220930_zOD1Nu632kXf" style="text-align: right" title="Exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3633">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Forfeited, cancelled, expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20220101__20220930_zy6h9enTvkJ8" style="text-align: right" title="Options for common shares, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3635">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220930_zcP6HwvO1dD1" style="text-align: right" title="Exercise price, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3637">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding as of September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220930_zZNuuAmnLhb1" style="text-align: right" title="Options for common shares, outstanding at ending">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220930_zrdarS60nlwj" style="text-align: right" title="Exercise price, vested and exercisable at ending">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220930_zRmWZCg5JUSk" title="Remaining contractual term, outstanding ending">1.25</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20220930_zUeXMsrSxxhk" style="text-align: right" title="Aggregate Intrinsic Value, outstanding at ending"><span style="-sec-ix-hidden: xdx2ixbrl3645">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vested and exercisable at September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20220101__20220930_zqkpY8lb5xV9" style="text-align: right" title="Options for common shares, vested and exercisable at ending">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20220101__20220930_zXesdwSABQod" style="text-align: right" title="Exercise price, vested and exercisable at end">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm_dtY_c20220101__20220930_zL7w0FJVpLK3" title="Remaining contractual term, vested and exercisable at ending">1.25</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20220101__20220930_z73KrOnSfX7a" style="text-align: right" title="Aggregate Intrinsic Value, vested and exercisable at ending">      <span style="-sec-ix-hidden: xdx2ixbrl3653">-</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zwBVlqkOrhWg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 500000 <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zFvEeSbFf7Bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables summarize stock option activity under the 2013 Plan for the nine months ended September 30, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_z5rLllKigv99" style="display: none">SCHEDULE OF OPTION ACTIVITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options for Common Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Remaining Contractual Term (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%">Outstanding as of January 1, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zbJaSNwFz834" style="width: 10%; text-align: right" title="Options for common shares, Outstanding at beginning">1,061,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_z3CngUs1pkWa" style="width: 10%; text-align: right" title="Exercise price, vested and exercisable at beginning">0.09</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_z0STKwhlBHCe" title="Remaining contractual term, outstanding at beginning">3.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20210101__20211231_zDUbdcbEMTwb" style="width: 10%; text-align: right" title="Aggregate intrinsic value, outstanding at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3589">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vested and exercisable at January 1, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iS_c20210101__20211231_zSmk30t5v7Kc" style="text-align: right" title="Options for common shares, vested and exercisable at beginning">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iS_c20210101__20211231_zX8bpK3rv294" style="text-align: right" title="Exercise price, outstanding at beginning">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_z9FaRsTZoxu2" title="Remaining contractual term, vested and exercisable at beginning">3.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_c20210101__20211231_zkXb9bEcjo77" style="text-align: right" title="Aggregate Intrinsic Value, vested and exercisable at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231_zw5nRdNYErCa" style="text-align: right" title="Options for common shares, granted"><span style="-sec-ix-hidden: xdx2ixbrl3599">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zadeBW2xKOyh" style="text-align: right" title="Exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl3601">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231_zx4lIVRK3gpk" style="text-align: right" title="Options for common shares, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3603">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zLqWe83wlVfe" style="text-align: right" title="Exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3605">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Forfeited, cancelled, expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20210101__20211231_z0vc42NYJsv9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Options for common shares, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3607">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zR9XMjrrcXf4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3609">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding as of December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220930_z0DECLUaiKv5" style="text-align: right" title="Options for common shares, oustanding at beginning">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220930_za1Q6vntZv3f" style="text-align: right" title="Exercise price, vested and exercisable at beginning">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220930_zIeGdlClmUm" title="Remaining contractual term, outstanding at beginning">2.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20220101__20220930_z3Fp3tfe8EPa" style="text-align: right" title="Aggregate Intrinsic Value, outstanding at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3617">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Vested and exercisable at December 31, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iS_c20220101__20220930_zcy885qjR21k" style="text-align: right" title="Options for common shares, vested and exercisable at beginning">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iS_c20220101__20220930_zMxpEPyogSS2" style="text-align: right" title="Exercise price, outstanding at beginning">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220930_zepxTeJtngyd" title="Remaining contractual term,vested and exercisable at beginning">2.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_pp0p0_c20220101__20220930_zlYEDvPZFMyl" style="text-align: right" title="Aggregate Intrinsic Value, vested and exercisable at beginning"><span style="-sec-ix-hidden: xdx2ixbrl3625">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220930_zaaMxSklohOc" style="text-align: right" title="Options for common shares, granted"><span style="-sec-ix-hidden: xdx2ixbrl3627">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220930_zXzSUc87Sqn2" style="text-align: right" title="Exercise price, granted"><span style="-sec-ix-hidden: xdx2ixbrl3629">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220930_z8wDwq9DytN3" style="text-align: right" title="Options for common shares, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3631">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220930_zOD1Nu632kXf" style="text-align: right" title="Exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl3633">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Forfeited, cancelled, expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20220101__20220930_zy6h9enTvkJ8" style="text-align: right" title="Options for common shares, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3635">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20220930_zcP6HwvO1dD1" style="text-align: right" title="Exercise price, forfeited, cancelled, expired"><span style="-sec-ix-hidden: xdx2ixbrl3637">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding as of September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220930_zZNuuAmnLhb1" style="text-align: right" title="Options for common shares, outstanding at ending">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220930_zrdarS60nlwj" style="text-align: right" title="Exercise price, vested and exercisable at ending">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20220101__20220930_zRmWZCg5JUSk" title="Remaining contractual term, outstanding ending">1.25</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20220101__20220930_zUeXMsrSxxhk" style="text-align: right" title="Aggregate Intrinsic Value, outstanding at ending"><span style="-sec-ix-hidden: xdx2ixbrl3645">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Vested and exercisable at September 30, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20220101__20220930_zqkpY8lb5xV9" style="text-align: right" title="Options for common shares, vested and exercisable at ending">1,061,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20220101__20220930_zXesdwSABQod" style="text-align: right" title="Exercise price, vested and exercisable at end">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm_dtY_c20220101__20220930_zL7w0FJVpLK3" title="Remaining contractual term, vested and exercisable at ending">1.25</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20220101__20220930_z73KrOnSfX7a" style="text-align: right" title="Aggregate Intrinsic Value, vested and exercisable at ending">      <span style="-sec-ix-hidden: xdx2ixbrl3653">-</span></td><td style="text-align: left"> </td></tr> </table> 1061333 0.09 P3Y 1061333 0.09 P3Y 1061333 0.09 P2Y 1061333 0.09 P2Y 1061333 0.09 P1Y3M 1061333 0.09 P1Y3M <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zapxrBTppmE4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15. <span id="xdx_82E_zBFq5oWAZx56">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract for Sale of Black Oak Lots</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 28, 2022, 150 CCM Black Oak Ltd. (the “Seller”), a Texas Limited Partnership and an indirect, majority-owned subsidiary of the Company, entered into a Contract for Purchase and Sale and Escrow Instructions (the “Agreement”) with Century Land Holdings of Texas, LLC, a Colorado limited liability company (the “Buyer”). Pursuant to the terms of the Agreement, the Seller has agreed to sell all of the approximately 242 single-family detached residential lots comprising a residential community in the city of Magnolia, Texas known as the “Lakes at Black Oak.” The lots will be sold at a range of prices, and the Seller will also be entitled to receive a community enhancement fee for each lot sold. The aggregate purchase price and community enhancement fees are anticipated to be $<span id="xdx_900_ecustom--CommunityEnhancementFees_c20221027__20221028__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRQPCV1qom32" title="Community enhancement fees">12,881,000</span>, however, such purchase price will be adjusted accordingly, if the total number of lots increases or decreases prior to the closing of the transactions contemplated by the Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The closing of the transactions described in the Agreement depends on the satisfaction of certain conditions set forth therein. There can be no assurance that such closings will be completed on the terms outlined herein or at all. The Buyer has agreed to purchase the lots in stages, with an estimated closing date of December of 2022 for the first 132 lots to be acquired, with the remainder to be acquired through 2023. Prior to such closing dates, the Buyer shall have a thirty (30) day inspection period in which to inspect the properties and determine their suitability; during such inspection period, the Buyer may decline to proceed with the closing of these transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Seller shall be required to develop and improve the property at the Seller’s cost pursuant to certain development plans and government regulations prior to the closings described above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchase of Value Exchange International, Inc. Shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 17, 2022, the Company’s subsidiary GigWorld Inc. entered into a Stock Purchase Agreement (the “Agreement”) with Chan Heng Fai, who is the Chairman of GigWorld’s Board of Directors and our Chairman, Chief Executive Officer and largest stockholder. Pursuant to the Agreement, GigWorld bought an aggregate of <span id="xdx_901_ecustom--CommonSharesOfValueExchange_iI_c20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zLj4vb9PUmCg" title="Common shares of value exchange">7,276,163</span> shares of Value Exchange International, Inc. (“VEII”), a Nevada corporation, for the following purchase prices: (i) $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp2d_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryOneMember_zRRSERGiVKG1" title="Number of shares issued">1,733,079.12</span> for <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryOneMember_zEGYHsfdsju2" title="Number shares issued">7,221,163</span> shares, representing a price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryOneMember_zJ8DxqYlZUHb" title="Shares issued, price per share">.24</span> per share; (ii) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryTwoMember_z3jLS8X7vWQ7" title="Value of shares of stock issued">$2,314</span> for <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryTwoMember_ztNbOMTprJFa" title="Number of shares of stock issued">10,000</span> shares, representing a price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryTwoMember_z6wWY3hwzvtc" title="Shares issued, price per share">.2314</span> per share; (iii) $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryThreeMember_z1xjLY0ATvhh" title="Number of shares issued">5,015</span> for <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryThreeMember_znwVRnpCnaB9" title="Number of shares issued">25,000</span> shares, representing a price of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryThreeMember_zvVGCW83gxb5" title="Shares issued, price per share">.2006</span> per share; and (iv) $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryFourMember_zbWqbBfumJB6" title="Value of shares of stock issued">3,326</span> for <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryFourMember_zcwgKWJ7uC5c" title="Number of shares of stock issued">20,000</span> shares, representing a price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryFourMember_zzpyaLjeiMBd" title="Shares issued, price per share">.1663</span> per share. Collectively, these purchases represent an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValuePurchaseOfAssets_pp2d_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zUpgMgde29X5" title="Value of shares of stock issued">1,743,734.12</span> for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesPurchaseOfAssets_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zELfFwPou8J2" title="Number of shares of stock issued">7,276,163</span> shares of VEII. Such purchase prices were negotiated between the parties to the Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Chan and another member of GigWorld’s Board of Directors, Lum Kan Fai Vincent, are both members of the Board of Directors of VEII. In addition to Mr. Chan, two other members of our Board of Directors are also members of the Board of Directors of VEII (Mr. Wong Shui Yeung and Mr. Wong Tat Keung). Following the acquisitions of shares pursuant to the Agreement, the Company now owns a total of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20221016__20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7L44YzUV3Q2" title="Number of shares acquisitions">13,834,643</span> shares of VEII, representing <span id="xdx_904_ecustom--OwnershipPercentage_iI_pid_dp_uPure_c20221017__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQw9TXVo0TD3" title="Ownership percentage">38.3</span>% of VEII.</span></p> 12881000 7276163 1733079.12 7221163 0.24 2314 10000 0.2314 5015 25000 0.2006 3326 20000 0.1663 1743734.12 7276163 13834643 0.383 Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.